<?xml version="1.0" encoding="UTF-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-05-30" modified="2017-12-20" version="180">
<accession>P56945</accession>
<accession>B3KWD7</accession>
<accession>B4DEV4</accession>
<accession>B4DGB5</accession>
<accession>B4DIW5</accession>
<accession>B7Z7X7</accession>
<accession>E9PCL5</accession>
<accession>E9PCV2</accession>
<accession>F5GXA2</accession>
<accession>F5GXV6</accession>
<accession>F5H7Z0</accession>
<accession>F8WA69</accession>
<accession>Q6QEF7</accession>
<name>BCAR1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Breast cancer anti-estrogen resistance protein 1</fullName>
</recommendedName>
<alternativeName>
<fullName>CRK-associated substrate</fullName>
</alternativeName>
<alternativeName>
<fullName>Cas scaffolding protein family member 1</fullName>
</alternativeName>
<alternativeName>
<fullName>p130cas</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">BCAR1</name>
<name type="synonym">CAS</name>
<name type="synonym">CASS1</name>
<name type="synonym">CRKAS</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="J. Natl. Cancer Inst." volume="92" first="112" last="120">
<title>BCAR1, a human homologue of the adapter protein p130Cas, induces anti-estrogen resistance in breast cancer cells.</title>
<authorList>
<person name="Brinkman A."/>
<person name="van der Flier S."/>
<person name="Kok E.M."/>
<person name="Dorssers L.C.J."/>
</authorList>
<dbReference type="PubMed" id="10639512"/>
<dbReference type="DOI" id="10.1093/jnci/92.2.112"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT SER-76</scope>
<source>
<tissue>Mammary cancer</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1999-12" db="EMBL/GenBank/DDBJ databases">
<title>Interaction between human Crk-associated substrate (p130Cas) and nephrocystin.</title>
<authorList>
<person name="Otto E."/>
<person name="Birnbaum S."/>
<person name="Verbeek M."/>
<person name="Hildebrandt F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT SER-76</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2000-03" db="EMBL/GenBank/DDBJ databases">
<title>The effects of growth factors on tyrosine phosphorylation of p130Cas in corneal epithelial cell.</title>
<authorList>
<person name="Imoto Y."/>
<person name="Ohguro N."/>
<person name="Yoshida A."/>
<person name="Tsujikawa M."/>
<person name="Inoue Y."/>
<person name="Tano Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT SER-76</scope>
<source>
<tissue>Cornea</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2004-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Lin L."/>
<person name="Li H."/>
<person name="Zhou G."/>
<person name="Shen C."/>
<person name="Ke R."/>
<person name="Zhong G."/>
<person name="Yang S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 4; 5; 6; 7 AND 8)</scope>
<scope>VARIANT SER-76</scope>
<source>
<tissue>Amygdala</tissue>
<tissue>Caudate nucleus</tissue>
<tissue>Cerebellum</tissue>
<tissue>Hippocampus</tissue>
<tissue>Teratocarcinoma</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
<title>The sequence and analysis of duplication-rich human chromosome 16.</title>
<authorList>
<person name="Martin J."/>
<person name="Han C."/>
<person name="Gordon L.A."/>
<person name="Terry A."/>
<person name="Prabhakar S."/>
<person name="She X."/>
<person name="Xie G."/>
<person name="Hellsten U."/>
<person name="Chan Y.M."/>
<person name="Altherr M."/>
<person name="Couronne O."/>
<person name="Aerts A."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Blumer H."/>
<person name="Branscomb E."/>
<person name="Brown N.C."/>
<person name="Bruno W.J."/>
<person name="Buckingham J.M."/>
<person name="Callen D.F."/>
<person name="Campbell C.S."/>
<person name="Campbell M.L."/>
<person name="Campbell E.W."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chasteen L.A."/>
<person name="Chertkov O."/>
<person name="Chi H.C."/>
<person name="Christensen M."/>
<person name="Clark L.M."/>
<person name="Cohn J.D."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Dickson M."/>
<person name="Dimitrijevic-Bussod M."/>
<person name="Escobar J."/>
<person name="Fawcett J.J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Goodwin L.A."/>
<person name="Grady D.L."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Hildebrand C.E."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Jewett P.B."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Krawczyk M.-C."/>
<person name="Leyba T."/>
<person name="Longmire J.L."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Ludeman T."/>
<person name="Manohar C.F."/>
<person name="Mark G.A."/>
<person name="McMurray K.L."/>
<person name="Meincke L.J."/>
<person name="Morgan J."/>
<person name="Moyzis R.K."/>
<person name="Mundt M.O."/>
<person name="Munk A.C."/>
<person name="Nandkeshwar R.D."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Parson-Quintana B."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Ricke D.O."/>
<person name="Robinson D.L."/>
<person name="Rodriguez A."/>
<person name="Salamov A."/>
<person name="Saunders E.H."/>
<person name="Scott D."/>
<person name="Shough T."/>
<person name="Stallings R.L."/>
<person name="Stalvey M."/>
<person name="Sutherland R.D."/>
<person name="Tapia R."/>
<person name="Tesmer J.G."/>
<person name="Thayer N."/>
<person name="Thompson L.S."/>
<person name="Tice H."/>
<person name="Torney D.C."/>
<person name="Tran-Gyamfi M."/>
<person name="Tsai M."/>
<person name="Ulanovsky L.E."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="White P.S."/>
<person name="Williams A.L."/>
<person name="Wills P.L."/>
<person name="Wu J.-R."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="DeJong P."/>
<person name="Bruce D."/>
<person name="Doggett N.A."/>
<person name="Deaven L."/>
<person name="Schmutz J."/>
<person name="Grimwood J."/>
<person name="Richardson P."/>
<person name="Rokhsar D.S."/>
<person name="Eichler E.E."/>
<person name="Gilna P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Pennacchio L.A."/>
</authorList>
<dbReference type="PubMed" id="15616553"/>
<dbReference type="DOI" id="10.1038/nature03187"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2009-10" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Lempens A."/>
<person name="Norman J.C."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 1-9; 380-391 AND 792-801</scope>
<scope>ACETYLATION AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Nat. Cell Biol." volume="1" first="507" last="513">
<title>Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas.</title>
<authorList>
<person name="Eisenmann K.M."/>
<person name="McCarthy J.B."/>
<person name="Simpson M.A."/>
<person name="Keely P.J."/>
<person name="Guan J.-L."/>
<person name="Tachibana K."/>
<person name="Lim L."/>
<person name="Manser E."/>
<person name="Furcht L.T."/>
<person name="Iida J."/>
</authorList>
<dbReference type="PubMed" id="10587647"/>
<dbReference type="DOI" id="10.1038/70302"/>
</citation>
<scope>INTERACTION WITH CSPG4</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="1416" last="1428">
<title>SH2-containing inositol 5'-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading.</title>
<authorList>
<person name="Prasad N."/>
<person name="Topping R.S."/>
<person name="Decker S.J."/>
</authorList>
<dbReference type="PubMed" id="11158326"/>
<dbReference type="DOI" id="10.1128/MCB.21.4.1416-1428.2001"/>
</citation>
<scope>INTERACTION WITH INPPL1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="35636" last="35643">
<title>p130Cas Couples the tyrosine kinase Bmx/Etk with regulation of the actin cytoskeleton and cell migration.</title>
<authorList>
<person name="Abassi Y.A."/>
<person name="Rehn M."/>
<person name="Ekman N."/>
<person name="Alitalo K."/>
<person name="Vuori K."/>
</authorList>
<dbReference type="PubMed" id="12832404"/>
<dbReference type="DOI" id="10.1074/jbc.M306438200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH BMX</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="37527" last="37535">
<title>Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas.</title>
<authorList>
<person name="Modzelewska K."/>
<person name="Newman L.P."/>
<person name="Desai R."/>
<person name="Keely P.J."/>
</authorList>
<dbReference type="PubMed" id="17038317"/>
<dbReference type="DOI" id="10.1074/jbc.M604342200"/>
</citation>
<scope>FUNCTION IN CELL MIGRATION</scope>
<scope>INTERACTION WITH BCAR1; CDC42 AND CRK</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134; SER-139; THR-269 AND SER-292</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Cell. Signal." volume="21" first="1423" last="1435">
<title>AND-34/BCAR3 regulates adhesion-dependent p130Cas serine phosphorylation and breast cancer cell growth pattern.</title>
<authorList>
<person name="Makkinje A."/>
<person name="Near R.I."/>
<person name="Infusini G."/>
<person name="Vanden Borre P."/>
<person name="Bloom A."/>
<person name="Cai D."/>
<person name="Costello C.E."/>
<person name="Lerner A."/>
</authorList>
<dbReference type="PubMed" id="19454314"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2009.05.006"/>
</citation>
<scope>PHOSPHORYLATION AT SER-139; SER-437 AND SER-639</scope>
<scope>INTERACTION WITH BCAR3</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="J. Cell. Physiol." volume="219" first="45" last="56">
<title>Pyk2 mediates endothelin-1 signaling via p130Cas/BCAR3 cascade and regulates human glomerular mesangial cell adhesion and spreading.</title>
<authorList>
<person name="Rufanova V.A."/>
<person name="Alexanian A."/>
<person name="Wakatsuki T."/>
<person name="Lerner A."/>
<person name="Sorokin A."/>
</authorList>
<dbReference type="PubMed" id="19086031"/>
<dbReference type="DOI" id="10.1002/jcp.21649"/>
</citation>
<scope>INTERACTION WITH PTK2B/PYK2</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="J. Clin. Invest." volume="119" first="252" last="266">
<title>Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling.</title>
<authorList>
<person name="Pylayeva Y."/>
<person name="Gillen K.M."/>
<person name="Gerald W."/>
<person name="Beggs H.E."/>
<person name="Reichardt L.F."/>
<person name="Giancotti F.G."/>
</authorList>
<dbReference type="PubMed" id="19147981"/>
<dbReference type="DOI" id="10.1172/JCI37160"/>
</citation>
<scope>PHOSPHORYLATION BY SRC UPON ACTIVATION OF PTK2/FAK1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="10920" last="10925">
<title>Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression.</title>
<authorList>
<person name="Wang Y."/>
<person name="Kelber J.A."/>
<person name="Tran Cao H.S."/>
<person name="Cantin G.T."/>
<person name="Lin R."/>
<person name="Wang W."/>
<person name="Kaushal S."/>
<person name="Bristow J.M."/>
<person name="Edgington T.S."/>
<person name="Hoffman R.M."/>
<person name="Bouvet M."/>
<person name="Yates J.R. III"/>
<person name="Klemke R.L."/>
</authorList>
<dbReference type="PubMed" id="20534451"/>
<dbReference type="DOI" id="10.1073/pnas.0914776107"/>
</citation>
<scope>INTERACTION WITH PEAK1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="13556" last="13556">
<authorList>
<person name="Wang Y."/>
<person name="Kelber J.A."/>
<person name="Tran Cao H.S."/>
<person name="Cantin G.T."/>
<person name="Lin R."/>
<person name="Wang W."/>
<person name="Kaushal S."/>
<person name="Bristow J.M."/>
<person name="Edgington T.S."/>
<person name="Hoffman R.M."/>
<person name="Bouvet M."/>
<person name="Yates J.R. III"/>
<person name="Klemke R.L."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134 AND SER-139</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND SER-639</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="Oncogene" volume="32" first="2087" last="2095">
<title>Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14.</title>
<authorList>
<person name="Zhang P."/>
<person name="Guo A."/>
<person name="Possemato A."/>
<person name="Wang C."/>
<person name="Beard L."/>
<person name="Carlin C."/>
<person name="Markowitz S.D."/>
<person name="Polakiewicz R.D."/>
<person name="Wang Z."/>
</authorList>
<dbReference type="PubMed" id="22710723"/>
<dbReference type="DOI" id="10.1038/onc.2012.220"/>
</citation>
<scope>DEPHOSPHORYLATION AT TYR-128 BY PTPN14</scope>
<scope>PHOSPHORYLATION AT TYR-128 BY SRC</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="J. Mol. Biol." volume="347" first="1005" last="1014">
<title>The 1.1 A resolution crystal structure of the p130cas SH3 domain and ramifications for ligand selectivity.</title>
<authorList>
<person name="Wisniewska M."/>
<person name="Bossenmaier B."/>
<person name="Georges G."/>
<person name="Hesse F."/>
<person name="Dangl M."/>
<person name="Kunkele K.P."/>
<person name="Ioannidis I."/>
<person name="Huber R."/>
<person name="Engh R.A."/>
</authorList>
<dbReference type="PubMed" id="15784259"/>
<dbReference type="DOI" id="10.1016/j.jmb.2005.02.017"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.14 ANGSTROMS) OF 3-71</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Nat. Struct. Mol. Biol." volume="18" first="1381" last="1387">
<title>NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling.</title>
<authorList>
<person name="Mace P.D."/>
<person name="Wallez Y."/>
<person name="Dobaczewska M.K."/>
<person name="Lee J.J."/>
<person name="Robinson H."/>
<person name="Pasquale E.B."/>
<person name="Riedl S.J."/>
</authorList>
<dbReference type="PubMed" id="22081014"/>
<dbReference type="DOI" id="10.1038/nsmb.2152"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 645-870 IN COMPLEX WITH SH2D3C</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] THR-407</scope>
</reference>
<comment type="function">
<text evidence="15 18">Docking protein which plays a central coordinating role for tyrosine kinase-based signaling related to cell adhesion. Implicated in induction of cell migration. Overexpression confers antiestrogen resistance on breast cancer cells.</text>
</comment>
<comment type="subunit">
<text evidence="12 14 15 18 19 21 22 23">Forms complexes in vivo with PTK2/FAK1, adapter protein CRKL and LYN kinase. Can heterodimerize with NEDD9. Interacts with BCAR3, the interaction regulates adhesion-dependent serine phosphorylation. Interacts with NPHP1 and SH2D3C. Interacts with activated CSPG4. Interacts with BMX, INPPL1/SHIP2 and PEAK1. Part of a collagen-stimulated complex involved in cell migration made of CDC42, CRK, TNK2 and BCAR1/p130cas. Interacts with TNK2 via SH3 domains. Interacts with PTK2B/PYK2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-15953103">
<id>O75815-1</id>
<label>BCAR3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-359063">
<id>P53618</id>
<label>COPB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-1384248">
<id>O15357</id>
<label>INPPL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-297509">
<id>P46940</id>
<label>IQGAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-992788">
<id>P50281</id>
<label>MMP14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-2609701">
<id>Q9H792</id>
<label>PEAK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-702142">
<id>Q05397</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-2266035">
<id>Q05209</id>
<label>PTPN12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-15952996">
<id>Q8N5H7-2</id>
<label>SH2D3C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-1393949">
<id>Q9C0H9</id>
<label>SRCIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-775592">
<id>Q9QWI6</id>
<label>Srcin1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-603457">
<id>Q07912</id>
<label>TNK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-2607590">
<id>Q04205</id>
<label>TNS</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702093"/>
<interactant intactId="EBI-1220488">
<id>Q68CZ2</id>
<label>TNS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="15">Cell junction</location>
<location evidence="15">focal adhesion</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Cytoplasm</location>
</subcellularLocation>
<text evidence="7">Unphosphorylated form localizes in the cytoplasm and can move to the membrane upon tyrosine phosphorylation.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P56945-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P56945-2</id>
<name>2</name>
<sequence type="described" ref="VSP_043559"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P56945-3</id>
<name>3</name>
<sequence type="described" ref="VSP_045355"/>
</isoform>
<isoform>
<id>P56945-4</id>
<name>4</name>
<sequence type="described" ref="VSP_046127 VSP_046128"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P56945-5</id>
<name>5</name>
<sequence type="described" ref="VSP_046748"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P56945-6</id>
<name>6</name>
<sequence type="described" ref="VSP_046749"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P56945-7</id>
<name>7</name>
<sequence type="described" ref="VSP_046750"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P56945-8</id>
<name>8</name>
<sequence type="described" ref="VSP_046751"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Widely expressed with an abundant expression in the testis. Low level of expression seen in the liver, thymus, and peripheral blood leukocytes. The protein has been detected in a B-cell line.</text>
</comment>
<comment type="domain">
<text evidence="7">Contains a central domain (substrate domain) containing multiple potential SH2-binding sites and a C-terminal domain containing a divergent helix-loop-helix (HLH) motif. The SH2-binding sites putatively bind CRK, NCK and ABL1 SH2 domains. The HLH motif is absolutely required for the induction of pseudohyphal growth in yeast and mediates heterodimerization with NEDD9 (By similarity).</text>
</comment>
<comment type="domain">
<text>A serine-rich region promotes activation of the serum response element (SRE).</text>
</comment>
<comment type="domain">
<text>The SH3 domain is necessary for the localization of the protein to focal adhesions and interacts with one proline-rich region of PTK2/FAK11.</text>
</comment>
<comment type="PTM">
<text evidence="15 20 21 24">PTK2/FAK1 activation mediates phosphorylation at the YDYVHL motif; phosphorylation is most likely catalyzed by SRC family members. SRC-family kinases are recruited to the phosphorylated sites and can phosphorylate other tyrosine residues. Tyrosine phosphorylation is triggered by integrin-mediated adhesion of cells to the extracellular matrix.</text>
</comment>
<comment type="PTM">
<text>Dephosphorylated by PTPN14 at Tyr-128.</text>
</comment>
<comment type="similarity">
<text evidence="30">Belongs to the CAS family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/BCAR1ID761ch16q23.html"/>
</comment>
<dbReference type="EMBL" id="AJ242987">
<property type="protein sequence ID" value="CAB75875.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF218451">
<property type="protein sequence ID" value="AAF27527.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB040024">
<property type="protein sequence ID" value="BAA92711.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY545071">
<property type="protein sequence ID" value="AAS48631.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK027608">
<property type="protein sequence ID" value="BAB55230.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK124815">
<property type="protein sequence ID" value="BAG54099.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK293808">
<property type="protein sequence ID" value="BAG57215.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK294513">
<property type="protein sequence ID" value="BAG57726.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK295809">
<property type="protein sequence ID" value="BAG58627.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK302617">
<property type="protein sequence ID" value="BAH13763.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC009078">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10915.1">
<molecule id="P56945-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54037.1">
<molecule id="P56945-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54038.1">
<molecule id="P56945-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54039.1">
<molecule id="P56945-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54040.1">
<molecule id="P56945-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54041.1">
<molecule id="P56945-8"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54042.1">
<molecule id="P56945-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54043.1">
<molecule id="P56945-7"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001164185.1">
<molecule id="P56945-6"/>
<property type="nucleotide sequence ID" value="NM_001170714.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001164186.1">
<molecule id="P56945-7"/>
<property type="nucleotide sequence ID" value="NM_001170715.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001164187.1">
<molecule id="P56945-2"/>
<property type="nucleotide sequence ID" value="NM_001170716.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001164188.1">
<molecule id="P56945-3"/>
<property type="nucleotide sequence ID" value="NM_001170717.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001164189.1">
<molecule id="P56945-8"/>
<property type="nucleotide sequence ID" value="NM_001170718.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001164190.1">
<molecule id="P56945-5"/>
<property type="nucleotide sequence ID" value="NM_001170719.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001164191.1">
<molecule id="P56945-4"/>
<property type="nucleotide sequence ID" value="NM_001170720.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055382.2">
<molecule id="P56945-1"/>
<property type="nucleotide sequence ID" value="NM_014567.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016879386.1">
<molecule id="P56945-6"/>
<property type="nucleotide sequence ID" value="XM_017023897.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.479747"/>
<dbReference type="PDB" id="1WYX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.14"/>
<property type="chains" value="A/B=3-71"/>
</dbReference>
<dbReference type="PDB" id="3T6G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B/D=645-870"/>
</dbReference>
<dbReference type="PDBsum" id="1WYX"/>
<dbReference type="PDBsum" id="3T6G"/>
<dbReference type="ProteinModelPortal" id="P56945"/>
<dbReference type="SMR" id="P56945"/>
<dbReference type="BioGrid" id="114934">
<property type="interactions" value="68"/>
</dbReference>
<dbReference type="CORUM" id="P56945"/>
<dbReference type="DIP" id="DIP-33855N"/>
<dbReference type="ELM" id="P56945"/>
<dbReference type="IntAct" id="P56945">
<property type="interactions" value="261"/>
</dbReference>
<dbReference type="MINT" id="MINT-1505539"/>
<dbReference type="STRING" id="9606.ENSP00000391669"/>
<dbReference type="iPTMnet" id="P56945"/>
<dbReference type="PhosphoSitePlus" id="P56945"/>
<dbReference type="BioMuta" id="BCAR1"/>
<dbReference type="DMDM" id="288558806"/>
<dbReference type="EPD" id="P56945"/>
<dbReference type="MaxQB" id="P56945"/>
<dbReference type="PaxDb" id="P56945"/>
<dbReference type="PeptideAtlas" id="P56945"/>
<dbReference type="PRIDE" id="P56945"/>
<dbReference type="DNASU" id="9564"/>
<dbReference type="Ensembl" id="ENST00000162330">
<molecule id="P56945-1"/>
<property type="protein sequence ID" value="ENSP00000162330"/>
<property type="gene ID" value="ENSG00000050820"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000393420">
<molecule id="P56945-3"/>
<property type="protein sequence ID" value="ENSP00000377072"/>
<property type="gene ID" value="ENSG00000050820"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000393422">
<molecule id="P56945-7"/>
<property type="protein sequence ID" value="ENSP00000377074"/>
<property type="gene ID" value="ENSG00000050820"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000418647">
<molecule id="P56945-6"/>
<property type="protein sequence ID" value="ENSP00000391669"/>
<property type="gene ID" value="ENSG00000050820"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000420641">
<molecule id="P56945-2"/>
<property type="protein sequence ID" value="ENSP00000392708"/>
<property type="gene ID" value="ENSG00000050820"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000535626">
<molecule id="P56945-4"/>
<property type="protein sequence ID" value="ENSP00000440370"/>
<property type="gene ID" value="ENSG00000050820"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000538440">
<molecule id="P56945-8"/>
<property type="protein sequence ID" value="ENSP00000443841"/>
<property type="gene ID" value="ENSG00000050820"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000542031">
<molecule id="P56945-5"/>
<property type="protein sequence ID" value="ENSP00000440415"/>
<property type="gene ID" value="ENSG00000050820"/>
</dbReference>
<dbReference type="GeneID" id="9564"/>
<dbReference type="KEGG" id="hsa:9564"/>
<dbReference type="UCSC" id="uc002fdv.4">
<molecule id="P56945-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9564"/>
<dbReference type="DisGeNET" id="9564"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000050820.16"/>
<dbReference type="GeneCards" id="BCAR1"/>
<dbReference type="H-InvDB" id="HIX0173293"/>
<dbReference type="HGNC" id="HGNC:971">
<property type="gene designation" value="BCAR1"/>
</dbReference>
<dbReference type="HPA" id="CAB000443"/>
<dbReference type="HPA" id="HPA042282"/>
<dbReference type="MIM" id="602941">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P56945"/>
<dbReference type="OpenTargets" id="ENSG00000050820"/>
<dbReference type="PharmGKB" id="PA25281"/>
<dbReference type="eggNOG" id="ENOG410IEDD">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZSUM">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00490000043324"/>
<dbReference type="HOGENOM" id="HOG000261698"/>
<dbReference type="HOVERGEN" id="HBG004354"/>
<dbReference type="InParanoid" id="P56945"/>
<dbReference type="KO" id="K05726"/>
<dbReference type="OMA" id="LANMPDY"/>
<dbReference type="OrthoDB" id="EOG091G0RVA"/>
<dbReference type="PhylomeDB" id="P56945"/>
<dbReference type="TreeFam" id="TF328782"/>
<dbReference type="Reactome" id="R-HSA-186763">
<property type="pathway name" value="Downstream signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-372708">
<property type="pathway name" value="p130Cas linkage to MAPK signaling for integrins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4420097">
<property type="pathway name" value="VEGFA-VEGFR2 Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849471">
<property type="pathway name" value="PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases"/>
</dbReference>
<dbReference type="SignaLink" id="P56945"/>
<dbReference type="SIGNOR" id="P56945"/>
<dbReference type="ChiTaRS" id="BCAR1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P56945"/>
<dbReference type="GeneWiki" id="BCAR1"/>
<dbReference type="GenomeRNAi" id="9564"/>
<dbReference type="PRO" id="PR:P56945"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000050820"/>
<dbReference type="CleanEx" id="HS_BCAR1"/>
<dbReference type="ExpressionAtlas" id="P56945">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P56945">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0015629">
<property type="term" value="C:actin cytoskeleton"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030027">
<property type="term" value="C:lamellipodium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001726">
<property type="term" value="C:ruffle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004871">
<property type="term" value="F:signal transducer activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007015">
<property type="term" value="P:actin filament organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050851">
<property type="term" value="P:antigen receptor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050853">
<property type="term" value="P:B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0060326">
<property type="term" value="P:cell chemotaxis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0035729">
<property type="term" value="P:cellular response to hepatocyte growth factor stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G-protein coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048012">
<property type="term" value="P:hepatocyte growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008286">
<property type="term" value="P:insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048011">
<property type="term" value="P:neurotrophin TRK receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048008">
<property type="term" value="P:platelet-derived growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010595">
<property type="term" value="P:positive regulation of endothelial cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001558">
<property type="term" value="P:regulation of cell growth"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd12001">
<property type="entry name" value="SH3_BCAR1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR028848">
<property type="entry name" value="BCAR1"/>
</dbReference>
<dbReference type="InterPro" id="IPR035745">
<property type="entry name" value="BCAR1_SH3"/>
</dbReference>
<dbReference type="InterPro" id="IPR021901">
<property type="entry name" value="CAS_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR037362">
<property type="entry name" value="CAS_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR014928">
<property type="entry name" value="Serine_rich"/>
</dbReference>
<dbReference type="InterPro" id="IPR036028">
<property type="entry name" value="SH3-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001452">
<property type="entry name" value="SH3_domain"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10654">
<property type="entry name" value="PTHR10654"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10654:SF15">
<property type="entry name" value="PTHR10654:SF15"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12026">
<property type="entry name" value="DUF3513"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08824">
<property type="entry name" value="Serine_rich"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00018">
<property type="entry name" value="SH3_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00452">
<property type="entry name" value="SH3DOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00326">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50044">
<property type="entry name" value="SSF50044"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50002">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0728">SH3 domain</keyword>
<keyword id="KW-0729">SH3-binding</keyword>
<feature type="chain" description="Breast cancer anti-estrogen resistance protein 1" id="PRO_0000064854">
<location>
<begin position="1"/>
<end position="870"/>
</location>
</feature>
<feature type="domain" description="SH3" evidence="11">
<location>
<begin position="3"/>
<end position="65"/>
</location>
</feature>
<feature type="region of interest" description="Substrate for kinases" evidence="7">
<location>
<begin position="115"/>
<end position="416"/>
</location>
</feature>
<feature type="region of interest" description="Divergent helix-loop-helix motif">
<location>
<begin position="746"/>
<end position="796"/>
</location>
</feature>
<feature type="short sequence motif" description="SH3-binding" evidence="10">
<location>
<begin position="635"/>
<end position="643"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="74"/>
<end position="87"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="422"/>
<end position="614"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="27">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC" evidence="24">
<location>
<position position="128"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4">
<location>
<position position="134"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 6 21">
<location>
<position position="139"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="8">
<location>
<position position="234"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by ABL1" evidence="9">
<location>
<position position="249"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="269"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="292"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="8">
<location>
<position position="362"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="8">
<location>
<position position="372"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="8">
<location>
<position position="410"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="428"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="437"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 21">
<location>
<position position="639"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_043559" evidence="28">
<original>MNHL</original>
<variation>MLTHRPQEAEQRGRTPGPSFEW</variation>
<location>
<begin position="1"/>
<end position="4"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_046127" evidence="28">
<original>MNHL</original>
<variation>MQGK</variation>
<location>
<begin position="1"/>
<end position="4"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_046748" evidence="28">
<original>MNHL</original>
<variation>ME</variation>
<location>
<begin position="1"/>
<end position="4"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_046749" evidence="28">
<original>MNHL</original>
<variation>MPAKPFLSSVLLSWKVLDFSGPGPQGTGQPCSCGHWAEGQGGPPEPAGGP</variation>
<location>
<begin position="1"/>
<end position="4"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_046750" evidence="28">
<original>MNHL</original>
<variation>MHCPGEAPLAAPRPTPKDPCLR</variation>
<location>
<begin position="1"/>
<end position="4"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8." id="VSP_046751" evidence="28">
<original>MNHL</original>
<variation>MSVP</variation>
<location>
<begin position="1"/>
<end position="4"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_046128" evidence="28">
<location>
<begin position="64"/>
<end position="211"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_045355" evidence="29">
<original>A</original>
<variation>AVSKCQGNARARLRLWGVW</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1035539." id="VAR_058970" evidence="13 16 25 26">
<original>P</original>
<variation>S</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035798" evidence="17">
<original>S</original>
<variation>T</variation>
<location>
<position position="407"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs16957558." id="VAR_057820">
<original>R</original>
<variation>L</variation>
<location>
<position position="491"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs16957552." id="VAR_057821">
<original>H</original>
<variation>R</variation>
<location>
<position position="558"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAB55230." ref="5" evidence="30">
<original>L</original>
<variation>S</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAF27527." ref="2" evidence="30">
<original>I</original>
<variation>T</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG54099." ref="5" evidence="30">
<original>V</original>
<variation>I</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAF27527." ref="2" evidence="30">
<original>A</original>
<variation>G</variation>
<location>
<position position="349"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAF27527." ref="2" evidence="30">
<original>D</original>
<variation>Y</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAS48631." ref="4" evidence="30">
<original>T</original>
<variation>A</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAB55230." ref="5" evidence="30">
<original>S</original>
<variation>P</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAB55230." ref="5" evidence="30">
<original>S</original>
<variation>G</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAS48631." ref="4" evidence="30">
<original>N</original>
<variation>S</variation>
<location>
<position position="600"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAH13763." ref="5" evidence="30">
<original>Q</original>
<variation>R</variation>
<location>
<position position="700"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG54099." ref="5" evidence="30">
<original>P</original>
<variation>L</variation>
<location>
<position position="714"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAS48631." ref="4" evidence="30">
<original>D</original>
<variation>G</variation>
<location>
<position position="740"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="5"/>
<end position="12"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="29"/>
<end position="34"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="37"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="43"/>
<end position="48"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="51"/>
<end position="56"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="57"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="60"/>
<end position="68"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="740"/>
<end position="770"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="775"/>
<end position="801"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="806"/>
<end position="835"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="840"/>
<end position="870"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1WYX"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3T6G"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61140"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q63767"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255"/>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00192"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10587647"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10639512"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11158326"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12832404"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17038317"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19086031"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19147981"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19454314"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20534451"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22081014"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22710723"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="2"/>
</evidence>
<evidence key="26" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="27" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<sequence length="870" mass="93372" checksum="B81EC3430049E795" modified="2010-02-09" version="2">
MNHLNVLAKALYDNVAESPDELSFRKGDIMTVLEQDTQGLDGWWLCSLHGRQGIVPGNRL
KILVGMYDKKPAGPGPGPPATPAQPQPGLHAPAPPASQYTPMLPNTYQPQPDSVYLVPTP
SKAQQGLYQVPGPSPQFQSPPAKQTSTFSKQTPHHPFPSPATDLYQVPPGPGGPAQDIYQ
VPPSAGMGHDIYQVPPSMDTRSWEGTKPPAKVVVPTRVGQGYVYEAAQPEQDEYDIPRHL
LAPGPQDIYDVPPVRGLLPSQYGQEVYDTPPMAVKGPNGRDPLLEVYDVPPSVEKGLPPS
NHHAVYDVPPSVSKDVPDGPLLREETYDVPPAFAKAKPFDPARTPLVLAAPPPDSPPAED
VYDVPPPAPDLYDVPPGLRRPGPGTLYDVPRERVLPPEVADGGVVDSGVYAVPPPAEREA
PAEGKRLSASSTGSTRSSQSASSLEVAGPGREPLELEVAVEALARLQQGVSATVAHLLDL
AGSAGATGSWRSPSEPQEPLVQDLQAAVAAVQSAVHELLEFARSAVGNAAHTSDRALHAK
LSRQLQKMEDVHQTLVAHGQALDAGRGGSGATLEDLDRLVACSRAVPEDAKQLASFLHGN
ASLLFRRTKATAPGPEGGGTLHPNPTDKTSSIQSRPLPSPPKFTSQDSPDGQYENSEGGW
MEDYDYVHLQGKEEFEKTQKELLEKGSITRQGKSQLELQQLKQFERLEQEVSRPIDHDLA
NWTPAQPLAPGRTGGLGPSDRQLLLFYLEQCEANLTTLTNAVDAFFTAVATNQPPKIFVA
HSKFVILSAHKLVFIGDTLSRQAKAADVRSQVTHYSNLLCDLLRGIVATTKAAALQYPSP
SAAQDMVERVKELGHSTQQFRRVLGQLAAA
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2007-10-02" modified="2018-01-31" version="112">
<accession>Q96JA3</accession>
<accession>B4DH00</accession>
<accession>Q7Z5V8</accession>
<accession>Q9BU78</accession>
<accession>Q9H274</accession>
<accession>Q9H8Z7</accession>
<name>PKHA8_HUMAN</name>
<protein>
<recommendedName>
<fullName>Pleckstrin homology domain-containing family A member 8</fullName>
<shortName>PH domain-containing family A member 8</shortName>
</recommendedName>
<alternativeName>
<fullName>Phosphatidylinositol-four-phosphate adapter protein 2</fullName>
<shortName>FAPP-2</shortName>
<shortName>Phosphoinositol 4-phosphate adapter protein 2</shortName>
<shortName>hFAPP2</shortName>
</alternativeName>
<alternativeName>
<fullName>Serologically defined breast cancer antigen NY-BR-86</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PLEKHA8</name>
<name type="synonym">FAPP2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Biochem. J." volume="351" first="19" last="31">
<title>Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities.</title>
<authorList>
<person name="Dowler S.J."/>
<person name="Currie R.A."/>
<person name="Campbell D.G."/>
<person name="Deak M."/>
<person name="Kular G."/>
<person name="Downes C.P."/>
<person name="Alessi D.R."/>
</authorList>
<dbReference type="PubMed" id="11001876"/>
<dbReference type="DOI" id="10.1042/0264-6021:3510019"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Cancer Immun." volume="1" first="4" last="4">
<title>Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.</title>
<authorList>
<person name="Scanlan M.J."/>
<person name="Gout I."/>
<person name="Gordon C.M."/>
<person name="Williamson B."/>
<person name="Stockert E."/>
<person name="Gure A.O."/>
<person name="Jaeger D."/>
<person name="Chen Y.-T."/>
<person name="Mackay A."/>
<person name="O'Hare M.J."/>
<person name="Old L.J."/>
</authorList>
<dbReference type="PubMed" id="12747765"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-365</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nat. Cell Biol." volume="6" first="393" last="404">
<title>FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P.</title>
<authorList>
<person name="Godi A."/>
<person name="Di Campli A."/>
<person name="Konstantakopoulos A."/>
<person name="Di Tullio G."/>
<person name="Alessi D.R."/>
<person name="Kular G.S."/>
<person name="Daniele T."/>
<person name="Marra P."/>
<person name="Lucocq J.M."/>
<person name="De Matteis M.A."/>
</authorList>
<dbReference type="PubMed" id="15107860"/>
<dbReference type="DOI" id="10.1038/ncb1119"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ARF1</scope>
<scope>DOMAIN</scope>
<scope>PHOSPHOLIPID-BINDING</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="170" first="521" last="526">
<title>FAPP2 is involved in the transport of apical cargo in polarized MDCK cells.</title>
<authorList>
<person name="Vieira O.V."/>
<person name="Verkade P."/>
<person name="Manninen A."/>
<person name="Simons K."/>
</authorList>
<dbReference type="PubMed" id="16103222"/>
<dbReference type="DOI" id="10.1083/jcb.200503078"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="Nature" volume="449" first="62" last="67">
<title>Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide.</title>
<authorList>
<person name="D'Angelo G."/>
<person name="Polishchuk E."/>
<person name="Di Tullio G."/>
<person name="Santoro M."/>
<person name="Di Campli A."/>
<person name="Godi A."/>
<person name="West G."/>
<person name="Bielawski J."/>
<person name="Chuang C.C."/>
<person name="van der Spoel A.C."/>
<person name="Platt F.M."/>
<person name="Hannun Y.A."/>
<person name="Polishchuk R."/>
<person name="Mattjus P."/>
<person name="De Matteis M.A."/>
</authorList>
<dbReference type="PubMed" id="17687330"/>
<dbReference type="DOI" id="10.1038/nature06097"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ARG-18 AND TRP-407</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] GLU-368</scope>
</reference>
<comment type="function">
<text evidence="4 5 7">Cargo transport protein that is required for apical transport from the Golgi complex. Transports AQP2 from the trans-Golgi network (TGN) to sites of AQP2 phosphorylation. Mediates the non-vesicular transport of glucosylceramide (GlcCer) from the trans-Golgi network (TGN) to the plasma membrane and plays a pivotal role in the synthesis of complex glycosphingolipids. Binding of both phosphatidylinositol 4-phosphate (PIP) and ARF1 are essential for the GlcCer transfer ability. Also required for primary cilium formation, possibly by being involved in the transport of raft lipids to the apical membrane, and for membrane tubulation.</text>
</comment>
<comment type="subunit">
<text evidence="1 4">Homodimer (By similarity). Interacts with ARF1; the interaction together with phosphatidylinositol 4-phosphate binding is required for FAPP2 GlcCer transfer ability.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4">Golgi apparatus</location>
<location evidence="4">trans-Golgi network membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Membrane</location>
<topology evidence="4">Peripheral membrane protein</topology>
</subcellularLocation>
<text evidence="4">Binds through its PH domain to PtdIns(4)P and ARF1, and subsequently localizes to TGN exit sites.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q96JA3-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q96JA3-2</id>
<name>2</name>
<sequence type="described" ref="VSP_028545 VSP_028546"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>Q96JA3-3</id>
<name>3</name>
<sequence type="described" ref="VSP_028543 VSP_028544"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="4">Expressed in kidney cell lines.</text>
</comment>
<comment type="domain">
<text evidence="4">The PH domain of FAPPS binds the small GTPase ARF1 and phosphatidylinositol-4-phosphate (PtdIns4P) with high selectivity, and is required for recruitment of FAPPs to the trans-Golgi network (TGN).</text>
</comment>
<comment type="sequence caution" evidence="9">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAG48267" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="9">
<conflict type="erroneous termination">
<sequence resource="EMBL-CDS" id="AAK55424" version="1"/>
</conflict>
<location>
<position position="508"/>
</location>
<text>Translated as Tyr.</text>
</comment>
<dbReference type="EMBL" id="AF380162">
<property type="protein sequence ID" value="AAK55424.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK023180">
<property type="protein sequence ID" value="BAB14449.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK294857">
<property type="protein sequence ID" value="BAG57961.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471073">
<property type="protein sequence ID" value="EAW93930.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002838">
<property type="protein sequence ID" value="AAH02838.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC053990">
<property type="protein sequence ID" value="AAH53990.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF308300">
<property type="protein sequence ID" value="AAG48267.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5424.1">
<molecule id="Q96JA3-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56473.1">
<molecule id="Q96JA3-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001183955.1">
<molecule id="Q96JA3-1"/>
<property type="nucleotide sequence ID" value="NM_001197026.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001183956.1">
<property type="nucleotide sequence ID" value="NM_001197027.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_116028.1">
<molecule id="Q96JA3-3"/>
<property type="nucleotide sequence ID" value="NM_032639.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011513896.1">
<property type="nucleotide sequence ID" value="XM_011515594.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.233495"/>
<dbReference type="UniGene" id="Hs.558495"/>
<dbReference type="UniGene" id="Hs.734170"/>
<dbReference type="ProteinModelPortal" id="Q96JA3"/>
<dbReference type="SMR" id="Q96JA3"/>
<dbReference type="BioGrid" id="124225">
<property type="interactions" value="7"/>
</dbReference>
<dbReference type="IntAct" id="Q96JA3">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000397947"/>
<dbReference type="iPTMnet" id="Q96JA3"/>
<dbReference type="PhosphoSitePlus" id="Q96JA3"/>
<dbReference type="BioMuta" id="PLEKHA8"/>
<dbReference type="DMDM" id="387912902"/>
<dbReference type="MaxQB" id="Q96JA3"/>
<dbReference type="PaxDb" id="Q96JA3"/>
<dbReference type="PeptideAtlas" id="Q96JA3"/>
<dbReference type="PRIDE" id="Q96JA3"/>
<dbReference type="DNASU" id="84725"/>
<dbReference type="Ensembl" id="ENST00000258679">
<molecule id="Q96JA3-3"/>
<property type="protein sequence ID" value="ENSP00000258679"/>
<property type="gene ID" value="ENSG00000106086"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396257">
<molecule id="Q96JA3-2"/>
<property type="protein sequence ID" value="ENSP00000379556"/>
<property type="gene ID" value="ENSG00000106086"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000449726">
<molecule id="Q96JA3-1"/>
<property type="protein sequence ID" value="ENSP00000397947"/>
<property type="gene ID" value="ENSG00000106086"/>
</dbReference>
<dbReference type="GeneID" id="84725"/>
<dbReference type="KEGG" id="hsa:84725"/>
<dbReference type="UCSC" id="uc003tan.4">
<molecule id="Q96JA3-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="84725"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000106086.18"/>
<dbReference type="GeneCards" id="PLEKHA8"/>
<dbReference type="H-InvDB" id="HIX0010564"/>
<dbReference type="HGNC" id="HGNC:30037">
<property type="gene designation" value="PLEKHA8"/>
</dbReference>
<dbReference type="HPA" id="HPA072314"/>
<dbReference type="MIM" id="608639">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96JA3"/>
<dbReference type="OpenTargets" id="ENSG00000106086"/>
<dbReference type="PharmGKB" id="PA134926954"/>
<dbReference type="eggNOG" id="KOG3221">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410YFEA">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00650000093230"/>
<dbReference type="HOGENOM" id="HOG000007705"/>
<dbReference type="HOVERGEN" id="HBG108255"/>
<dbReference type="InParanoid" id="Q96JA3"/>
<dbReference type="KO" id="K08051"/>
<dbReference type="TreeFam" id="TF317467"/>
<dbReference type="Reactome" id="R-HSA-1660499">
<property type="pathway name" value="Synthesis of PIPs at the plasma membrane"/>
</dbReference>
<dbReference type="GenomeRNAi" id="84725"/>
<dbReference type="PRO" id="PR:Q96JA3"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000106086"/>
<dbReference type="CleanEx" id="HS_PLEKHA8"/>
<dbReference type="ExpressionAtlas" id="Q96JA3">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96JA3">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005802">
<property type="term" value="C:trans-Golgi network"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097001">
<property type="term" value="F:ceramide binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051861">
<property type="term" value="F:glycolipid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017089">
<property type="term" value="F:glycolipid transporter activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0120013">
<property type="term" value="F:intermembrane lipid transfer activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0070273">
<property type="term" value="F:phosphatidylinositol-4-phosphate binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035621">
<property type="term" value="P:ER to Golgi ceramide transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006869">
<property type="term" value="P:lipid transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006661">
<property type="term" value="P:phosphatidylinositol biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0015031">
<property type="term" value="P:protein transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR036497">
<property type="entry name" value="GLTP_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR014830">
<property type="entry name" value="Glycolipid_transfer_prot_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001849">
<property type="entry name" value="PH_domain"/>
</dbReference>
<dbReference type="Pfam" id="PF08718">
<property type="entry name" value="GLTP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00169">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00233">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF110004">
<property type="entry name" value="SSF110004"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50729">
<property type="entry name" value="SSF50729"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50003">
<property type="entry name" value="PH_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0445">Lipid transport</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0653">Protein transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="chain" description="Pleckstrin homology domain-containing family A member 8" id="PRO_0000306865">
<location>
<begin position="1"/>
<end position="519"/>
</location>
</feature>
<feature type="domain" description="PH" evidence="3">
<location>
<begin position="1"/>
<end position="93"/>
</location>
</feature>
<feature type="region of interest" description="Glycolipid transfer protein homology domain">
<location>
<begin position="310"/>
<end position="519"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2">
<location>
<position position="139"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="145"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2">
<location>
<position position="153"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_028543" evidence="8">
<original>NNAYGK</original>
<variation>RNPTEN</variation>
<location>
<begin position="434"/>
<end position="439"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_028544" evidence="8">
<location>
<begin position="441"/>
<end position="519"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_028545" evidence="8">
<original>L</original>
<variation>V</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_028546" evidence="8">
<location>
<begin position="456"/>
<end position="519"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035444" evidence="6">
<original>V</original>
<variation>E</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to phosphatylinositol 4-phosphate, less association with Golgi and no preference for TGN location." evidence="7">
<original>R</original>
<variation>L</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glucosylceramide transfer activity from the TGN to the plasma membrane." evidence="7">
<original>W</original>
<variation>A</variation>
<location>
<position position="407"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAB14449." ref="4" evidence="9">
<original>E</original>
<variation>G</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAK55424." ref="1" evidence="9">
<original>T</original>
<variation>S</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAK55424." ref="1" evidence="9">
<original>Y</original>
<variation>C</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAG48267." ref="5" evidence="9">
<original>MDLVGNI</original>
<variation>DGSCWKY</variation>
<location>
<begin position="359"/>
<end position="365"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAK55424." ref="1" evidence="9">
<original>G</original>
<variation>E</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAB14449." ref="4" evidence="9">
<original>QKY</original>
<variation>RSI</variation>
<location>
<begin position="370"/>
<end position="372"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAK55424." ref="1" evidence="9">
<original>A</original>
<variation>T</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAK55424." ref="1" evidence="9">
<original>Q</original>
<variation>R</variation>
<location>
<position position="478"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAK55424." ref="1" evidence="9">
<original>E</original>
<variation>K</variation>
<location>
<position position="498"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAK55424." ref="1" evidence="9">
<original>L</original>
<variation>M</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAK55424." ref="1" evidence="9">
<original>T</original>
<variation>A</variation>
<location>
<position position="506"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="D3ZY60"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00145"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15107860"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16103222"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17687330"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000305"/>
<sequence length="519" mass="58261" checksum="3E2D0746C00C722B" modified="2012-05-16" version="3">
MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCEIQVHSVDNTR
MDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRTQKEKEFAENTENLKTKMSEL
RLYCDLLVQQVDKTKEVTTTGVSNSEEGIDVGTLLKSTCNTFLKTLEECMQIANAAFTSE
LLYRTPPGSPQLAMLKSSKMKHPIIPIHNSLERQMELSTCENGSLNMEINGEEEILMKNK
NSLYLKSAEIDCSISSEENTDDNITVQGEIRKEDGMENLKNHDNNLTQSGSDSSCSPECL
WEEGKEVIPTFFSTMNTSFSDIELLEDSGIPTEAFLASCYAVVPVLDKLGPTVFAPVKMD
LVGNIKKVNQKYITNKEEFTTLQKIVLHEVEADVAQVRNSATEALLWLKRGLKFLKGFLT
EVKNGEKDIQTALNNAYGKTLRQHHGWVVRGVFALALRAAPSYEDFVAALTVKEGDHQKE
AFSIGMQRDLSLYLPAMEKQLAILDTLYEVHGLESDEVV
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2006-01-10" modified="2018-01-31" version="128">
<accession>Q5FBB7</accession>
<accession>Q588H5</accession>
<accession>Q5FBB4</accession>
<accession>Q5FBB5</accession>
<accession>Q5FBB6</accession>
<accession>Q5FBB8</accession>
<accession>Q8N579</accession>
<accession>Q8WVL0</accession>
<accession>Q9BVA8</accession>
<accession>Q9H275</accession>
<name>SGO1_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="30">Shugoshin 1</fullName>
</recommendedName>
<alternativeName>
<fullName>Serologically defined breast cancer antigen NY-BR-85</fullName>
</alternativeName>
<alternativeName>
<fullName>Shugoshin-like 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="30">SGO1</name>
<name type="synonym">SGOL1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2005" name="PLoS Biol." volume="3" first="433" last="449">
<title>Shugoshin prevents dissociation of cohesin from centromeres during mitosis in vertebrate cells.</title>
<authorList>
<person name="McGuinness B.E."/>
<person name="Hirota T."/>
<person name="Kudo N.R."/>
<person name="Peters J.-M."/>
<person name="Nasmyth K."/>
</authorList>
<dbReference type="PubMed" id="15737064"/>
<dbReference type="DOI" id="10.1371/journal.pbio.0030086"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6 AND 7)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="2">
<citation type="submission" date="2004-08" db="EMBL/GenBank/DDBJ databases">
<title>Human SgoL1 inhibits precocious separation of sister centromere in early mitosis.</title>
<authorList>
<person name="Suzuki H."/>
<person name="Akiyama N."/>
<person name="Tsuji M."/>
<person name="Saito S."/>
<person name="Eto Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5 AND 6)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 25-561 (ISOFORM 6)</scope>
<source>
<tissue>Cervix</tissue>
<tissue>Lung</tissue>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Cancer Immun." volume="1" first="4" last="4">
<title>Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.</title>
<authorList>
<person name="Scanlan M.J."/>
<person name="Gout I."/>
<person name="Gordon C.M."/>
<person name="Williamson B."/>
<person name="Stockert E."/>
<person name="Gure A.O."/>
<person name="Jaeger D."/>
<person name="Chen Y.-T."/>
<person name="Mackay A."/>
<person name="O'Hare M.J."/>
<person name="Old L.J."/>
</authorList>
<dbReference type="PubMed" id="12747765"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 250-527 (ISOFORM 6)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Curr. Biol." volume="15" first="353" last="359">
<title>Human Bub1 defines the persistent cohesion site along the mitotic chromosome by affecting Shugoshin localization.</title>
<authorList>
<person name="Kitajima T.S."/>
<person name="Hauf S."/>
<person name="Ohsugi M."/>
<person name="Yamamoto T."/>
<person name="Watanabe Y."/>
</authorList>
<dbReference type="PubMed" id="15723797"/>
<dbReference type="DOI" id="10.1016/j.cub.2004.12.044"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="18012" last="18017">
<title>Human Bub1 protects centromeric sister-chromatid cohesion through Shugoshin during mitosis.</title>
<authorList>
<person name="Tang Z."/>
<person name="Sun Y."/>
<person name="Harley S.E."/>
<person name="Zou H."/>
<person name="Yu H."/>
</authorList>
<dbReference type="PubMed" id="15604152"/>
<dbReference type="DOI" id="10.1073/pnas.0408600102"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Cell Cycle" volume="5" first="635" last="640">
<title>Differential subcellular localizations of two human Sgo1 isoforms: implications in regulation of sister chromatid cohesion and microtubule dynamics.</title>
<authorList>
<person name="Wang X."/>
<person name="Yang Y."/>
<person name="Dai W."/>
</authorList>
<dbReference type="PubMed" id="16582621"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Dev. Cell" volume="10" first="575" last="585">
<title>PP2A is required for centromeric localization of Sgo1 and proper chromosome segregation.</title>
<authorList>
<person name="Tang Z."/>
<person name="Shu H."/>
<person name="Qi W."/>
<person name="Mahmood N.A."/>
<person name="Mumby M.C."/>
<person name="Yu H."/>
</authorList>
<dbReference type="PubMed" id="16580887"/>
<dbReference type="DOI" id="10.1016/j.devcel.2006.03.010"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PPP2CA; PPP2R1A AND PPP2R5C</scope>
<scope>MUTAGENESIS OF ASN-61 AND LYS-492</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Nature" volume="441" first="46" last="52">
<title>Shugoshin collaborates with protein phosphatase 2A to protect cohesin.</title>
<authorList>
<person name="Kitajima T.S."/>
<person name="Sakuno T."/>
<person name="Ishiguro K."/>
<person name="Iemura S."/>
<person name="Natsume T."/>
<person name="Kawashima S.A."/>
<person name="Watanabe Y."/>
</authorList>
<dbReference type="PubMed" id="16541025"/>
<dbReference type="DOI" id="10.1038/nature04663"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PPP2CA/PPP2CB; PPP2R1B; PPP2R5A; PPP2R5B; PPP2R5C; PPP2R5D; PPP2R5E; SET; LRRC59; RBM10/RBM5; RPL10A; RPL28; RPL7; RPL7A AND RPLP1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Cell Cycle" volume="6" first="1579" last="1585">
<title>Shugoshin 1 plays a central role in kinetochore assembly and is required for kinetochore targeting of Plk1.</title>
<authorList>
<person name="Pouwels J."/>
<person name="Kukkonen A.M."/>
<person name="Lan W."/>
<person name="Daum J.R."/>
<person name="Gorbsky G.J."/>
<person name="Stukenberg T."/>
<person name="Kallio M.J."/>
</authorList>
<dbReference type="PubMed" id="17617734"/>
<dbReference type="DOI" id="10.4161/cc.6.13.4442"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Cell Res." volume="17" first="608" last="618">
<title>Phosphorylation of human Sgo1 by NEK2A is essential for chromosome congression in mitosis.</title>
<authorList>
<person name="Fu G."/>
<person name="Ding X."/>
<person name="Yuan K."/>
<person name="Aikhionbare F."/>
<person name="Yao J."/>
<person name="Cai X."/>
<person name="Jiang K."/>
<person name="Yao X."/>
</authorList>
<dbReference type="PubMed" id="17621308"/>
<dbReference type="DOI" id="10.1038/cr.2007.55"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH NEK2</scope>
<scope>PHOSPHORYLATION AT SER-14 AND SER-507</scope>
<scope>MUTAGENESIS OF SER-14 AND SER-507</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Dev. Cell" volume="14" first="331" last="341">
<title>sSgo1, a major splice variant of Sgo1, functions in centriole cohesion where it is regulated by Plk1.</title>
<authorList>
<person name="Wang X."/>
<person name="Yang Y."/>
<person name="Duan Q."/>
<person name="Jiang N."/>
<person name="Huang Y."/>
<person name="Darzynkiewicz Z."/>
<person name="Dai W."/>
</authorList>
<dbReference type="PubMed" id="18331714"/>
<dbReference type="DOI" id="10.1016/j.devcel.2007.12.007"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PLK1</scope>
<scope>MUTAGENESIS OF SER-73 AND THR-146</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-436</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-507</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="1772" last="1780">
<title>Multiple anaphase-promoting complex/cyclosome degrons mediate the degradation of human Sgo1.</title>
<authorList>
<person name="Karamysheva Z."/>
<person name="Diaz-Martinez L.A."/>
<person name="Crow S.E."/>
<person name="Li B."/>
<person name="Yu H."/>
</authorList>
<dbReference type="PubMed" id="19015261"/>
<dbReference type="DOI" id="10.1074/jbc.M807083200"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DOMAIN KEN BOX AND D-BOX</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Nature" volume="467" first="719" last="723">
<title>Phosphorylation of the CPC by Cdk1 promotes chromosome bi-orientation.</title>
<authorList>
<person name="Tsukahara T."/>
<person name="Tanno Y."/>
<person name="Watanabe Y."/>
</authorList>
<dbReference type="PubMed" id="20739936"/>
<dbReference type="DOI" id="10.1038/nature09390"/>
</citation>
<scope>INTERACTION WITH CDCA8</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-256 AND SER-507</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-256</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-256 AND SER-436</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="Nat. Genet." volume="46" first="1245" last="1249">
<title>Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm.</title>
<authorList>
<consortium name="FORGE Canada Consortium"/>
<person name="Chetaille P."/>
<person name="Preuss C."/>
<person name="Burkhard S."/>
<person name="Cote J.M."/>
<person name="Houde C."/>
<person name="Castilloux J."/>
<person name="Piche J."/>
<person name="Gosset N."/>
<person name="Leclerc S."/>
<person name="Wuennemann F."/>
<person name="Thibeault M."/>
<person name="Gagnon C."/>
<person name="Galli A."/>
<person name="Tuck E."/>
<person name="Hickson G.R."/>
<person name="El Amine N."/>
<person name="Boufaied I."/>
<person name="Lemyre E."/>
<person name="de Santa Barbara P."/>
<person name="Faure S."/>
<person name="Jonzon A."/>
<person name="Cameron M."/>
<person name="Dietz H.C."/>
<person name="Gallo-McFarlane E."/>
<person name="Benson D.W."/>
<person name="Moreau C."/>
<person name="Labuda D."/>
<person name="Zhan S.H."/>
<person name="Shen Y."/>
<person name="Jomphe M."/>
<person name="Jones S.J."/>
<person name="Bakkers J."/>
<person name="Andelfinger G."/>
</authorList>
<dbReference type="PubMed" id="25282101"/>
<dbReference type="DOI" id="10.1038/ng.3113"/>
</citation>
<scope>INVOLVEMENT IN CAID</scope>
<scope>VARIANT CAID GLU-23</scope>
<scope>CHARACTERIZATION OF VARIANT CAID GLU-23</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Mol. Biol. Cell" volume="22" first="1181" last="1190">
<title>Mitotic centromeric targeting of HP1 and its binding to Sgo1 are dispensable for sister-chromatid cohesion in human cells.</title>
<authorList>
<person name="Kang J."/>
<person name="Chaudhary J."/>
<person name="Dong H."/>
<person name="Kim S."/>
<person name="Brautigam C.A."/>
<person name="Yu H."/>
</authorList>
<dbReference type="PubMed" id="21346195"/>
<dbReference type="DOI" id="10.1091/mbc.E11-01-0009"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) OF 445-463 IN COMPLEX WITH CBX1</scope>
<scope>INTERACTION WITH CBX5</scope>
<scope>MUTAGENESIS OF PRO-451; VAL-453 AND ILE-455</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="10 11 12 14 16 17 18 20">Plays a central role in chromosome cohesion during mitosis by preventing premature dissociation of cohesin complex from centromeres after prophase, when most of cohesin complex dissociates from chromosomes arms. May act by preventing phosphorylation of the STAG2 subunit of cohesin complex at the centromere, ensuring cohesin persistence at centromere until cohesin cleavage by ESPL1/separase at anaphase. Essential for proper chromosome segregation during mitosis and this function requires interaction with PPP2R1A. Its phosphorylated form is necessary for chromosome congression and for the proper attachment of spindle microtubule to the kinetochore. Necessary for kinetochore localization of PLK1 and CENPF. May play a role in the tension sensing mechanism of the spindle-assembly checkpoint by regulating PLK1 kinetochore affinity. Isoform 3 plays a role in maintaining centriole cohesion involved in controlling spindle pole integrity. Involved in centromeric enrichment of AUKRB in prometaphase.</text>
</comment>
<comment type="subunit">
<text evidence="13 14 17 18 20">Interacts with PPP2CA (or PPP2CB), PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E, SET, LRRC59, RBM10 (or RBM5), RPL10A, RPL28, RPL7, RPL7A and RPLP1. Interaction with protein phosphatase 2A occurs most probably through direct binding to the regulatory B56 subunits: PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E. Interacts with PPP2R1A and NEK2. Isoform 3 interacts with PLK1. Interacts with CDCA8.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-989069"/>
<interactant intactId="EBI-78129">
<id>P83916</id>
<label>CBX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-989069"/>
<interactant intactId="EBI-78219">
<id>P45973</id>
<label>CBX5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-989069"/>
<interactant intactId="EBI-718805">
<id>Q96FF9</id>
<label>CDCA5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-989069"/>
<interactant intactId="EBI-979174">
<id>Q53HL2</id>
<label>CDCA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-989069"/>
<interactant intactId="EBI-712311">
<id>P67775</id>
<label>PPP2CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-989069"/>
<interactant intactId="EBI-641666">
<id>Q15172</id>
<label>PPP2R5A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-989069"/>
<interactant intactId="EBI-80690">
<id>Q14683</id>
<label>SMC1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-989069"/>
<interactant intactId="EBI-1057252">
<id>Q8N3U4</id>
<label>STAG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="28">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10 11 13 14 21">Chromosome</location>
<location evidence="10 11 13 14 21">centromere</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15 16 17">Chromosome</location>
<location evidence="15 16 17">centromere</location>
<location evidence="15 16 17">kinetochore</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15 18">Cytoplasm</location>
<location evidence="15 18">cytoskeleton</location>
<location evidence="15 18">spindle pole</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="18">Cytoplasm</location>
<location evidence="18">cytoskeleton</location>
<location evidence="18">microtubule organizing center</location>
<location evidence="18">centrosome</location>
</subcellularLocation>
<text evidence="10 13 14 15 16 17">Localizes to the inner centromere throughout prophase until metaphase and disappears at anaphase (PubMed:16541025). Centromeric localization requires the presence of BUB1 and the interaction with PPP2R1A (PubMed:16580887)(PubMed:16541025)(PubMed:15604152). Colocalizes with NEK2 at the kinetochore (PubMed:17621308). Colocalizes with and SS18L1 at the kinetochore (PubMed:16582621). Phosphorylation by AUKRB and the presence of BUB1 are required for localization to the kinetochore (PubMed:17617734). Isoform 1 primarily localizes to kinetochores during G2 phase and mitotic prophase, metaphase, and anaphase and does not appear to be associated with kinetochores during late mitosis (PubMed:16582621). Isoform 3 is found at the centrosome in interphase and at spindle poles in mitosis and its spindle pole localization is PLK1 dependent (PubMed:16582621). Isoform 3 does not localize to kinetochores during any stages of the cell cycle (PubMed:16582621).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q5FBB7-1</id>
<name>1</name>
<name>1EF</name>
<name>SgoL1-A2</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q5FBB7-2</id>
<name>2</name>
<name>1GH</name>
<name>SgoL1-B2</name>
<sequence type="described" ref="VSP_016792 VSP_016794"/>
</isoform>
<isoform>
<id>Q5FBB7-3</id>
<name>3</name>
<name>1KL</name>
<name>sSGO1</name>
<name>SgoL1-C2</name>
<sequence type="described" ref="VSP_016790 VSP_016791"/>
</isoform>
<isoform>
<id>Q5FBB7-4</id>
<name>4</name>
<name>1CD</name>
<name>SgoL1-B1</name>
<sequence type="described" ref="VSP_016792 VSP_016794 VSP_016795"/>
</isoform>
<isoform>
<id>Q5FBB7-5</id>
<name>5</name>
<name>1AB</name>
<name>SgoL1-C1</name>
<sequence type="described" ref="VSP_016790 VSP_016791 VSP_016795"/>
</isoform>
<isoform>
<id>Q5FBB7-6</id>
<name>6</name>
<name>1AB</name>
<name>SgoL1-A1</name>
<sequence type="described" ref="VSP_016795"/>
</isoform>
<isoform>
<id>Q5FBB7-7</id>
<name>7</name>
<name>1J</name>
<sequence type="described" ref="VSP_016793"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="9">Widely expressed. Highly expressed in testis. Expressed in lung, small intestine, breast, liver and placenta. Strongly overexpressed in 90% of breast cancers tested.</text>
</comment>
<comment type="developmental stage">
<text evidence="11">Appears in prophase cells and remains present until metaphase. Strongly decreases at the onset of anaphase and completely disappears at telophase. Not present in interphase cells (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="19">The KEN box and D-box 3 are required for its ubiquitination and degradation.</text>
</comment>
<comment type="PTM">
<text evidence="19">Ubiquitinated and degraded during mitotic exit by APC/C-Cdh1.</text>
</comment>
<comment type="PTM">
<text evidence="15 16 17">Phosphorylation by NEK2 is essential for chromosome congression in mitosis and for the proper attachment of spindle microtubule to the kinetochore. Phosphorylated by PLK1 and AUKRB.</text>
</comment>
<comment type="disease" evidence="22">
<disease id="DI-04314">
<name>Chronic atrial and intestinal dysrhythmia</name>
<acronym>CAID</acronym>
<description>A disease characterized by dysregulation of the cardiac sinus node resulting in sick sinus syndrome, in association with chronic intestinal pseudo-obstruction, a disorder of gastrointestinal motility in which intestinal obstruction occurs in the absence of a mechanical obstacle.</description>
<dbReference type="MIM" id="616201"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Shugoshin is Japanese for guardian spirit (as it is known to be a protector of centromeric cohesin).</text>
</comment>
<comment type="similarity">
<text evidence="27">Belongs to the shugoshin family.</text>
</comment>
<comment type="sequence caution" evidence="27">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH01339" version="2"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="27">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH32696" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<dbReference type="EMBL" id="AB190994">
<property type="protein sequence ID" value="BAD91318.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193056">
<property type="protein sequence ID" value="BAD95529.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193057">
<property type="protein sequence ID" value="BAD95530.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193058">
<property type="protein sequence ID" value="BAD95531.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193059">
<property type="protein sequence ID" value="BAD95532.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193060">
<property type="protein sequence ID" value="BAD95533.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193061">
<property type="protein sequence ID" value="BAD95534.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193062">
<property type="protein sequence ID" value="BAD95535.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193063">
<property type="protein sequence ID" value="BAD95536.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193064">
<property type="protein sequence ID" value="BAD95537.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193065">
<property type="protein sequence ID" value="BAD95538.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193066">
<property type="protein sequence ID" value="BAD95539.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB187577">
<property type="protein sequence ID" value="BAD89587.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB187578">
<property type="protein sequence ID" value="BAD89588.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB187579">
<property type="protein sequence ID" value="BAD89589.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB187580">
<property type="protein sequence ID" value="BAD89590.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB187581">
<property type="protein sequence ID" value="BAD89591.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB187582">
<property type="protein sequence ID" value="BAD89592.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001339">
<property type="protein sequence ID" value="AAH01339.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC017867">
<property type="protein sequence ID" value="AAH17867.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032696">
<property type="protein sequence ID" value="AAH32696.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF308299">
<property type="protein sequence ID" value="AAG48266.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2635.1">
<molecule id="Q5FBB7-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33716.1">
<molecule id="Q5FBB7-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46771.1">
<molecule id="Q5FBB7-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46772.1">
<molecule id="Q5FBB7-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46773.1">
<molecule id="Q5FBB7-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46774.1">
<molecule id="Q5FBB7-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56243.1">
<molecule id="Q5FBB7-7"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001012409.1">
<molecule id="Q5FBB7-6"/>
<property type="nucleotide sequence ID" value="NM_001012409.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001012410.1">
<molecule id="Q5FBB7-1"/>
<property type="nucleotide sequence ID" value="NM_001012410.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001012411.1">
<molecule id="Q5FBB7-4"/>
<property type="nucleotide sequence ID" value="NM_001012411.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001012412.1">
<molecule id="Q5FBB7-2"/>
<property type="nucleotide sequence ID" value="NM_001012412.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001012413.1">
<molecule id="Q5FBB7-5"/>
<property type="nucleotide sequence ID" value="NM_001012413.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001186180.1">
<molecule id="Q5FBB7-6"/>
<property type="nucleotide sequence ID" value="NM_001199251.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001186181.1">
<molecule id="Q5FBB7-1"/>
<property type="nucleotide sequence ID" value="NM_001199252.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001186182.1">
<molecule id="Q5FBB7-4"/>
<property type="nucleotide sequence ID" value="NM_001199253.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001186183.1">
<molecule id="Q5FBB7-2"/>
<property type="nucleotide sequence ID" value="NM_001199254.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001186184.1">
<molecule id="Q5FBB7-5"/>
<property type="nucleotide sequence ID" value="NM_001199255.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001186185.1">
<molecule id="Q5FBB7-3"/>
<property type="nucleotide sequence ID" value="NM_001199256.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001186186.1">
<molecule id="Q5FBB7-7"/>
<property type="nucleotide sequence ID" value="NM_001199257.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_612493.1">
<molecule id="Q5FBB7-3"/>
<property type="nucleotide sequence ID" value="NM_138484.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011531675.1">
<molecule id="Q5FBB7-1"/>
<property type="nucleotide sequence ID" value="XM_011533373.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011531677.1">
<molecule id="Q5FBB7-1"/>
<property type="nucleotide sequence ID" value="XM_011533375.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011531678.1">
<molecule id="Q5FBB7-1"/>
<property type="nucleotide sequence ID" value="XM_011533376.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011531679.1">
<molecule id="Q5FBB7-1"/>
<property type="nucleotide sequence ID" value="XM_011533377.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.105153"/>
<dbReference type="PDB" id="3FGA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="D=51-96"/>
</dbReference>
<dbReference type="PDB" id="3Q6S">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.93"/>
<property type="chains" value="E/F=445-463"/>
</dbReference>
<dbReference type="PDB" id="4A0I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="C/D=2-6"/>
</dbReference>
<dbReference type="PDBsum" id="3FGA"/>
<dbReference type="PDBsum" id="3Q6S"/>
<dbReference type="PDBsum" id="4A0I"/>
<dbReference type="ProteinModelPortal" id="Q5FBB7"/>
<dbReference type="SMR" id="Q5FBB7"/>
<dbReference type="BioGrid" id="127395">
<property type="interactions" value="57"/>
</dbReference>
<dbReference type="DIP" id="DIP-36614N"/>
<dbReference type="IntAct" id="Q5FBB7">
<property type="interactions" value="47"/>
</dbReference>
<dbReference type="MINT" id="MINT-4989914"/>
<dbReference type="STRING" id="9606.ENSP00000263753"/>
<dbReference type="iPTMnet" id="Q5FBB7"/>
<dbReference type="PhosphoSitePlus" id="Q5FBB7"/>
<dbReference type="BioMuta" id="SGOL1"/>
<dbReference type="DMDM" id="74741474"/>
<dbReference type="EPD" id="Q5FBB7"/>
<dbReference type="MaxQB" id="Q5FBB7"/>
<dbReference type="PaxDb" id="Q5FBB7"/>
<dbReference type="PeptideAtlas" id="Q5FBB7"/>
<dbReference type="PRIDE" id="Q5FBB7"/>
<dbReference type="Ensembl" id="ENST00000263753">
<molecule id="Q5FBB7-1"/>
<property type="protein sequence ID" value="ENSP00000263753"/>
<property type="gene ID" value="ENSG00000129810"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000306698">
<molecule id="Q5FBB7-3"/>
<property type="protein sequence ID" value="ENSP00000306581"/>
<property type="gene ID" value="ENSG00000129810"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000412997">
<molecule id="Q5FBB7-6"/>
<property type="protein sequence ID" value="ENSP00000410458"/>
<property type="gene ID" value="ENSG00000129810"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000417364">
<molecule id="Q5FBB7-4"/>
<property type="protein sequence ID" value="ENSP00000394613"/>
<property type="gene ID" value="ENSG00000129810"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000419233">
<molecule id="Q5FBB7-2"/>
<property type="protein sequence ID" value="ENSP00000394625"/>
<property type="gene ID" value="ENSG00000129810"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000421451">
<molecule id="Q5FBB7-1"/>
<property type="protein sequence ID" value="ENSP00000414129"/>
<property type="gene ID" value="ENSG00000129810"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000425061">
<molecule id="Q5FBB7-2"/>
<property type="protein sequence ID" value="ENSP00000414960"/>
<property type="gene ID" value="ENSG00000129810"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000437051">
<molecule id="Q5FBB7-4"/>
<property type="protein sequence ID" value="ENSP00000389034"/>
<property type="gene ID" value="ENSG00000129810"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000442720">
<molecule id="Q5FBB7-5"/>
<property type="protein sequence ID" value="ENSP00000394957"/>
<property type="gene ID" value="ENSG00000129810"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000443724">
<molecule id="Q5FBB7-7"/>
<property type="protein sequence ID" value="ENSP00000413070"/>
<property type="gene ID" value="ENSG00000129810"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000452020">
<molecule id="Q5FBB7-3"/>
<property type="protein sequence ID" value="ENSP00000411200"/>
<property type="gene ID" value="ENSG00000129810"/>
</dbReference>
<dbReference type="GeneID" id="151648"/>
<dbReference type="KEGG" id="hsa:151648"/>
<dbReference type="UCSC" id="uc003cbr.4">
<molecule id="Q5FBB7-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="151648"/>
<dbReference type="DisGeNET" id="151648"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000129810.14"/>
<dbReference type="GeneCards" id="SGO1"/>
<dbReference type="HGNC" id="HGNC:25088">
<property type="gene designation" value="SGO1"/>
</dbReference>
<dbReference type="HPA" id="HPA069857"/>
<dbReference type="MalaCards" id="SGO1"/>
<dbReference type="MIM" id="609168">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616201">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q5FBB7"/>
<dbReference type="OpenTargets" id="ENSG00000129810"/>
<dbReference type="PharmGKB" id="PA134988556"/>
<dbReference type="eggNOG" id="ENOG410IPKX">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4111FBS">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000014987"/>
<dbReference type="HOVERGEN" id="HBG080777"/>
<dbReference type="InParanoid" id="Q5FBB7"/>
<dbReference type="KO" id="K11580"/>
<dbReference type="OMA" id="TPFRQKM"/>
<dbReference type="OrthoDB" id="EOG091G0AX7"/>
<dbReference type="PhylomeDB" id="Q5FBB7"/>
<dbReference type="TreeFam" id="TF334213"/>
<dbReference type="Reactome" id="R-HSA-141444">
<property type="pathway name" value="Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2467813">
<property type="pathway name" value="Separation of Sister Chromatids"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2500257">
<property type="pathway name" value="Resolution of Sister Chromatid Cohesion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5663220">
<property type="pathway name" value="RHO GTPases Activate Formins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-68877">
<property type="pathway name" value="Mitotic Prometaphase"/>
</dbReference>
<dbReference type="SIGNOR" id="Q5FBB7"/>
<dbReference type="ChiTaRS" id="SGOL1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q5FBB7"/>
<dbReference type="GeneWiki" id="SGOL1"/>
<dbReference type="GenomeRNAi" id="151648"/>
<dbReference type="PRO" id="PR:Q5FBB7"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000129810"/>
<dbReference type="ExpressionAtlas" id="Q5FBB7">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q5FBB7">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000775">
<property type="term" value="C:chromosome, centromeric region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000777">
<property type="term" value="C:condensed chromosome kinetochore"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0000779">
<property type="term" value="C:condensed chromosome, centromeric region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000776">
<property type="term" value="C:kinetochore"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0000922">
<property type="term" value="C:spindle pole"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0008608">
<property type="term" value="P:attachment of spindle microtubules to kinetochore"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0010457">
<property type="term" value="P:centriole-centriole cohesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007059">
<property type="term" value="P:chromosome segregation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045132">
<property type="term" value="P:meiotic chromosome segregation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071962">
<property type="term" value="P:mitotic sister chromatid cohesion, centromeric"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007062">
<property type="term" value="P:sister chromatid cohesion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR028321">
<property type="entry name" value="Sgo1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011515">
<property type="entry name" value="Shugoshin_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR011516">
<property type="entry name" value="Shugoshin_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR21577:SF3">
<property type="entry name" value="PTHR21577:SF3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07557">
<property type="entry name" value="Shugoshin_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07558">
<property type="entry name" value="Shugoshin_N"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0137">Centromere</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0159">Chromosome partition</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0995">Kinetochore</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Shugoshin 1" id="PRO_0000055436">
<location>
<begin position="1"/>
<end position="561"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for interaction with PPP2CA and PPP2R1A" evidence="14">
<location>
<begin position="1"/>
<end position="176"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="8">
<location>
<begin position="7"/>
<end position="89"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="8">
<location>
<begin position="273"/>
<end position="313"/>
</location>
</feature>
<feature type="short sequence motif" description="D-box 1">
<location>
<begin position="192"/>
<end position="200"/>
</location>
</feature>
<feature type="short sequence motif" description="KEN box">
<location>
<begin position="310"/>
<end position="312"/>
</location>
</feature>
<feature type="short sequence motif" description="D-box 2">
<location>
<begin position="438"/>
<end position="446"/>
</location>
</feature>
<feature type="short sequence motif" description="PXVXL/I motif" evidence="29">
<location>
<begin position="451"/>
<end position="455"/>
</location>
</feature>
<feature type="short sequence motif" description="D-box 3">
<location>
<begin position="457"/>
<end position="465"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by NEK2" evidence="17">
<location>
<position position="14"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 7">
<location>
<position position="256"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 7">
<location>
<position position="436"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by NEK2" evidence="4 5 17">
<location>
<position position="507"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 5." id="VSP_016790" evidence="24 25 26">
<original>D</original>
<variation>A</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 5." id="VSP_016791" evidence="24 25 26">
<location>
<begin position="160"/>
<end position="428"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_016792" evidence="25 26">
<original>G</original>
<variation>A</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_016793" evidence="25">
<location>
<begin position="177"/>
<end position="522"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_016794" evidence="25 26">
<location>
<begin position="177"/>
<end position="428"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4, isoform 5 and isoform 6." id="VSP_016795" evidence="23 24 25 26">
<original>RALEVSPAKEAIFILYYVREFVSRFPDCRKCKLETHICLR</original>
<variation>SMKQIQ</variation>
<location>
<begin position="522"/>
<end position="561"/>
</location>
</feature>
<feature type="sequence variant" description="In CAID; patient fibroblasts exhibit significantly faster cell proliferation than controls; during mitosis the mutant protein is localized in an ordered fashion around the centromeres but display a rather homogeneous cytoplasmic localization pattern; dbSNP:rs199815268." id="VAR_072709" evidence="22">
<original>K</original>
<variation>E</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6806241." id="VAR_051968">
<original>V</original>
<variation>A</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9868701." id="VAR_051969">
<original>Q</original>
<variation>P</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation and presence of misaligned chromosomes; when associated with A-507." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with PPP2CA and PPP2R1A and loss of centromeric localization." evidence="14">
<original>N</original>
<variation>I</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of proper localization to spindle pole and mitotic spindle. Significant increase in split spindle poles." evidence="18">
<original>S</original>
<variation>A</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of proper localization to spindle pole and mitotic spindle. Significant increase in split spindle poles." evidence="18">
<original>T</original>
<variation>A</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with CBX5, loss of localization to centromeres in interphase, no effect on localization to centromeres in mitosis; when associated with A-453 and A-455." evidence="21">
<original>P</original>
<variation>A</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with CBX5, loss of localization to centromeres in interphase, no effect on localization to centromeres in mitosis; when associated with A-451 and A-455." evidence="21">
<original>V</original>
<variation>A</variation>
<location>
<position position="453"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with CBX5, loss of localization to centromeres in interphase, no effect on localization to centromeres in mitosis; when associated with A-451 and A-453." evidence="21">
<original>I</original>
<variation>A</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of centromeric localization." evidence="14">
<original>K</original>
<variation>A</variation>
<location>
<position position="492"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation; and presence of misaligned chromosomes; when associated with A-14." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="51"/>
<end position="93"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="448"/>
<end position="455"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3FGA"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3Q6S"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255"/>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12747765"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15604152"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15723797"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15737064"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16541025"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16580887"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16582621"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17617734"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17621308"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18331714"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19015261"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20739936"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21346195"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25282101"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12747765"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15737064"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16582621"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21346195"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:25088"/>
</source>
</evidence>
<sequence length="561" mass="64190" checksum="90CEE0FD2B40CD9C" modified="2005-03-15" version="1">
MAKERCLKKSFQDSLEDIKKRMKEKRNKNLAEIGKRRSFIAAPCQIITNTSTLLKNYQDN
NKMLVLALENEKSKVKEAQDIILQLRKECYYLTCQLYALKGKLTSQQTVEPAQNQEICSS
GMDPNSDDSSRNLFVKDLPQIPLEETELPGQGESFQIEDQIPTIPQDTLGVDFDSGEAKS
TDNVLPRTVSVRSSLKKHCNSICQFDSLDDFETSHLAGKSFEFERVGFLDPLVNMHIPEN
VQHNACQWSKDQVNLSPKLIQPGTFTKTKEDILESKSEQTKSKQRDTQERKREEKRKANR
RKSKRMSKYKENKSENKKTVPQKKMHKSVSSNDAYNFNLEEGVHLTPFRQKVSNDSNREE
NNESEVSLCESSGSGDDSDDLYLPTCKYIQNPTSNSDRPVTRPLAKRALKYTDEKETEGS
KPTKTPTTTPPETQQSPHLSLKDITNVSLYPVVKIRRLSLSPKKNKASPAVALPKRRCTA
SVNYKEPTLASKLRRGDPFTDLCFLNSPIFKQKKDLRRSKKRALEVSPAKEAIFILYYVR
EFVSRFPDCRKCKLETHICLR
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-02-12" modified="2017-11-22" version="128">
<accession>Q9JL19</accession>
<accession>Q9JLT9</accession>
<name>NCOA6_MOUSE</name>
<protein>
<recommendedName>
<fullName>Nuclear receptor coactivator 6</fullName>
</recommendedName>
<alternativeName>
<fullName>Activating signal cointegrator 2</fullName>
<shortName>ASC-2</shortName>
</alternativeName>
<alternativeName>
<fullName>Amplified in breast cancer protein 3</fullName>
</alternativeName>
<alternativeName>
<fullName>Cancer-amplified transcriptional coactivator ASC-2</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear receptor coactivator RAP250</fullName>
<shortName>NRC</shortName>
</alternativeName>
<alternativeName>
<fullName>Nuclear receptor-activating protein, 250 kDa</fullName>
</alternativeName>
<alternativeName>
<fullName>Peroxisome proliferator-activated receptor-interacting protein</fullName>
<shortName>PPAR-interacting protein</shortName>
</alternativeName>
<alternativeName>
<fullName>Thyroid hormone receptor-binding protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">Ncoa6</name>
<name type="synonym">Aib3</name>
<name type="synonym">Prip</name>
<name type="synonym">Rap250</name>
<name type="synonym">Trbp</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="13510" last="13516">
<title>Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR.</title>
<authorList>
<person name="Zhu Y.-J."/>
<person name="Kan L."/>
<person name="Qi C."/>
<person name="Kanwar Y.S."/>
<person name="Yeldandi A.V."/>
<person name="Rao M.S."/>
<person name="Reddy J.K."/>
</authorList>
<dbReference type="PubMed" id="10788465"/>
<dbReference type="DOI" id="10.1074/jbc.275.18.13510"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>INTERACTION WITH PPARA; PPARG; RARA; RXRA; ESR1; ESR2 AND THRB</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<strain>FVB/N</strain>
<tissue>Mammary tumor</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="5308" last="5317">
<title>Cloning and characterization of RAP250, a nuclear receptor coactivator.</title>
<authorList>
<person name="Caira F."/>
<person name="Antonson P."/>
<person name="Pelto-Huikko M."/>
<person name="Treuter E."/>
<person name="Gustafsson J.-A."/>
</authorList>
<dbReference type="PubMed" id="10681503"/>
<dbReference type="DOI" id="10.1074/jbc.275.8.5308"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 786-1142 (ISOFORM 1)</scope>
<scope>INTERACTION WITH PPARA; PPARG; ESR1; ESR2; THRA AND THRB</scope>
<scope>MUTAGENESIS OF 891-LEU--LEU-894</scope>
<source>
<tissue>Embryo</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="1229" last="1234">
<title>Molecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptors.</title>
<authorList>
<person name="Jung D.-J."/>
<person name="Na S.-Y."/>
<person name="Na D.S."/>
<person name="Lee J.W."/>
</authorList>
<dbReference type="PubMed" id="11704680"/>
<dbReference type="DOI" id="10.1074/jbc.M110417200"/>
</citation>
<scope>INTERACTION WITH RBM39</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2010" name="Cell" volume="143" first="1174" last="1189">
<title>A tissue-specific atlas of mouse protein phosphorylation and expression.</title>
<authorList>
<person name="Huttlin E.L."/>
<person name="Jedrychowski M.P."/>
<person name="Elias J.E."/>
<person name="Goswami T."/>
<person name="Rad R."/>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Haas W."/>
<person name="Sowa M.E."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="21183079"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.12.001"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2022</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Lung</tissue>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2013" name="Mol. Cell" volume="50" first="919" last="930">
<title>SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways.</title>
<authorList>
<person name="Park J."/>
<person name="Chen Y."/>
<person name="Tishkoff D.X."/>
<person name="Peng C."/>
<person name="Tan M."/>
<person name="Dai L."/>
<person name="Xie Z."/>
<person name="Zhang Y."/>
<person name="Zwaans B.M."/>
<person name="Skinner M.E."/>
<person name="Lombard D.B."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="23806337"/>
<dbReference type="DOI" id="10.1016/j.molcel.2013.06.001"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1822 AND LYS-1825</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic fibroblast</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.O113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-95; ARG-1050; ARG-1061 AND ARG-1099</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Embryo</tissue>
</source>
</reference>
<comment type="function">
<text>Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Coactivates expression in an agonist- and AF2-dependent manner. Involved in the coactivation of different nuclear receptors, such as for steroids (GR and ERs), retinoids (RARs and RXRs), thyroid hormone (TRs), vitamin D3 (VDR) and prostanoids (PPARs). Probably functions as a general coactivator, rather than just a nuclear receptor coactivator. May also be involved in the coactivation of the NF-kappa-B pathway. May coactivate expression via a remodeling of chromatin and its interaction with histone acetyltransferase proteins. Involved in placental, cardiac, hepatic and embryonic development.</text>
</comment>
<comment type="subunit">
<text evidence="4">Monomer and homodimer. Interacts in vitro with the basal transcription factors GTF2A and TBP, suggesting an autonomous transactivation function. Interacts with NCOA1, CRSP3, RBM14, the histone acetyltransferase proteins EP300 and CREBBP, and with methyltransferase proteins NCOA6IP and PRMT2 (By similarity). Interacts with RBM39. Component of the MLL2/3 complex (also named ASCOM complex), at least composed of KMT2D/MLL2 or KMT2C/MLL3, ASH2L, RBBP5, WDR5, NCOA6, DPY30, KDM6A, PAXIP1/PTIP, PAGR1 and alpha- and beta-tubulin (By similarity). Interacts with ZNF335; may enhance ligand-dependent transcriptional activation by nuclear hormone receptors (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9JL19-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9JL19-2</id>
<name>2</name>
<sequence type="described" ref="VSP_003410"/>
<text>Acts as a dominant negative repressor.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Widely expressed. High expression in testis and weak expression in small intestine.</text>
</comment>
<comment type="developmental stage">
<text>Expressed at E9 in placenta and at weaker level in uterus. High expression in neural tube and in CNS throughout development. High expression in sensory ganglia and retina from E11. In the alimentary tract and olfactory epithelium expression was seen from E13. Strong expression present in liver and kidney, from E11 and E13 respectively, and then expression decreased at later stages of development. Moderate expression in lung from E13, while it decreases during postnatal life. Strong expression in thymus from E15 onwards, and in spleen from E17 and during early postnatal life, then, the expression decreases.</text>
</comment>
<comment type="domain">
<text>Contains two Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. Only motif 1 is essential for the association with nuclear receptors.</text>
</comment>
<comment type="PTM">
<text evidence="4">Phosphorylated.</text>
</comment>
<dbReference type="EMBL" id="AF216186">
<property type="protein sequence ID" value="AAF35860.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC031113">
<property type="protein sequence ID" value="AAH31113.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF135169">
<property type="protein sequence ID" value="AAF35973.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="UniGene" id="Mm.27592"/>
<dbReference type="ProteinModelPortal" id="Q9JL19"/>
<dbReference type="SMR" id="Q9JL19"/>
<dbReference type="DIP" id="DIP-61283N"/>
<dbReference type="ELM" id="Q9JL19"/>
<dbReference type="IntAct" id="Q9JL19">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="MINT" id="MINT-5200950"/>
<dbReference type="STRING" id="10090.ENSMUSP00000045386"/>
<dbReference type="iPTMnet" id="Q9JL19"/>
<dbReference type="PhosphoSitePlus" id="Q9JL19"/>
<dbReference type="EPD" id="Q9JL19"/>
<dbReference type="PaxDb" id="Q9JL19"/>
<dbReference type="PeptideAtlas" id="Q9JL19"/>
<dbReference type="PRIDE" id="Q9JL19"/>
<dbReference type="MGI" id="MGI:1929915">
<property type="gene designation" value="Ncoa6"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410IK20">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XW4F">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOVERGEN" id="HBG052586"/>
<dbReference type="InParanoid" id="Q9JL19"/>
<dbReference type="ChiTaRS" id="Ncoa6">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9JL19"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="CleanEx" id="MM_NCOA6"/>
<dbReference type="GO" id="GO:0035097">
<property type="term" value="C:histone methyltransferase complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription factor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0051427">
<property type="term" value="F:hormone receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030374">
<property type="term" value="F:ligand-dependent nuclear receptor transcription coactivator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046966">
<property type="term" value="F:thyroid hormone receptor binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0080182">
<property type="term" value="P:histone H3-K4 trimethylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0060716">
<property type="term" value="P:labyrinthine layer blood vessel development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030099">
<property type="term" value="P:myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010468">
<property type="term" value="P:regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009725">
<property type="term" value="P:response to hormone"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="2.130.10.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR026638">
<property type="entry name" value="NCOA6"/>
</dbReference>
<dbReference type="InterPro" id="IPR032715">
<property type="entry name" value="NCOA6_nucleic_acid-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR015943">
<property type="entry name" value="WD40/YVTN_repeat-like_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15690">
<property type="entry name" value="PTHR15690"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF13820">
<property type="entry name" value="Nucleic_acid_bd"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="chain" description="Nuclear receptor coactivator 6" id="PRO_0000094414">
<location>
<begin position="1"/>
<end position="2067"/>
</location>
</feature>
<feature type="region of interest" description="NCOA1-binding region" evidence="4">
<location>
<begin position="1"/>
<end position="1314"/>
</location>
</feature>
<feature type="region of interest" description="CREBBP-binding region" evidence="4">
<location>
<begin position="1"/>
<end position="1060"/>
</location>
</feature>
<feature type="region of interest" description="TBP/GTF2A-binding region" evidence="4">
<location>
<begin position="1"/>
<end position="932"/>
</location>
</feature>
<feature type="region of interest" description="NCOA6IP-binding region" evidence="4">
<location>
<begin position="777"/>
<end position="931"/>
</location>
</feature>
<feature type="region of interest" description="EP300/CRSP3-binding region" evidence="4">
<location>
<begin position="1644"/>
<end position="2067"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 1">
<location>
<begin position="891"/>
<end position="895"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 2">
<location>
<begin position="1495"/>
<end position="1499"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln-rich">
<location>
<begin position="227"/>
<end position="1044"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="376"/>
<end position="381"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="917"/>
<end position="922"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="1543"/>
<end position="1592"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="3">
<location>
<position position="95"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="888"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="3">
<location>
<position position="1050"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="3">
<location>
<position position="1061"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="3">
<location>
<position position="1099"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5">
<location>
<position position="1325"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="2">
<location>
<position position="1822"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="2">
<location>
<position position="1825"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="2022"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_003410" evidence="7 8">
<location>
<begin position="458"/>
<end position="2067"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with nuclear receptors." evidence="6">
<original>LVNL</original>
<variation>AVNA</variation>
<location>
<begin position="891"/>
<end position="894"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAH31113." ref="2" evidence="9">
<original>G</original>
<variation>S</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAH31113." ref="2" evidence="9">
<original>W</original>
<variation>R</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAH31113." ref="2" evidence="9">
<original>M</original>
<variation>I</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAH31113." ref="2" evidence="9">
<original>Q</original>
<variation>QQ</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAF35973." ref="3" evidence="9">
<original>P</original>
<variation>L</variation>
<location>
<position position="1014"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAF35973." ref="3" evidence="9">
<original>SE</original>
<variation>RS</variation>
<location>
<begin position="1141"/>
<end position="1142"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21183079"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23806337"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q14686"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10681503"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10788465"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000305"/>
<sequence length="2067" mass="219663" checksum="C855F8777167AD48" modified="2000-10-01" version="1">
MVLDDLPNFEDIYTSLCSSTMGDSEVEFDSGLEDDDTKGDSILEDSTIFVAFKGNIDDKD
FKWKLDAILKNVPNLLHMESSKLKVQKVEPWNSVRVTFNIPREAAERLWILAQSNNQQLR
DLGILSVQIEGEGAINLALGQNRSQDVRMNGPVASGNSVRMEAGFPMASGPGLIRMTSPA
AVMTPQGGNMSSSMMAPGPNPELQPRTPRPASQSDAMDPLLSGLHIQQQSHPSGSLPPAH
HSMQPVPVNRQMNPANFPQLQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQLQTRPLQQHQ
QQPQGIRPQFTAPTQVPVPPGWNQLPSGALQPPPAQGSLGTMTTNQGWKKAPLPSPMQAQ
LQARPSLATVQTPSHPPPPYPFGSQQASQAHTNFPQMSNPGQFTAPQMKGLQGGPSRVPT
PLQQPHLTNKSPASSPSSFQQGSPASSPTVNQTQQQMGPRPPQNNPLSQGFQQPVSSPGR
NPMVQQGNVPPNFMVMQQQPPNQGPQSLHPGLGGMPKRLPPGFSAGQANPNFMQGQVPST
TAATPGNSGALQLQANQNVQHAGGQGAGPPQNQMQVSHGPPNMMQPSLMGIHGNINNQQA
GSSGVPQVTLGNMQGQPQQGPPSQLMGMHQQIVPSQGQMAQQQGTLNPQNPMILSRAQLM
PQGQMMVNAQNQNLGPSPQRMTPPKQMLPQQGPQMMAPHNQMMGPQGQVLLQQNPMIEQI
MTNQMQGNKAQFNSQNQSNVMPGPAQIMRGPTPNMQGNMVQFTGQMSGQMLPQQGPVNNS
PSQVMGIQGQVLRPPGPSPHMAQQHTDPVTTANNDVNLSQMMPDVSMQQASMVPPHVQSM
QGNSASGSHFSGHGVSFNAPFGGAPNGSQMSCGQNPGFPVNKDVTLTSPLLVNLLQSDIS
AGHFGVNNKQNNTNANKPKKKKPPRKKKNCHQDLNTPDNRPTGLEEVDQQSLPGEQGINL
DTTGPKLPDFSNRPPGYPTQPVEQRPLPQMPPQLMQHVAPPPQPPQQQPQPQLPQQQQPP
PPSQPQSQQQQQQQQMMMMLMMQQDPKSIRLPVSQNVHPPRGPLNPDSQRMPVQQSGNVP
VMVGLQGPASVPPSPDKQRMPMSVNTPMGSNSRKMVYQENPQNSSSSPLGEMSSLPEASG
SEVPSVAGGPNNMPSHLVVSQNQLMMTGPKPGPSPLSATQGATPQQPPVNSLPSSHGHHF
PNVAAPTQTSRPKTPNRASPRPYYPQTPNNRPPSTEPSEISLSPERLNASIAGLFPPQIN
IPLPPRPNLNRGFDQQGLNPTTLKAIGQAPSNLTITNPPNFAAPQAHKLDSVVVNSGKQS
NPGTTKRASPSNSRRSSPGSSRKTTPSPGRQNSKAPKLTLASQTSTTMLQNMELPRNVLV
GPTPLANPPLPGSFPNNTGLNPQNPTVPVPAMGTVLEDNKESVNIPQDSDCQNAQGRKEQ
VNTELKVVPTQEAKMAVPEDQSKKDGQPLDPNKLPSVEENKNLMSPAMREAPTSLSQLLD
NSGAPNVTIKPPGLTDLEVTPPVVSGEDLRKASVIPTLQDPPSKEPSTSLSSPHSSEPCS
TLARSELSEVSSNAAPSIPPVMSRPVSSSSISTPLPPNQITVFVTSNPITTSSNTSAALP
THLQSALMSTVVTMPNVGNKVMVSEGQSAAQSNARPQFITPVFINSSSIIQVMKGSQPST
IPATPLTTNSGLMPPSVAVVGPLHIPQNIKFSSAPVTPNVPSSSPAPNIQTGRPLVLSSR
ATPVQLPSPPCTSSPVVAPNPSVQQVKELNPDEASPQTNTSADQSTLPPSQPTTVVSSLL
TNSPGSSANRRSPVSSSKGKGKVDKIGQILLTKACKKVTGSLEKGEEQYGADGETEGPGL
EITTPGLMGTEQCSTELDSKTPTPSAPTLLKMTSSPMAPSSTSTGPILPGGALPTSVRSI
VTTLVPSELISTAPTTKGNHGGVTSEPLAGGLVEEKVGSHPELLPSIAPSQNLAPKETPA
TALQGSVARPELEANAAIASGQSCEPKEIVEKSKTLTSRRNSRTEEPTMASESVENGHRK
RSSRPASASSSTKDITGAVQSKRRKSK
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-02-12" modified="2018-01-31" version="163">
<accession>Q14686</accession>
<accession>A6NLF1</accession>
<accession>B2RMN5</accession>
<accession>E1P5P7</accession>
<accession>Q9NTZ9</accession>
<accession>Q9UH74</accession>
<accession>Q9UK86</accession>
<name>NCOA6_HUMAN</name>
<protein>
<recommendedName>
<fullName>Nuclear receptor coactivator 6</fullName>
</recommendedName>
<alternativeName>
<fullName>Activating signal cointegrator 2</fullName>
<shortName>ASC-2</shortName>
</alternativeName>
<alternativeName>
<fullName>Amplified in breast cancer protein 3</fullName>
</alternativeName>
<alternativeName>
<fullName>Cancer-amplified transcriptional coactivator ASC-2</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear receptor coactivator RAP250</fullName>
<shortName>NRC RAP250</shortName>
</alternativeName>
<alternativeName>
<fullName>Nuclear receptor-activating protein, 250 kDa</fullName>
</alternativeName>
<alternativeName>
<fullName>Peroxisome proliferator-activated receptor-interacting protein</fullName>
<shortName>PPAR-interacting protein</shortName>
<shortName>PRIP</shortName>
</alternativeName>
<alternativeName>
<fullName>Thyroid hormone receptor-binding protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NCOA6</name>
<name type="synonym">AIB3</name>
<name type="synonym">KIAA0181</name>
<name type="synonym">RAP250</name>
<name type="synonym">TRBP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="34283" last="34293">
<title>A nuclear factor ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo.</title>
<authorList>
<person name="Lee S.-K."/>
<person name="Anzick S.L."/>
<person name="Choi J.-E."/>
<person name="Bubendorf L."/>
<person name="Guan X.-Y."/>
<person name="Jung Y.-K."/>
<person name="Kallioniemi O.-P."/>
<person name="Kononen J."/>
<person name="Trent J.M."/>
<person name="Azorsa D."/>
<person name="Jhun B.-H."/>
<person name="Cheong J.H."/>
<person name="Lee Y.C."/>
<person name="Meltzer P.S."/>
<person name="Lee J.W."/>
</authorList>
<dbReference type="PubMed" id="10567404"/>
<dbReference type="DOI" id="10.1074/jbc.274.48.34283"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>INTERACTION WITH CREBBP; NCOA1; GTF2A; TBP; RXRA; ESR1; RARA AND THRA</scope>
<scope>VARIANT SER-955</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="5048" last="5063">
<title>A new family of nuclear receptor coregulators that integrates nuclear receptor signaling through CBP.</title>
<authorList>
<person name="Mahajan M.A."/>
<person name="Samuels H.H."/>
</authorList>
<dbReference type="PubMed" id="10866662"/>
<dbReference type="DOI" id="10.1128/MCB.20.14.5048-5063.2000"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>HOMODIMERIZATION</scope>
<scope>INTERACTION WITH CREBBP; RXRA; ESR1; NR3C1; RARA; VDR AND THRA</scope>
<scope>VARIANT SER-955</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="5308" last="5317">
<title>Cloning and characterization of RAP250, a nuclear receptor coactivator.</title>
<authorList>
<person name="Caira F."/>
<person name="Antonson P."/>
<person name="Pelto-Huikko M."/>
<person name="Treuter E."/>
<person name="Gustafsson J.-A."/>
</authorList>
<dbReference type="PubMed" id="10681503"/>
<dbReference type="DOI" id="10.1074/jbc.275.8.5308"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>INTERACTION WITH PPARA; PPARG; ESR1; ESR2 AND THR</scope>
<scope>VARIANT SER-955</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="6212" last="6217">
<title>Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator.</title>
<authorList>
<person name="Ko L."/>
<person name="Cardona G.R."/>
<person name="Chin W.W."/>
</authorList>
<dbReference type="PubMed" id="10823961"/>
<dbReference type="DOI" id="10.1073/pnas.97.11.6212"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PHOSPHORYLATION BY PRKDC</scope>
<scope>INTERACTION WITH THR; RAR; EP300 AND CRSP3</scope>
<scope>VARIANT SER-955</scope>
<source>
<tissue>Lymphocyte</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1996" name="DNA Res." volume="3" first="17" last="24">
<title>Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.</title>
<authorList>
<person name="Nagase T."/>
<person name="Seki N."/>
<person name="Ishikawa K."/>
<person name="Tanaka A."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="8724849"/>
<dbReference type="DOI" id="10.1093/dnares/3.1.17"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT SER-955</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="DNA Res." volume="9" first="99" last="106">
<title>Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.</title>
<authorList>
<person name="Nakajima D."/>
<person name="Okazaki N."/>
<person name="Yamakawa H."/>
<person name="Kikuno R."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
</authorList>
<dbReference type="PubMed" id="12168954"/>
<dbReference type="DOI" id="10.1093/dnares/9.3.99"/>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="10380" last="10385">
<title>Cloning and characterization of PIMT, a protein with a methyltransferase domain, which interacts with and enhances nuclear receptor coactivator PRIP function.</title>
<authorList>
<person name="Zhu Y.-J."/>
<person name="Qi C."/>
<person name="Cao W.-Q."/>
<person name="Yeldandi A.V."/>
<person name="Rao M.S."/>
<person name="Reddy J.K."/>
</authorList>
<dbReference type="PubMed" id="11517327"/>
<dbReference type="DOI" id="10.1073/pnas.181347498"/>
</citation>
<scope>INTERACTION WITH NCOA6IP</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="33375" last="33383">
<title>Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM).</title>
<authorList>
<person name="Iwasaki T."/>
<person name="Chin W.W."/>
<person name="Ko L."/>
</authorList>
<dbReference type="PubMed" id="11443112"/>
<dbReference type="DOI" id="10.1074/jbc.M101517200"/>
</citation>
<scope>INTERACTION WITH RBM14</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="28624" last="28630">
<title>Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha.</title>
<authorList>
<person name="Qi C."/>
<person name="Chang J."/>
<person name="Zhu Y."/>
<person name="Yeldandi A.V."/>
<person name="Rao S.M."/>
<person name="Zhu Y.-J."/>
</authorList>
<dbReference type="PubMed" id="12039952"/>
<dbReference type="DOI" id="10.1074/jbc.M201053200"/>
</citation>
<scope>INTERACTION WITH PRMT2</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="6883" last="6894">
<title>NRC-interacting factor 1 is a novel cotransducer that interacts with and regulates the activity of the nuclear hormone receptor coactivator NRC.</title>
<authorList>
<person name="Mahajan M.A."/>
<person name="Murray A."/>
<person name="Samuels H.H."/>
</authorList>
<dbReference type="PubMed" id="12215545"/>
<dbReference type="DOI" id="10.1128/MCB.22.19.6883-6894.2002"/>
</citation>
<scope>INTERACTION WITH ZNF335</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="140" last="149">
<title>Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.</title>
<authorList>
<person name="Goo Y.-H."/>
<person name="Sohn Y.C."/>
<person name="Kim D.-H."/>
<person name="Kim S.-W."/>
<person name="Kang M.-J."/>
<person name="Jung D.-J."/>
<person name="Kwak E."/>
<person name="Barlev N.A."/>
<person name="Berger S.L."/>
<person name="Chow V.T."/>
<person name="Roeder R.G."/>
<person name="Azorsa D.O."/>
<person name="Meltzer P.S."/>
<person name="Suh P.-G."/>
<person name="Song E.J."/>
<person name="Lee K.-J."/>
<person name="Lee Y.C."/>
<person name="Lee J.W."/>
</authorList>
<dbReference type="PubMed" id="12482968"/>
<dbReference type="DOI" id="10.1128/MCB.23.1.140-149.2003"/>
</citation>
<scope>IDENTIFICATION IN THE MLL2/3 (ASCOM) COMPLEX</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="Mol. Endocrinol." volume="16" first="128" last="140">
<title>Ser-884 adjacent to the LXXLL motif of coactivator TRBP defines selectivity for ERs and TRs.</title>
<authorList>
<person name="Ko L."/>
<person name="Cardona G.R."/>
<person name="Iwasaki T."/>
<person name="Bramlett K.S."/>
<person name="Burris T.P."/>
<person name="Chin W.W."/>
</authorList>
<dbReference type="PubMed" id="11773444"/>
<dbReference type="DOI" id="10.1210/mend.16.1.0755"/>
</citation>
<scope>MUTAGENESIS OF 883-THR--GLU-894</scope>
<scope>PHOSPHORYLATION AT SER-884</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="15392" last="15397">
<title>Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases.</title>
<authorList>
<person name="Lee S."/>
<person name="Lee D.K."/>
<person name="Dou Y."/>
<person name="Lee J."/>
<person name="Lee B."/>
<person name="Kwak E."/>
<person name="Kong Y.Y."/>
<person name="Lee S.K."/>
<person name="Roeder R.G."/>
<person name="Lee J.W."/>
</authorList>
<dbReference type="PubMed" id="17021013"/>
<dbReference type="DOI" id="10.1073/pnas.0607313103"/>
</citation>
<scope>IDENTIFICATION IN THE MLL2/3 (ASCOM) COMPLEX</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="20395" last="20406">
<title>PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.</title>
<authorList>
<person name="Cho Y.-W."/>
<person name="Hong T."/>
<person name="Hong S."/>
<person name="Guo H."/>
<person name="Yu H."/>
<person name="Kim D."/>
<person name="Guszczynski T."/>
<person name="Dressler G.R."/>
<person name="Copeland T.D."/>
<person name="Kalkum M."/>
<person name="Ge K."/>
</authorList>
<dbReference type="PubMed" id="17500065"/>
<dbReference type="DOI" id="10.1074/jbc.M701574200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE MLL2/3 COMPLEX</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2018</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.O113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-95</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] SER-1060 AND ARG-1191</scope>
</reference>
<comment type="function">
<text>Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Coactivates expression in an agonist- and AF2-dependent manner. Involved in the coactivation of different nuclear receptors, such as for steroids (GR and ERs), retinoids (RARs and RXRs), thyroid hormone (TRs), vitamin D3 (VDR) and prostanoids (PPARs). Probably functions as a general coactivator, rather than just a nuclear receptor coactivator. May also be involved in the coactivation of the NF-kappa-B pathway. May coactivate expression via a remodeling of chromatin and its interaction with histone acetyltransferase proteins.</text>
</comment>
<comment type="subunit">
<text evidence="3 5 6 7 8 9 10 12 13 14 16 17">Monomer and homodimer. Interacts with RBM39 (By similarity). Interacts in vitro with the basal transcription factors GTF2A and TBP, suggesting an autonomous transactivation function. Interacts with NCOA1, CRSP3, RBM14, the histone acetyltransferases EP300 and CREBBP, and with the methyltransferases NCOA6IP and PRMT2/HRMT1L1. Component of the MLL2/3 complex (also named ASCOM complex), at least composed of KMT2D/MLL2 or KMT2C/MLL3, ASH2L, RBBP5, WDR5, NCOA6, DPY30, KDM6A, PAXIP1/PTIP, PAGR1 and alpha- and beta-tubulin. Interacts with ZNF335; may enhance ligand-dependent transcriptional activation by nuclear hormone receptors.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78670"/>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78670"/>
<interactant intactId="EBI-540797">
<id>Q9UBL3</id>
<label>ASH2L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78670"/>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78670"/>
<interactant intactId="EBI-765774">
<id>Q9UMN6</id>
<label>KMT2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78670"/>
<interactant intactId="EBI-1042997">
<id>Q8NEZ4</id>
<label>KMT2C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78670"/>
<interactant intactId="EBI-491274">
<id>P06400</id>
<label>RB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78670"/>
<interactant intactId="EBI-396540">
<id>Q12888</id>
<label>TP53BP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78670"/>
<interactant intactId="EBI-8022649">
<id>Q12888-1</id>
<label>TP53BP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78670"/>
<interactant intactId="EBI-540834">
<id>P61964</id>
<label>WDR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Ubiquitous. Highly expressed in brain, prostate, testis and ovary; weakly expressed in lung, thymus and small intestine.</text>
</comment>
<comment type="domain">
<text>Contains two Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. Only motif 1 is essential for the association with nuclear receptors, while adjacent Ser-884 displays selectivity for nuclear receptors.</text>
</comment>
<comment type="PTM">
<text>Phosphorylated by PRKDC.</text>
</comment>
<comment type="PTM">
<text evidence="7 11">Phosphorylation on Ser-884 leads to a strong decrease in binding to ESR1 and ESR2.</text>
</comment>
<comment type="miscellaneous">
<text>Frequently amplified or overexpressed in colon, breast and lung cancers.</text>
</comment>
<comment type="sequence caution" evidence="19">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAF16403" version="1"/>
</conflict>
<location>
<position position="88"/>
</location>
</comment>
<comment type="sequence caution" evidence="19">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA11498" version="2"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<dbReference type="EMBL" id="AF177388">
<property type="protein sequence ID" value="AAF13595.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF208227">
<property type="protein sequence ID" value="AAF16403.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF245115">
<property type="protein sequence ID" value="AAF78480.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF128458">
<property type="protein sequence ID" value="AAF37003.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF171667">
<property type="protein sequence ID" value="AAF71829.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D80003">
<property type="protein sequence ID" value="BAA11498.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL109824">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW76254.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW76255.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136272">
<property type="protein sequence ID" value="AAI36273.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13241.1"/>
<dbReference type="RefSeq" id="NP_001229468.1">
<property type="nucleotide sequence ID" value="NM_001242539.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305169.1">
<property type="nucleotide sequence ID" value="NM_001318240.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_054790.2">
<property type="nucleotide sequence ID" value="NM_014071.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.368971"/>
<dbReference type="UniGene" id="Hs.736403"/>
<dbReference type="ProteinModelPortal" id="Q14686"/>
<dbReference type="SMR" id="Q14686"/>
<dbReference type="BioGrid" id="116691">
<property type="interactions" value="81"/>
</dbReference>
<dbReference type="CORUM" id="Q14686"/>
<dbReference type="DIP" id="DIP-30934N"/>
<dbReference type="IntAct" id="Q14686">
<property type="interactions" value="40"/>
</dbReference>
<dbReference type="MINT" id="MINT-1194462"/>
<dbReference type="STRING" id="9606.ENSP00000351894"/>
<dbReference type="iPTMnet" id="Q14686"/>
<dbReference type="PhosphoSitePlus" id="Q14686"/>
<dbReference type="BioMuta" id="NCOA6"/>
<dbReference type="DMDM" id="116242672"/>
<dbReference type="EPD" id="Q14686"/>
<dbReference type="MaxQB" id="Q14686"/>
<dbReference type="PaxDb" id="Q14686"/>
<dbReference type="PeptideAtlas" id="Q14686"/>
<dbReference type="PRIDE" id="Q14686"/>
<dbReference type="Ensembl" id="ENST00000359003">
<property type="protein sequence ID" value="ENSP00000351894"/>
<property type="gene ID" value="ENSG00000198646"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000374796">
<property type="protein sequence ID" value="ENSP00000363929"/>
<property type="gene ID" value="ENSG00000198646"/>
</dbReference>
<dbReference type="GeneID" id="23054"/>
<dbReference type="KEGG" id="hsa:23054"/>
<dbReference type="UCSC" id="uc002xav.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="23054"/>
<dbReference type="DisGeNET" id="23054"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000198646.13"/>
<dbReference type="GeneCards" id="NCOA6"/>
<dbReference type="H-InvDB" id="HIX0015752"/>
<dbReference type="HGNC" id="HGNC:15936">
<property type="gene designation" value="NCOA6"/>
</dbReference>
<dbReference type="HPA" id="HPA004198"/>
<dbReference type="HPA" id="HPA050211"/>
<dbReference type="MIM" id="605299">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14686"/>
<dbReference type="OpenTargets" id="ENSG00000198646"/>
<dbReference type="PharmGKB" id="PA31475"/>
<dbReference type="eggNOG" id="ENOG410IK20">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XW4F">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00730000111114"/>
<dbReference type="HOVERGEN" id="HBG052586"/>
<dbReference type="InParanoid" id="Q14686"/>
<dbReference type="KO" id="K14971"/>
<dbReference type="OMA" id="GMPKRLP"/>
<dbReference type="OrthoDB" id="EOG091G00CR"/>
<dbReference type="PhylomeDB" id="Q14686"/>
<dbReference type="TreeFam" id="TF332639"/>
<dbReference type="Reactome" id="R-HSA-1368082">
<property type="pathway name" value="RORA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1368108">
<property type="pathway name" value="BMAL1:CLOCK,NPAS2 activates circadian gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1989781">
<property type="pathway name" value="PPARA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2032785">
<property type="pathway name" value="YAP1- and WWTR1 (TAZ)-stimulated gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2151201">
<property type="pathway name" value="Transcriptional activation of mitochondrial biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2426168">
<property type="pathway name" value="Activation of gene expression by SREBF (SREBP)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381340">
<property type="pathway name" value="Transcriptional regulation of white adipocyte differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400206">
<property type="pathway name" value="Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5617472">
<property type="pathway name" value="Activation of anterior HOX genes in hindbrain development during early embryogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951671">
<property type="pathway name" value="RUNX3 regulates YAP1-mediated transcription"/>
</dbReference>
<dbReference type="ChiTaRS" id="NCOA6">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="NCOA6"/>
<dbReference type="GenomeRNAi" id="23054"/>
<dbReference type="PRO" id="PR:Q14686"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000198646"/>
<dbReference type="CleanEx" id="HS_NCOA6"/>
<dbReference type="ExpressionAtlas" id="Q14686">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14686">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0035097">
<property type="term" value="C:histone methyltransferase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription factor complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030331">
<property type="term" value="F:estrogen receptor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030374">
<property type="term" value="F:ligand-dependent nuclear receptor transcription coactivator activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046965">
<property type="term" value="F:retinoid X receptor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046966">
<property type="term" value="F:thyroid hormone receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006310">
<property type="term" value="P:DNA recombination"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006352">
<property type="term" value="P:DNA-templated transcription, initiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042921">
<property type="term" value="P:glucocorticoid receptor signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030520">
<property type="term" value="P:intracellular estrogen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030099">
<property type="term" value="P:myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019216">
<property type="term" value="P:regulation of lipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009725">
<property type="term" value="P:response to hormone"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.130.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR026638">
<property type="entry name" value="NCOA6"/>
</dbReference>
<dbReference type="InterPro" id="IPR032715">
<property type="entry name" value="NCOA6_nucleic_acid-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR015943">
<property type="entry name" value="WD40/YVTN_repeat-like_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15690">
<property type="entry name" value="PTHR15690"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF13820">
<property type="entry name" value="Nucleic_acid_bd"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="chain" description="Nuclear receptor coactivator 6" id="PRO_0000094413">
<location>
<begin position="1"/>
<end position="2063"/>
</location>
</feature>
<feature type="region of interest" description="NCOA1-binding region">
<location>
<begin position="1"/>
<end position="1310"/>
</location>
</feature>
<feature type="region of interest" description="CREBBP-binding region">
<location>
<begin position="1"/>
<end position="1057"/>
</location>
</feature>
<feature type="region of interest" description="TBP/GTF2A-binding region">
<location>
<begin position="1"/>
<end position="928"/>
</location>
</feature>
<feature type="region of interest" description="NCOA6IP-binding region">
<location>
<begin position="773"/>
<end position="927"/>
</location>
</feature>
<feature type="region of interest" description="EP300/CRSP3-binding region">
<location>
<begin position="1641"/>
<end position="2063"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 1">
<location>
<begin position="887"/>
<end position="891"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 2">
<location>
<begin position="1491"/>
<end position="1495"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln-rich">
<location>
<begin position="227"/>
<end position="1041"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="372"/>
<end position="377"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="913"/>
<end position="918"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
<location>
<position position="95"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK; in vitro" evidence="11">
<location>
<position position="884"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="4">
<location>
<position position="1047"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="4">
<location>
<position position="1058"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="4">
<location>
<position position="1096"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="1819"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="1822"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="2018"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6060031." id="VAR_027874">
<original>P</original>
<variation>L</variation>
<location>
<position position="512"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17092079." id="VAR_027875" evidence="5 6 7 8 18">
<original>N</original>
<variation>S</variation>
<location>
<position position="955"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_036551" evidence="15">
<original>P</original>
<variation>S</variation>
<location>
<position position="1060"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_036552" evidence="15">
<original>S</original>
<variation>R</variation>
<location>
<position position="1191"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6060022." id="VAR_027876">
<original>I</original>
<variation>V</variation>
<location>
<position position="1995"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced binding to THRB, RXRA, ESR2 and ESR1." evidence="11">
<original>TSPLLVNLLQSD</original>
<variation>ENPLLVNLLQFI</variation>
<location>
<begin position="883"/>
<end position="894"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced binding to THRB, RXRA, ESR2 and ESR1." evidence="11">
<original>TSPLLVNLLQSD</original>
<variation>NLPLLVNLLQHT</variation>
<location>
<begin position="883"/>
<end position="894"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced binding to THRB, RXRA, ESR2 and ESR1." evidence="11">
<original>TSPLLVNLLQSD</original>
<variation>VNPLLVNLLQFI</variation>
<location>
<begin position="883"/>
<end position="894"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strong increase in binding to THRB, RXRA and ESR2, but dramatic decrease in binding to ESR1.">
<original>TS</original>
<variation>SY</variation>
<location>
<begin position="883"/>
<end position="884"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced binding to THRB, RXRA, ESR2 and ESR1.">
<original>SPLLVNLLQSD</original>
<variation>NPLLVNLLQLL</variation>
<location>
<begin position="884"/>
<end position="894"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9JL19"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10567404"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10681503"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10823961"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10866662"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11443112"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11517327"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11773444"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12039952"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12215545"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12482968"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17021013"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17500065"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8724849"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000305"/>
<sequence length="2063" mass="219145" checksum="73219502F5138427" modified="2006-10-17" version="3">
MVLDDLPNLEDIYTSLCSSTMEDSEMDFDSGLEDDDTKSDSILEDSTIFVAFKGNIDDKD
FKWKLDAILKNVPNLLHMESSKLKVQKVEPWNSVRVTFNIPREAAERLRILAQSNNQQLR
DLGILSVQIEGEGAINLALAQNRSQDVRMNGPMGAGNSVRMEAGFPMASGPGIIRMNNPA
TVMIPPGGNVSSSMMAPGPNPELQPRTPRPASQSDAMDPLLSGLHIQQQSHPSGSLAPPH
HPMQPVSVNRQMNPANFPQLQQQQQQQQQQQQQQQQQQQQQQQQQLQARPPQQHQQQQPQ
GIRPQFTAPTQVPVPPGWNQLPSGALQPPPAQGSLGTMTANQGWKKAPLPGPMQQQLQAR
PSLATVQTPSHPPPPYPFGSQQASQAHTNFPQMSNPGQFTAPQMKSLQGGPSRVPTPLQQ
PHLTNKSPASSPSSFQQGSPASSPTVNQTQQQMGPRPPQNNPLPQGFQQPVSSPGRNPMV
QQGNVPPNFMVMQQQPPNQGPQSLHPGLGGMPKRLPPGFSAGQANPNFMQGQVPSTTATT
PGNSGAPQLQANQNVQHAGGQGAGPPQNQMQVSHGPPNMMQPSLMGIHGNMNNQQAGTSG
VPQVNLSNMQGQPQQGPPSQLMGMHQQIVPSQGQMVQQQGTLNPQNPMILSRAQLMPQGQ
MMVNPPSQNLGPSPQRMTPPKQMLSQQGPQMMAPHNQMMGPQGQVLLQQNPMIEQIMTNQ
MQGNKQQFNTQNQSNVMPGPAQIMRGPTPNMQGNMVQFTGQMSGQMLPQQGPVNNSPSQV
MGIQGQVLRPPGPSPHMAQQHGDPATTANNDVSLSQMMPDVSIQQTNMVPPHVQAMQGNS
ASGNHFSGHGMSFNAPFSGAPNGNQMSCGQNPGFPVNKDVTLTSPLLVNLLQSDISAGHF
GVNNKQNNTNANKPKKKKPPRKKKNSQQDLNTPDTRPAGLEEADQPPLPGEQGINLDNSG
PKLPEFSNRPPGYPSQPVEQRPLQQMPPQLMQHVAPPPQPPQQQPQPQLPQQQQPPPPSQ
PQSQQQQQQQQQMMMMLMMQQDPKSVRLPVSQNVHPPRGPLNPDSQRMPMQQSGSVPVMV
SLQGPASVPPSPDKQRMPMPVNTPLGSNSRKMVYQESPQNPSSSPLAEMASLPEASGSEA
PSVPGGPNNMPSHVVLPQNQLMMTGPKPGPSPLSATQGATPQQPPVNSLPSSHGHHFPNV
AAPTQTSRPKTPNRASPRPYYPQTPNNRPPSTEPSEISLSPERLNASIAGLFPPQINIPL
PPRPNLNRGFDQQGLNPTTLKAIGQAPSNLTMNPSNFATPQTHKLDSVVVNSGKQSNSGA
TKRASPSNSRRSSPGSSRKTTPSPGRQNSKAPKLTLASQTNAALLQNVELPRNVLVSPTP
LANPPVPGSFPNNSGLNPQNSTVSVAAVGGVVEDNKESLNVPQDSDCQNSQSRKEQVNIE
LKAVPAQEVKMVVPEDQSKKDGQPSDPNKLPSVEENKNLVSPAMREAPTSLSQLLDNSGA
PNVTIKPPGLTDLEVTPPVVSGEDLKKASVIPTLQDLSSSKEPSNSLNLPHSNELCSSLV
HPELSEVSSNVAPSIPPVMSRPVSSSSISTPLPPNQITVFVTSNPITTSANTSAALPTHL
QSALMSTVVTMPNAGSKVMVSEGQSAAQSNARPQFITPVFINSSSIIQVMKGSQPSTIPA
APLTTNSGLMPPSVAVVGPLHIPQNIKFSSAPVPPNALSSSPAPNIQTGRPLVLSSRATP
VQLPSPPCTSSPVVPSHPPVQQVKELNPDEASPQVNTSADQNTLPSSQSTTMVSPLLTNS
PGSSGNRRSPVSSSKGKGKVDKIGQILLTKACKKVTGSLEKGEEQYGADGETEGQGLDTT
APGLMGTEQLSTELDSKTPTPPAPTLLKMTSSPVGPGTASAGPSLPGGALPTSVRSIVTT
LVPSELISAVPTTKSNHGGIASESLAGGLVEEKVGSHPELLPSIAPSQNLVSKETSTTAL
QASVARPELEVNAAIVSGQSSEPKEIVEKSKIPGRRNSRTEEPTVASESVENGHRKRSSR
PASASSSTKDITSAVQSKRRKSK
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2002-09-19" modified="2018-01-31" version="193">
<accession>Q9Y6Q9</accession>
<accession>A4LAZ5</accession>
<accession>Q0VF45</accession>
<accession>Q5JYD9</accession>
<accession>Q5JYE0</accession>
<accession>Q9BR49</accession>
<accession>Q9UPC9</accession>
<accession>Q9UPG4</accession>
<accession>Q9UPG7</accession>
<name>NCOA3_HUMAN</name>
<protein>
<recommendedName>
<fullName>Nuclear receptor coactivator 3</fullName>
<shortName>NCoA-3</shortName>
<ecNumber>2.3.1.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName>ACTR</fullName>
</alternativeName>
<alternativeName>
<fullName>Amplified in breast cancer 1 protein</fullName>
<shortName>AIB-1</shortName>
</alternativeName>
<alternativeName>
<fullName>CBP-interacting protein</fullName>
<shortName>pCIP</shortName>
</alternativeName>
<alternativeName>
<fullName>Class E basic helix-loop-helix protein 42</fullName>
<shortName>bHLHe42</shortName>
</alternativeName>
<alternativeName>
<fullName>Receptor-associated coactivator 3</fullName>
<shortName>RAC-3</shortName>
</alternativeName>
<alternativeName>
<fullName>Steroid receptor coactivator protein 3</fullName>
<shortName>SRC-3</shortName>
</alternativeName>
<alternativeName>
<fullName>Thyroid hormone receptor activator molecule 1</fullName>
<shortName>TRAM-1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">NCOA3</name>
<name type="synonym">AIB1</name>
<name type="synonym">BHLHE42</name>
<name type="synonym">RAC3</name>
<name type="synonym">TRAM1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="27629" last="27634">
<title>TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1.</title>
<authorList>
<person name="Takeshita A."/>
<person name="Cardona G.R."/>
<person name="Koibuchi N."/>
<person name="Suen C.-S."/>
<person name="Chin W.W."/>
</authorList>
<dbReference type="PubMed" id="9346901"/>
<dbReference type="DOI" id="10.1074/jbc.272.44.27629"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>INTERACTION WITH CREBBP; PCAF; RARA; RXRA; THRA AND ESR</scope>
<source>
<tissue>Pituitary</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Cell" volume="90" first="569" last="580">
<title>Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.</title>
<authorList>
<person name="Chen H."/>
<person name="Lin R.J."/>
<person name="Schiltz R.L."/>
<person name="Chakravarti D."/>
<person name="Nash A."/>
<person name="Nagy L."/>
<person name="Privalsky M.L."/>
<person name="Nakatani Y."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="9267036"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80516-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4)</scope>
<scope>ENZYME ACTIVITY</scope>
<scope>VARIANT 1248-GLN--GLN-1250 DEL</scope>
<source>
<tissue>Leukemia</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Science" volume="277" first="965" last="968">
<title>AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.</title>
<authorList>
<person name="Anzick S.L."/>
<person name="Kononen J."/>
<person name="Walker R.L."/>
<person name="Azorsa D.O."/>
<person name="Tanner M.M."/>
<person name="Guan X.-Y."/>
<person name="Sauter G."/>
<person name="Kallioniemi O.-P."/>
<person name="Trent J.M."/>
<person name="Meltzer P.S."/>
</authorList>
<dbReference type="PubMed" id="9252329"/>
<dbReference type="DOI" id="10.1126/science.277.5328.965"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<scope>INTERACTION WITH ESR</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="8479" last="8484">
<title>RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2.</title>
<authorList>
<person name="Li H."/>
<person name="Gomes P.J."/>
<person name="Chen J.D."/>
</authorList>
<dbReference type="PubMed" id="9238002"/>
<dbReference type="DOI" id="10.1073/pnas.94.16.8479"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<scope>INTERACTION WITH VDR; RARA; PPARA; RXRA; THRA AND ESR</scope>
<scope>VARIANT 1248-GLN--GLN-1250 DEL</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2007-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS CYS-218; ILE-220; VAL-556; SER-559; HIS-586; ALA-777; LEU-1247 AND LYS-1247</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="Clin. Genet." volume="54" first="102" last="103">
<title>Polymorphic exonic CAG microsatellites in the gene amplified in breast cancer (AIB1 gene).</title>
<authorList>
<person name="Shirazi S.K."/>
<person name="Bober M.A."/>
<person name="Coetzee G.A."/>
</authorList>
<dbReference type="PubMed" id="9727751"/>
</citation>
<scope>POLYMORPHISM OF POLY-GLN REGION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Cell" volume="98" first="675" last="686">
<title>Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase.</title>
<authorList>
<person name="Chen H."/>
<person name="Lin R.J."/>
<person name="Xie W."/>
<person name="Wilpitz D."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="10490106"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80054-9"/>
</citation>
<scope>ACETYLATION AT LYS-616; LYS-619 AND LYS-620 BY CREBBP</scope>
<scope>MUTAGENESIS OF LYS-616; 619-LYS-LYS-620; LYS-647; LYS-681; LYS-687; LYS-700 AND LYS-708</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="FEBS Lett." volume="485" first="195" last="199">
<title>RAC-3 is a NF-kappa B coactivator.</title>
<authorList>
<person name="Werbajh S."/>
<person name="Nojek I."/>
<person name="Lanz R."/>
<person name="Costas M.A."/>
</authorList>
<dbReference type="PubMed" id="11094166"/>
<dbReference type="DOI" id="10.1016/S0014-5793(00)02223-7"/>
</citation>
<scope>INTERACTION WITH NFKB1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="1341" last="1352">
<title>A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA.</title>
<authorList>
<person name="Watanabe M."/>
<person name="Yanagisawa J."/>
<person name="Kitagawa H."/>
<person name="Takeyama K."/>
<person name="Ogawa S."/>
<person name="Arao Y."/>
<person name="Suzawa M."/>
<person name="Kobayashi Y."/>
<person name="Yano T."/>
<person name="Yoshikawa H."/>
<person name="Masuhiro Y."/>
<person name="Kato S."/>
</authorList>
<dbReference type="PubMed" id="11250900"/>
<dbReference type="DOI" id="10.1093/emboj/20.6.1341"/>
</citation>
<scope>INTERACTION WITH DDX5</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="3549" last="3561">
<title>Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase.</title>
<authorList>
<person name="Wu R.-C."/>
<person name="Qin J."/>
<person name="Hashimoto Y."/>
<person name="Wong J."/>
<person name="Xu J."/>
<person name="Tsai S.Y."/>
<person name="Tsai M.-J."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="11971985"/>
<dbReference type="DOI" id="10.1128/MCB.22.10.3549-3561.2002"/>
</citation>
<scope>SUBUNIT OF A COMPLEX CONTAINING CREBBP; NCOA2; IKKA; IKKB AND IKBKG</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="6210" last="6220">
<title>BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation.</title>
<authorList>
<person name="Hsiao P.W."/>
<person name="Fryer C.J."/>
<person name="Trotter K.W."/>
<person name="Wang W."/>
<person name="Archer T.K."/>
</authorList>
<dbReference type="PubMed" id="12917342"/>
<dbReference type="DOI" id="10.1128/MCB.23.17.6210-6220.2003"/>
</citation>
<scope>INTERACTION WITH NR3C1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="7091" last="7097">
<title>Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.</title>
<authorList>
<person name="Curtis A.M."/>
<person name="Seo S.B."/>
<person name="Westgate E.J."/>
<person name="Rudic R.D."/>
<person name="Smyth E.M."/>
<person name="Chakravarti D."/>
<person name="FitzGerald G.A."/>
<person name="McNamara P."/>
</authorList>
<dbReference type="PubMed" id="14645221"/>
<dbReference type="DOI" id="10.1074/jbc.M311973200"/>
</citation>
<scope>INTERACTION WITH NPAS2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="J. Steroid Biochem. Mol. Biol." volume="92" first="357" last="363">
<title>FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors.</title>
<authorList>
<person name="Kino T."/>
<person name="Ichijo T."/>
<person name="Chrousos G.P."/>
</authorList>
<dbReference type="PubMed" id="15698540"/>
<dbReference type="DOI" id="10.1016/j.jsbmb.2004.09.003"/>
</citation>
<scope>INTERACTION WITH CASP8AP2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="8439" last="8447">
<title>Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells.</title>
<authorList>
<person name="Ma A.H."/>
<person name="Xia L."/>
<person name="Desai S.J."/>
<person name="Boucher D.L."/>
<person name="Guan Y."/>
<person name="Shih H.M."/>
<person name="Shi X.B."/>
<person name="deVere White R.W."/>
<person name="Chen H.W."/>
<person name="Tepper C.G."/>
<person name="Kung H.J."/>
</authorList>
<dbReference type="PubMed" id="16951154"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-1636"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="4223" last="4233">
<title>The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription.</title>
<authorList>
<person name="Zhang H."/>
<person name="Sun L."/>
<person name="Liang J."/>
<person name="Yu W."/>
<person name="Zhang Y."/>
<person name="Wang Y."/>
<person name="Chen Y."/>
<person name="Li R."/>
<person name="Sun X."/>
<person name="Shang Y."/>
</authorList>
<dbReference type="PubMed" id="16957778"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601306"/>
</citation>
<scope>INTERACTION WITH PSMB9</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-857 AND SER-867</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="18067" last="18072">
<title>ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.</title>
<authorList>
<person name="Zou J.X."/>
<person name="Revenko A.S."/>
<person name="Li L.B."/>
<person name="Gemo A.T."/>
<person name="Chen H.-W."/>
</authorList>
<dbReference type="PubMed" id="17998543"/>
<dbReference type="DOI" id="10.1073/pnas.0705814104"/>
</citation>
<scope>INTERACTION WITH ATAD2</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214; SER-551; SER-728 AND SER-857</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Nucleic Acids Res." volume="37" first="3110" last="3123">
<title>CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions.</title>
<authorList>
<person name="Giamas G."/>
<person name="Castellano L."/>
<person name="Feng Q."/>
<person name="Knippschild U."/>
<person name="Jacob J."/>
<person name="Thomas R.S."/>
<person name="Coombes R.C."/>
<person name="Smith C.L."/>
<person name="Jiao L.R."/>
<person name="Stebbing J."/>
</authorList>
<dbReference type="PubMed" id="19339517"/>
<dbReference type="DOI" id="10.1093/nar/gkp136"/>
</citation>
<scope>PHOSPHORYLATION AT SER-601 BY CSNK1D/CK1</scope>
<scope>INTERACTION WITH CSNK1D</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-857</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-687</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214; SER-857 AND SER-867</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214; SER-551; SER-694; SER-728; SER-857; SER-1033 AND SER-1330</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-551</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.O113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-1171; ARG-1177 AND ARG-1188</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<comment type="function">
<text>Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Plays a central role in creating a multisubunit coactivator complex, which probably acts via remodeling of chromatin. Involved in the coactivation of different nuclear receptors, such as for steroids (GR and ER), retinoids (RARs and RXRs), thyroid hormone (TRs), vitamin D3 (VDR) and prostanoids (PPARs). Displays histone acetyltransferase activity. Also involved in the coactivation of the NF-kappa-B pathway via its interaction with the NFKB1 subunit.</text>
</comment>
<comment type="catalytic activity">
<text evidence="30">Acetyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-acetyl-L-lysine.</text>
</comment>
<comment type="enzyme regulation">
<text>Coactivator activity on nuclear receptors and NF-kappa-B pathways is enhanced by various hormones, and the TNF cytokine, respectively. TNF stimulation probably enhances phosphorylation, which in turn activates coactivator function. In contrast, acetylation by CREBBP apparently suppresses coactivation of target genes by disrupting its association with nuclear receptors. Binds to CSNK1D.</text>
</comment>
<comment type="subunit">
<text evidence="13 14 18 19 20 21 22 23 24 25 26 27 28 29 31">Interacts with CARM1 (By similarity). Present in a complex containing NCOA2, IKKA, IKKB, IKBKG and the histone acetyltransferase protein CREBBP. Interacts with CASP8AP2, NR3C1 and PCAF. Interacts with ATAD2 and this interaction is enhanced by estradiol. Found in a complex containing NCOA3, AR and MAK. Interacts with DDX5. Interacts with PSMB9. Interacts with NPAS2. Interacts with NR4A3 (By similarity). Interacts with ESRRB; mediates the interaction between ESRRB and RNA polymerase II complexes and allows NCOA3 corecruitment to ESRRB, KLF4, NANOG, and SOX2 enhancer regions to trigger ESRRB-dependent gene activation involved in self-renewal and pluripotency (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-6598454">
<id>Q6PL18</id>
<label>ATAD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-2339854">
<id>Q86X55</id>
<label>CARM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-746012">
<id>Q92841</id>
<label>DDX17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-81266">
<id>O14920</id>
<label>IKBKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-15626132">
<id>Q8VIM5-1</id>
<label>Myocd</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-603300">
<id>P28065</id>
<label>PSMB9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-355546">
<id>P61289</id>
<label>PSME3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-696162">
<id>P60484</id>
<label>PTEN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-413374">
<id>P10276</id>
<label>RARA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-743549">
<id>O43791</id>
<label>SPOP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-346797">
<id>P48281</id>
<label>Vdr</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Mainly cytoplasmic and weakly nuclear. Upon TNF activation and subsequent phosphorylation, it translocates from the cytoplasm to the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9Y6Q9-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9Y6Q9-2</id>
<name>2</name>
<sequence type="described" ref="VSP_003407"/>
</isoform>
<isoform>
<id>Q9Y6Q9-3</id>
<name>3</name>
<sequence type="described" ref="VSP_003405 VSP_003407 VSP_003408"/>
</isoform>
<isoform>
<id>Q9Y6Q9-4</id>
<name>4</name>
<sequence type="described" ref="VSP_003405 VSP_003406 VSP_003407 VSP_003408"/>
</isoform>
<isoform>
<id>Q9Y6Q9-5</id>
<name>5</name>
<sequence type="described" ref="VSP_003408"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text>Widely expressed. High expression in heart, skeletal muscle, pancreas and placenta. Low expression in brain, and very low in lung, liver and kidney.</text>
</comment>
<comment type="domain">
<text>Contains three Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. Motifs 1 and 2 are essential for the association with nuclear receptors, and constitute the RID domain (Receptor-interacting domain).</text>
</comment>
<comment type="PTM">
<text evidence="17">Acetylated by CREBBP. Acetylation occurs in the RID domain, and disrupts the interaction with nuclear receptors and regulates its function.</text>
</comment>
<comment type="PTM">
<text evidence="13">Methylated by CARM1.</text>
</comment>
<comment type="PTM">
<text evidence="20 27">Phosphorylated by IKK complex. Regulated its function. Phosphorylation at Ser-601 by CK1 promotes coactivator function.</text>
</comment>
<comment type="polymorphism">
<text evidence="32">The length of the poly-Gln region is polymorphic in the normal population.</text>
</comment>
<comment type="miscellaneous">
<text>NCOA3 is frequently amplified or overexpressed in breast and ovarian cancers.</text>
</comment>
<comment type="similarity">
<text evidence="39">Belongs to the SRC/p160 nuclear receptor coactivator family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/NCOA3ID505ch20q13.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/ncoa3/"/>
</comment>
<dbReference type="EC" id="2.3.1.48"/>
<dbReference type="EMBL" id="AF016031">
<property type="protein sequence ID" value="AAC51849.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF036892">
<property type="protein sequence ID" value="AAB92368.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF012108">
<property type="protein sequence ID" value="AAC51677.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF010227">
<property type="protein sequence ID" value="AAC51663.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF488684">
<property type="protein sequence ID" value="ABO43042.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL034418">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW75698.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW75702.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC119001">
<property type="protein sequence ID" value="AAI19002.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13406.1">
<molecule id="Q9Y6Q9-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13407.1">
<molecule id="Q9Y6Q9-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54472.1">
<molecule id="Q9Y6Q9-3"/>
</dbReference>
<dbReference type="PIR" id="T03851">
<property type="entry name" value="T03851"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001167559.1">
<molecule id="Q9Y6Q9-3"/>
<property type="nucleotide sequence ID" value="NM_001174088.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006525.2">
<molecule id="Q9Y6Q9-5"/>
<property type="nucleotide sequence ID" value="NM_006534.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_858045.1">
<molecule id="Q9Y6Q9-1"/>
<property type="nucleotide sequence ID" value="NM_181659.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.592142"/>
<dbReference type="PDB" id="1KBH">
<property type="method" value="NMR"/>
<property type="chains" value="A=1045-1091"/>
</dbReference>
<dbReference type="PDB" id="3L3X">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="B=618-629"/>
</dbReference>
<dbReference type="PDB" id="3L3Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B=735-746"/>
</dbReference>
<dbReference type="PDBsum" id="1KBH"/>
<dbReference type="PDBsum" id="3L3X"/>
<dbReference type="PDBsum" id="3L3Z"/>
<dbReference type="DisProt" id="DP00343"/>
<dbReference type="ProteinModelPortal" id="Q9Y6Q9"/>
<dbReference type="SMR" id="Q9Y6Q9"/>
<dbReference type="BioGrid" id="113841">
<property type="interactions" value="110"/>
</dbReference>
<dbReference type="CORUM" id="Q9Y6Q9"/>
<dbReference type="DIP" id="DIP-30876N"/>
<dbReference type="ELM" id="Q9Y6Q9"/>
<dbReference type="IntAct" id="Q9Y6Q9">
<property type="interactions" value="55"/>
</dbReference>
<dbReference type="MINT" id="MINT-231818"/>
<dbReference type="STRING" id="9606.ENSP00000361066"/>
<dbReference type="BindingDB" id="Q9Y6Q9"/>
<dbReference type="ChEMBL" id="CHEMBL1615382"/>
<dbReference type="iPTMnet" id="Q9Y6Q9"/>
<dbReference type="PhosphoSitePlus" id="Q9Y6Q9"/>
<dbReference type="SwissPalm" id="Q9Y6Q9"/>
<dbReference type="BioMuta" id="NCOA3"/>
<dbReference type="DMDM" id="23396777"/>
<dbReference type="EPD" id="Q9Y6Q9"/>
<dbReference type="PaxDb" id="Q9Y6Q9"/>
<dbReference type="PeptideAtlas" id="Q9Y6Q9"/>
<dbReference type="PRIDE" id="Q9Y6Q9"/>
<dbReference type="Ensembl" id="ENST00000371997">
<molecule id="Q9Y6Q9-3"/>
<property type="protein sequence ID" value="ENSP00000361065"/>
<property type="gene ID" value="ENSG00000124151"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000371998">
<molecule id="Q9Y6Q9-1"/>
<property type="protein sequence ID" value="ENSP00000361066"/>
<property type="gene ID" value="ENSG00000124151"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000372004">
<molecule id="Q9Y6Q9-5"/>
<property type="protein sequence ID" value="ENSP00000361073"/>
<property type="gene ID" value="ENSG00000124151"/>
</dbReference>
<dbReference type="GeneID" id="8202"/>
<dbReference type="KEGG" id="hsa:8202"/>
<dbReference type="UCSC" id="uc002xtk.4">
<molecule id="Q9Y6Q9-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8202"/>
<dbReference type="DisGeNET" id="8202"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000124151.18"/>
<dbReference type="GeneCards" id="NCOA3"/>
<dbReference type="HGNC" id="HGNC:7670">
<property type="gene designation" value="NCOA3"/>
</dbReference>
<dbReference type="HPA" id="CAB009800"/>
<dbReference type="HPA" id="HPA024210"/>
<dbReference type="MIM" id="601937">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y6Q9"/>
<dbReference type="OpenTargets" id="ENSG00000124151"/>
<dbReference type="PharmGKB" id="PA31472"/>
<dbReference type="eggNOG" id="ENOG410IQ5R">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZDZC">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063109"/>
<dbReference type="HOVERGEN" id="HBG052583"/>
<dbReference type="InParanoid" id="Q9Y6Q9"/>
<dbReference type="KO" id="K11256"/>
<dbReference type="OMA" id="MQCFALS"/>
<dbReference type="OrthoDB" id="EOG091G152H"/>
<dbReference type="PhylomeDB" id="Q9Y6Q9"/>
<dbReference type="TreeFam" id="TF332652"/>
<dbReference type="Reactome" id="R-HSA-1989781">
<property type="pathway name" value="PPARA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381340">
<property type="pathway name" value="Transcriptional regulation of white adipocyte differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5617472">
<property type="pathway name" value="Activation of anterior HOX genes in hindbrain development during early embryogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5687128">
<property type="pathway name" value="MAPK6/MAPK4 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="Q9Y6Q9"/>
<dbReference type="SIGNOR" id="Q9Y6Q9"/>
<dbReference type="ChiTaRS" id="NCOA3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9Y6Q9"/>
<dbReference type="GeneWiki" id="Nuclear_receptor_coactivator_3"/>
<dbReference type="GenomeRNAi" id="8202"/>
<dbReference type="PRO" id="PR:Q9Y6Q9"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000124151"/>
<dbReference type="CleanEx" id="HS_NCOA3"/>
<dbReference type="CleanEx" id="HS_RAC3"/>
<dbReference type="CleanEx" id="HS_TRAM1"/>
<dbReference type="Genevisible" id="Q9Y6Q9">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0050681">
<property type="term" value="F:androgen receptor binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097718">
<property type="term" value="F:disordered domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004402">
<property type="term" value="F:histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016922">
<property type="term" value="F:ligand-dependent nuclear receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030374">
<property type="term" value="F:ligand-dependent nuclear receptor transcription coactivator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035257">
<property type="term" value="F:nuclear hormone receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0047485">
<property type="term" value="F:protein N-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000993">
<property type="term" value="F:RNA polymerase II core binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046966">
<property type="term" value="F:thyroid hormone receptor binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030521">
<property type="term" value="P:androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043697">
<property type="term" value="P:cell dedifferentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071392">
<property type="term" value="P:cellular response to estradiol stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032870">
<property type="term" value="P:cellular response to hormone stimulus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030522">
<property type="term" value="P:intracellular receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045618">
<property type="term" value="P:positive regulation of keratinocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902459">
<property type="term" value="P:positive regulation of stem cell population maintenance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035624">
<property type="term" value="P:receptor transactivation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001141">
<property type="term" value="P:regulation of RNA biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000035">
<property type="term" value="P:regulation of stem cell division"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd00083">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd00130">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.287.1070">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.130.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.280.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011598">
<property type="entry name" value="bHLH_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR010011">
<property type="entry name" value="DUF1518"/>
</dbReference>
<dbReference type="InterPro" id="IPR032565">
<property type="entry name" value="DUF4927"/>
</dbReference>
<dbReference type="InterPro" id="IPR036638">
<property type="entry name" value="HLH_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR028818">
<property type="entry name" value="NCOA3"/>
</dbReference>
<dbReference type="InterPro" id="IPR009110">
<property type="entry name" value="Nuc_rcpt_coact"/>
</dbReference>
<dbReference type="InterPro" id="IPR014920">
<property type="entry name" value="Nuc_rcpt_coact_Ncoa-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR037077">
<property type="entry name" value="Nuc_rcpt_coact_Ncoa_int_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR017426">
<property type="entry name" value="Nuclear_rcpt_coactivator"/>
</dbReference>
<dbReference type="InterPro" id="IPR000014">
<property type="entry name" value="PAS"/>
</dbReference>
<dbReference type="InterPro" id="IPR035965">
<property type="entry name" value="PAS-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013767">
<property type="entry name" value="PAS_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR014935">
<property type="entry name" value="SRC/p160_LXXLL"/>
</dbReference>
<dbReference type="InterPro" id="IPR015943">
<property type="entry name" value="WD40/YVTN_repeat-like_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10684">
<property type="entry name" value="PTHR10684"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10684:SF3">
<property type="entry name" value="PTHR10684:SF3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07469">
<property type="entry name" value="DUF1518"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16279">
<property type="entry name" value="DUF4927"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08815">
<property type="entry name" value="Nuc_rec_co-act"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00989">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08832">
<property type="entry name" value="SRC-1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF038181">
<property type="entry name" value="Nuclear_receptor_coactivator"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01151">
<property type="entry name" value="DUF1518"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00353">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00091">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47459">
<property type="entry name" value="SSF47459"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55785">
<property type="entry name" value="SSF55785"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF69125">
<property type="entry name" value="SSF69125"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50888">
<property type="entry name" value="BHLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50112">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="initiator methionine" description="Removed" evidence="9">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Nuclear receptor coactivator 3" id="PRO_0000094406">
<location>
<begin position="2"/>
<end position="1424"/>
</location>
</feature>
<feature type="domain" description="bHLH" evidence="16">
<location>
<begin position="25"/>
<end position="82"/>
</location>
</feature>
<feature type="domain" description="PAS" evidence="15">
<location>
<begin position="110"/>
<end position="180"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CREBBP" evidence="31">
<location>
<begin position="1023"/>
<end position="1093"/>
</location>
</feature>
<feature type="region of interest" description="Acetyltransferase">
<location>
<begin position="1097"/>
<end position="1304"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 1">
<location>
<begin position="685"/>
<end position="689"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 2">
<location>
<begin position="738"/>
<end position="742"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 3">
<location>
<begin position="1057"/>
<end position="1061"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="505"/>
<end position="671"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="976"/>
<end position="980"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="1248"/>
<end position="1278"/>
</location>
</feature>
<feature type="compositionally biased region" description="Met-rich">
<location>
<begin position="1392"/>
<end position="1417"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="9">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 8 10">
<location>
<position position="214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 10 12">
<location>
<position position="551"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="569"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK1" evidence="27">
<location>
<position position="601"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by CREBBP" evidence="17">
<location>
<position position="616"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by CREBBP" evidence="17">
<location>
<position position="619"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by CREBBP" evidence="17">
<location>
<position position="620"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="6">
<location>
<position position="687"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="694"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 10">
<location>
<position position="728"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 7 8 10">
<location>
<position position="857"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="860"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 8">
<location>
<position position="867"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1033"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="11">
<location>
<position position="1171"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="11">
<location>
<position position="1177"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="11">
<location>
<position position="1188"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1330"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 4." id="VSP_003405" evidence="37">
<original>E</original>
<variation>EVTSDGIFSPT</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_003406" evidence="37">
<location>
<begin position="837"/>
<end position="901"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 3 and isoform 4." id="VSP_003407" evidence="37 38">
<location>
<begin position="903"/>
<end position="917"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 4 and isoform 5." id="VSP_003408" evidence="34 35 36 37">
<location>
<begin position="1214"/>
<end position="1217"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6094752." id="VAR_053527" evidence="33">
<original>R</original>
<variation>C</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs72645252." id="VAR_060695" evidence="33">
<original>R</original>
<variation>I</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6094756." id="VAR_053528">
<original>L</original>
<variation>F</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1052765." id="VAR_013831">
<original>G</original>
<variation>R</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs72645272." id="VAR_060696" evidence="33">
<original>I</original>
<variation>V</variation>
<location>
<position position="556"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230781." id="VAR_013832" evidence="33">
<original>P</original>
<variation>S</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230782." id="VAR_013833" evidence="33">
<original>Q</original>
<variation>H</variation>
<location>
<position position="586"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230783." id="VAR_053529" evidence="33">
<original>S</original>
<variation>A</variation>
<location>
<position position="777"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs72645299." id="VAR_060697" evidence="33">
<original>M</original>
<variation>K</variation>
<location>
<position position="1247"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs72645298." id="VAR_060698" evidence="33">
<original>M</original>
<variation>L</variation>
<location>
<position position="1247"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_013834" evidence="28 30">
<location>
<begin position="1248"/>
<end position="1250"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="616"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes acetylation by CREBBP." evidence="17">
<original>KK</original>
<variation>QQ</variation>
<location>
<begin position="619"/>
<end position="620"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="647"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="687"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="700"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="708"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAC51663." ref="4" evidence="39">
<original>DG</original>
<variation>EA</variation>
<location>
<begin position="131"/>
<end position="132"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="619"/>
<end position="626"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="736"/>
<end position="743"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1049"/>
<end position="1060"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1069"/>
<end position="1075"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1078"/>
<end position="1084"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1086"/>
<end position="1088"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1KBH"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3L3X"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3L3Z"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250"/>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O09000"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00140"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00981"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10490106"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11094166"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11250900"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11971985"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12917342"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14645221"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15698540"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16951154"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16957778"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17998543"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19339517"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9238002"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9252329"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9267036"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9346901"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9727751"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9238002"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9252329"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9267036"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9346901"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305"/>
<sequence length="1424" mass="155293" checksum="732CDF0423161679" modified="1999-11-01" version="1">
MSGLGENLDPLASDSRKRKLPCDTPGQGLTCSGEKRRREQESKYIEELAELISANLSDID
NFNVKPDKCAILKETVRQIRQIKEQGKTISNDDDVQKADVSSTGQGVIDKDSLGPLLLQA
LDGFLFVVNRDGNIVFVSENVTQYLQYKQEDLVNTSVYNILHEEDRKDFLKNLPKSTVNG
VSWTNETQRQKSHTFNCRMLMKTPHDILEDINASPEMRQRYETMQCFALSQPRAMMEEGE
DLQSCMICVARRITTGERTFPSNPESFITRHDLSGKVVNIDTNSLRSSMRPGFEDIIRRC
IQRFFSLNDGQSWSQKRHYQEAYLNGHAETPVYRFSLADGTIVTAQTKSKLFRNPVTNDR
HGFVSTHFLQREQNGYRPNPNPVGQGIRPPMAGCNSSVGGMSMSPNQGLQMPSSRAYGLA
DPSTTGQMSGARYGGSSNIASLTPGPGMQSPSSYQNNNYGLNMSSPPHGSPGLAPNQQNI
MISPRNRGSPKIASHQFSPVAGVHSPMASSGNTGNHSFSSSSLSALQAISEGVGTSLLST
LSSPGPKLDNSPNMNITQPSKVSNQDSKSPLGFYCDQNPVESSMCQSNSRDHLSDKESKE
SSVEGAENQRGPLESKGHKKLLQLLTCSSDDRGHSSLTNSPLDSSCKESSVSVTSPSGVS
SSTSGGVSSTSNMHGSLLQEKHRILHKLLQNGNSPAEVAKITAEATGKDTSSITSCGDGN
VVKQEQLSPKKKENNALLRYLLDRDDPSDALSKELQPQVEGVDNKMSQCTSSTIPSSSQE
KDPKIKTETSEEGSGDLDNLDAILGDLTSSDFYNNSISSNGSHLGTKQQVFQGTNSLGLK
SSQSVQSIRPPYNRAVSLDSPVSVGSSPPVKNISAFPMLPKQPMLGGNPRMMDSQENYGS
SMGGPNRNVTVTQTPSSGDWGLPNSKAGRMEPMNSNSMGRPGGDYNTSLPRPALGGSIPT
LPLRSNSIPGARPVLQQQQQMLQMRPGEIPMGMGANPYGQAAASNQLGSWPDGMLSMEQV
SHGTQNRPLLRNSLDDLVGPPSNLEGQSDERALLDQLHTLLSNTDATGLEEIDRALGIPE
LVNQGQALEPKQDAFQGQEAAVMMDQKAGLYGQTYPAQGPPMQGGFHLQGQSPSFNSMMN
QMNQQGNFPLQGMHPRANIMRPRTNTPKQLRMQLQQRLQGQQFLNQSRQALELKMENPTA
GGAAVMRPMMQPQVSSQQGFLNAQMVAQRSRELLSHHFRQQRVAMMMQQQQQQQQQQQQQ
QQQQQQQQQQQQQQQQTQAFSPPPNVTASPSMDGLLAGPTMPQAPPQQFPYQPNYGMGQQ
PDPAFGRVSSPPNAMMSSRMGPSQNPMMQHPQAASIYQSSEMKGWPSGNLARNSSFSQQQ
FAHQGNPAVYSMVHMNGSSGHMGQMNMNPMPMSGMPMGPDQKYC
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-02-12" modified="2017-11-22" version="98">
<accession>Q9JLI4</accession>
<accession>Q9JIH6</accession>
<name>NCOA6_RAT</name>
<protein>
<recommendedName>
<fullName>Nuclear receptor coactivator 6</fullName>
</recommendedName>
<alternativeName>
<fullName>Activating signal cointegrator 2</fullName>
<shortName>ASC-2</shortName>
</alternativeName>
<alternativeName>
<fullName>Amplified in breast cancer protein 3</fullName>
</alternativeName>
<alternativeName>
<fullName>Cancer-amplified transcriptional coactivator ASC-2</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear receptor coactivator RAP250</fullName>
<shortName>NRC</shortName>
</alternativeName>
<alternativeName>
<fullName>Nuclear receptor-activating protein, 250 kDa</fullName>
</alternativeName>
<alternativeName>
<fullName>Peroxisome proliferator-activated receptor-interacting protein</fullName>
<shortName>PPAR-interacting protein</shortName>
<shortName>PRIP</shortName>
</alternativeName>
<alternativeName>
<fullName>Thyroid hormone receptor-binding protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">Ncoa6</name>
<name type="synonym">Aib3</name>
<name type="synonym">Rap250</name>
<name type="synonym">Trbp</name>
</gene>
<organism>
<name type="scientific">Rattus norvegicus</name>
<name type="common">Rat</name>
<dbReference type="NCBI Taxonomy" id="10116"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Rattus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="6212" last="6217">
<title>Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator.</title>
<authorList>
<person name="Ko L."/>
<person name="Cardona G.R."/>
<person name="Chin W.W."/>
</authorList>
<dbReference type="PubMed" id="10823961"/>
<dbReference type="DOI" id="10.1073/pnas.97.11.6212"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-285</scope>
<scope>INTERACTION WITH THRB</scope>
<source>
<tissue>Pituitary</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="5048" last="5063">
<title>A new family of nuclear receptor coregulators that integrates nuclear receptor signaling through CBP.</title>
<authorList>
<person name="Mahajan M.A."/>
<person name="Samuels H.H."/>
</authorList>
<dbReference type="PubMed" id="10866662"/>
<dbReference type="DOI" id="10.1128/MCB.20.14.5048-5063.2000"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 135-418</scope>
<scope>INTERACTION WITH THRA; THRB; RAR; RXR; ESR; VDR; NR3C1</scope>
<scope>MUTAGENESIS OF 174-LEU--LEU-178</scope>
<source>
<strain>Sprague-Dawley</strain>
<tissue>Pituitary</tissue>
</source>
</reference>
<comment type="function">
<text evidence="1">Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Coactivate expression in an agonist- and AF2-dependent manner. May coactivate expression via a remodeling of chromatin and its interaction with histone acetyltransferase proteins. Involved in the coactivation of different nuclear receptors, such as for steroids (GR and ERs), retinoids (RARs and RXRs), thyroid hormone (TRs), vitamin D3 (VDR) and prostanoids (PPARs). Probably functions as a general coactivator, rather than just a nuclear receptor coactivator. May also be involved in the coactivation of the NF-kappa-B pathway (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="1">Monomer and homodimer. Interacts in vitro with the basal transcription factors GTF2A and TBP, suggesting an autonomous transactivation function. Interacts with NCOA1, CRSP3, RBM14, the histone acetyltransferase proteins EP300 and CREBBP, and with methyltransferase proteins NCOA6IP and PRMT2 (By similarity). Component of the MLL2/3 complex (also named ASCOM complex), at least composed of KMT2D/MLL2 or KMT2C/MLL3, ASH2L, RBBP5, WDR5, NCOA6, DPY30, KDM6A, PAXIP1/PTIP, PAGR1 and alpha- and beta-tubulin (By similarity). Interacts with ZNF335; may enhance ligand-dependent transcriptional activation by nuclear hormone receptors (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286271"/>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286271"/>
<interactant intactId="EBI-286316">
<id>P10912</id>
<label>GHR</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286271"/>
<interactant intactId="EBI-78598">
<id>P19793</id>
<label>RXRA</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286271"/>
<interactant intactId="EBI-286285">
<id>P10827</id>
<label>THRA</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286271"/>
<interactant intactId="EBI-286357">
<id>P11473</id>
<label>VDR</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="domain">
<text>Contains one Leu-Xaa-Xaa-Leu-Leu (LXXLL) motif, which is essential for the association with nuclear receptors.</text>
</comment>
<comment type="PTM">
<text evidence="1">Phosphorylated.</text>
</comment>
<dbReference type="EMBL" id="AF228043">
<property type="protein sequence ID" value="AAF76422.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF176351">
<property type="protein sequence ID" value="AAF71830.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="UniGene" id="Rn.234544"/>
<dbReference type="UniGene" id="Rn.9077"/>
<dbReference type="IntAct" id="Q9JLI4">
<property type="interactions" value="9"/>
</dbReference>
<dbReference type="STRING" id="10116.ENSRNOP00000024714"/>
<dbReference type="PhosphoSitePlus" id="Q9JLI4"/>
<dbReference type="PaxDb" id="Q9JLI4"/>
<dbReference type="PRIDE" id="Q9JLI4"/>
<dbReference type="UCSC" id="RGD:620111">
<property type="organism name" value="rat"/>
</dbReference>
<dbReference type="RGD" id="620111">
<property type="gene designation" value="Ncoa6"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410IK20">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XW4F">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000113745"/>
<dbReference type="InParanoid" id="Q9JLI4"/>
<dbReference type="Proteomes" id="UP000002494">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0035097">
<property type="term" value="C:histone methyltransferase complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription factor complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0035259">
<property type="term" value="F:glucocorticoid receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0016922">
<property type="term" value="F:ligand-dependent nuclear receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0030374">
<property type="term" value="F:ligand-dependent nuclear receptor transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0035257">
<property type="term" value="F:nuclear hormone receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0042975">
<property type="term" value="F:peroxisome proliferator activated receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0042974">
<property type="term" value="F:retinoic acid receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0046965">
<property type="term" value="F:retinoid X receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0046966">
<property type="term" value="F:thyroid hormone receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006352">
<property type="term" value="P:DNA-templated transcription, initiation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0080182">
<property type="term" value="P:histone H3-K4 trimethylation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0060716">
<property type="term" value="P:labyrinthine layer blood vessel development"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0030099">
<property type="term" value="P:myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001541">
<property type="term" value="P:ovarian follicle development"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0035774">
<property type="term" value="P:positive regulation of insulin secretion involved in cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0002793">
<property type="term" value="P:positive regulation of peptide secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0010468">
<property type="term" value="P:regulation of gene expression"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0009725">
<property type="term" value="P:response to hormone"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="InterPro" id="IPR026638">
<property type="entry name" value="NCOA6"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15690">
<property type="entry name" value="PTHR15690"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="chain" description="Nuclear receptor coactivator 6" id="PRO_0000094415">
<location>
<begin position="1" status="less than"/>
<end position="418"/>
</location>
</feature>
<feature type="region of interest" description="NCOA1-binding region" evidence="1">
<location>
<begin position="1" status="less than"/>
<end position="418"/>
</location>
</feature>
<feature type="region of interest" description="CREBBP-binding region" evidence="1">
<location>
<begin position="1" status="less than"/>
<end position="352"/>
</location>
</feature>
<feature type="region of interest" description="TBP/GTF2A-binding region" evidence="1">
<location>
<begin position="1" status="less than"/>
<end position="215"/>
</location>
</feature>
<feature type="region of interest" description="NCOA6IP-binding region" evidence="1">
<location>
<begin position="60"/>
<end position="214"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif">
<location>
<begin position="174"/>
<end position="178"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="200"/>
<end position="205"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="301"/>
<end position="308"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="310"/>
<end position="327"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Met">
<location>
<begin position="328"/>
<end position="334"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="171"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="3">
<location>
<position position="342"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="3">
<location>
<position position="353"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="3">
<location>
<position position="391"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with nuclear receptors." evidence="4">
<original>LVNLL</original>
<variation>AVNAA</variation>
<location>
<begin position="174"/>
<end position="178"/>
</location>
</feature>
<feature type="non-terminal residue">
<location>
<position position="1"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q14686"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9JL19"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10866662"/>
</source>
</evidence>
<sequence length="418" mass="45574" checksum="A90D7C4111C67CAE" modified="2003-02-12" version="2" fragment="single">
EQIMTNQMQGNKAQFNSQNQSNVMPGPAQIMRGPTPNMQGNMVQFTGQMSGQMLPQQGPV
SNSPSQVMGIQGQVLRPPGPSPHMAQQHTDPATTANNDVNLSQMMPDVSMQQTSMVPPHV
QSMQGNSASGSHFSGHGVSFNAPFGGAPNGTQMSCGQNPGFPVNKDVTLTSPLLVNLLQS
DISAGHFGVNNKQNNTNANKQKKKKPPRKKKNCHQDLNTPDSRPAGLEEVDQQSLPGEQG
INLDNTGPKLPDFSNRPPGYPTQPVEQRPLQQMPPQLMQHVAPPPQPPQQQPQPQLPQQQ
PQPQPPPPSQPQSQQQQQQQQQQQQQQMMMMLMMQQDPKSIRLPVSQNVHPPRGPLNPDS
QRVPMQQSGNVPVMVSLQGPASVPPSPDKQRMPMPVNTPLGSNSRKMVYQESPQNSSS
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1990-04-01" modified="2018-01-31" version="201">
<accession>P15941</accession>
<accession>A5YRV1</accession>
<accession>A6ZID9</accession>
<accession>A6ZIE0</accession>
<accession>B1AVQ8</accession>
<accession>B1AVR0</accession>
<accession>B6ECA1</accession>
<accession>E7ESE5</accession>
<accession>E7EUG9</accession>
<accession>P13931</accession>
<accession>P15942</accession>
<accession>P17626</accession>
<accession>Q0VAP5</accession>
<accession>Q0VAP6</accession>
<accession>Q14128</accession>
<accession>Q14876</accession>
<accession>Q16437</accession>
<accession>Q16442</accession>
<accession>Q16615</accession>
<accession>Q6S4Y3</accession>
<accession>Q7Z547</accession>
<accession>Q7Z548</accession>
<accession>Q7Z550</accession>
<accession>Q7Z552</accession>
<accession>Q9BXA4</accession>
<accession>Q9UE75</accession>
<accession>Q9UE76</accession>
<accession>Q9UQL1</accession>
<accession>Q9Y4J2</accession>
<name>MUC1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Mucin-1</fullName>
<shortName>MUC-1</shortName>
</recommendedName>
<alternativeName>
<fullName>Breast carcinoma-associated antigen DF3</fullName>
</alternativeName>
<alternativeName>
<fullName>Cancer antigen 15-3</fullName>
<shortName>CA 15-3</shortName>
</alternativeName>
<alternativeName>
<fullName>Carcinoma-associated mucin</fullName>
</alternativeName>
<alternativeName>
<fullName>Episialin</fullName>
</alternativeName>
<alternativeName>
<fullName>H23AG</fullName>
</alternativeName>
<alternativeName>
<fullName>Krebs von den Lungen-6</fullName>
<shortName>KL-6</shortName>
</alternativeName>
<alternativeName>
<fullName>PEMT</fullName>
</alternativeName>
<alternativeName>
<fullName>Peanut-reactive urinary mucin</fullName>
<shortName>PUM</shortName>
</alternativeName>
<alternativeName>
<fullName>Polymorphic epithelial mucin</fullName>
<shortName>PEM</shortName>
</alternativeName>
<alternativeName>
<fullName>Tumor-associated epithelial membrane antigen</fullName>
<shortName>EMA</shortName>
</alternativeName>
<alternativeName>
<fullName>Tumor-associated mucin</fullName>
</alternativeName>
<cdAntigenName>CD227</cdAntigenName>
<component>
<recommendedName>
<fullName>Mucin-1 subunit alpha</fullName>
<shortName>MUC1-NT</shortName>
<shortName>MUC1-alpha</shortName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Mucin-1 subunit beta</fullName>
<shortName>MUC1-beta</shortName>
</recommendedName>
<alternativeName>
<fullName>MUC1-CT</fullName>
</alternativeName>
</component>
</protein>
<gene>
<name type="primary">MUC1</name>
<name type="synonym">PUM</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="15294" last="15299">
<title>Cloning and sequencing of a human pancreatic tumor mucin cDNA.</title>
<authorList>
<person name="Lan M.S."/>
<person name="Batra S.K."/>
<person name="Qi W.-N."/>
<person name="Metzgar R.S."/>
<person name="Hollingsworth M.A."/>
</authorList>
<dbReference type="PubMed" id="2394722"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Pancreatic carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="5573" last="5578">
<title>Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini.</title>
<authorList>
<person name="Ligtenberg M.J.L."/>
<person name="Vos H.L."/>
<person name="Gennissen A.M.C."/>
<person name="Hilkens J."/>
</authorList>
<dbReference type="PubMed" id="2318825"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="15286" last="15293">
<title>Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin.</title>
<authorList>
<person name="Gendler S.J."/>
<person name="Lancaster C.A."/>
<person name="Taylor-Papadimitriou J."/>
<person name="Duhig T."/>
<person name="Peat N."/>
<person name="Burchell J."/>
<person name="Pemberton L."/>
<person name="Lalani E.-N."/>
<person name="Wilson D."/>
</authorList>
<dbReference type="PubMed" id="1697589"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1990" name="Biochem. Biophys. Res. Commun." volume="173" first="1019" last="1029">
<title>Structure and expression of the human polymorphic epithelial mucin gene: an expressed VNTR unit.</title>
<authorList>
<person name="Lancaster C.A."/>
<person name="Peat N."/>
<person name="Duhig T."/>
<person name="Wilson D."/>
<person name="Taylor-Papadimitriou J."/>
<person name="Gendler S.J."/>
</authorList>
<dbReference type="PubMed" id="2268309"/>
<dbReference type="DOI" id="10.1016/S0006-291X(05)80888-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1990" name="Eur. J. Biochem." volume="189" first="463" last="473">
<title>Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms.</title>
<authorList>
<person name="Wreschner D.H."/>
<person name="Hareuveni M."/>
<person name="Tsarfaty I."/>
<person name="Smorodinsky N."/>
<person name="Horev J."/>
<person name="Zaretsky J."/>
<person name="Kotkes P."/>
<person name="Weiss M."/>
<person name="Lathe R."/>
<person name="Dion A."/>
<person name="Keydar I."/>
</authorList>
<dbReference type="PubMed" id="2351132"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1990.tb15511.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<source>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1990" name="Eur. J. Biochem." volume="189" first="475" last="486">
<title>A transcribed gene, containing a variable number of tandem repeats, codes for a human epithelial tumor antigen. cDNA cloning, expression of the transfected gene and over-expression in breast cancer tissue.</title>
<authorList>
<person name="Hareuveni M."/>
<person name="Tsarfaty I."/>
<person name="Zaretsky J."/>
<person name="Kotkes P."/>
<person name="Horev J."/>
<person name="Zrihan S."/>
<person name="Weiss M."/>
<person name="Green S."/>
<person name="Lathe R."/>
<person name="Keydar I."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="2112460"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1990.tb15512.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1990" name="Gene" volume="93" first="313" last="318">
<title>Isolation and characterization of an expressed hypervariable gene coding for a breast-cancer-associated antigen.</title>
<authorList>
<person name="Tsarfaty I."/>
<person name="Hareuveni M."/>
<person name="Horev J."/>
<person name="Zaretsky J."/>
<person name="Weiss M."/>
<person name="Jeltsch J.-M."/>
<person name="Garnier J.-M."/>
<person name="Lathe R."/>
<person name="Keydar I."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="1688329"/>
<dbReference type="DOI" id="10.1016/0378-1119(90)90242-J"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="Eur. J. Biochem." volume="224" first="787" last="795">
<title>Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue.</title>
<authorList>
<person name="Zrihan-Licht S."/>
<person name="Vos H.L."/>
<person name="Baruch A."/>
<person name="Elroy-Stein O."/>
<person name="Sagiv D."/>
<person name="Keydar I."/>
<person name="Hilkens J."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="7925397"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1994.00787.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM Y)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="Int. J. Cancer" volume="72" first="87" last="94">
<title>Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z).</title>
<authorList>
<person name="Oosterkamp H.M."/>
<person name="Scheiner L."/>
<person name="Stefanova M.C."/>
<person name="Lloyd K.O."/>
<person name="Finstad C.L."/>
</authorList>
<dbReference type="PubMed" id="9212228"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-0215(19970703)72:1&lt;87::AID-IJC13&gt;3.0.CO;2-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; Y AND 8)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="10655" last="10663">
<title>A novel protein derived from the MUC1 gene by alternative splicing and frameshifting.</title>
<authorList>
<person name="Levitin F."/>
<person name="Baruch A."/>
<person name="Weiss M."/>
<person name="Stiegman K."/>
<person name="Hartmann M.L."/>
<person name="Yoeli-Lerner M."/>
<person name="Ziv R."/>
<person name="Zrihan-Licht S."/>
<person name="Shina S."/>
<person name="Gat A."/>
<person name="Lifschitz B."/>
<person name="Simha M."/>
<person name="Stadler Y."/>
<person name="Cholostoy A."/>
<person name="Gil B."/>
<person name="Greaves D."/>
<person name="Keydar I."/>
<person name="Zaretsky J."/>
<person name="Smorodinsky N."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="15623537"/>
<dbReference type="DOI" id="10.1074/jbc.M406943200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ZD)</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2013" name="Cancer Immunol. Immunother." volume="62" first="423" last="435">
<title>Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms.</title>
<authorList>
<person name="Zhang L."/>
<person name="Vlad A."/>
<person name="Milcarek C."/>
<person name="Finn O.J."/>
</authorList>
<dbReference type="PubMed" id="22941036"/>
<dbReference type="DOI" id="10.1007/s00262-012-1325-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; E2; J13; M6; S2; T10; Y-LSP AND ZD)</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>VARIANT MET-1117</scope>
</reference>
<reference key="12">
<citation type="submission" date="2001-02" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of a new potential secreted short variant form of MUC1 mucin in epithelial cancer cell line.</title>
<authorList>
<person name="Zhang L.X."/>
<person name="Li C.H."/>
<person name="Sun L.Y."/>
<person name="Yue W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 9)</scope>
<source>
<tissue>Carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Sheng Wu Gong Cheng Xue Bao" volume="19" first="337" last="342">
<title>Soluble expression of peptide containing MUC1/Y-specific epitope in Escherichia coli and preparation of the antibody.</title>
<authorList>
<person name="Zhang L.X."/>
<person name="Li C.H."/>
<person name="Sun L.Y."/>
<person name="Wang M."/>
<person name="Lu H.J."/>
</authorList>
<dbReference type="PubMed" id="15969018"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM Y)</scope>
<scope>VARIANT MET-1117</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="submission" date="2003-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of a new MUC1 short variant mRNA F from HeLa cells.</title>
<authorList>
<person name="Zhang L.X."/>
<person name="Lu H.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F)</scope>
</reference>
<reference key="15">
<citation type="submission" date="2003-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of a new MUC1 short variant mRNA S2 from HeLa cells.</title>
<authorList>
<person name="Zhang L.X."/>
<person name="Lu H.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM S2)</scope>
</reference>
<reference key="16">
<citation type="submission" date="2007-06" db="EMBL/GenBank/DDBJ databases">
<title>Isolation of MUC1 isoforms from MCF7 cells.</title>
<authorList>
<person name="Zhang L."/>
<person name="Finn O.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM M6)</scope>
</reference>
<reference key="17">
<citation type="submission" date="2003-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS MET-1117 AND ASN-1142</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="19">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS Y AND Y-LSP)</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="12820" last="12823">
<title>A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.</title>
<authorList>
<person name="Gendler S.J."/>
<person name="Taylor-Papadimitriou J."/>
<person name="Duhig T."/>
<person name="Rothbard J."/>
<person name="Burchell J."/>
</authorList>
<dbReference type="PubMed" id="3417635"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1989" name="Biochem. Biophys. Res. Commun." volume="165" first="644" last="649">
<title>Sequence analysis of the 5' region of the human DF3 breast carcinoma-associated antigen gene.</title>
<authorList>
<person name="Abe M."/>
<person name="Siddiqui J."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="2597151"/>
<dbReference type="DOI" id="10.1016/S0006-291X(89)80014-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-160 (ISOFORM 2)</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1996" name="Int. J. Cancer" volume="66" first="55" last="59">
<title>Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene.</title>
<authorList>
<person name="Weiss M."/>
<person name="Baruch A."/>
<person name="Keydar I."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="8608966"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-0215(19960328)66:1&lt;55::AID-IJC10&gt;3.0.CO;2-A"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-109 (ISOFORM 2)</scope>
<source>
<tissue>Thyroid</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="1996" name="Oncology" volume="53" first="118" last="126">
<title>Mucin mRNA expression in lung adenocarcinoma cell lines and tissues.</title>
<authorList>
<person name="Yu C.J."/>
<person name="Yang P.C."/>
<person name="Shew J.Y."/>
<person name="Hong T.M."/>
<person name="Yang S.C."/>
<person name="Lee Y.C."/>
<person name="Lee L.N."/>
<person name="Luh K.T."/>
<person name="Wu C.W."/>
</authorList>
<dbReference type="PubMed" id="8604237"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-89</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="25">
<citation type="submission" date="1992-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Buluwela L."/>
<person name="Liu Q."/>
<person name="Luqmani Y.A."/>
<person name="Gomm J.J."/>
<person name="Coombes R.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-46 (ISOFORMS 3 AND 4)</scope>
<source>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="283" first="715" last="720">
<title>Identification of MUC1 proteolytic cleavage sites in vivo.</title>
<authorList>
<person name="Parry S."/>
<person name="Silverman H.S."/>
<person name="McDermott K."/>
<person name="Willis A."/>
<person name="Hollingsworth M.A."/>
<person name="Harris A."/>
</authorList>
<dbReference type="PubMed" id="11341784"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.4775"/>
</citation>
<scope>PROTEIN SEQUENCE OF 24-33; 28-37 AND 1098-1107</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="33374" last="33386">
<title>The MUC1 SEA module is a self-cleaving domain.</title>
<authorList>
<person name="Levitin F."/>
<person name="Stern O."/>
<person name="Weiss M."/>
<person name="Gil-Henn C."/>
<person name="Ziv R."/>
<person name="Prokocimer Z."/>
<person name="Smorodinsky N.I."/>
<person name="Rubinstein D.B."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="15987679"/>
<dbReference type="DOI" id="10.1074/jbc.M506047200"/>
</citation>
<scope>PROTEIN SEQUENCE OF 1098-1111</scope>
<scope>PROTEOLYTIC CLEAVAGE</scope>
<scope>MUTAGENESIS OF SER-1098</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="18165" last="18172">
<title>High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells.</title>
<authorList>
<person name="Mueller S."/>
<person name="Alving K."/>
<person name="Peter-Katalinic J."/>
<person name="Zachara N."/>
<person name="Gooley A.A."/>
<person name="Hanisch F.-G."/>
</authorList>
<dbReference type="PubMed" id="10373415"/>
<dbReference type="DOI" id="10.1074/jbc.274.26.18165"/>
</citation>
<scope>PROTEIN SEQUENCE OF TANDEM REPEAT</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1994" name="FEBS Lett." volume="356" first="130" last="136">
<title>Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules.</title>
<authorList>
<person name="Zrihan-Licht S."/>
<person name="Baruch A."/>
<person name="Elroy-Stein O."/>
<person name="Keydar I."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="7988707"/>
<dbReference type="DOI" id="10.1016/0014-5793(94)01251-2"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1995" name="Cancer Res." volume="55" first="4000" last="4003">
<title>Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein.</title>
<authorList>
<person name="Pandey P."/>
<person name="Kharbanda S."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="7664271"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH SOS1 AND GRB2</scope>
<scope>INTERACTION WITH GRB2 AND SOS1</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1995" name="Eur. J. Biochem." volume="229" first="140" last="147">
<title>Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells.</title>
<authorList>
<person name="Stadie T.R."/>
<person name="Chai W."/>
<person name="Lawson A.M."/>
<person name="Byfield P.G."/>
<person name="Hanisch F.G."/>
</authorList>
<dbReference type="PubMed" id="7744025"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1995.0140l.x"/>
</citation>
<scope>GLYCOSYLATION AT THR-131 AND THR-139</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="12492" last="12494">
<title>Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion.</title>
<authorList>
<person name="Yamamoto M."/>
<person name="Bharti A."/>
<person name="Li Y."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="9139698"/>
<dbReference type="DOI" id="10.1074/jbc.272.19.12492"/>
</citation>
<scope>INTERACTION WITH CTNNB1 AND JUP</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="24780" last="24793">
<title>Localization of O-glycosylation sites on glycopeptide fragments from lactation-associated MUC1. All putative sites within the tandem repeat are glycosylation targets in vivo.</title>
<authorList>
<person name="Mueller S."/>
<person name="Goletz S."/>
<person name="Packer N.H."/>
<person name="Gooley A.A."/>
<person name="Lawson A.M."/>
<person name="Hanisch F.-G."/>
</authorList>
<dbReference type="PubMed" id="9312074"/>
<dbReference type="DOI" id="10.1074/jbc.272.40.24780"/>
</citation>
<scope>GLYCOSYLATION WITHIN TANDEM REPEAT</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1998" name="Gut" volume="42" first="220" last="226">
<title>Developmental expression of mucin genes in the human gastrointestinal system.</title>
<authorList>
<person name="Reid C.J."/>
<person name="Harris A."/>
</authorList>
<dbReference type="PubMed" id="9536947"/>
<dbReference type="DOI" id="10.1136/gut.42.2.220"/>
</citation>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1998" name="J. Mass Spectrom." volume="33" first="358" last="362">
<title>Localization of O-glycosylation sites of MUC1 tandem repeats by QTOF ESI mass spectrometry.</title>
<authorList>
<person name="Hanisch F.G."/>
<person name="Green B.N."/>
<person name="Bateman R."/>
<person name="Peter-Katalinic J."/>
</authorList>
<dbReference type="PubMed" id="9597769"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-9888(199804)33:4&lt;358::AID-JMS642&gt;3.0.CO;2-3"/>
</citation>
<scope>GLYCOSYLATION AT THR-131 AND THR-139</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="7216" last="7224">
<title>Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin.</title>
<authorList>
<person name="Li Y."/>
<person name="Bharti A."/>
<person name="Chen D."/>
<person name="Gong J."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="9819408"/>
<dbReference type="DOI" id="10.1128/MCB.18.12.7216"/>
</citation>
<scope>INTERACTION WITH GSK3B AND CTNNB1</scope>
<scope>PHOSPHORYLATION AT SER-1227</scope>
<scope>MUTAGENESIS OF SER-1223 AND SER-1227</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1999" name="Cancer Res." volume="59" first="1552" last="1561">
<title>The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein.</title>
<authorList>
<person name="Baruch A."/>
<person name="Hartmann M.-L."/>
<person name="Yoeli M."/>
<person name="Adereth Y."/>
<person name="Greenstein S."/>
<person name="Stadler Y."/>
<person name="Skornik Y."/>
<person name="Zaretsky J."/>
<person name="Smorodinsky N.I."/>
<person name="Keydar I."/>
<person name="Wreschner D.H."/>
</authorList>
<dbReference type="PubMed" id="10197628"/>
</citation>
<scope>CHARACTERIZATION (ISOFORM Y)</scope>
<scope>MUTAGENESIS OF ASP-1116</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2001" name="Digestion 63 Suppl." volume="1" first="87" last="92">
<title>MUC1 mucin core protein binds to the domain 1 of ICAM-1.</title>
<authorList>
<person name="Hayashi T."/>
<person name="Takahashi T."/>
<person name="Motoya S."/>
<person name="Ishida T."/>
<person name="Itoh F."/>
<person name="Adachi M."/>
<person name="Hinoda Y."/>
<person name="Imai K."/>
</authorList>
<dbReference type="PubMed" id="11173916"/>
<dbReference type="DOI" id="10.1159/000051917"/>
</citation>
<scope>INTERACTION WITH ICAM1</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2001" name="J. Histochem. Cytochem." volume="49" first="67" last="77">
<title>Mucin MUC1 is seen in cell surface protrusions together with ezrin in immunoelectron tomography and is concentrated at tips of filopodial protrusions in MCF-7 breast carcinoma cells.</title>
<authorList>
<person name="Bennett R. Jr."/>
<person name="Jaervelae T."/>
<person name="Engelhardt P."/>
<person name="Kostamovaara L."/>
<person name="Sparks P."/>
<person name="Carpen O."/>
<person name="Turunen O."/>
<person name="Vaheri A."/>
</authorList>
<dbReference type="PubMed" id="11118479"/>
<dbReference type="DOI" id="10.1177/002215540104900107"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="6061" last="6064">
<title>The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin.</title>
<authorList>
<person name="Li Y."/>
<person name="Kuwahara H."/>
<person name="Ren J."/>
<person name="Wen G."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11152665"/>
<dbReference type="DOI" id="10.1074/jbc.C000754200"/>
</citation>
<scope>INTERACTION WITH SRC; GSK3B AND CTNNB1</scope>
<scope>PHOSPHORYLATION AT TYR-1229</scope>
<scope>MUTAGENESIS OF TYR-1229</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="27764" last="27769">
<title>Identification and topology of variant sequences within individual repeat domains of the human epithelial tumor mucin MUC1.</title>
<authorList>
<person name="Engelmann K."/>
<person name="Baldus S.E."/>
<person name="Hanisch F.-G."/>
</authorList>
<dbReference type="PubMed" id="11350974"/>
<dbReference type="DOI" id="10.1074/jbc.M103187200"/>
</citation>
<scope>POLYMORPHISM WITHIN THE REPEAT</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="35239" last="35242">
<title>The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.</title>
<authorList>
<person name="Li Y."/>
<person name="Ren J."/>
<person name="Yu W."/>
<person name="Li Q."/>
<person name="Kuwahara H."/>
<person name="Yin L."/>
<person name="Carraway K.L. III"/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11483589"/>
<dbReference type="DOI" id="10.1074/jbc.C100359200"/>
</citation>
<scope>INTERACTION WITH EGFR</scope>
<scope>PHOSPHORYLATION AT TYR-1229 BY EGFR</scope>
<scope>MUTAGENESIS OF TYR-1191; TYR-1203; TYR-1209; TYR-1218 AND TYR-1229</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="17616" last="17622">
<title>Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling.</title>
<authorList>
<person name="Ren J."/>
<person name="Li Y."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11877440"/>
<dbReference type="DOI" id="10.1074/jbc.M200436200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-1224</scope>
<scope>INTERACTION WITH PRKCD</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-1223; THR-1224 AND SER-1227</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="310" first="341" last="346">
<title>Identification of four sites of stimulated tyrosine phosphorylation in the MUC1 cytoplasmic tail.</title>
<authorList>
<person name="Wang H."/>
<person name="Lillehoj E.P."/>
<person name="Kim K.C."/>
</authorList>
<dbReference type="PubMed" id="14521915"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2003.09.030"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1203; TYR-1212; TYR-1229 AND TYR-1243</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2003" name="Cancer Biol. Ther." volume="2" first="187" last="193">
<title>DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7.</title>
<authorList>
<person name="Li Y."/>
<person name="Chen W."/>
<person name="Ren J."/>
<person name="Yu W.H."/>
<person name="Li Q."/>
<person name="Yoshida K."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="12750561"/>
<dbReference type="DOI" id="10.4161/cbt.2.2.282"/>
</citation>
<scope>INTERACTION WITH LYN</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2003" name="Cancer Biol. Ther." volume="2" first="702" last="706">
<title>MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation.</title>
<authorList>
<person name="Huang L."/>
<person name="Ren J."/>
<person name="Chen D."/>
<person name="Li Y."/>
<person name="Kharbanda S."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="14688481"/>
</citation>
<scope>INTERACTION WITH CTNNB1</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF TYR-1229</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="3386" last="3394">
<title>Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding.</title>
<authorList>
<person name="Thathiah A."/>
<person name="Blobel C.P."/>
<person name="Carson D.D."/>
</authorList>
<dbReference type="PubMed" id="12441351"/>
<dbReference type="DOI" id="10.1074/jbc.M208326200"/>
</citation>
<scope>INTERACTION WITH ADAM17</scope>
<scope>CLEAVAGE</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="38029" last="38039">
<title>Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin.</title>
<authorList>
<person name="Wen Y."/>
<person name="Caffrey T.C."/>
<person name="Wheelock M.J."/>
<person name="Johnson K.R."/>
<person name="Hollingsworth M.A."/>
</authorList>
<dbReference type="PubMed" id="12832415"/>
<dbReference type="DOI" id="10.1074/jbc.M304333200"/>
</citation>
<scope>INTERACTION WITH CTNNB1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2003" name="Mol. Cancer Res." volume="1" first="765" last="775">
<title>Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.</title>
<authorList>
<person name="Li Y."/>
<person name="Yu W.-H."/>
<person name="Ren J."/>
<person name="Chen W."/>
<person name="Huang L."/>
<person name="Kharbanda S."/>
<person name="Loda M."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="12939402"/>
</citation>
<scope>INTERACTION WITH ERBB2; ERBB3 AND ERBB4</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 1187-ARG--LYS-1189</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="53071" last="53077">
<title>MUC1 membrane trafficking is modulated by multiple interactions.</title>
<authorList>
<person name="Kinlough C.L."/>
<person name="Poland P.A."/>
<person name="Bruns J.B."/>
<person name="Harkleroad K.L."/>
<person name="Hughey R.P."/>
</authorList>
<dbReference type="PubMed" id="15471854"/>
<dbReference type="DOI" id="10.1074/jbc.M409360200"/>
</citation>
<scope>INTERACTION WITH AP1S2 AND GRB2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-1191; TYR-1203; TYR-1229 AND TYR-1243</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2005" name="Cancer Cell" volume="7" first="167" last="178">
<title>Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.</title>
<authorList>
<person name="Wei X."/>
<person name="Xu H."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="15710329"/>
<dbReference type="DOI" id="10.1016/j.ccr.2005.01.008"/>
</citation>
<scope>INTERACTION WITH TP53</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="10413" last="10422">
<title>MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.</title>
<authorList>
<person name="Huang L."/>
<person name="Chen D."/>
<person name="Liu D."/>
<person name="Yin L."/>
<person name="Kharbanda S."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="16288032"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-2474"/>
</citation>
<scope>INTERACTION WITH GSK3B</scope>
<scope>PHOSPHORYLATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="28827" last="28827">
<authorList>
<person name="Kinlough C.L."/>
<person name="Poland P.A."/>
<person name="Bruns J.B."/>
<person name="Harkleroad K.L."/>
<person name="Hughey R.P."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2005" name="Glycobiology" volume="15" first="1111" last="1124">
<title>Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles.</title>
<authorList>
<person name="Engelmann K."/>
<person name="Kinlough C.L."/>
<person name="Muller S."/>
<person name="Razawi H."/>
<person name="Baldus S.E."/>
<person name="Hughey R.P."/>
<person name="Hanisch F.-G."/>
</authorList>
<dbReference type="PubMed" id="15972891"/>
<dbReference type="DOI" id="10.1093/glycob/cwi099"/>
</citation>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2005" name="J. Leukoc. Biol." volume="77" first="90" last="99">
<title>MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells.</title>
<authorList>
<person name="Mukherjee P."/>
<person name="Tinder T.L."/>
<person name="Basu G.D."/>
<person name="Gendler S.J."/>
</authorList>
<dbReference type="PubMed" id="15513966"/>
<dbReference type="DOI" id="10.1189/jlb.0604333"/>
</citation>
<scope>INTERACTION WITH LCK</scope>
<scope>PHOSPHORYLATION</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="12112" last="12122">
<title>Recycling of MUC1 is dependent on its palmitoylation.</title>
<authorList>
<person name="Kinlough C.L."/>
<person name="McMahan R.J."/>
<person name="Poland P.A."/>
<person name="Bruns J.B."/>
<person name="Harkleroad K.L."/>
<person name="Stremple R.J."/>
<person name="Kashlan O.B."/>
<person name="Weixel K.M."/>
<person name="Weisz O.A."/>
<person name="Hughey R.P."/>
</authorList>
<dbReference type="PubMed" id="16507569"/>
<dbReference type="DOI" id="10.1074/jbc.M512996200"/>
</citation>
<scope>PALMITOYLATION AT CYS-1184 AND CYS-1186</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH AP1S1 AND AP1S2</scope>
<scope>MUTAGENESIS OF CYS-1184; CYS-1186; TYR-1203 AND 1187-ARG--LYS-1189</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="295" last="305">
<title>MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.</title>
<authorList>
<person name="Wei X."/>
<person name="Xu H."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="16427018"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.11.030"/>
</citation>
<scope>INTERACTION WITH ESR1</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2007" name="Biochim. Biophys. Acta" volume="1773" first="1028" last="1038">
<title>MUC1 inhibits cell proliferation by a beta-catenin-dependent mechanism.</title>
<authorList>
<person name="Lillehoj E.P."/>
<person name="Lu W."/>
<person name="Kiser T."/>
<person name="Goldblum S.E."/>
<person name="Kim K.C."/>
</authorList>
<dbReference type="PubMed" id="17524503"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2007.04.009"/>
</citation>
<scope>INTERACTION WITH CTNNB1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="1853" last="1858">
<title>Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene.</title>
<authorList>
<person name="Wei X."/>
<person name="Xu H."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="17308127"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-3063"/>
</citation>
<scope>INTERACTION WITH KLF4</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="5201" last="5210">
<title>Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells.</title>
<authorList>
<person name="Singh P.K."/>
<person name="Wen Y."/>
<person name="Swanson B.J."/>
<person name="Shanmugam K."/>
<person name="Kazlauskas A."/>
<person name="Cerny R.L."/>
<person name="Gendler S.J."/>
<person name="Hollingsworth M.A."/>
</authorList>
<dbReference type="PubMed" id="17545600"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-4647"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1203; TYR-1218 AND TYR-1229</scope>
<scope>MUTAGENESIS OF TYR-1203 AND TYR-1218</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="1693" last="1701">
<title>MUC1 is a novel regulator of ErbB1 receptor trafficking.</title>
<authorList>
<person name="Pochampalli M.R."/>
<person name="el Bejjani R.M."/>
<person name="Schroeder J.A."/>
</authorList>
<dbReference type="PubMed" id="16983337"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209976"/>
</citation>
<scope>INTERACTION WITH EGFR</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2010" name="Clin. Chim. Acta" volume="411" first="1869" last="1874">
<title>CA 15-3: uses and limitation as a biomarker for breast cancer.</title>
<authorList>
<person name="Duffy M.J."/>
<person name="Evoy D."/>
<person name="McDermott E.W."/>
</authorList>
<dbReference type="PubMed" id="20816948"/>
<dbReference type="DOI" id="10.1016/j.cca.2010.08.039"/>
</citation>
<scope>MARKER IN BREAST CANCER</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1227</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="64">
<citation type="journal article" date="2013" name="Nat. Genet." volume="45" first="299" last="303">
<title>Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing.</title>
<authorList>
<person name="Kirby A."/>
<person name="Gnirke A."/>
<person name="Jaffe D.B."/>
<person name="Baresova V."/>
<person name="Pochet N."/>
<person name="Blumenstiel B."/>
<person name="Ye C."/>
<person name="Aird D."/>
<person name="Stevens C."/>
<person name="Robinson J.T."/>
<person name="Cabili M.N."/>
<person name="Gat-Viks I."/>
<person name="Kelliher E."/>
<person name="Daza R."/>
<person name="DeFelice M."/>
<person name="Hulkova H."/>
<person name="Sovova J."/>
<person name="Vylet'al P."/>
<person name="Antignac C."/>
<person name="Guttman M."/>
<person name="Handsaker R.E."/>
<person name="Perrin D."/>
<person name="Steelman S."/>
<person name="Sigurdsson S."/>
<person name="Scheinman S.J."/>
<person name="Sougnez C."/>
<person name="Cibulskis K."/>
<person name="Parkin M."/>
<person name="Green T."/>
<person name="Rossin E."/>
<person name="Zody M.C."/>
<person name="Xavier R.J."/>
<person name="Pollak M.R."/>
<person name="Alper S.L."/>
<person name="Lindblad-Toh K."/>
<person name="Gabriel S."/>
<person name="Hart P.S."/>
<person name="Regev A."/>
<person name="Nusbaum C."/>
<person name="Kmoch S."/>
<person name="Bleyer A.J."/>
<person name="Lander E.S."/>
<person name="Daly M.J."/>
</authorList>
<dbReference type="PubMed" id="23396133"/>
<dbReference type="DOI" id="10.1038/ng.2543"/>
</citation>
<scope>INVOLVEMENT IN MCKD1</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2006" name="Glycobiology" volume="16" first="623" last="634">
<title>N-glycosylation of the MUC1 mucin in epithelial cells and secretions.</title>
<authorList>
<person name="Parry S."/>
<person name="Hanisch F.G."/>
<person name="Leir S.H."/>
<person name="Sutton-Smith M."/>
<person name="Morris H.R."/>
<person name="Dell A."/>
<person name="Harris A."/>
</authorList>
<dbReference type="PubMed" id="16585136"/>
<dbReference type="DOI" id="10.1093/glycob/cwj110"/>
</citation>
<scope>STRUCTURE BY NMR OF 1041-1097 AND 1098-1152 OF WILD TYPE AND MUTANT ALA-1098</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<scope>AUTOCATALYTIC CLEAVAGE</scope>
</reference>
<comment type="function">
<text>The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion protein. May provide a protective layer on epithelial cells against bacterial and enzyme attack.</text>
</comment>
<comment type="function">
<text>The beta subunit contains a C-terminal domain which is involved in cell signaling, through phosphorylations and protein-protein interactions. Modulates signaling in ERK, SRC and NF-kappa-B pathways. In activated T-cells, influences directly or indirectly the Ras/MAPK pathway. Promotes tumor progression. Regulates TP53-mediated transcription and determines cell fate in the genotoxic stress response. Binds, together with KLF4, the PE21 promoter element of TP53 and represses TP53 activity.</text>
</comment>
<comment type="subunit">
<text evidence="8 9 12 13 14 15 16 17 19 20 21 22 26 27 28 29 30 31 36 39 44">The alpha subunit forms a tight, non-covalent heterodimeric complex with the proteolytically-released beta-subunit. Interaction, via the tandem repeat region, with domain 1 of ICAM1 is implicated in cell migration and metastases. Isoform 1 binds directly the SH2 domain of GRB2, and forms a MUC1/GRB2/SOS1 complex involved in RAS signaling. The cytoplasmic tail (MUC1CT) interacts with several proteins such as SRC, CTNNB1 and ERBs. Interaction with the SH2 domain of CSK decreases interaction with GSK3B. Interacts with CTNNB1/beta-catenin and JUP/gamma-catenin and promotes cell adhesion. Interaction with JUP/gamma-catenin is induced by heregulin. Binds PRKCD, ERBB2, ERBB3 and ERBB4. Heregulin (HRG) stimulates the interaction with ERBB2 and, to a much lesser extent, the interaction with ERBB3 and ERBB4. Interacts with P53 in response to DNA damage. Interacts with KLF4. Interacts with estrogen receptor alpha/ESR1, through its DNA-binding domain, and stimulates its transcription activity. Binds ADAM17. Isoform ZD forms disulfide-linked oligomers.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2804728"/>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10053698"/>
<interactant intactId="EBI-969696">
<id>P17676</id>
<label>CEBPB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2804728"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2804728"/>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2804728"/>
<interactant intactId="EBI-4396776">
<id>P15941-7</id>
<label>MUC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2804728"/>
<interactant intactId="EBI-742339">
<id>P26368</id>
<label>U2AF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="7 16 17 20 24 28 31 32">Apical cell membrane</location>
<topology evidence="7 16 17 20 24 28 31 32">Single-pass type I membrane protein</topology>
</subcellularLocation>
<text>Exclusively located in the apical domain of the plasma membrane of highly polarized epithelial cells. After endocytosis, internalized and recycled to the cell membrane. Located to microvilli and to the tips of long filopodial protusions.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 5</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform Y</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 9</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Mucin-1 subunit beta</molecule>
<subcellularLocation>
<location>Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>On EGF and PDGFRB stimulation, transported to the nucleus through interaction with CTNNB1, a process which is stimulated by phosphorylation. On HRG stimulation, colocalizes with JUP/gamma-catenin at the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P15941-1</id>
<name>1</name>
<name>A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P15941-2</id>
<name>2</name>
<name>B</name>
<sequence type="described" ref="VSP_003280"/>
</isoform>
<isoform>
<id>P15941-3</id>
<name>3</name>
<name>C</name>
<sequence type="described" ref="VSP_003281"/>
</isoform>
<isoform>
<id>P15941-4</id>
<name>4</name>
<name>D</name>
<sequence type="described" ref="VSP_003282"/>
</isoform>
<isoform>
<id>P15941-5</id>
<name>5</name>
<name>SEC</name>
<sequence type="described" ref="VSP_003288 VSP_003289"/>
</isoform>
<isoform>
<id>P15941-6</id>
<name>6</name>
<name>X</name>
<sequence type="described" ref="VSP_003283 VSP_003284"/>
</isoform>
<isoform>
<id>P15941-7</id>
<name>Y</name>
<name>MUC1/Y</name>
<sequence type="described" ref="VSP_003285"/>
</isoform>
<isoform>
<id>P15941-8</id>
<name>8</name>
<name>Z</name>
<sequence type="described" ref="VSP_003286"/>
</isoform>
<isoform>
<id>P15941-9</id>
<name>9</name>
<name>S</name>
<sequence type="described" ref="VSP_003286 VSP_003287"/>
</isoform>
<isoform>
<id>P15941-10</id>
<name>F</name>
<sequence type="described" ref="VSP_035046 VSP_035047"/>
</isoform>
<isoform>
<id>P15941-11</id>
<name>Y-LSP</name>
<sequence type="described" ref="VSP_003280 VSP_003285"/>
<text>Lacks the mucin repeats.</text>
</isoform>
<isoform>
<id>P15941-12</id>
<name>S2</name>
<sequence type="described" ref="VSP_003280 VSP_003285 VSP_003287"/>
</isoform>
<isoform>
<id>P15941-13</id>
<name>M6</name>
<sequence type="described" ref="VSP_003286 VSP_046962 VSP_046963"/>
</isoform>
<isoform>
<id>P15941-14</id>
<name>ZD</name>
<name>J19</name>
<sequence type="described" ref="VSP_047575 VSP_047576"/>
<text>Lacks the mucin repeats. Exists as a disulfide-linked oligomer.</text>
</isoform>
<isoform>
<id>P15941-15</id>
<name>T10</name>
<sequence type="described" ref="VSP_003280 VSP_047873"/>
</isoform>
<isoform>
<id>P15941-16</id>
<name>E2</name>
<sequence type="described" ref="VSP_003280 VSP_047872"/>
</isoform>
<isoform>
<id>P15941-17</id>
<name>J13</name>
<sequence type="described" ref="VSP_003280 VSP_003285 VSP_047874"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text evidence="21 40">Expressed on the apical surface of epithelial cells, especially of airway passages, breast and uterus. Also expressed in activated and unactivated T-cells. Overexpressed in epithelial tumors, such as breast or ovarian cancer and also in non-epithelial tumor cells. Isoform Y is expressed in tumor cells only.</text>
</comment>
<comment type="developmental stage">
<text evidence="42">During fetal development, expressed at low levels in the colonic epithelium from 13 weeks of gestation.</text>
</comment>
<comment type="PTM">
<text evidence="6 37 41 43">Highly glycosylated (N- and O-linked carbohydrates and sialic acid). O-glycosylated to a varying degree on serine and threonine residues within each tandem repeat, ranging from mono- to penta-glycosylation. The average density ranges from about 50% in human milk to over 90% in T47D breast cancer cells. Further sialylation occurs during recycling. Membrane-shed glycoproteins from kidney and breast cancer cells have preferentially sialyated core 1 structures, while secreted forms from the same tissues display mainly core 2 structures. The O-glycosylated content is overlapping in both these tissues with terminal fucose and galactose, 2- and 3-linked galactose, 3- and 3,6-linked GalNAc-ol and 4-linked GlcNAc predominating. Differentially O-glycosylated in breast carcinomas with 3,4-linked GlcNAc. N-glycosylation consists of high-mannose, acidic complex-type and hybrid glycans in the secreted form MUC1/SEC, and neutral complex-type in the transmembrane form, MUC1/TM.</text>
</comment>
<comment type="PTM">
<text evidence="10 14 25">Proteolytic cleavage in the SEA domain occurs in the endoplasmic reticulum by an autoproteolytic mechanism and requires the full-length SEA domain as well as requiring a Ser, Thr or Cys residue at the P + 1 site. Cleavage at this site also occurs on isoform MUC1/X but not on isoform MUC1/Y. Ectodomain shedding is mediated by ADAM17.</text>
</comment>
<comment type="PTM">
<text evidence="28">Dual palmitoylation on cysteine residues in the CQC motif is required for recycling from endosomes back to the plasma membrane.</text>
</comment>
<comment type="PTM">
<text evidence="8 12 13 15 18 21 26 32 36 38 44">Phosphorylated on tyrosines and serine residues in the C-terminal. Phosphorylation on tyrosines in the C-terminal increases the nuclear location of MUC1 and beta-catenin. Phosphorylation by PKC delta induces binding of MUC1 to beta-catenin/CTNNB1 and thus decreases the formation of the beta-catenin/E-cadherin complex. Src-mediated phosphorylation inhibits interaction with GSK3B. Src- and EGFR-mediated phosphorylation on Tyr-1229 increases binding to beta-catenin/CTNNB1. GSK3B-mediated phosphorylation on Ser-1227 decreases this interaction but restores the formation of the beta-cadherin/E-cadherin complex. On T-cell receptor activation, phosphorylated by LCK. PDGFR-mediated phosphorylation increases nuclear colocalization of MUC1CT and CTNNB1.</text>
</comment>
<comment type="PTM">
<text evidence="10">The N-terminal sequence has been shown to begin at position 24 or 28.</text>
</comment>
<comment type="polymorphism">
<text>The number of repeats is highly polymorphic. It varies from 21 to 125 in the northern European population. The most frequent alleles contains 41 and 85 repeats. The tandemly repeated icosapeptide underlies polymorphism at three positions: PAPGSTAP[PAQT]AHGVTSAP[DT/ES]R, DT -&gt; ES and the single replacements P -&gt; A, P -&gt; Q and P-&gt; T. The most frequent replacement DT -&gt; ES occurs in up to 50% of the repeats.</text>
</comment>
<comment type="disease">
<text evidence="33">MUC1/CA 15-3 is used as a serological clinical marker of breast cancer to monitor response to breast cancer treatment and disease recurrence (PubMed:20816948). Decreased levels over time may be indicative of a positive response to treatment. Conversely, increased levels may indicate disease progression. At an early stage disease, only 21% of patients exhibit high MUC1/CA 15-3 levels, that is why CA 15-3 is not a useful screening test. Most antibodies target the highly immunodominant core peptide domain of 20 amino acid (APDTRPAPGSTAPPAHGVTS) tandem repeats. Some antibodies recognize glycosylated epitopes.</text>
</comment>
<comment type="disease" evidence="35">
<disease id="DI-03826">
<name>Medullary cystic kidney disease 1</name>
<acronym>MCKD1</acronym>
<description>A form of tubulointerstitial nephropathy characterized by formation of renal cysts at the corticomedullary junction. It is characterized by adult onset of impaired renal function and salt wasting resulting in end-stage renal failure by the sixth decade.</description>
<dbReference type="MIM" id="174000"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>The name KL-6 was originally that of a murine monoclonal antibody reacting with pulmonary adenocarcinoma cell lines and pulmonary epithelial cells. This antibody recognizes a sialylated carbohydrate chain on MUC1.</text>
</comment>
<comment type="caution">
<text evidence="62 63">O-glycosylation sites are annotated in first sequence repeat only. Residues at similar position are probably glycosylated in all repeats. Experimental sites were determined in a synthetic peptide glycosylated in vitro (PubMed:7744025, PubMed:9597769).</text>
</comment>
<comment type="sequence caution" evidence="61">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAD14369" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="61">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAD14376" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="Mucin database">
<link uri="http://www.medkem.gu.se/mucinbiology/databases/"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/muc1/"/>
</comment>
<dbReference type="EMBL" id="J05582">
<property type="protein sequence ID" value="AAA60019.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M32738">
<property type="protein sequence ID" value="AAA35804.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M32739">
<property type="protein sequence ID" value="AAA35806.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M34089">
<property type="protein sequence ID" value="AAA35807.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M34088">
<property type="protein sequence ID" value="AAA35805.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J05581">
<property type="protein sequence ID" value="AAA59876.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M61170">
<property type="protein sequence ID" value="AAB53150.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X52229">
<property type="protein sequence ID" value="CAA36478.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X52228">
<property type="protein sequence ID" value="CAA36477.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M35093">
<property type="protein sequence ID" value="AAB59612.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X80761">
<property type="protein sequence ID" value="CAA56734.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U60259">
<property type="protein sequence ID" value="AAD10856.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U60260">
<property type="protein sequence ID" value="AAD10857.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U60261">
<property type="protein sequence ID" value="AAD10858.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF125525">
<property type="protein sequence ID" value="AAD27842.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY466157">
<property type="protein sequence ID" value="AAR28764.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY327582">
<property type="protein sequence ID" value="AAP97013.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY327584">
<property type="protein sequence ID" value="AAP97015.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY327586">
<property type="protein sequence ID" value="AAP97017.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY327587">
<property type="protein sequence ID" value="AAP97018.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF583653">
<property type="protein sequence ID" value="ABQ59628.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF670711">
<property type="protein sequence ID" value="ABS01298.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF670712">
<property type="protein sequence ID" value="ABS01299.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ226040">
<property type="protein sequence ID" value="ACI25172.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ226047">
<property type="protein sequence ID" value="ACI25179.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF348143">
<property type="protein sequence ID" value="AAK30142.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY463543">
<property type="protein sequence ID" value="AAR18816.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL713999">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53116.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53117.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53118.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53119.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC120974">
<property type="protein sequence ID" value="AAI20975.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC120975">
<property type="protein sequence ID" value="AAI20976.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z17324">
<property type="protein sequence ID" value="CAA78972.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z17325">
<property type="protein sequence ID" value="CAA78973.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M31823">
<property type="protein sequence ID" value="AAA35757.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S81781">
<property type="protein sequence ID" value="AAD14376.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S81736">
<property type="protein sequence ID" value="AAD14369.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M21868">
<property type="protein sequence ID" value="AAA59874.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1098.1">
<molecule id="P15941-8"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30882.1">
<molecule id="P15941-11"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30883.1">
<molecule id="P15941-7"/>
</dbReference>
<dbReference type="CCDS" id="CCDS41408.1">
<molecule id="P15941-12"/>
</dbReference>
<dbReference type="CCDS" id="CCDS41409.1">
<molecule id="P15941-10"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55641.1">
<molecule id="P15941-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55642.1">
<molecule id="P15941-13"/>
</dbReference>
<dbReference type="PIR" id="A35175">
<property type="entry name" value="A35175"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001018016.1">
<molecule id="P15941-11"/>
<property type="nucleotide sequence ID" value="NM_001018016.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001018017.1">
<molecule id="P15941-7"/>
<property type="nucleotide sequence ID" value="NM_001018017.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001037855.1">
<molecule id="P15941-10"/>
<property type="nucleotide sequence ID" value="NM_001044390.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001037856.1">
<property type="nucleotide sequence ID" value="NM_001044391.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001037857.1">
<molecule id="P15941-12"/>
<property type="nucleotide sequence ID" value="NM_001044392.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001037858.1">
<property type="nucleotide sequence ID" value="NM_001044393.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191214.1">
<property type="nucleotide sequence ID" value="NM_001204285.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191215.1">
<property type="nucleotide sequence ID" value="NM_001204286.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191216.1">
<property type="nucleotide sequence ID" value="NM_001204287.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191217.1">
<property type="nucleotide sequence ID" value="NM_001204288.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191218.1">
<property type="nucleotide sequence ID" value="NM_001204289.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191219.1">
<property type="nucleotide sequence ID" value="NM_001204290.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191220.1">
<property type="nucleotide sequence ID" value="NM_001204291.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191221.1">
<property type="nucleotide sequence ID" value="NM_001204292.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191222.1">
<molecule id="P15941-13"/>
<property type="nucleotide sequence ID" value="NM_001204293.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191223.1">
<molecule id="P15941-6"/>
<property type="nucleotide sequence ID" value="NM_001204294.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191224.1">
<property type="nucleotide sequence ID" value="NM_001204295.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191225.1">
<property type="nucleotide sequence ID" value="NM_001204296.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191226.1">
<property type="nucleotide sequence ID" value="NM_001204297.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002447.4">
<molecule id="P15941-8"/>
<property type="nucleotide sequence ID" value="NM_002456.5"/>
</dbReference>
<dbReference type="UniGene" id="Hs.89603"/>
<dbReference type="PDB" id="1SM3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="P=919-931"/>
</dbReference>
<dbReference type="PDB" id="2ACM">
<property type="method" value="NMR"/>
<property type="chains" value="A=1042-1097, B=1098-1152"/>
</dbReference>
<dbReference type="PDB" id="2FO4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="P=140-146"/>
</dbReference>
<dbReference type="PDB" id="5T6P">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="E/F=921-928"/>
</dbReference>
<dbReference type="PDB" id="5T78">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="E/F=921-928"/>
</dbReference>
<dbReference type="PDBsum" id="1SM3"/>
<dbReference type="PDBsum" id="2ACM"/>
<dbReference type="PDBsum" id="2FO4"/>
<dbReference type="PDBsum" id="5T6P"/>
<dbReference type="PDBsum" id="5T78"/>
<dbReference type="ProteinModelPortal" id="P15941"/>
<dbReference type="SMR" id="P15941"/>
<dbReference type="BioGrid" id="110669">
<property type="interactions" value="44"/>
</dbReference>
<dbReference type="DIP" id="DIP-41890N"/>
<dbReference type="IntAct" id="P15941">
<property type="interactions" value="11"/>
</dbReference>
<dbReference type="MINT" id="MINT-156679"/>
<dbReference type="STRING" id="9606.ENSP00000357380"/>
<dbReference type="ChEMBL" id="CHEMBL3580494"/>
<dbReference type="MEROPS" id="S71.001"/>
<dbReference type="iPTMnet" id="P15941"/>
<dbReference type="PhosphoSitePlus" id="P15941"/>
<dbReference type="SwissPalm" id="P15941"/>
<dbReference type="UniCarbKB" id="P15941"/>
<dbReference type="BioMuta" id="MUC1"/>
<dbReference type="DMDM" id="296439295"/>
<dbReference type="MaxQB" id="P15941"/>
<dbReference type="PaxDb" id="P15941"/>
<dbReference type="PeptideAtlas" id="P15941"/>
<dbReference type="PRIDE" id="P15941"/>
<dbReference type="DNASU" id="4582"/>
<dbReference type="Ensembl" id="ENST00000337604">
<molecule id="P15941-8"/>
<property type="protein sequence ID" value="ENSP00000338983"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000342482">
<molecule id="P15941-16"/>
<property type="protein sequence ID" value="ENSP00000342814"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000343256">
<molecule id="P15941-10"/>
<property type="protein sequence ID" value="ENSP00000339690"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368389">
<molecule id="P15941-9"/>
<property type="protein sequence ID" value="ENSP00000357374"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368390">
<molecule id="P15941-7"/>
<property type="protein sequence ID" value="ENSP00000357375"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368392">
<molecule id="P15941-11"/>
<property type="protein sequence ID" value="ENSP00000357377"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368393">
<molecule id="P15941-13"/>
<property type="protein sequence ID" value="ENSP00000357378"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368396">
<molecule id="P15941-12"/>
<property type="protein sequence ID" value="ENSP00000357381"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368398">
<molecule id="P15941-6"/>
<property type="protein sequence ID" value="ENSP00000357383"/>
<property type="gene ID" value="ENSG00000185499"/>
</dbReference>
<dbReference type="GeneID" id="4582"/>
<dbReference type="KEGG" id="hsa:4582"/>
<dbReference type="UCSC" id="uc001fia.4">
<molecule id="P15941-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4582"/>
<dbReference type="DisGeNET" id="4582"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000185499.16"/>
<dbReference type="GeneCards" id="MUC1"/>
<dbReference type="GeneReviews" id="MUC1"/>
<dbReference type="HGNC" id="HGNC:7508">
<property type="gene designation" value="MUC1"/>
</dbReference>
<dbReference type="HPA" id="CAB000036"/>
<dbReference type="HPA" id="CAB001986"/>
<dbReference type="HPA" id="HPA004179"/>
<dbReference type="HPA" id="HPA007235"/>
<dbReference type="HPA" id="HPA008855"/>
<dbReference type="MalaCards" id="MUC1"/>
<dbReference type="MIM" id="113720">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="158340">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="174000">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P15941"/>
<dbReference type="OpenTargets" id="ENSG00000185499"/>
<dbReference type="Orphanet" id="34149">
<property type="disease" value="Autosomal dominant medullary cystic kidney disease with or without hyperuricemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA31309"/>
<dbReference type="eggNOG" id="ENOG410IX6R">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZQ7Z">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00710000106874"/>
<dbReference type="HOGENOM" id="HOG000290201"/>
<dbReference type="HOVERGEN" id="HBG003075"/>
<dbReference type="InParanoid" id="P15941"/>
<dbReference type="KO" id="K06568"/>
<dbReference type="PhylomeDB" id="P15941"/>
<dbReference type="Reactome" id="R-HSA-5083625">
<property type="pathway name" value="Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5083632">
<property type="pathway name" value="Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5083636">
<property type="pathway name" value="Defective GALNT12 causes colorectal cancer 1 (CRCS1)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621480">
<property type="pathway name" value="Dectin-2 family"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and 13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-913709">
<property type="pathway name" value="O-linked glycosylation of mucins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977068">
<property type="pathway name" value="Termination of O-glycan biosynthesis"/>
</dbReference>
<dbReference type="SIGNOR" id="P15941"/>
<dbReference type="ChiTaRS" id="MUC1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P15941"/>
<dbReference type="GeneWiki" id="MUC1"/>
<dbReference type="GenomeRNAi" id="4582"/>
<dbReference type="PRO" id="PR:P15941"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000185499"/>
<dbReference type="ExpressionAtlas" id="P15941">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P15941">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005796">
<property type="term" value="C:Golgi lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031982">
<property type="term" value="C:vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II proximal promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003712">
<property type="term" value="F:transcription cofactor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006977">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006978">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033629">
<property type="term" value="P:negative regulation of cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:1902166">
<property type="term" value="P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010944">
<property type="term" value="P:negative regulation of transcription by competitive promoter binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016266">
<property type="term" value="P:O-glycan processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0090240">
<property type="term" value="P:positive regulation of histone H4 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0036003">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter in response to stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043618">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter in response to stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.70.960">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000082">
<property type="entry name" value="SEA_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036364">
<property type="entry name" value="SEA_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF01390">
<property type="entry name" value="SEA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00200">
<property type="entry name" value="SEA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF82671">
<property type="entry name" value="SSF82671"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50024">
<property type="entry name" value="SEA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0068">Autocatalytic cleavage</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<feature type="signal peptide" evidence="6 10">
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="chain" description="Mucin-1" id="PRO_0000019277">
<location>
<begin position="24"/>
<end position="1255"/>
</location>
</feature>
<feature type="chain" description="Mucin-1 subunit alpha" id="PRO_0000317446">
<location>
<begin position="24"/>
<end position="1097"/>
</location>
</feature>
<feature type="chain" description="Mucin-1 subunit beta" id="PRO_0000317447">
<location>
<begin position="1098"/>
<end position="1255"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="24"/>
<end position="1158"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="1159"/>
<end position="1181"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="1182"/>
<end position="1255"/>
</location>
</feature>
<feature type="repeat" description="1; approximate" evidence="11">
<location>
<begin position="61"/>
<end position="80"/>
</location>
</feature>
<feature type="repeat" description="2; approximate" evidence="11">
<location>
<begin position="81"/>
<end position="100"/>
</location>
</feature>
<feature type="repeat" description="3" evidence="11">
<location>
<begin position="101"/>
<end position="120"/>
</location>
</feature>
<feature type="repeat" description="4" evidence="11">
<location>
<begin position="121"/>
<end position="140"/>
</location>
</feature>
<feature type="repeat" description="5" evidence="11">
<location>
<begin position="141"/>
<end position="160"/>
</location>
</feature>
<feature type="repeat" description="6" evidence="11">
<location>
<begin position="161"/>
<end position="180"/>
</location>
</feature>
<feature type="repeat" description="7" evidence="11">
<location>
<begin position="181"/>
<end position="200"/>
</location>
</feature>
<feature type="repeat" description="8" evidence="11">
<location>
<begin position="201"/>
<end position="220"/>
</location>
</feature>
<feature type="repeat" description="9" evidence="11">
<location>
<begin position="221"/>
<end position="240"/>
</location>
</feature>
<feature type="repeat" description="10" evidence="11">
<location>
<begin position="241"/>
<end position="260"/>
</location>
</feature>
<feature type="repeat" description="11" evidence="11">
<location>
<begin position="261"/>
<end position="280"/>
</location>
</feature>
<feature type="repeat" description="12" evidence="11">
<location>
<begin position="281"/>
<end position="300"/>
</location>
</feature>
<feature type="repeat" description="13" evidence="11">
<location>
<begin position="301"/>
<end position="320"/>
</location>
</feature>
<feature type="repeat" description="14" evidence="11">
<location>
<begin position="321"/>
<end position="340"/>
</location>
</feature>
<feature type="repeat" description="15" evidence="11">
<location>
<begin position="341"/>
<end position="360"/>
</location>
</feature>
<feature type="repeat" description="16" evidence="11">
<location>
<begin position="361"/>
<end position="380"/>
</location>
</feature>
<feature type="repeat" description="17" evidence="11">
<location>
<begin position="381"/>
<end position="400"/>
</location>
</feature>
<feature type="repeat" description="18" evidence="11">
<location>
<begin position="401"/>
<end position="420"/>
</location>
</feature>
<feature type="repeat" description="19" evidence="11">
<location>
<begin position="421"/>
<end position="440"/>
</location>
</feature>
<feature type="repeat" description="20" evidence="11">
<location>
<begin position="441"/>
<end position="460"/>
</location>
</feature>
<feature type="repeat" description="21" evidence="11">
<location>
<begin position="461"/>
<end position="480"/>
</location>
</feature>
<feature type="repeat" description="22" evidence="11">
<location>
<begin position="481"/>
<end position="500"/>
</location>
</feature>
<feature type="repeat" description="23" evidence="11">
<location>
<begin position="501"/>
<end position="520"/>
</location>
</feature>
<feature type="repeat" description="24" evidence="11">
<location>
<begin position="521"/>
<end position="540"/>
</location>
</feature>
<feature type="repeat" description="25" evidence="11">
<location>
<begin position="541"/>
<end position="560"/>
</location>
</feature>
<feature type="repeat" description="26" evidence="11">
<location>
<begin position="561"/>
<end position="580"/>
</location>
</feature>
<feature type="repeat" description="27" evidence="11">
<location>
<begin position="581"/>
<end position="600"/>
</location>
</feature>
<feature type="repeat" description="28" evidence="11">
<location>
<begin position="601"/>
<end position="620"/>
</location>
</feature>
<feature type="repeat" description="29" evidence="11">
<location>
<begin position="621"/>
<end position="640"/>
</location>
</feature>
<feature type="repeat" description="30" evidence="11">
<location>
<begin position="641"/>
<end position="660"/>
</location>
</feature>
<feature type="repeat" description="31" evidence="11">
<location>
<begin position="661"/>
<end position="680"/>
</location>
</feature>
<feature type="repeat" description="32" evidence="11">
<location>
<begin position="681"/>
<end position="700"/>
</location>
</feature>
<feature type="repeat" description="33" evidence="11">
<location>
<begin position="701"/>
<end position="720"/>
</location>
</feature>
<feature type="repeat" description="34" evidence="11">
<location>
<begin position="721"/>
<end position="740"/>
</location>
</feature>
<feature type="repeat" description="35" evidence="11">
<location>
<begin position="741"/>
<end position="760"/>
</location>
</feature>
<feature type="repeat" description="36" evidence="11">
<location>
<begin position="761"/>
<end position="780"/>
</location>
</feature>
<feature type="repeat" description="37" evidence="11">
<location>
<begin position="781"/>
<end position="800"/>
</location>
</feature>
<feature type="repeat" description="38" evidence="11">
<location>
<begin position="801"/>
<end position="820"/>
</location>
</feature>
<feature type="repeat" description="39" evidence="11">
<location>
<begin position="821"/>
<end position="840"/>
</location>
</feature>
<feature type="repeat" description="40" evidence="11">
<location>
<begin position="841"/>
<end position="860"/>
</location>
</feature>
<feature type="repeat" description="41" evidence="11">
<location>
<begin position="861"/>
<end position="880"/>
</location>
</feature>
<feature type="repeat" description="42" evidence="11">
<location>
<begin position="881"/>
<end position="900"/>
</location>
</feature>
<feature type="repeat" description="43" evidence="11">
<location>
<begin position="901"/>
<end position="920"/>
</location>
</feature>
<feature type="repeat" description="44" evidence="11">
<location>
<begin position="921"/>
<end position="940"/>
</location>
</feature>
<feature type="repeat" description="45" evidence="11">
<location>
<begin position="941"/>
<end position="960"/>
</location>
</feature>
<feature type="repeat" description="46; approximate" evidence="11">
<location>
<begin position="961"/>
<end position="980"/>
</location>
</feature>
<feature type="repeat" description="47; approximate" evidence="11">
<location>
<begin position="981"/>
<end position="1000"/>
</location>
</feature>
<feature type="repeat" description="48; approximate" evidence="11">
<location>
<begin position="1001"/>
<end position="1020"/>
</location>
</feature>
<feature type="domain" description="SEA" evidence="4">
<location>
<begin position="1039"/>
<end position="1148"/>
</location>
</feature>
<feature type="region of interest" description="42 X 20 AA approximate tandem repeats of P-A-P-G-S-T-A-P-P-A-H-G-V-T-S-A-P-D-T-R">
<location>
<begin position="126"/>
<end position="965"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with P53">
<location>
<begin position="1192"/>
<end position="1228"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with GSK3B">
<location>
<begin position="1223"/>
<end position="1230"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with beta- and gamma-catenins">
<location>
<begin position="1233"/>
<end position="1241"/>
</location>
</feature>
<feature type="short sequence motif" description="Interaction with GRB2">
<location>
<begin position="1203"/>
<end position="1206"/>
</location>
</feature>
<feature type="short sequence motif" description="Interaction with SRC and ESR1">
<location>
<begin position="1229"/>
<end position="1232"/>
</location>
</feature>
<feature type="short sequence motif" description="Required for interaction with AP1S2">
<location>
<begin position="1243"/>
<end position="1246"/>
</location>
</feature>
<feature type="site" description="Cleavage; by autolysis">
<location>
<begin position="1097"/>
<end position="1098"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PDGFR" evidence="18 32">
<location>
<position position="1203"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="18">
<location>
<position position="1212"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PDGFR" evidence="32">
<location>
<position position="1218"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKC/PRKCD" evidence="13">
<location>
<position position="1224"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta" evidence="2 44">
<location>
<position position="1227"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK, EGFR and SRC" evidence="8 12 18 32">
<location>
<position position="1229"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="18">
<location>
<position position="1243"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="28">
<location>
<position position="1184"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="28">
<location>
<position position="1186"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="62 63">
<location>
<position position="131"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="62 63">
<location>
<position position="139"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="3">
<location>
<position position="140"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="3">
<location>
<position position="144"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="957"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="975"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="1029"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="1055"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="1133"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_003281" evidence="60">
<location>
<begin position="19"/>
<end position="21"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform Y-LSP, isoform E2, isoform J13, isoform S2 and isoform T10." id="VSP_003280" evidence="46 49 50 52 54 58">
<original>T</original>
<variation>TATTAPKPAT</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_003282" evidence="60">
<location>
<begin position="20"/>
<end position="31"/>
</location>
</feature>
<feature type="splice variant" description="In isoform E2." id="VSP_047872" evidence="49">
<location>
<begin position="54"/>
<end position="1151"/>
</location>
</feature>
<feature type="splice variant" description="In isoform T10." id="VSP_047873" evidence="49">
<location>
<begin position="54"/>
<end position="1093"/>
</location>
</feature>
<feature type="splice variant" description="In isoform J13, isoform Y, isoform Y-LSP and isoform S2." id="VSP_003285" evidence="46 48 49 53 55 58">
<location>
<begin position="54"/>
<end position="1053"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8, isoform 9 and isoform M6." id="VSP_003286" evidence="49 55 56 59">
<location>
<begin position="54"/>
<end position="1035"/>
</location>
</feature>
<feature type="splice variant" description="In isoform ZD." id="VSP_047575" evidence="47 49">
<original>VSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPASGSAATWGQ</original>
<variation>IPAPTTTKSCRETFLKCFCRFINKGVFWASPILSSGQDLWWYN</variation>
<location>
<begin position="54"/>
<end position="96"/>
</location>
</feature>
<feature type="splice variant" description="In isoform F." id="VSP_035046" evidence="57">
<original>VSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPA</original>
<variation>IPAPTTTKSCRETFLKCFCRFINKGVFWASPILS</variation>
<location>
<begin position="54"/>
<end position="87"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_003283" evidence="49 55">
<original>VSMTSSVLSSHSPGSGS</original>
<variation>IPAPTTTKSCRETFLKW</variation>
<location>
<begin position="54"/>
<end position="70"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_003284" evidence="49 55">
<location>
<begin position="71"/>
<end position="1095"/>
</location>
</feature>
<feature type="splice variant" description="In isoform F." id="VSP_035047" evidence="57">
<location>
<begin position="88"/>
<end position="1139"/>
</location>
</feature>
<feature type="splice variant" description="In isoform ZD." id="VSP_047576" evidence="47 49">
<location>
<begin position="97"/>
<end position="1255"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 9 and isoform S2." id="VSP_003287" evidence="49 56 58">
<location>
<begin position="1077"/>
<end position="1181"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_003288" evidence="51">
<original>FLQIYKQGGFL</original>
<variation>VSIGLSFPMLP</variation>
<location>
<begin position="1077"/>
<end position="1087"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_003289" evidence="51">
<location>
<begin position="1088"/>
<end position="1255"/>
</location>
</feature>
<feature type="splice variant" description="In isoform M6." id="VSP_046962" evidence="49 59">
<original>VSDVPFPFSAQSGAGVPGWGIALLVLVCVLVALAIVYLIA</original>
<variation>GCLSVPPKELRAAGHLSSPGYLPSYERVPHLPHPWALCAP</variation>
<location>
<begin position="1141"/>
<end position="1180"/>
</location>
</feature>
<feature type="splice variant" description="In isoform M6." id="VSP_046963" evidence="49 59">
<location>
<begin position="1181"/>
<end position="1255"/>
</location>
</feature>
<feature type="splice variant" description="In isoform J13." id="VSP_047874" evidence="49">
<original>VSAGNGGSSLSYTNPAVAATSANL</original>
<variation>RQNGWSTMPRGALPEESQG</variation>
<location>
<begin position="1232"/>
<end position="1255"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1611770." id="VAR_019390" evidence="23 34 45">
<original>V</original>
<variation>M</variation>
<location>
<position position="1117"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11465207." id="VAR_019391" evidence="45">
<original>S</original>
<variation>N</variation>
<location>
<position position="1142"/>
</location>
</feature>
<feature type="mutagenesis site" description="Completely abrogates cleavage." evidence="25">
<original>S</original>
<variation>A</variation>
<variation>D</variation>
<variation>E</variation>
<variation>F</variation>
<variation>G</variation>
<variation>H</variation>
<variation>I</variation>
<variation>K</variation>
<variation>L</variation>
<variation>M</variation>
<variation>N</variation>
<variation>P</variation>
<variation>Q</variation>
<variation>R</variation>
<variation>V</variation>
<variation>W</variation>
<variation>Y</variation>
<location>
<position position="1098"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost complete cleavage." evidence="25">
<original>S</original>
<variation>C</variation>
<variation>T</variation>
<location>
<position position="1098"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced formation of isoform 5/isoform Y complex." evidence="5">
<original>D</original>
<variation>A</variation>
<location>
<position position="1116"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on formation of isoform 5/isoform Y complex." evidence="5">
<original>D</original>
<variation>E</variation>
<location>
<position position="1116"/>
</location>
</feature>
<feature type="mutagenesis site" description="S-palmitoylation reduced by 50%. Complete loss of palmitoylation, no effect on endocytosis, recycling inhibited and AP1S1 binding reduced by 30%; when associated with C-1186. Accumulates in intracellular compartments; when associated with C-1186 and N-1203." evidence="28">
<original>C</original>
<variation>A</variation>
<location>
<position position="1184"/>
</location>
</feature>
<feature type="mutagenesis site" description="S-palmitoylation reduced by 50%. Complete loss of palmitoylation, no effect on endocytosis, recycling inhibited, and AP1S1 binding reduced by 30%; when associated with C-1184. Accumulates in intracellular compartments; when associated with C-1184 and N-1203." evidence="28">
<original>C</original>
<variation>A</variation>
<location>
<position position="1186"/>
</location>
</feature>
<feature type="mutagenesis site" description="No nuclear targeting of HRG-stimulated MUC1 C-terminal nor JUP/gamma-catenin. No effect on interaction with JUP/gamma-catenin." evidence="17 28">
<original>RRK</original>
<variation>AAA</variation>
<location>
<begin position="1187"/>
<end position="1189"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on palmitoylation." evidence="17 28">
<original>RRK</original>
<variation>QQQ</variation>
<location>
<begin position="1187"/>
<end position="1189"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on EGFR-mediated phosphorylation." evidence="12 20">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1191"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on endocytosis." evidence="12 20">
<original>Y</original>
<variation>N</variation>
<location>
<position position="1191"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on nuclear colocalization of MUC1CT and CTNNB1. No effect on in vitro PDFGR-induced cell invasiveness." evidence="12 20 28 32">
<original>Y</original>
<variation>E</variation>
<location>
<position position="1203"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on EGFR-mediated phosphorylation. No nuclear localization of MUC1CT. Reduced in vitro PDGFR-induced cell invasiveness." evidence="12 20 28 32">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1203"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced endocytosis by 30%. Greatly reduced binding to AP1S2 and GRB2. Binding AP1S1 reduced by 25%. Reduced endocytosis by 77%; when associated with N-1243. Accumulates in intracellular compartments; when associated with C-1184 and C-1186." evidence="12 20 28 32">
<original>Y</original>
<variation>N</variation>
<location>
<position position="1203"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some reduction in EGFR-mediated phosphorylation." evidence="12">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1209"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on EGFR-mediated phosphorylation. No nuclear colocalization of MUC1CT and CTNNB1." evidence="12 32">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1218"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in PRKCD- nor GSK3B-mediated phosphorylation." evidence="13 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="1223"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of PRKCD-mediated phosphorylation. Decreased PRKCD binding. No increased binding to CTNNB1 in the presence of autophosphorylated PRKCD. Increases formation of E-cadherin/beta-catenin complex." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="1224"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in PRKCD-mediated phosphorylation. Loss of GSK3B-mediated phosphorylation. CTNNB1." evidence="13 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="1227"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced EGFR- and Src-mediated phosphorylation. No nuclear localization of MUC1CT. Reduced in vitro PDGFR-mediated phosphorylation. Decreased Src-binding." evidence="8 12 19 20">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1229"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on endocytosis." evidence="8 12 19 20">
<original>Y</original>
<variation>N</variation>
<location>
<position position="1229"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces binding to AP1S2 by 33%. Greatly reduced binding to GRB2. Reduced endocytosis by 50%. Reduced endocytosis by 77%; when associated with N-1203." evidence="20">
<original>Y</original>
<variation>N</variation>
<location>
<position position="1243"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 24; AAD14369." ref="24" evidence="61">
<original>T</original>
<variation>A</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 22; AAA35757." ref="22" evidence="61">
<original>P</original>
<variation>Q</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 22; AAA35757." ref="22" evidence="61">
<original>P</original>
<variation>Q</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA35805/AAA35807 and 3; AAA59876." ref="2 3" evidence="61">
<original>S</original>
<variation>T</variation>
<location>
<position position="1021"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11; AAP97018." ref="11" evidence="61">
<original>D</original>
<variation>G</variation>
<location>
<position position="1143"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAK30142." ref="13" evidence="61">
<original>Q</original>
<variation>L</variation>
<location>
<position position="1193"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AAD10858." ref="9" evidence="61">
<original>K</original>
<variation>T</variation>
<location>
<position position="1231"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA60019." ref="1" evidence="61">
<original>T</original>
<variation>A</variation>
<location>
<position position="1251"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1042"/>
<end position="1052"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1056"/>
<end position="1059"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1064"/>
<end position="1080"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1082"/>
<end position="1085"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1086"/>
<end position="1096"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1099"/>
<end position="1107"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1109"/>
<end position="1111"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1114"/>
<end position="1132"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1136"/>
<end position="1142"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ACM"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00188"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10197628"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10373415"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11118479"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11152665"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11173916"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11341784"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11350974"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11483589"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11877440"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12441351"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12750561"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12832415"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12939402"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14521915"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14688481"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15471854"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15513966"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15710329"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15969018"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15972891"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15987679"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16288032"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16427018"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16507569"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16983337"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17308127"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17524503"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17545600"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20816948"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22941036"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23396133"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7664271"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7744025"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7988707"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9139698"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9212228"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9312074"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9536947"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9597769"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9819408"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source ref="17"/>
</evidence>
<evidence key="46" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15623537"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15969018"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="22941036"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2318825"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2351132"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2597151"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7925397"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8608966"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9212228"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000303">
<source ref="12"/>
</evidence>
<evidence key="57" type="ECO:0000303">
<source ref="14"/>
</evidence>
<evidence key="58" type="ECO:0000303">
<source ref="15"/>
</evidence>
<evidence key="59" type="ECO:0000303">
<source ref="16"/>
</evidence>
<evidence key="60" type="ECO:0000303">
<source ref="25"/>
</evidence>
<evidence key="61" type="ECO:0000305"/>
<evidence key="62" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="7744025"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="9597769"/>
</source>
</evidence>
<sequence length="1255" mass="122102" checksum="5E28DFC4C20D9A82" modified="2010-05-18" version="3" precursor="true">
MTPGTQSPFFLLLLLTVLTVVTGSGHASSTPGGEKETSATQRSSVPSSTEKNAVSMTSSV
LSSHSPGSGSSTTQGQDVTLAPATEPASGSAATWGQDVTSVPVTRPALGSTTPPAHDVTS
APDNKPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTS
APDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDNRPALGSTAPPVHNVTS
ASGSASGSASTLVHNGTSARATTTPASKSTPFSIPSHHSDTPTTLASHSTKTDASSTHHS
SVPPLTSSNHSTSPQLSTGVSFFFLSFHISNLQFNSSLEDPSTDYYQELQRDISEMFLQI
YKQGGFLGLSNIKFRPGSVVVQLTLAFREGTINVHDVETQFNQYKTEAASRYNLTISDVS
VSDVPFPFSAQSGAGVPGWGIALLVLVCVLVALAIVYLIALAVCQCRRKNYGQLDIFPAR
DTYHPMSEYPTYHTHGRYVPPSSTDRSPYEKVSAGNGGSSLSYTNPAVAATSANL
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1998-12-15" modified="2017-12-20" version="164">
<accession>P97929</accession>
<accession>F8VPU5</accession>
<accession>O35922</accession>
<accession>P97383</accession>
<name>BRCA2_MOUSE</name>
<protein>
<recommendedName>
<fullName>Breast cancer type 2 susceptibility protein homolog</fullName>
</recommendedName>
<alternativeName>
<fullName>Fanconi anemia group D1 protein homolog</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">Brca2</name>
<name type="synonym">Fancd1</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Hum. Mol. Genet." volume="6" first="291" last="300">
<title>Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene.</title>
<authorList>
<person name="Connor F."/>
<person name="Smith A."/>
<person name="Wooster R."/>
<person name="Stratton M."/>
<person name="Dixon A."/>
<person name="Campbell E."/>
<person name="Tait T.M."/>
<person name="Freeman T."/>
<person name="Ashworth A."/>
</authorList>
<dbReference type="PubMed" id="9063750"/>
<dbReference type="DOI" id="10.1093/hmg/6.2.291"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<strain>129</strain>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Genomics" volume="40" first="234" last="241">
<title>Murine Brca2: sequence, map position, and expression pattern.</title>
<authorList>
<person name="Sharan S.K."/>
<person name="Bradley A."/>
</authorList>
<dbReference type="PubMed" id="9119389"/>
<dbReference type="DOI" id="10.1006/geno.1996.4573"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<strain>C57BL/6J</strain>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Cancer Res." volume="57" first="3121" last="3125">
<title>Characterization of the rat and mouse homologues of the BRCA2 breast cancer susceptibility gene.</title>
<authorList>
<person name="McAllister K.A."/>
<person name="Haugen-Strano A."/>
<person name="Hagevik S."/>
<person name="Brownlee H.A."/>
<person name="Collins N.K."/>
<person name="Futreal P.A."/>
<person name="Bennett L.M."/>
<person name="Wiseman R.W."/>
</authorList>
<dbReference type="PubMed" id="9242436"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<strain>129/Sv</strain>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2009" name="PLoS Biol." volume="7" first="E1000112" last="E1000112">
<title>Lineage-specific biology revealed by a finished genome assembly of the mouse.</title>
<authorList>
<person name="Church D.M."/>
<person name="Goodstadt L."/>
<person name="Hillier L.W."/>
<person name="Zody M.C."/>
<person name="Goldstein S."/>
<person name="She X."/>
<person name="Bult C.J."/>
<person name="Agarwala R."/>
<person name="Cherry J.L."/>
<person name="DiCuccio M."/>
<person name="Hlavina W."/>
<person name="Kapustin Y."/>
<person name="Meric P."/>
<person name="Maglott D."/>
<person name="Birtle Z."/>
<person name="Marques A.C."/>
<person name="Graves T."/>
<person name="Zhou S."/>
<person name="Teague B."/>
<person name="Potamousis K."/>
<person name="Churas C."/>
<person name="Place M."/>
<person name="Herschleb J."/>
<person name="Runnheim R."/>
<person name="Forrest D."/>
<person name="Amos-Landgraf J."/>
<person name="Schwartz D.C."/>
<person name="Cheng Z."/>
<person name="Lindblad-Toh K."/>
<person name="Eichler E.E."/>
<person name="Ponting C.P."/>
</authorList>
<dbReference type="PubMed" id="19468303"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000112"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>C57BL/6J</strain>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="13078" last="13083">
<title>Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells.</title>
<authorList>
<person name="Rajan J.V."/>
<person name="Wang M."/>
<person name="Marquis S.T."/>
<person name="Chodosh L.A."/>
</authorList>
<dbReference type="PubMed" id="8917547"/>
<dbReference type="DOI" id="10.1073/pnas.93.23.13078"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 18-200</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Mamm. Genome" volume="8" first="540" last="541">
<title>Genetic mapping of the Brca2 breast cancer susceptibility gene on mouse chromosome 5.</title>
<authorList>
<person name="McAllister K.A."/>
<person name="Ramachandran S."/>
<person name="Haugen-Strano A."/>
<person name="Fiedorek F.T. Jr."/>
<person name="Wiseman R.W."/>
</authorList>
<dbReference type="PubMed" id="9196008"/>
<dbReference type="DOI" id="10.1007/s003359900497"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 569-625</scope>
</reference>
<reference key="7">
<citation type="submission" date="2009-01" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Sunyer B."/>
<person name="Chen W.-Q."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 784-790</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<strain>OF1</strain>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Science" volume="297" first="1837" last="1848">
<title>BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.</title>
<authorList>
<person name="Yang H."/>
<person name="Jeffrey P.D."/>
<person name="Miller J."/>
<person name="Kinnucan E."/>
<person name="Sun Y."/>
<person name="Thoma N.H."/>
<person name="Zheng N."/>
<person name="Chen P.L."/>
<person name="Lee W.H."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="12228710"/>
<dbReference type="DOI" id="10.1126/science.297.5588.1837"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 2378-3115 IN COMPLEX WITH SEM1</scope>
<scope>INTERACTION WITH SEM1</scope>
</reference>
<comment type="function">
<text evidence="3 4">Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SEM1, and is required to prevent R-loop-associated DNA damage and thus transcription-associated genomic instability, independently of its known role in homologous recombination (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="3 4 5">Monomer and dimer. Interacts with RAD51; regulates RAD51 recruitment and function at sites of DNA repair. Interacts with SEM1, WDR16, USP11, DMC1, ROCK2 and NPM1. Interacts with both nonubiquitinated and monoubiquitinated FANCD2; this complex also includes XRCC3 and phosphorylated FANCG. Part of a BRCA complex containing BRCA1, BRCA2 and PALB2. Interacts directly with PALB2 which may serve as a scaffold for a HR complex containing PALB2, BRCA2, RAD51C, RAD51 and XRCC3. Interacts with BRCA1 only in the presence of PALB2 which serves as the bridging protein. Interacts with POLH; the interaction is direct. Interacts with the TREX-2 complex subunits PCID2 and SEM1 (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Cytoplasm</location>
<location evidence="3">cytoskeleton</location>
<location evidence="3">microtubule organizing center</location>
<location evidence="3">centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Widely expressed. Highest expression in cerebellum, testis, ileum, appendix, epididymis, ovary and mammary gland. No expression in lung.</text>
</comment>
<comment type="developmental stage">
<text>In the mammary gland, expression increases dramatically during pregnancy.</text>
</comment>
<comment type="PTM">
<text evidence="3">Phosphorylation by CHEK1 and CHEK2 regulates interaction with RAD51. Phosphorylation at Ser-3214 by CDK1 and CDK2 is low in S phase when recombination is active, but increases as cells progress towards mitosis; this phosphorylation prevents homologous recombination-dependent repair during S phase and G2 by inhibiting RAD51 binding (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated in the absence of DNA damage; this does not lead to proteasomal degradation. In contrast, ubiquitination in response to DNA damage leads to proteasomal degradation (By similarity).</text>
</comment>
<dbReference type="EMBL" id="U82270">
<property type="protein sequence ID" value="AAB48306.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U65594">
<property type="protein sequence ID" value="AAC23702.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U89652">
<property type="protein sequence ID" value="AAB71377.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC154885">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U72947">
<property type="protein sequence ID" value="AAB40720.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U89503">
<property type="protein sequence ID" value="AAC53276.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS39411.1"/>
<dbReference type="PIR" id="T30835">
<property type="entry name" value="T30835"/>
</dbReference>
<dbReference type="PIR" id="T30904">
<property type="entry name" value="T30904"/>
</dbReference>
<dbReference type="PIR" id="T42205">
<property type="entry name" value="T42205"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001074470.1">
<property type="nucleotide sequence ID" value="NM_001081001.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_033895.2">
<property type="nucleotide sequence ID" value="NM_009765.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_017176117.1">
<property type="nucleotide sequence ID" value="XM_017320628.1"/>
</dbReference>
<dbReference type="UniGene" id="Mm.236256"/>
<dbReference type="PDB" id="1MIU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=2378-3115"/>
</dbReference>
<dbReference type="PDB" id="1MJE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A=2378-3113"/>
</dbReference>
<dbReference type="PDBsum" id="1MIU"/>
<dbReference type="PDBsum" id="1MJE"/>
<dbReference type="ProteinModelPortal" id="P97929"/>
<dbReference type="SMR" id="P97929"/>
<dbReference type="BioGrid" id="198384">
<property type="interactions" value="7"/>
</dbReference>
<dbReference type="IntAct" id="P97929">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000038576"/>
<dbReference type="iPTMnet" id="P97929"/>
<dbReference type="PhosphoSitePlus" id="P97929"/>
<dbReference type="EPD" id="P97929"/>
<dbReference type="MaxQB" id="P97929"/>
<dbReference type="PaxDb" id="P97929"/>
<dbReference type="PeptideAtlas" id="P97929"/>
<dbReference type="PRIDE" id="P97929"/>
<dbReference type="Ensembl" id="ENSMUST00000044620">
<property type="protein sequence ID" value="ENSMUSP00000038576"/>
<property type="gene ID" value="ENSMUSG00000041147"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000202313">
<property type="protein sequence ID" value="ENSMUSP00000144150"/>
<property type="gene ID" value="ENSMUSG00000041147"/>
</dbReference>
<dbReference type="GeneID" id="12190"/>
<dbReference type="KEGG" id="mmu:12190"/>
<dbReference type="UCSC" id="uc009aty.2">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="675"/>
<dbReference type="MGI" id="MGI:109337">
<property type="gene designation" value="Brca2"/>
</dbReference>
<dbReference type="eggNOG" id="KOG4751">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410Y06W">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000003602"/>
<dbReference type="HOGENOM" id="HOG000139693"/>
<dbReference type="HOVERGEN" id="HBG050731"/>
<dbReference type="InParanoid" id="P97929"/>
<dbReference type="KO" id="K08775"/>
<dbReference type="OMA" id="HRQMLND"/>
<dbReference type="OrthoDB" id="EOG091G0C79"/>
<dbReference type="TreeFam" id="TF105041"/>
<dbReference type="Reactome" id="R-MMU-5685942">
<property type="pathway name" value="HDR through Homologous Recombination (HRR)"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5693554">
<property type="pathway name" value="Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5693568">
<property type="pathway name" value="Resolution of D-loop Structures through Holliday Junction Intermediates"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5693579">
<property type="pathway name" value="Homologous DNA Pairing and Strand Exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-912497">
<property type="pathway name" value="Meiotic Recombination"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P97929"/>
<dbReference type="PRO" id="PR:P97929"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000041147"/>
<dbReference type="CleanEx" id="MM_BRCA2"/>
<dbReference type="ExpressionAtlas" id="P97929">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P97929">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0033593">
<property type="term" value="C:BRCA2-MAGE-D1 complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000800">
<property type="term" value="C:lateral element"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000784">
<property type="term" value="C:nuclear chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030141">
<property type="term" value="C:secretory granule"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043015">
<property type="term" value="F:gamma-tubulin binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010484">
<property type="term" value="F:H3 histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010485">
<property type="term" value="F:H4 histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003697">
<property type="term" value="F:single-stranded DNA binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007569">
<property type="term" value="P:cell aging"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051298">
<property type="term" value="P:centrosome duplication"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043009">
<property type="term" value="P:chordate embryonic development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0051276">
<property type="term" value="P:chromosome organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000910">
<property type="term" value="P:cytokinesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006978">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070200">
<property type="term" value="P:establishment of protein localization to telomere"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008585">
<property type="term" value="P:female gonad development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030097">
<property type="term" value="P:hemopoiesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043966">
<property type="term" value="P:histone H3 acetylation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043967">
<property type="term" value="P:histone H4 acetylation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001833">
<property type="term" value="P:inner cell mass cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0008630">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007141">
<property type="term" value="P:male meiosis I"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1990426">
<property type="term" value="P:mitotic recombination-dependent replication fork processing"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0033600">
<property type="term" value="P:negative regulation of mammary gland epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006289">
<property type="term" value="P:nucleotide-excision repair"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001556">
<property type="term" value="P:oocyte maturation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045931">
<property type="term" value="P:positive regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032465">
<property type="term" value="P:regulation of cytokinesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048478">
<property type="term" value="P:replication fork protection"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010332">
<property type="term" value="P:response to gamma radiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010225">
<property type="term" value="P:response to UV-C"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010165">
<property type="term" value="P:response to X-ray"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000722">
<property type="term" value="P:telomere maintenance via recombination"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd04493">
<property type="entry name" value="BRCA2DBD_OB1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd04495">
<property type="entry name" value="BRCA2DBD_OB3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015525">
<property type="entry name" value="BRCA2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015252">
<property type="entry name" value="BRCA2_hlx"/>
</dbReference>
<dbReference type="InterPro" id="IPR036315">
<property type="entry name" value="BRCA2_hlx_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR015187">
<property type="entry name" value="BRCA2_OB_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015188">
<property type="entry name" value="BRCA2_OB_3"/>
</dbReference>
<dbReference type="InterPro" id="IPR002093">
<property type="entry name" value="BRCA2_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR012340">
<property type="entry name" value="NA-bd_OB-fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR015205">
<property type="entry name" value="Tower_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11289">
<property type="entry name" value="PTHR11289"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09169">
<property type="entry name" value="BRCA-2_helical"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09103">
<property type="entry name" value="BRCA-2_OB1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09104">
<property type="entry name" value="BRCA-2_OB3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00634">
<property type="entry name" value="BRCA2"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="Pfam" id="PF09121">
<property type="entry name" value="Tower"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF002397">
<property type="entry name" value="BRCA2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01341">
<property type="entry name" value="Tower"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50249">
<property type="entry name" value="SSF50249"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81872">
<property type="entry name" value="SSF81872"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50138">
<property type="entry name" value="BRCA2_REPEAT"/>
<property type="match status" value="6"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0233">DNA recombination</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Breast cancer type 2 susceptibility protein homolog" id="PRO_0000064985">
<location>
<begin position="1"/>
<end position="3329"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 1">
<location>
<begin position="981"/>
<end position="1015"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 2">
<location>
<begin position="1192"/>
<end position="1226"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 3">
<location>
<begin position="1394"/>
<end position="1428"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 4">
<location>
<begin position="1491"/>
<end position="1525"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 5">
<location>
<begin position="1623"/>
<end position="1657"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 6">
<location>
<begin position="1924"/>
<end position="1958"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 7">
<location>
<begin position="2004"/>
<end position="2038"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PALB2" evidence="3">
<location>
<begin position="1"/>
<end position="40"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NPM1" evidence="3">
<location>
<begin position="628"/>
<end position="979"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with FANCD2" evidence="3">
<location>
<begin position="2298"/>
<end position="2466"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SEM1" evidence="4">
<location>
<begin position="2402"/>
<end position="2753"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal; masked by interaction with SEM1" evidence="4">
<location>
<begin position="2603"/>
<end position="2619"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="435"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="481"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="735"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="2048"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1 and CDK2" evidence="4">
<location>
<position position="3214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="3241"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6 and 129/Sv.">
<original>S</original>
<variation>F</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 129/Sv.">
<original>T</original>
<variation>P</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>N</original>
<variation>H</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>H</original>
<variation>P</variation>
<location>
<position position="407"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>I</original>
<variation>V</variation>
<location>
<position position="661"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>P</original>
<variation>H</variation>
<location>
<position position="739"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>GF</original>
<variation>RI</variation>
<location>
<begin position="1198"/>
<end position="1199"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>Q</original>
<variation>P</variation>
<location>
<position position="1257"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>Q</original>
<variation>R</variation>
<location>
<position position="1392"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>FD</original>
<variation>CG</variation>
<location>
<begin position="1520"/>
<end position="1521"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>R</original>
<variation>W</variation>
<location>
<position position="1583"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>C</original>
<variation>W</variation>
<location>
<position position="1613"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>S</original>
<variation>R</variation>
<location>
<position position="1686"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 129/Sv.">
<original>S</original>
<variation>F</variation>
<location>
<position position="1799"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>P</original>
<variation>L</variation>
<location>
<position position="1881"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 129/Sv.">
<original>S</original>
<variation>F</variation>
<location>
<position position="1894"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>Q</original>
<variation>K</variation>
<location>
<position position="2141"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>S</original>
<variation>R</variation>
<location>
<position position="2392"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>K</original>
<variation>Q</variation>
<location>
<position position="2605"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>A</original>
<variation>P</variation>
<location>
<position position="2648"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 129/Sv.">
<original>R</original>
<variation>C</variation>
<location>
<position position="2717"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 129/Sv.">
<original>L</original>
<variation>M</variation>
<location>
<position position="2729"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>Q</original>
<variation>H</variation>
<location>
<position position="2814"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>A</original>
<variation>P</variation>
<location>
<position position="2827"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 129/Sv.">
<original>S</original>
<variation>I</variation>
<location>
<position position="2907"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 129/Sv.">
<original>H</original>
<variation>L</variation>
<location>
<position position="2929"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>A</original>
<variation>G</variation>
<location>
<position position="3058"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>A</original>
<variation>G</variation>
<location>
<position position="3071"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>K</original>
<variation>E</variation>
<location>
<position position="3081"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>T</original>
<variation>S</variation>
<location>
<position position="3089"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<original>DSPKW</original>
<variation>SQSQV</variation>
<location>
<begin position="3105"/>
<end position="3109"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 129/Sv.">
<original>A</original>
<variation>G</variation>
<location>
<position position="3220"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 129/Sv.">
<original>E</original>
<variation>K</variation>
<location>
<position position="3238"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: C57BL/6.">
<location>
<position position="3243"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 129/Sv.">
<original>R</original>
<variation>K</variation>
<location>
<position position="3245"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB48306." ref="1" evidence="6">
<original>L</original>
<variation>I</variation>
<location>
<position position="1038"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2404"/>
<end position="2420"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2430"/>
<end position="2435"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2446"/>
<end position="2448"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2456"/>
<end position="2458"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2462"/>
<end position="2464"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2468"/>
<end position="2472"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2475"/>
<end position="2480"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2486"/>
<end position="2489"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2490"/>
<end position="2492"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2495"/>
<end position="2497"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2503"/>
<end position="2505"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="2512"/>
<end position="2514"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2518"/>
<end position="2527"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2538"/>
<end position="2554"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2560"/>
<end position="2562"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2564"/>
<end position="2569"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2570"/>
<end position="2584"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="2585"/>
<end position="2587"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2592"/>
<end position="2597"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2606"/>
<end position="2608"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2640"/>
<end position="2643"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2648"/>
<end position="2653"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2655"/>
<end position="2662"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2671"/>
<end position="2674"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2675"/>
<end position="2677"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2679"/>
<end position="2681"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2696"/>
<end position="2699"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2701"/>
<end position="2703"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2704"/>
<end position="2707"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2713"/>
<end position="2715"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2726"/>
<end position="2728"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2731"/>
<end position="2733"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2736"/>
<end position="2746"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2751"/>
<end position="2754"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2756"/>
<end position="2758"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2760"/>
<end position="2763"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2767"/>
<end position="2778"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2782"/>
<end position="2791"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2813"/>
<end position="2817"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2822"/>
<end position="2830"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2833"/>
<end position="2835"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2836"/>
<end position="2840"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2848"/>
<end position="2850"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2851"/>
<end position="2853"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2855"/>
<end position="2858"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2861"/>
<end position="2871"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2873"/>
<end position="2876"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2877"/>
<end position="2881"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2889"/>
<end position="2900"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2904"/>
<end position="2910"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2913"/>
<end position="2918"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2924"/>
<end position="2930"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2938"/>
<end position="2940"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2945"/>
<end position="2957"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2961"/>
<end position="2964"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2965"/>
<end position="2967"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2977"/>
<end position="2980"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2981"/>
<end position="2983"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2986"/>
<end position="2989"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2990"/>
<end position="3001"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="3004"/>
<end position="3006"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3009"/>
<end position="3013"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3015"/>
<end position="3017"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3019"/>
<end position="3026"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3037"/>
<end position="3044"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3050"/>
<end position="3052"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3056"/>
<end position="3058"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3063"/>
<end position="3067"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="3071"/>
<end position="3073"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="3074"/>
<end position="3080"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="3082"/>
<end position="3085"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="3090"/>
<end position="3102"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1MIU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1MJE"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P51587"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12228710"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="3329" mass="370664" checksum="50A32E8BADE2CF7E" modified="2012-10-03" version="2">
MPVEYKRRPTFWEIFKARCSTADLGPISLNWFEELSSEAPPYNSEPPEESEYKPHGYEPQ
LFKTPQRNPPYHQFASTPIMFKERSQTLPLDQSPFRELGKVVASSKHKTHSKKKTKVDPV
VDVASPPLKSCLSESPLTLRCTQAVLQREKPVVSGSLFYTPKLKEGQTPKPISESLGVEV
DPDMSWTSSLATPPTLSSTVLIARDEEARSSVTPADSPATLKSCFSNHNESPQKNDRSVP
SVIDSENKNQQEAFSQGLGKMLGDSSGKRNSFKDCLRKPIPNILEDGETAVDTSEEDSFS
LCFPKRRTRNLQKMRMGKTRKKIFSETRTDELSEEARRQTDDKNSFVFEMELRESDPLDP
GVTSQKPFYSQNEEICNEAVQCSDSRWSQSNLSGLNETQTGKITLPHISSHSQNISEDFI
DMKKEGTGSITSEKSLPHISSLPEPEKMFSEETVVDKEHEGQHFESLEDSIAGKQMVSRT
SQAACLSPSIRKSIFKMREPLDETLGTVFSDSMTNSTFTEEHEASACGLGILTACSQRED
SICPSSVDTGSWPTTLTDTSATVKNAGLISTLKNKKRKFIYSVSDDASLQGKKLQTHRQL
ELTNLSAQLEASAFEVPLTFTNVNSGIPDSSDKKRCLPNDPEEPSLTNSFGTATSKEISY
IHALISQDLNDKEAIVIEEKPQPYTAREADFLLCLPERTCENDQKSPKVSNGKEKVLVSA
CLPSAVQLSSISFESQENPLGDHNGTSTLKLTPSSKLPLSKADMVSREKMCKMPEKLQCE
SCKVNIELSKNILEVNEICILSENSKTPGLLPPGENIIEVASSMKSQFNQNAKIVIQKDQ
KGSPFISEVAVNMNSEELFPDSGNNFAFQVTNKCNKPDLGSSVELQEEDLSHTQGPSLKN
SPMAVDEDVDDAHAAQVLITKDSDSLAVVHDYTEKSRNNIEQHQKGTEDKDFKSNSSLNM
KSDGNSDCSDKWSEFLDPVLNHNFGGSFRTASNKEIKLSEHNVKKSKMFFKDIEEQYPTR
LACIDIVNTLPLANQKKLSEPHIFDLKSVTTVSTQSHNQSSVSHEDTDTAPQMLSSKQDF
HSNNLTTSQKAEITELSTILEESGSQFEFTQFRKPSHIAQNTSEVPGNQMVVLSTASKEW
KDTDLHLPVDPSVGQTDHSKQFEGSAGVKQSFPHLLEDTCNKNTSCFLPNINEMEFGGFC
SALGTKLSVSNEALRKAMKLFSDIENSEEPSAKVGPRGFSSSAHHDSVASVFKIKKQNTE
KSFDEKSSKCQVTLQNNIEMTTCIFVGRNPEKYIKNTKHEDSYTSSQRNNLENSDGSMSS
TSGPVYIHKGDSDLPADQGSKCPESCTQYAREENTQIKENISDLTCLEIMKAEETCMKSS
DKKQLPSDKMEQNIKEFNISFQTASGKNTRVSKESLNKSVNIFNRETDELTVISDSLNSK
ILHGINKDKMHTSCHKKAISIKKVFEDHFPIVTVSQLPAQQHPEYEIESTKEPTLLSFHT
ASGKKVKIMQESLDKVKNLFDETQYVRKTASFSQGSKPLKDSKKELTLAYEKIEVTASKC
EEMQNFVSKETEMLPQQNYHMYRQTENLKTSNGTSSKVQENIENNVEKNPRICCICQSSY
PVTEDSALAYYTEDSRKTCVRESSLSKGRKWLREQGDKLGTRNTIKIECVKEHTEDFAGN
ASYEHSLVIIRTEIDTNHVSENQVSTLLSDPNVCHSYLSQSSFCHCDDMHNDSGYFLKNK
IDSDVPPDMKNAEGNTISPRVSATKERNLHPQTINEYCVQKLETNTSPHANKDVAIDPSL
LDSRNCKVGSLVFITAHSQETERTKEIVTDNCYKIVEQNRQSKPDTCQTSCHKVLDDSKD
FICPSSSGDVCINSRKDSFCPHNEQILQHNQSMSGLKKAATPPVGLETWDTSKSIREPPQ
AAHPSRTYGIFSTASGKAIQVSDASLEKARQVFSEMDGDAKQLSSMVSLEGNEKPHHSVK
RENSVVHSTQGVLSLPKPLPGNVNSSVFSGFSTAGGKLVTVSESALHKVKGMLEEFDLIR
TEHTLQHSPIPEDVSKILPQPCAEIRTPEYPVNSKLQKTYNDKSSLPSNYKESGSSGNTQ
SIEVSLQLSQMERNQDTQLVLGTKVSHSKANLLGKEQTLPQNIKVKTDEMKTFSDVPVKT
NVGEYYSKESENYFETEAVESAKAFMEDDELTDSEQTHAKCSLFTCPQNETLFNSRTRKR
GGVTVDAVGQPPIKRSLLNEFDRIIESKGKSLTPSKSTPDGTVKDRSLFTHHMSLEPVTC
GPFCSSKERQGAQRPHLTSPAQELLSKGHPWRHSALEKSPSSPIVSILPAHDVSATRTER
TRHSGKSTKVFVPPFKMKSQFHGDEHFNSKNVNLEGKNQKSTDGDREDGNDSHVRQFNKD
LMSSLQSARDLQDMRIKNKERRHLRLQPGSLYLTKSSTLPRISLQAAVGDRAPSACSPKQ
LYIYGVSKECINVNSKNAEYFQFDIQDHFGKEDLCAGKGFQLADGGWLIPSNDGKAGKEE
FYRALCDTPGVDPKLISSIWVANHYRWIVWKLAAMEFAFPKEFANRCLNPERVLLQLKYR
YDVEIDNSRRSALKKILERDDTAAKTLVLCISDIISPSTKVSETSGGKTSGEDANKVDTI
ELTDGWYAVRAQLDPPLMALVKSGKLTVGQKIITQGAELVGSPDACAPLEAPDSLRLKIS
ANSTRPARWHSRLGFFRDPRPFPLPLSSLFSDGGNVGCVDIIVQRVYPLQWVEKTVSGLY
IFRSEREEEKEALRFAEAQQKKLEALFTKVHTEFKDHEEDTTQRCVLSRTLTRQQVHALQ
DGAELYAAVQYASDPDHLEACFSEEQLRALNNYRQMLNDKKQARIQSEFRKALESAEKEE
GLSRDVTTVWKLRVTSYKKKEKSALLSIWRPSSDLSSLLTEGKRYRIYHLAVSKSKSKFE
RPSIQLTATKRTQYQQLPVSSETLLQVYQPRESLHFSRLSDPAFQPPCSEVDVVGVVVSV
VKPIGLAPLVYLSDECLNLLVVKFGIDLNEDIKPRVLIAASNLQCQPESTSGVPTLFAGH
FSIFSASPKEAYFQEKVNNLKHAIENIDTFYKEAEKKLIHVLEGDSPKWSTPNKDPTREP
HAASTCCASDLLGSGGQFLRISPTGQQSYQSPLSHCTLKGKSMPLAHSAQMAAKSWSGEN
EIDDPKTCRKRRALDFLSRLPLPSPVSPICTFVSPAAQKAFQPPRSCGTKYATPIKKEPS
SPRRRTPFQKTSGVSLPDCDSVADEELALLSTQALTPDSVGGNEQAFPGDSTRNPQPAQR
PDQQVGPRSRKESLRDCRGDSSEKLAVES
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2007-03-20" modified="2017-12-20" version="125">
<accession>Q9NWK9</accession>
<accession>B2RBA1</accession>
<accession>B4DP13</accession>
<accession>D3DT20</accession>
<accession>Q9H278</accession>
<accession>Q9H3X3</accession>
<accession>Q9NWN0</accession>
<name>BCD1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Box C/D snoRNA protein 1</fullName>
</recommendedName>
<alternativeName>
<fullName>Serologically defined breast cancer antigen NY-BR-75</fullName>
</alternativeName>
<alternativeName>
<fullName>Zinc finger HIT domain-containing protein 6</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">ZNHIT6</name>
<name type="synonym">BCD1</name>
<name type="synonym">C1orf181</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Hepatoma</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Cancer Immun." volume="1" first="4" last="4">
<title>Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.</title>
<authorList>
<person name="Scanlan M.J."/>
<person name="Gout I."/>
<person name="Gordon C.M."/>
<person name="Williamson B."/>
<person name="Stockert E."/>
<person name="Gure A.O."/>
<person name="Jaeger D."/>
<person name="Chen Y.-T."/>
<person name="Mackay A."/>
<person name="O'Hare M.J."/>
<person name="Old L.J."/>
</authorList>
<dbReference type="PubMed" id="12747765"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 69-470 (ISOFORM 1)</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="6782" last="6793">
<title>A dynamic scaffold of pre-snoRNP factors facilitates human box C/D snoRNP assembly.</title>
<authorList>
<person name="McKeegan K.S."/>
<person name="Debieux C.M."/>
<person name="Boulon S."/>
<person name="Bertrand E."/>
<person name="Watkins N.J."/>
</authorList>
<dbReference type="PubMed" id="17636026"/>
<dbReference type="DOI" id="10.1128/MCB.01097-07"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FBL; SNU13; NOP58; NUFIP1; RUVBL1; RUVBL2 AND TAF9</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-143; LYS-162; LYS-200 AND LYS-459</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.O114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-138 AND LYS-200</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-79; LYS-108; LYS-118; LYS-138; LYS-143; LYS-153; LYS-162; LYS-173; LYS-183; LYS-200 AND LYS-459</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] HIS-455</scope>
</reference>
<comment type="function">
<text evidence="9">Required for box C/D snoRNAs accumulation involved in snoRNA processing, snoRNA transport to the nucleolus and ribosome biogenesis.</text>
</comment>
<comment type="subunit">
<text evidence="9">Interacts with FBL, SNU13, NOP58, NUFIP1, RUVBL1, RUVBL2 and TAF9.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2563515"/>
<interactant intactId="EBI-2563549">
<id>Q9UHK0</id>
<label>NUFIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9NWK9-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9NWK9-2</id>
<name>2</name>
<sequence type="described" ref="VSP_042946"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="similarity">
<text evidence="11">Belongs to the BCD1 family.</text>
</comment>
<comment type="sequence caution" evidence="11">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAG48263" version="1"/>
</conflict>
<location>
<position position="365"/>
</location>
<location>
<position position="412"/>
</location>
<location>
<position position="416"/>
</location>
<location>
<position position="419"/>
</location>
<location>
<position position="432"/>
</location>
</comment>
<comment type="sequence caution" evidence="11">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA91349" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="AK000736">
<property type="protein sequence ID" value="BAA91349.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK000767">
<property type="protein sequence ID" value="BAA91371.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK298149">
<property type="protein sequence ID" value="BAG60425.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314566">
<property type="protein sequence ID" value="BAG37148.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL442074">
<property type="protein sequence ID" value="CAC09440.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX323040">
<property type="protein sequence ID" value="CAH73976.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC092807">
<property type="protein sequence ID" value="CAH73976.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC099561">
<property type="protein sequence ID" value="CAH73976.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471097">
<property type="protein sequence ID" value="EAW73194.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471097">
<property type="protein sequence ID" value="EAW73195.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC026236">
<property type="protein sequence ID" value="AAH26236.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC110898">
<property type="protein sequence ID" value="AAI10899.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF308296">
<property type="protein sequence ID" value="AAG48263.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53338.1">
<molecule id="Q9NWK9-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS707.1">
<molecule id="Q9NWK9-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001164141.1">
<molecule id="Q9NWK9-2"/>
<property type="nucleotide sequence ID" value="NM_001170670.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_060423.3">
<molecule id="Q9NWK9-1"/>
<property type="nucleotide sequence ID" value="NM_017953.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.5111"/>
<dbReference type="ProteinModelPortal" id="Q9NWK9"/>
<dbReference type="SMR" id="Q9NWK9"/>
<dbReference type="BioGrid" id="120099">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="IntAct" id="Q9NWK9">
<property type="interactions" value="9"/>
</dbReference>
<dbReference type="MINT" id="MINT-1186429"/>
<dbReference type="STRING" id="9606.ENSP00000359606"/>
<dbReference type="iPTMnet" id="Q9NWK9"/>
<dbReference type="PhosphoSitePlus" id="Q9NWK9"/>
<dbReference type="BioMuta" id="ZNHIT6"/>
<dbReference type="DMDM" id="74753026"/>
<dbReference type="EPD" id="Q9NWK9"/>
<dbReference type="MaxQB" id="Q9NWK9"/>
<dbReference type="PaxDb" id="Q9NWK9"/>
<dbReference type="PeptideAtlas" id="Q9NWK9"/>
<dbReference type="PRIDE" id="Q9NWK9"/>
<dbReference type="DNASU" id="54680"/>
<dbReference type="Ensembl" id="ENST00000370574">
<molecule id="Q9NWK9-1"/>
<property type="protein sequence ID" value="ENSP00000359606"/>
<property type="gene ID" value="ENSG00000117174"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000431532">
<molecule id="Q9NWK9-2"/>
<property type="protein sequence ID" value="ENSP00000414344"/>
<property type="gene ID" value="ENSG00000117174"/>
</dbReference>
<dbReference type="GeneID" id="54680"/>
<dbReference type="KEGG" id="hsa:54680"/>
<dbReference type="UCSC" id="uc001dlh.4">
<molecule id="Q9NWK9-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="54680"/>
<dbReference type="DisGeNET" id="54680"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000117174.10"/>
<dbReference type="GeneCards" id="ZNHIT6"/>
<dbReference type="H-InvDB" id="HIX0000749"/>
<dbReference type="HGNC" id="HGNC:26089">
<property type="gene designation" value="ZNHIT6"/>
</dbReference>
<dbReference type="HPA" id="HPA018132"/>
<dbReference type="neXtProt" id="NX_Q9NWK9"/>
<dbReference type="OpenTargets" id="ENSG00000117174"/>
<dbReference type="PharmGKB" id="PA162410929"/>
<dbReference type="eggNOG" id="KOG2858">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4111QF2">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000017201"/>
<dbReference type="HOGENOM" id="HOG000054208"/>
<dbReference type="InParanoid" id="Q9NWK9"/>
<dbReference type="OMA" id="MSRCETC"/>
<dbReference type="OrthoDB" id="EOG091G0E2X"/>
<dbReference type="PhylomeDB" id="Q9NWK9"/>
<dbReference type="TreeFam" id="TF323923"/>
<dbReference type="ChiTaRS" id="ZNHIT6">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GenomeRNAi" id="54680"/>
<dbReference type="PRO" id="PR:Q9NWK9"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000117174"/>
<dbReference type="CleanEx" id="HS_ZNHIT6"/>
<dbReference type="Genevisible" id="Q9NWK9">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070761">
<property type="term" value="C:pre-snoRNP complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051117">
<property type="term" value="F:ATPase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001094">
<property type="term" value="F:TFIID-class transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000492">
<property type="term" value="P:box C/D snoRNP assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051259">
<property type="term" value="P:protein oligomerization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042254">
<property type="term" value="P:ribosome biogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0048254">
<property type="term" value="P:snoRNA localization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR007529">
<property type="entry name" value="Znf_HIT"/>
</dbReference>
<dbReference type="Pfam" id="PF04438">
<property type="entry name" value="zf-HIT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51083">
<property type="entry name" value="ZF_HIT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0690">Ribosome biogenesis</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Box C/D snoRNA protein 1" id="PRO_0000280239">
<location>
<begin position="1"/>
<end position="470"/>
</location>
</feature>
<feature type="zinc finger region" description="HIT-type" evidence="7">
<location>
<begin position="220"/>
<end position="254"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu-rich">
<location>
<begin position="40"/>
<end position="202"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2 3">
<location>
<position position="25"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="79"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="108"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="118"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5 6">
<location>
<position position="138"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4 6">
<location>
<position position="143"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="153"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4 6">
<location>
<position position="162"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="173"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="183"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4 5 6">
<location>
<position position="200"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4 6">
<location>
<position position="459"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_042946" evidence="10">
<location>
<begin position="78"/>
<end position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17399721." id="VAR_031096">
<original>G</original>
<variation>R</variation>
<location>
<position position="9"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation." id="VAR_035721" evidence="8">
<original>L</original>
<variation>H</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAC09440." ref="2" evidence="11">
<original>E</original>
<variation>G</variation>
<location>
<position position="144"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00453"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17636026"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000305"/>
<sequence length="470" mass="53918" checksum="34A50A1C62E4F4E8" modified="2000-10-01" version="1">
MEFAAENEGKSGGGLHSVAEGVRLSPEPGREGVRDLAGAEEFGGGEEGTGLTGIKEIGDG
EEGSGQRPEEIPMDLTVVKQEIIDWPGTEGRLAGQWVEQEVEDRPEVKDENAGVLEVKQE
TDSSLVVKEAKVGEPEVKEEKVKEEVMDWSEVKEEKDNLEIKQEEKFVGQCIKEELMHGE
CVKEEKDFLKKEIVDDTKVKEEPPINHPVGCKRKLAMSRCETCGTEEAKYRCPRCMRYSC
SLPCVKKHKAELTCNGVRDKTAYISIQQFTEMNLLSDYRFLEDVARTADHISRDAFLKRP
ISNKYMYFMKNRARRQGINLKLLPNGFTKRKENSTFFDKKKQQFCWHVKLQFPQSQAEYI
EKRVPDDKTINEILKPYIDPEKSDPVIRQRLKAYIRSQTGVQILMKIEYMQQNLVRYYEL
DPYKSLLDNLRNKVIIEYPTLHVVLKGSNNDMKVLHQVKSESTKNVGNEN
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2009-02-10" modified="2017-12-20" version="120">
<accession>Q8RXD4</accession>
<accession>Q9SUA7</accession>
<name>BRCA1_ARATH</name>
<protein>
<recommendedName>
<fullName evidence="7">Protein BREAST CANCER SUSCEPTIBILITY 1 homolog</fullName>
<shortName evidence="7">AtBRCA1</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary" evidence="7">BRCA1</name>
<name type="ordered locus" evidence="9">At4g21070</name>
<name type="ORF" evidence="10">T13K14.230</name>
</gene>
<organism>
<name type="scientific">Arabidopsis thaliana</name>
<name type="common">Mouse-ear cress</name>
<dbReference type="NCBI Taxonomy" id="3702"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Viridiplantae</taxon>
<taxon>Streptophyta</taxon>
<taxon>Embryophyta</taxon>
<taxon>Tracheophyta</taxon>
<taxon>Spermatophyta</taxon>
<taxon>Magnoliophyta</taxon>
<taxon>eudicotyledons</taxon>
<taxon>Gunneridae</taxon>
<taxon>Pentapetalae</taxon>
<taxon>rosids</taxon>
<taxon>malvids</taxon>
<taxon>Brassicales</taxon>
<taxon>Brassicaceae</taxon>
<taxon>Camelineae</taxon>
<taxon>Arabidopsis</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2003" name="Nucleic Acids Res." volume="31" first="1148" last="1155">
<title>Characterization of Arabidopsis thaliana ortholog of the human breast cancer susceptibility gene 1: AtBRCA1, strongly induced by gamma rays.</title>
<authorList>
<person name="Lafarge S."/>
<person name="Montane M.-H."/>
</authorList>
<dbReference type="PubMed" id="12582233"/>
<dbReference type="DOI" id="10.1093/nar/gkg202"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>INDUCTION BY GAMMA RAYS</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<strain>cv. Columbia</strain>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Nature" volume="402" first="769" last="777">
<title>Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana.</title>
<authorList>
<person name="Mayer K.F.X."/>
<person name="Schueller C."/>
<person name="Wambutt R."/>
<person name="Murphy G."/>
<person name="Volckaert G."/>
<person name="Pohl T."/>
<person name="Duesterhoeft A."/>
<person name="Stiekema W."/>
<person name="Entian K.-D."/>
<person name="Terryn N."/>
<person name="Harris B."/>
<person name="Ansorge W."/>
<person name="Brandt P."/>
<person name="Grivell L.A."/>
<person name="Rieger M."/>
<person name="Weichselgartner M."/>
<person name="de Simone V."/>
<person name="Obermaier B."/>
<person name="Mache R."/>
<person name="Mueller M."/>
<person name="Kreis M."/>
<person name="Delseny M."/>
<person name="Puigdomenech P."/>
<person name="Watson M."/>
<person name="Schmidtheini T."/>
<person name="Reichert B."/>
<person name="Portetelle D."/>
<person name="Perez-Alonso M."/>
<person name="Boutry M."/>
<person name="Bancroft I."/>
<person name="Vos P."/>
<person name="Hoheisel J."/>
<person name="Zimmermann W."/>
<person name="Wedler H."/>
<person name="Ridley P."/>
<person name="Langham S.-A."/>
<person name="McCullagh B."/>
<person name="Bilham L."/>
<person name="Robben J."/>
<person name="van der Schueren J."/>
<person name="Grymonprez B."/>
<person name="Chuang Y.-J."/>
<person name="Vandenbussche F."/>
<person name="Braeken M."/>
<person name="Weltjens I."/>
<person name="Voet M."/>
<person name="Bastiaens I."/>
<person name="Aert R."/>
<person name="Defoor E."/>
<person name="Weitzenegger T."/>
<person name="Bothe G."/>
<person name="Ramsperger U."/>
<person name="Hilbert H."/>
<person name="Braun M."/>
<person name="Holzer E."/>
<person name="Brandt A."/>
<person name="Peters S."/>
<person name="van Staveren M."/>
<person name="Dirkse W."/>
<person name="Mooijman P."/>
<person name="Klein Lankhorst R."/>
<person name="Rose M."/>
<person name="Hauf J."/>
<person name="Koetter P."/>
<person name="Berneiser S."/>
<person name="Hempel S."/>
<person name="Feldpausch M."/>
<person name="Lamberth S."/>
<person name="Van den Daele H."/>
<person name="De Keyser A."/>
<person name="Buysshaert C."/>
<person name="Gielen J."/>
<person name="Villarroel R."/>
<person name="De Clercq R."/>
<person name="van Montagu M."/>
<person name="Rogers J."/>
<person name="Cronin A."/>
<person name="Quail M.A."/>
<person name="Bray-Allen S."/>
<person name="Clark L."/>
<person name="Doggett J."/>
<person name="Hall S."/>
<person name="Kay M."/>
<person name="Lennard N."/>
<person name="McLay K."/>
<person name="Mayes R."/>
<person name="Pettett A."/>
<person name="Rajandream M.A."/>
<person name="Lyne M."/>
<person name="Benes V."/>
<person name="Rechmann S."/>
<person name="Borkova D."/>
<person name="Bloecker H."/>
<person name="Scharfe M."/>
<person name="Grimm M."/>
<person name="Loehnert T.-H."/>
<person name="Dose S."/>
<person name="de Haan M."/>
<person name="Maarse A.C."/>
<person name="Schaefer M."/>
<person name="Mueller-Auer S."/>
<person name="Gabel C."/>
<person name="Fuchs M."/>
<person name="Fartmann B."/>
<person name="Granderath K."/>
<person name="Dauner D."/>
<person name="Herzl A."/>
<person name="Neumann S."/>
<person name="Argiriou A."/>
<person name="Vitale D."/>
<person name="Liguori R."/>
<person name="Piravandi E."/>
<person name="Massenet O."/>
<person name="Quigley F."/>
<person name="Clabauld G."/>
<person name="Muendlein A."/>
<person name="Felber R."/>
<person name="Schnabl S."/>
<person name="Hiller R."/>
<person name="Schmidt W."/>
<person name="Lecharny A."/>
<person name="Aubourg S."/>
<person name="Chefdor F."/>
<person name="Cooke R."/>
<person name="Berger C."/>
<person name="Monfort A."/>
<person name="Casacuberta E."/>
<person name="Gibbons T."/>
<person name="Weber N."/>
<person name="Vandenbol M."/>
<person name="Bargues M."/>
<person name="Terol J."/>
<person name="Torres A."/>
<person name="Perez-Perez A."/>
<person name="Purnelle B."/>
<person name="Bent E."/>
<person name="Johnson S."/>
<person name="Tacon D."/>
<person name="Jesse T."/>
<person name="Heijnen L."/>
<person name="Schwarz S."/>
<person name="Scholler P."/>
<person name="Heber S."/>
<person name="Francs P."/>
<person name="Bielke C."/>
<person name="Frishman D."/>
<person name="Haase D."/>
<person name="Lemcke K."/>
<person name="Mewes H.-W."/>
<person name="Stocker S."/>
<person name="Zaccaria P."/>
<person name="Bevan M."/>
<person name="Wilson R.K."/>
<person name="de la Bastide M."/>
<person name="Habermann K."/>
<person name="Parnell L."/>
<person name="Dedhia N."/>
<person name="Gnoj L."/>
<person name="Schutz K."/>
<person name="Huang E."/>
<person name="Spiegel L."/>
<person name="Sekhon M."/>
<person name="Murray J."/>
<person name="Sheet P."/>
<person name="Cordes M."/>
<person name="Abu-Threideh J."/>
<person name="Stoneking T."/>
<person name="Kalicki J."/>
<person name="Graves T."/>
<person name="Harmon G."/>
<person name="Edwards J."/>
<person name="Latreille P."/>
<person name="Courtney L."/>
<person name="Cloud J."/>
<person name="Abbott A."/>
<person name="Scott K."/>
<person name="Johnson D."/>
<person name="Minx P."/>
<person name="Bentley D."/>
<person name="Fulton B."/>
<person name="Miller N."/>
<person name="Greco T."/>
<person name="Kemp K."/>
<person name="Kramer J."/>
<person name="Fulton L."/>
<person name="Mardis E."/>
<person name="Dante M."/>
<person name="Pepin K."/>
<person name="Hillier L.W."/>
<person name="Nelson J."/>
<person name="Spieth J."/>
<person name="Ryan E."/>
<person name="Andrews S."/>
<person name="Geisel C."/>
<person name="Layman D."/>
<person name="Du H."/>
<person name="Ali J."/>
<person name="Berghoff A."/>
<person name="Jones K."/>
<person name="Drone K."/>
<person name="Cotton M."/>
<person name="Joshu C."/>
<person name="Antonoiu B."/>
<person name="Zidanic M."/>
<person name="Strong C."/>
<person name="Sun H."/>
<person name="Lamar B."/>
<person name="Yordan C."/>
<person name="Ma P."/>
<person name="Zhong J."/>
<person name="Preston R."/>
<person name="Vil D."/>
<person name="Shekher M."/>
<person name="Matero A."/>
<person name="Shah R."/>
<person name="Swaby I.K."/>
<person name="O'Shaughnessy A."/>
<person name="Rodriguez M."/>
<person name="Hoffman J."/>
<person name="Till S."/>
<person name="Granat S."/>
<person name="Shohdy N."/>
<person name="Hasegawa A."/>
<person name="Hameed A."/>
<person name="Lodhi M."/>
<person name="Johnson A."/>
<person name="Chen E."/>
<person name="Marra M.A."/>
<person name="Martienssen R."/>
<person name="McCombie W.R."/>
</authorList>
<dbReference type="PubMed" id="10617198"/>
<dbReference type="DOI" id="10.1038/47134"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>cv. Columbia</strain>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2016-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="The Arabidopsis Information Portal (Araport)"/>
</authorList>
</citation>
<scope>GENOME REANNOTATION</scope>
<source>
<strain>cv. Columbia</strain>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Science" volume="302" first="842" last="846">
<title>Empirical analysis of transcriptional activity in the Arabidopsis genome.</title>
<authorList>
<person name="Yamada K."/>
<person name="Lim J."/>
<person name="Dale J.M."/>
<person name="Chen H."/>
<person name="Shinn P."/>
<person name="Palm C.J."/>
<person name="Southwick A.M."/>
<person name="Wu H.C."/>
<person name="Kim C.J."/>
<person name="Nguyen M."/>
<person name="Pham P.K."/>
<person name="Cheuk R.F."/>
<person name="Karlin-Newmann G."/>
<person name="Liu S.X."/>
<person name="Lam B."/>
<person name="Sakano H."/>
<person name="Wu T."/>
<person name="Yu G."/>
<person name="Miranda M."/>
<person name="Quach H.L."/>
<person name="Tripp M."/>
<person name="Chang C.H."/>
<person name="Lee J.M."/>
<person name="Toriumi M.J."/>
<person name="Chan M.M."/>
<person name="Tang C.C."/>
<person name="Onodera C.S."/>
<person name="Deng J.M."/>
<person name="Akiyama K."/>
<person name="Ansari Y."/>
<person name="Arakawa T."/>
<person name="Banh J."/>
<person name="Banno F."/>
<person name="Bowser L."/>
<person name="Brooks S.Y."/>
<person name="Carninci P."/>
<person name="Chao Q."/>
<person name="Choy N."/>
<person name="Enju A."/>
<person name="Goldsmith A.D."/>
<person name="Gurjal M."/>
<person name="Hansen N.F."/>
<person name="Hayashizaki Y."/>
<person name="Johnson-Hopson C."/>
<person name="Hsuan V.W."/>
<person name="Iida K."/>
<person name="Karnes M."/>
<person name="Khan S."/>
<person name="Koesema E."/>
<person name="Ishida J."/>
<person name="Jiang P.X."/>
<person name="Jones T."/>
<person name="Kawai J."/>
<person name="Kamiya A."/>
<person name="Meyers C."/>
<person name="Nakajima M."/>
<person name="Narusaka M."/>
<person name="Seki M."/>
<person name="Sakurai T."/>
<person name="Satou M."/>
<person name="Tamse R."/>
<person name="Vaysberg M."/>
<person name="Wallender E.K."/>
<person name="Wong C."/>
<person name="Yamamura Y."/>
<person name="Yuan S."/>
<person name="Shinozaki K."/>
<person name="Davis R.W."/>
<person name="Theologis A."/>
<person name="Ecker J.R."/>
</authorList>
<dbReference type="PubMed" id="14593172"/>
<dbReference type="DOI" id="10.1126/science.1088305"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<strain>cv. Columbia</strain>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="4326" last="4337">
<title>A homologue of the breast cancer-associated gene BARD1 is involved in DNA repair in plants.</title>
<authorList>
<person name="Reidt W."/>
<person name="Wurz R."/>
<person name="Wanieck K."/>
<person name="Chu H.H."/>
<person name="Puchta H."/>
</authorList>
<dbReference type="PubMed" id="16957774"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601313"/>
</citation>
<scope>FUNCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<scope>INTERACTION WITH BARD1/ROW1</scope>
<scope>INDUCTION BY GAMMA RAYS</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2011" name="Front. Plant Sci." volume="2" first="19" last="19">
<title>Homologs of breast cancer genes in plants.</title>
<authorList>
<person name="Trapp O."/>
<person name="Seeliger K."/>
<person name="Puchta H."/>
</authorList>
<dbReference type="PubMed" id="22629260"/>
<dbReference type="DOI" id="10.3389/fpls.2011.00019"/>
</citation>
<scope>REVIEW</scope>
<scope>GENE FAMILY</scope>
</reference>
<comment type="function">
<text evidence="6">Plays a role in DNA repair and in cell-cycle control. Required for the repair of DNA double-strand breaks (DSBs), both natural and induced by genotoxic stress, by homologous recombination (HR).</text>
</comment>
<comment type="subunit">
<text evidence="6">Forms heterodimer with BARD1/ROW1.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3 6">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="5 6">Expressed ubiquitously with highest levels in flower buds (PubMed:12582233). Mostly expressed in flowers and siliques, and, to a lower extent, in roots, rosette leaves, inflorescence and young cauline leaves (PubMed:16957774).</text>
</comment>
<comment type="induction">
<text evidence="5 6">By gamma rays treatment.</text>
</comment>
<comment type="disruption phenotype">
<text evidence="6">Enhanced sensitivity to mitomycin C.</text>
</comment>
<comment type="sequence caution" evidence="8">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="CAB45902" version="1"/>
</conflict>
<text>The predicted gene has been split into 2 genes: At4g21065 and At4g21070.</text>
</comment>
<comment type="sequence caution" evidence="8">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="CAB79107" version="1"/>
</conflict>
<text>The predicted gene has been split into 2 genes: At4g21065 and At4g21070.</text>
</comment>
<dbReference type="EMBL" id="AY081328">
<property type="protein sequence ID" value="AAL91217.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL080282">
<property type="protein sequence ID" value="CAB45902.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL161554">
<property type="protein sequence ID" value="CAB79107.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CP002687">
<property type="protein sequence ID" value="AEE84396.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF515728">
<property type="protein sequence ID" value="AAO39850.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT010547">
<property type="protein sequence ID" value="AAQ65170.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_193839.4">
<property type="nucleotide sequence ID" value="NM_118225.5"/>
</dbReference>
<dbReference type="UniGene" id="At.32665"/>
<dbReference type="ProteinModelPortal" id="Q8RXD4"/>
<dbReference type="SMR" id="Q8RXD4"/>
<dbReference type="BioGrid" id="13145">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="MINT" id="MINT-3289893"/>
<dbReference type="STRING" id="3702.AT4G21070.1"/>
<dbReference type="PaxDb" id="Q8RXD4"/>
<dbReference type="PRIDE" id="Q8RXD4"/>
<dbReference type="EnsemblPlants" id="AT4G21070.1">
<property type="protein sequence ID" value="AT4G21070.1"/>
<property type="gene ID" value="AT4G21070"/>
</dbReference>
<dbReference type="GeneID" id="827854"/>
<dbReference type="Gramene" id="AT4G21070.1">
<property type="protein sequence ID" value="AT4G21070.1"/>
<property type="gene ID" value="AT4G21070"/>
</dbReference>
<dbReference type="KEGG" id="ath:AT4G21070"/>
<dbReference type="Araport" id="AT4G21070"/>
<dbReference type="TAIR" id="locus:2133109">
<property type="gene designation" value="AT4G21070"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ITQ6">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4111WR7">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000084100"/>
<dbReference type="InParanoid" id="Q8RXD4"/>
<dbReference type="KO" id="K10683"/>
<dbReference type="OMA" id="SEIFEWT"/>
<dbReference type="OrthoDB" id="EOG093603WW"/>
<dbReference type="PhylomeDB" id="Q8RXD4"/>
<dbReference type="Reactome" id="R-ATH-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-ATH-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="PRO" id="PR:Q8RXD4"/>
<dbReference type="Proteomes" id="UP000006548">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q8RXD4">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8RXD4">
<property type="organism ID" value="AT"/>
</dbReference>
<dbReference type="GO" id="GO:0070531">
<property type="term" value="C:BRCA1-A complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031436">
<property type="term" value="C:BRCA1-BARD1 complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="TAIR"/>
</dbReference>
<dbReference type="GO" id="GO:0071480">
<property type="term" value="P:cellular response to gamma radiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006310">
<property type="term" value="P:DNA recombination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="TAIR"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="TAIR"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045717">
<property type="term" value="P:negative regulation of fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035067">
<property type="term" value="P:negative regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071158">
<property type="term" value="P:positive regulation of cell cycle arrest"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035066">
<property type="term" value="P:positive regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0010332">
<property type="term" value="P:response to gamma radiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="TAIR"/>
</dbReference>
<dbReference type="CDD" id="cd00027">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10190">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR031099">
<property type="entry name" value="BRCA1-associated"/>
</dbReference>
<dbReference type="InterPro" id="IPR001357">
<property type="entry name" value="BRCT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036420">
<property type="entry name" value="BRCT_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR034732">
<property type="entry name" value="EPHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13763">
<property type="entry name" value="PTHR13763"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00533">
<property type="entry name" value="BRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16589">
<property type="entry name" value="BRCT_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001734">
<property type="entry name" value="BRCA1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00292">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52113">
<property type="entry name" value="SSF52113"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50172">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51805">
<property type="entry name" value="EPHD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Protein BREAST CANCER SUSCEPTIBILITY 1 homolog" id="PRO_0000363413">
<location>
<begin position="1"/>
<end position="941"/>
</location>
</feature>
<feature type="domain" description="BRCT 1" evidence="1">
<location>
<begin position="724"/>
<end position="819"/>
</location>
</feature>
<feature type="domain" description="BRCT 2" evidence="1">
<location>
<begin position="840"/>
<end position="941"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="2">
<location>
<begin position="16"/>
<end position="54"/>
</location>
</feature>
<feature type="zinc finger region" description="C2HC pre-PHD-type" evidence="4">
<location>
<begin position="561"/>
<end position="612"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type; degenerate" evidence="4">
<location>
<begin position="632"/>
<end position="681"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal 1" evidence="3">
<location>
<begin position="298"/>
<end position="305"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal 2" evidence="3">
<location>
<begin position="444"/>
<end position="451"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00033"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00768"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01146"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12582233"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16957774"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12582233"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000305"/>
<evidence key="9" type="ECO:0000312">
<source>
<dbReference type="Araport" id="AT4G21070"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="CAB45902.1"/>
</source>
</evidence>
<sequence length="941" mass="103922" checksum="4EF2D20BA443C9AA" modified="2002-06-01" version="1">
MADTSHLERMGRELKCPICLSLYNSAVSLSCNHVFCNACIVKSMKMDATCPVCKIPYHRR
EIRGAPHMDSLVSIYKNMEDASGIKLFVSQNNPSPSDKEKQVRDASVEKASDKNRQGSRK
GRASKRNEYGKTKEIDVDAPGPIVMKPSSQTKKRVQLLQNLSAESLTKPTESVETAEKPK
DYTENTVIRLDEHPSLNKEGNLSPFFWLRDEDDGENSSQRTESDQLLGTTPVNVPSFSDL
MDSDHESPSKEDEQQKPNPGDMFDSEMFEWTQRPCSPEILPSPVKAKVLGRDEIDLTQKK
LPKVKVASSKCKNRKAGSARNTVARRSIGVSQEDNMESSAAATISEQQDSRGTSGTIIRN
DVNTDENVKAKRATRSKAQSTRVQSDLNVSNEADGKQGTKRKRSSIKSSPAHPIAGPNEL
SLGTEIVGKGDQDQAHGPSDTHPEKRSPTEKPSLKKRGRKSNASSSLKDLSGKTQKKTSE
KKLKLDSHMISSKATQPHGNGILTAGLNQGGDKQDSRNNRKSTVGKDDHTMQVIEKCSTI
NKSSSGGSAHLRRCNGSLTKKFTCAFCQCSEDTEASGEMTHYYRGEPVSADFNGGSKVIH
VHKNCAEWAPNVYFNDLTIVNLDVELTRSRRISCSCCGLKGAALGCYNKSCKNSFHVTCA
KLIPECRWDNVKFVMLCPLDASIKLPCEEANSKDRKCKRTPKEPLHSQPKQVSGKANIRE
LHIKQFHGFSKKLVLSCSGLTVEEKTVIAEFAELSGVTISKNWDSTVTHVIASINENGAC
KRTLKFMMAILEGKWILTIDWIKACMKNTKYVSEEPYEITMDVHGIREGPYLGRQRALKK
KPKLFTGLKFYIMGDFELAYKGYLQDLIVAAGGTILRRRPVSSDDNEASTIVVFSVEPSK
KKTLTQRRSDAEALAKSARARAASSSWVLDSIAGCQILVLI
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1994-10-01" modified="2018-01-31" version="233">
<accession>P38398</accession>
<accession>E9PFZ0</accession>
<accession>O15129</accession>
<accession>Q1RMC1</accession>
<accession>Q3LRJ0</accession>
<accession>Q3LRJ6</accession>
<accession>Q6IN79</accession>
<accession>Q7KYU9</accession>
<name>BRCA1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Breast cancer type 1 susceptibility protein</fullName>
<ecNumber evidence="23 41 42 58 64 74">2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName>RING finger protein 53</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="107">RING-type E3 ubiquitin transferase BRCA1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">BRCA1</name>
<name type="synonym">RNF53</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Science" volume="266" first="66" last="71">
<title>A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.</title>
<authorList>
<person name="Miki Y."/>
<person name="Swensen J."/>
<person name="Shattuck-Eidens D."/>
<person name="Futreal P.A."/>
<person name="Harshman K."/>
<person name="Tavtigian S."/>
<person name="Liu Q."/>
<person name="Cochran C."/>
<person name="Bennett L.M."/>
<person name="Ding W."/>
<person name="Bell R."/>
<person name="Rosenthal J."/>
<person name="Hussey C."/>
<person name="Tran T."/>
<person name="McClure M."/>
<person name="Frye C."/>
<person name="Hattier T."/>
<person name="Phelps R."/>
<person name="Haugen-Strano A."/>
<person name="Katcher H."/>
<person name="Yakumo K."/>
<person name="Gholami Z."/>
<person name="Shaffer D."/>
<person name="Stone S."/>
<person name="Bayer S."/>
<person name="Wray C."/>
<person name="Bogden R."/>
<person name="Dayananth P."/>
<person name="Ward J."/>
<person name="Tonin P."/>
<person name="Narod S."/>
<person name="Bristow P.K."/>
<person name="Norris F.H."/>
<person name="Helvering L."/>
<person name="Morrison P."/>
<person name="Rosteck P."/>
<person name="Lai M."/>
<person name="Barrett J.C."/>
<person name="Lewis C."/>
<person name="Neuhausen S."/>
<person name="Cannon-Albright L."/>
<person name="Godlgar D."/>
<person name="Wiseman R."/>
<person name="Kamb A."/>
<person name="Skolnick M.H."/>
</authorList>
<dbReference type="PubMed" id="7545954"/>
<dbReference type="DOI" id="10.1126/science.7545954"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT BC ARG-1775</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Genome Res." volume="6" first="1029" last="1049">
<title>Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1.</title>
<authorList>
<person name="Smith T.M."/>
<person name="Lee M.K."/>
<person name="Szabo C.I."/>
<person name="Jerome N."/>
<person name="McEuen M."/>
<person name="Taylor M."/>
<person name="Hood L."/>
<person name="King M.-C."/>
</authorList>
<dbReference type="PubMed" id="8938427"/>
<dbReference type="DOI" id="10.1101/gr.6.11.1029"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Oncogene" volume="14" first="1" last="16">
<title>Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b.</title>
<authorList>
<person name="Wilson C.A."/>
<person name="Payton M.N."/>
<person name="Elliott G.S."/>
<person name="Buaas F.W."/>
<person name="Cajulis E.E."/>
<person name="Grosshans D."/>
<person name="Ramos L."/>
<person name="Reese D.M."/>
<person name="Slamon D.J."/>
<person name="Calzone F.J."/>
</authorList>
<dbReference type="PubMed" id="9010228"/>
<dbReference type="DOI" id="10.1038/sj.onc.1200924"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 2)</scope>
<scope>VARIANTS ARG-239 AND GLY-1613</scope>
<scope>TISSUE SPECIFICITY (ISOFORMS 1 AND 3)</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="1997-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Holt J.T."/>
<person name="Robinson-Benion C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Raymond C.K."/>
<person name="Paddock M."/>
<person name="Subramanian S."/>
<person name="Deodato C."/>
<person name="Zhou Y."/>
<person name="Haugen E."/>
<person name="Kaul R."/>
<person name="Olson M.V."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ARG-356</scope>
</reference>
<reference key="6">
<citation type="submission" date="2003-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS SER-275; ARG-356; ASN-693; LEU-871; GLY-1038; ASN-1040; GLY-1140; ARG-1183; GLY-1613 AND ALA-1620</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 6 AND 7)</scope>
<scope>VARIANTS LEU-871; GLY-1038; ARG-1183; GLY-1613 AND ILE-1652</scope>
<source>
<tissue>PNS</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="2767" last="2773">
<title>Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DeltaBRCA1(17aa).</title>
<authorList>
<person name="Liu J."/>
<person name="Prolla G."/>
<person name="Rostagno A."/>
<person name="Chiarle R."/>
<person name="Feiner H."/>
<person name="Inghirami G."/>
</authorList>
<dbReference type="PubMed" id="10851077"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203599"/>
</citation>
<scope>PROTEIN SEQUENCE OF 6-18 (ISOFORM 1)</scope>
<scope>PROTEIN SEQUENCE OF 18-26 (ISOFORM 4)</scope>
<scope>ALTERNATIVE INITIATION (ISOFORM 4)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="444" last="452">
<title>Localization of BRCA1 and a splice variant identifies the nuclear localization signal.</title>
<authorList>
<person name="Thakur S."/>
<person name="Zhang H.B."/>
<person name="Peng Y."/>
<person name="Le H."/>
<person name="Carroll B."/>
<person name="Ward T."/>
<person name="Yao J."/>
<person name="Farid L.M."/>
<person name="Couch F.J."/>
<person name="Wilson R.B."/>
<person name="Weber B.L."/>
</authorList>
<dbReference type="PubMed" id="8972225"/>
<dbReference type="DOI" id="10.1128/MCB.17.1.444"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORM 5)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 5)</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="Nat. Genet." volume="19" first="254" last="256">
<title>BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A.</title>
<authorList>
<person name="Anderson S.F."/>
<person name="Schlegel B.P."/>
<person name="Nakajima T."/>
<person name="Wolpin E.S."/>
<person name="Parvin J.D."/>
</authorList>
<dbReference type="PubMed" id="9662397"/>
<dbReference type="DOI" id="10.1038/930"/>
</citation>
<scope>INTERACTION WITH DHX9</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="Oncogene" volume="16" first="1097" last="1112">
<title>BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.</title>
<authorList>
<person name="Jensen D.E."/>
<person name="Proctor M."/>
<person name="Marquis S.T."/>
<person name="Gardner H.P."/>
<person name="Ha S.I."/>
<person name="Chodosh L.A."/>
<person name="Ishov A.M."/>
<person name="Tommerup N."/>
<person name="Vissing H."/>
<person name="Sekido Y."/>
<person name="Minna J."/>
<person name="Borodovsky A."/>
<person name="Schultz D.C."/>
<person name="Wilkinson K.D."/>
<person name="Maul G.G."/>
<person name="Barlev N."/>
<person name="Berger S."/>
<person name="Prendergast G.C."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="9528852"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201861"/>
</citation>
<scope>INTERACTION WITH BAP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANTS GLY-61 AND GLY-64</scope>
<scope>MUTAGENESIS OF ARG-71</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="Oncogene" volume="17" first="2279" last="2285">
<title>Characterization of a carboxy-terminal BRCA1 interacting protein.</title>
<authorList>
<person name="Wong A.K."/>
<person name="Ormonde P.A."/>
<person name="Pero R."/>
<person name="Chen Y."/>
<person name="Lian L."/>
<person name="Salada G."/>
<person name="Berry S."/>
<person name="Lawrence Q."/>
<person name="Dayananth P."/>
<person name="Ha P."/>
<person name="Tavtigian S.V."/>
<person name="Teng D.H."/>
<person name="Bartel P.L."/>
</authorList>
<dbReference type="PubMed" id="9811458"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202150"/>
</citation>
<scope>INTERACTION WITH RBBP8</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="11364" last="11369">
<title>RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination.</title>
<authorList>
<person name="Lorick K.L."/>
<person name="Jensen J.P."/>
<person name="Fang S."/>
<person name="Ong A.M."/>
<person name="Hatakeyama S."/>
<person name="Weissman A.M."/>
</authorList>
<dbReference type="PubMed" id="10500182"/>
<dbReference type="DOI" id="10.1073/pnas.96.20.11364"/>
</citation>
<scope>FUNCTION AS AN E2-DEPENDENT UBIQUITIN-PROTEIN LIGASE</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="927" last="939">
<title>BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.</title>
<authorList>
<person name="Wang Y."/>
<person name="Cortez D."/>
<person name="Yazdi P."/>
<person name="Neff N."/>
<person name="Elledge S.J."/>
<person name="Qin J."/>
</authorList>
<dbReference type="PubMed" id="10783165"/>
</citation>
<scope>IDENTIFICATION IN THE BASC COMPLEX</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="2989" last="3002">
<title>Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.</title>
<authorList>
<person name="Tibbetts R.S."/>
<person name="Cortez D."/>
<person name="Brumbaugh K.M."/>
<person name="Scully R."/>
<person name="Livingston D."/>
<person name="Elledge S.J."/>
<person name="Abraham R.T."/>
</authorList>
<dbReference type="PubMed" id="11114888"/>
<dbReference type="DOI" id="10.1101/gad.851000"/>
</citation>
<scope>PHOSPHORYLATION AT SER-1143; SER-1280; SER-1387; THR-1394; SER-1423 AND SER-1457</scope>
<scope>MUTAGENESIS OF SER-1143; SER-1239; SER-1280; SER-1298; SER-1330; SER-1387; THR-1394; SER-1423; SER-1457; SER-1466; SER-1524 AND SER-1755</scope>
<scope>CHARACTERIZATION OF VARIANT BC ALA-1720</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Nature" volume="404" first="201" last="204">
<title>hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response.</title>
<authorList>
<person name="Lee J.S."/>
<person name="Collins K.M."/>
<person name="Brown A.L."/>
<person name="Lee C.H."/>
<person name="Chung J.H."/>
</authorList>
<dbReference type="PubMed" id="10724175"/>
<dbReference type="DOI" id="10.1038/35004614"/>
</citation>
<scope>FUNCTION IN DNA DAMAGE RESPONSE</scope>
<scope>PHOSPHORYLATION AT SER-988 BY CHEK2</scope>
<scope>INTERACTION WITH CHEK2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="Cell" volume="105" first="149" last="160">
<title>BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.</title>
<authorList>
<person name="Cantor S.B."/>
<person name="Bell D.W."/>
<person name="Ganesan S."/>
<person name="Kass E.M."/>
<person name="Drapkin R."/>
<person name="Grossman S."/>
<person name="Wahrer D.C.R."/>
<person name="Sgroi D.C."/>
<person name="Lane W.S."/>
<person name="Haber D.A."/>
<person name="Livingston D.M."/>
</authorList>
<dbReference type="PubMed" id="11301010"/>
<dbReference type="DOI" id="10.1016/S0092-8674(01)00304-X"/>
</citation>
<scope>INTERACTION WITH BRIP1</scope>
<scope>CHARACTERIZATION OF VARIANT OVARIAN CANCER ARG-1749</scope>
<scope>CHARACTERIZATION OF VARIANT BC ARG-1775</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="J. Cell Biol." volume="155" first="911" last="921">
<title>BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.</title>
<authorList>
<person name="Ye Q."/>
<person name="Hu Y.-F."/>
<person name="Zhong H."/>
<person name="Nye A.C."/>
<person name="Belmont A.S."/>
<person name="Li R."/>
</authorList>
<dbReference type="PubMed" id="11739404"/>
<dbReference type="DOI" id="10.1083/jcb.200108049"/>
</citation>
<scope>INTERACTION WITH NELFB</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="249" last="262">
<title>Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.</title>
<authorList>
<person name="Garcia-Higuera I."/>
<person name="Taniguchi T."/>
<person name="Ganesan S."/>
<person name="Meyn M.S."/>
<person name="Timmers C."/>
<person name="Hejna J."/>
<person name="Grompe M."/>
<person name="D'Andrea A.D."/>
</authorList>
<dbReference type="PubMed" id="11239454"/>
<dbReference type="DOI" id="10.1016/S1097-2765(01)00173-3"/>
</citation>
<scope>INTERACTION WITH FANCD2</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="Cancer Res." volume="62" first="4588" last="4591">
<title>Phosphorylation of serine 1387 in BRCA1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation.</title>
<authorList>
<person name="Xu B."/>
<person name="O'Donnell A.H."/>
<person name="Kim S.-T."/>
<person name="Kastan M.B."/>
</authorList>
<dbReference type="PubMed" id="12183412"/>
</citation>
<scope>PHOSPHORYLATION BY ATM</scope>
<scope>MUTAGENESIS OF SER-1387; SER-1423 AND SER-1524</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="Curr. Biol." volume="12" first="1846" last="1851">
<title>NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain.</title>
<authorList>
<person name="Kobayashi J."/>
<person name="Tauchi H."/>
<person name="Sakamoto S."/>
<person name="Nakamura A."/>
<person name="Morishima K."/>
<person name="Matsuura S."/>
<person name="Kobayashi T."/>
<person name="Tamai K."/>
<person name="Tanimoto K."/>
<person name="Komatsu K."/>
</authorList>
<dbReference type="PubMed" id="12419185"/>
<dbReference type="DOI" id="10.1016/S0960-9822(02)01259-9"/>
</citation>
<scope>INTERACTION WITH H2AFX</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="Genes Dev." volume="16" first="571" last="582">
<title>SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.</title>
<authorList>
<person name="Yazdi P.T."/>
<person name="Wang Y."/>
<person name="Zhao S."/>
<person name="Patel N."/>
<person name="Lee E.Y.-H.P."/>
<person name="Qin J."/>
</authorList>
<dbReference type="PubMed" id="11877377"/>
<dbReference type="DOI" id="10.1101/gad.970702"/>
</citation>
<scope>INTERACTION WITH SMC1A</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="7849" last="7856">
<title>The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity.</title>
<authorList>
<person name="Sum E.Y."/>
<person name="Peng B."/>
<person name="Yu X."/>
<person name="Chen J."/>
<person name="Byrne J."/>
<person name="Lindeman G.J."/>
<person name="Visvader J.E."/>
</authorList>
<dbReference type="PubMed" id="11751867"/>
<dbReference type="DOI" id="10.1074/jbc.M110603200"/>
</citation>
<scope>INTERACTION WITH LMO4</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2002" name="Nat. Genet." volume="30" first="285" last="289">
<title>BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.</title>
<authorList>
<person name="Yarden R.I."/>
<person name="Pardo-Reoyo S."/>
<person name="Sgagias M."/>
<person name="Cowan K.H."/>
<person name="Brody L.C."/>
</authorList>
<dbReference type="PubMed" id="11836499"/>
<dbReference type="DOI" id="10.1038/ng837"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CHEK1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="6729" last="6739">
<title>BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains.</title>
<authorList>
<person name="Magnard C."/>
<person name="Bachelier R."/>
<person name="Vincent A."/>
<person name="Jaquinod M."/>
<person name="Kieffer S."/>
<person name="Lenoir G.M."/>
<person name="Venezia N.D."/>
</authorList>
<dbReference type="PubMed" id="12360400"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205915"/>
</citation>
<scope>INTERACTION WITH ACACA</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="34743" last="34746">
<title>The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.</title>
<authorList>
<person name="Wu-Baer F."/>
<person name="Lagrazon K."/>
<person name="Yuan W."/>
<person name="Baer R."/>
</authorList>
<dbReference type="PubMed" id="12890688"/>
<dbReference type="DOI" id="10.1074/jbc.C300249200"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH BARD1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="Mol. Cell" volume="12" first="247" last="254">
<title>BRCA1-independent ubiquitination of FANCD2.</title>
<authorList>
<person name="Vandenberg C.J."/>
<person name="Gergely F."/>
<person name="Ong C.Y."/>
<person name="Pace P."/>
<person name="Mallery D.L."/>
<person name="Hiom K."/>
<person name="Patel K.J."/>
</authorList>
<dbReference type="PubMed" id="12887909"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00281-8"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2003" name="Mol. Cell" volume="12" first="1087" last="1099">
<title>Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair.</title>
<authorList>
<person name="Dong Y."/>
<person name="Hakimi M.-A."/>
<person name="Chen X."/>
<person name="Kumaraswamy E."/>
<person name="Cooch N.S."/>
<person name="Godwin A.K."/>
<person name="Shiekhattar R."/>
</authorList>
<dbReference type="PubMed" id="14636569"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00424-6"/>
</citation>
<scope>INTERACTION WITH BRCC3</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="807" last="817">
<title>BRCA1:BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.</title>
<authorList>
<person name="Morris J.R."/>
<person name="Solomon E."/>
</authorList>
<dbReference type="PubMed" id="14976165"/>
<dbReference type="DOI" id="10.1093/hmg/ddh095"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BARD1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="19643" last="19648">
<title>BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition.</title>
<authorList>
<person name="Ouchi M."/>
<person name="Fujiuchi N."/>
<person name="Sasai K."/>
<person name="Katayama H."/>
<person name="Minamishima Y.A."/>
<person name="Ongusaha P.P."/>
<person name="Deng C."/>
<person name="Sen S."/>
<person name="Lee S.W."/>
<person name="Ouchi T."/>
</authorList>
<dbReference type="PubMed" id="14990569"/>
<dbReference type="DOI" id="10.1074/jbc.M311780200"/>
</citation>
<scope>INTERACTION WITH AURKA</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-308</scope>
<scope>PHOSPHORYLATION AT SER-308</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="9207" last="9220">
<title>Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response.</title>
<authorList>
<person name="Zhang X."/>
<person name="Succi J."/>
<person name="Feng Z."/>
<person name="Prithivirajsingh S."/>
<person name="Story M.D."/>
<person name="Legerski R.J."/>
</authorList>
<dbReference type="PubMed" id="15456891"/>
<dbReference type="DOI" id="10.1128/MCB.24.20.9207-9220.2004"/>
</citation>
<scope>INTERACTION WITH DCLRE1C</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="6484" last="6489">
<title>Human claspin works with BRCA1 to both positively and negatively regulate cell proliferation.</title>
<authorList>
<person name="Lin S.-Y."/>
<person name="Li K."/>
<person name="Stewart G.S."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="15096610"/>
<dbReference type="DOI" id="10.1073/pnas.0401847101"/>
</citation>
<scope>INTERACTION WITH CLSPN</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1336</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="Genes Dev." volume="20" first="1721" last="1726">
<title>BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.</title>
<authorList>
<person name="Yu X."/>
<person name="Fu S."/>
<person name="Lai M."/>
<person name="Baer R."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="16818604"/>
<dbReference type="DOI" id="10.1101/gad.1431006"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH RBBP8</scope>
<scope>MUTAGENESIS OF ILE-26</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="3172" last="3181">
<title>BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase.</title>
<authorList>
<person name="Moreau K."/>
<person name="Dizin E."/>
<person name="Ray H."/>
<person name="Luquain C."/>
<person name="Lefai E."/>
<person name="Foufelle F."/>
<person name="Billaud M."/>
<person name="Lenoir G.M."/>
<person name="Venezia N.D."/>
</authorList>
<dbReference type="PubMed" id="16326698"/>
<dbReference type="DOI" id="10.1074/jbc.M504652200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ACACA</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="J. Mol. Biol." volume="359" first="973" last="982">
<title>ACCA phosphopeptide recognition by the BRCT repeats of BRCA1.</title>
<authorList>
<person name="Ray H."/>
<person name="Moreau K."/>
<person name="Dizin E."/>
<person name="Callebaut I."/>
<person name="Venezia N.D."/>
</authorList>
<dbReference type="PubMed" id="16698035"/>
<dbReference type="DOI" id="10.1016/j.jmb.2006.04.010"/>
</citation>
<scope>INTERACTION WITH ACACA</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="11186" last="11194">
<title>Aurora-A kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation.</title>
<authorList>
<person name="Sankaran S."/>
<person name="Crone D.E."/>
<person name="Palazzo R.E."/>
<person name="Parvin J.D."/>
</authorList>
<dbReference type="PubMed" id="18056443"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-2578"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION BY AURKA</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2007" name="Nat. Struct. Mol. Biol." volume="14" first="710" last="715">
<title>CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response.</title>
<authorList>
<person name="Kim H."/>
<person name="Huang J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="17643122"/>
<dbReference type="DOI" id="10.1038/nsmb1277"/>
</citation>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="Nat. Struct. Mol. Biol." volume="14" first="716" last="720">
<title>CCDC98 targets BRCA1 to DNA damage sites.</title>
<authorList>
<person name="Liu Z."/>
<person name="Wu J."/>
<person name="Yu X."/>
</authorList>
<dbReference type="PubMed" id="17643121"/>
<dbReference type="DOI" id="10.1038/nsmb1279"/>
</citation>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2007" name="Science" volume="316" first="1194" last="1198">
<title>Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response.</title>
<authorList>
<person name="Wang B."/>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Zhang D."/>
<person name="Smogorzewska A."/>
<person name="Giyi S."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525340"/>
<dbReference type="DOI" id="10.1126/science.1139476"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2008" name="Hum. Genet." volume="124" first="271" last="278">
<title>Germline BRCA1 mutations predispose to pancreatic adenocarcinoma.</title>
<authorList>
<person name="Al-Sukhni W."/>
<person name="Rothenmund H."/>
<person name="Borgida A.E."/>
<person name="Zogopoulos G."/>
<person name="O'Shea A.M."/>
<person name="Pollett A."/>
<person name="Gallinger S."/>
</authorList>
<dbReference type="PubMed" id="18762988"/>
<dbReference type="DOI" id="10.1007/s00439-008-0554-0"/>
</citation>
<scope>INVOLVEMENT IN PNCA4</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-395; SER-398; SER-753; SER-1211; SER-1217 AND SER-1218</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="719" last="728">
<title>MERIT40 facilitates BRCA1 localization and DNA damage repair.</title>
<authorList>
<person name="Feng L."/>
<person name="Huang J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19261748"/>
<dbReference type="DOI" id="10.1101/gad.1770609"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE BRCA1-A COMPLEX</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="729" last="739">
<title>NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control.</title>
<authorList>
<person name="Wang B."/>
<person name="Hurov K."/>
<person name="Hofmann K."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="19261749"/>
<dbReference type="DOI" id="10.1101/gad.1770309"/>
</citation>
<scope>IDENTIFICATION IN THE BRCA1-A COMPLEX</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="740" last="754">
<title>MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks.</title>
<authorList>
<person name="Shao G."/>
<person name="Patterson-Fortin J."/>
<person name="Messick T.E."/>
<person name="Feng D."/>
<person name="Shanbhag N."/>
<person name="Wang Y."/>
<person name="Greenberg R.A."/>
</authorList>
<dbReference type="PubMed" id="19261746"/>
<dbReference type="DOI" id="10.1101/gad.1739609"/>
</citation>
<scope>IDENTIFICATION IN THE BRCA1-A COMPLEX</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="7155" last="7160">
<title>PALB2 is an integral component of the BRCA complex required for homologous recombination repair.</title>
<authorList>
<person name="Sy S.M."/>
<person name="Huen M.S."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19369211"/>
<dbReference type="DOI" id="10.1073/pnas.0811159106"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PALB2</scope>
<scope>IDENTIFICATION IN A BRCA COMPLEX WITH BRCA1 AND PALB2</scope>
<scope>CHARACTERIZATION OF VARIANT OVARIAN CANCER 1411-THR</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-395 AND SER-398</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2010" name="Br. J. Cancer" volume="102" first="1061" last="1067">
<title>Identification of DBC1 as a transcriptional repressor for BRCA1.</title>
<authorList>
<person name="Hiraike H."/>
<person name="Wada-Hiraike O."/>
<person name="Nakagawa S."/>
<person name="Koyama S."/>
<person name="Miyamoto Y."/>
<person name="Sone K."/>
<person name="Tanikawa M."/>
<person name="Tsuruga T."/>
<person name="Nagasaka K."/>
<person name="Matsumoto Y."/>
<person name="Oda K."/>
<person name="Shoji K."/>
<person name="Fukuhara H."/>
<person name="Saji S."/>
<person name="Nakagawa K."/>
<person name="Kato S."/>
<person name="Yano T."/>
<person name="Taketani Y."/>
</authorList>
<dbReference type="PubMed" id="20160719"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6605577"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CCAR2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="2787" last="2798">
<title>The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.</title>
<authorList>
<person name="Wu-Baer F."/>
<person name="Ludwig T."/>
<person name="Baer R."/>
</authorList>
<dbReference type="PubMed" id="20351172"/>
<dbReference type="DOI" id="10.1128/MCB.01056-09"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH BARD1 AND UBXN1</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF ILE-26</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="492" last="499">
<title>The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells.</title>
<authorList>
<person name="Stolz A."/>
<person name="Ertych N."/>
<person name="Kienitz A."/>
<person name="Vogel C."/>
<person name="Schneider V."/>
<person name="Fritz B."/>
<person name="Jacob R."/>
<person name="Dittmar G."/>
<person name="Weichert W."/>
<person name="Petersen I."/>
<person name="Bastians H."/>
</authorList>
<dbReference type="PubMed" id="20364141"/>
<dbReference type="DOI" id="10.1038/ncb2051"/>
</citation>
<scope>FUNCTION IN CHROMOSOMAL STABILITY</scope>
<scope>PHOSPHORYLATION AT SER-988 BY CHEK2</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-423; SER-694; SER-1328; SER-1336 AND SER-1342</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="54">
<citation type="journal article" date="2011" name="Biochem. Biophys. Res. Commun." volume="404" first="476" last="481">
<title>Protein phosphatase 5 is necessary for ATR-mediated DNA repair.</title>
<authorList>
<person name="Kang Y."/>
<person name="Cheong H.M."/>
<person name="Lee J.H."/>
<person name="Song P.I."/>
<person name="Lee K.H."/>
<person name="Kim S.Y."/>
<person name="Jun J.Y."/>
<person name="You H.J."/>
</authorList>
<dbReference type="PubMed" id="21144835"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.12.005"/>
</citation>
<scope>PHOSPHORYLATION AT SER-1524</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2011" name="Mol. Cancer Res." volume="9" first="1091" last="1099">
<title>KIAA0101 interacts with BRCA1 and regulates centrosome number.</title>
<authorList>
<person name="Kais Z."/>
<person name="Barsky S.H."/>
<person name="Mathsyaraja H."/>
<person name="Zha A."/>
<person name="Ransburgh D.J."/>
<person name="He G."/>
<person name="Pilarski R.T."/>
<person name="Shapiro C.L."/>
<person name="Huang K."/>
<person name="Parvin J.D."/>
</authorList>
<dbReference type="PubMed" id="21673012"/>
<dbReference type="DOI" id="10.1158/1541-7786.MCR-10-0503"/>
</citation>
<scope>INTERACTION WITH PCLAF</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-1218; SER-1336 AND SER-1342</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-434; SER-551; SER-694; SER-708; SER-1009; SER-1189; SER-1191 AND SER-1542</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="59">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339; LYS-459; LYS-583; LYS-654; LYS-734 AND LYS-739</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.O114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339; LYS-443 AND LYS-583</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2016" name="Nat. Cell Biol." volume="18" first="271" last="280">
<title>EXD2 promotes homologous recombination by facilitating DNA end resection.</title>
<authorList>
<person name="Broderick R."/>
<person name="Nieminuszczy J."/>
<person name="Baddock H.T."/>
<person name="Deshpande R.A."/>
<person name="Gileadi O."/>
<person name="Paull T.T."/>
<person name="McHugh P.J."/>
<person name="Niedzwiedz W."/>
</authorList>
<dbReference type="PubMed" id="26807646"/>
<dbReference type="DOI" id="10.1038/ncb3303"/>
</citation>
<scope>INTERACTION WITH EXD2</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-109; LYS-301; LYS-339; LYS-443; LYS-459; LYS-519; LYS-583; LYS-918; LYS-987 AND LYS-1079</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2017" name="Oncogene" volume="36" first="4161" last="4170">
<title>Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.</title>
<authorList>
<person name="Foo T.K."/>
<person name="Tischkowitz M."/>
<person name="Simhadri S."/>
<person name="Boshari T."/>
<person name="Zayed N."/>
<person name="Burke K.A."/>
<person name="Berman S.H."/>
<person name="Blecua P."/>
<person name="Riaz N."/>
<person name="Huo Y."/>
<person name="Ding Y.C."/>
<person name="Neuhausen S.L."/>
<person name="Weigelt B."/>
<person name="Reis-Filho J.S."/>
<person name="Foulkes W.D."/>
<person name="Xia B."/>
</authorList>
<dbReference type="PubMed" id="28319063"/>
<dbReference type="DOI" id="10.1038/onc.2017.46"/>
</citation>
<scope>INTERACTION WITH PALB2</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2001" name="Nat. Struct. Biol." volume="8" first="833" last="837">
<title>Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.</title>
<authorList>
<person name="Brzovic P.S."/>
<person name="Rajagopal P."/>
<person name="Hoyt D.W."/>
<person name="King M.C."/>
<person name="Klevit R.E."/>
</authorList>
<dbReference type="PubMed" id="11573085"/>
<dbReference type="DOI" id="10.1038/nsb1001-833"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-110 IN COMPLEX WITH ZINC IONS AND BARD1</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2001" name="Nat. Struct. Biol." volume="8" first="838" last="842">
<title>Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.</title>
<authorList>
<person name="Williams R.S."/>
<person name="Green R."/>
<person name="Glover J.N."/>
</authorList>
<dbReference type="PubMed" id="11573086"/>
<dbReference type="DOI" id="10.1038/nsb1001-838"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1646-1859</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="2630" last="2635">
<title>Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.</title>
<authorList>
<person name="Williams R.S."/>
<person name="Glover J.N."/>
</authorList>
<dbReference type="PubMed" id="12427738"/>
<dbReference type="DOI" id="10.1074/jbc.M210019200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1646-1859 OF VARIANT BC ARG-1775</scope>
<scope>CHARACTERIZATION OF VARIANT BC ARG-1775</scope>
<scope>CIRCULAR DICHROISM</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2004" name="Biochemistry" volume="43" first="15983" last="15995">
<title>Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.</title>
<authorList>
<person name="Gaiser O.J."/>
<person name="Ball L.J."/>
<person name="Schmieder P."/>
<person name="Leitner D."/>
<person name="Strauss H."/>
<person name="Wahl M."/>
<person name="Kuhne R."/>
<person name="Oschkinat H."/>
<person name="Heinemann U."/>
</authorList>
<dbReference type="PubMed" id="15609993"/>
<dbReference type="DOI" id="10.1021/bi049550q"/>
</citation>
<scope>STRUCTURE BY NMR OF 1755-1863</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2004" name="Nat. Struct. Mol. Biol." volume="11" first="512" last="518">
<title>Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.</title>
<authorList>
<person name="Clapperton J.A."/>
<person name="Manke I.A."/>
<person name="Lowery D.M."/>
<person name="Ho T."/>
<person name="Haire L.F."/>
<person name="Yaffe M.B."/>
<person name="Smerdon S.J."/>
</authorList>
<dbReference type="PubMed" id="15133502"/>
<dbReference type="DOI" id="10.1038/nsmb775"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 1649-1859 IN COMPLEX WITH WITH PHOSPHORYLATED BRIP1 PEPTIDE</scope>
<scope>MUTAGENESIS OF SER-1655; LYS-1702 AND GLY-1738</scope>
<scope>CHARACTERIZATION OF VARIANT OVARIAN CANCER ARG-1749</scope>
<scope>CHARACTERIZATION OF VARIANT BC ARG-1775</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PHOSPHORYLATED BRIP1</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2005" name="Biochemistry" volume="44" first="10941" last="10946">
<title>Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex.</title>
<authorList>
<person name="Varma A.K."/>
<person name="Brown R.S."/>
<person name="Birrane G."/>
<person name="Ladias J.A."/>
</authorList>
<dbReference type="PubMed" id="16101277"/>
<dbReference type="DOI" id="10.1021/bi0509651"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH PHOSPHORYLATED RBBP8 PEPTIDE</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2008" name="Biochemistry" volume="47" first="5767" last="5773">
<title>Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1.</title>
<authorList>
<person name="Shen Y."/>
<person name="Tong L."/>
</authorList>
<dbReference type="PubMed" id="18452305"/>
<dbReference type="DOI" id="10.1021/bi800314m"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.21 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH PHOSPHORYLATED ACACA PEPTIDE</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2008" name="Eur. J. Hum. Genet." volume="16" first="820" last="832">
<title>Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.</title>
<authorList>
<person name="Tischkowitz M."/>
<person name="Hamel N."/>
<person name="Carvalho M.A."/>
<person name="Birrane G."/>
<person name="Soni A."/>
<person name="van Beers E.H."/>
<person name="Joosse S.A."/>
<person name="Wong N."/>
<person name="Novak D."/>
<person name="Quenneville L.A."/>
<person name="Grist S.A."/>
<person name="Nederlof P.M."/>
<person name="Goldgar D.E."/>
<person name="Tavtigian S.V."/>
<person name="Monteiro A.N."/>
<person name="Ladias J.A."/>
<person name="Foulkes W.D."/>
</authorList>
<dbReference type="PubMed" id="18285836"/>
<dbReference type="DOI" id="10.1038/ejhg.2008.13"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.6 ANGSTROMS) OF 1649-1859 OF VARIANT BC LYS-1775</scope>
<scope>VARIANT BC LYS-1775</scope>
<scope>CHARACTERIZATION OF VARIANT BC LYS-1775</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2010" name="Structure" volume="18" first="167" last="176">
<title>Comparison of the structures and peptide binding specificities of the BRCT domains of MDC1 and BRCA1.</title>
<authorList>
<person name="Campbell S.J."/>
<person name="Edwards R.A."/>
<person name="Glover J.N."/>
</authorList>
<dbReference type="PubMed" id="20159462"/>
<dbReference type="DOI" id="10.1016/j.str.2009.12.008"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH PHOSPHORYLATED PEPTIDES</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2011" name="Biochemistry" volume="50" first="4579" last="4589">
<title>Impact of BRCA1 BRCT domain missense substitutions on phosphopeptide recognition.</title>
<authorList>
<person name="Coquelle N."/>
<person name="Green R."/>
<person name="Glover J.N."/>
</authorList>
<dbReference type="PubMed" id="21473589"/>
<dbReference type="DOI" id="10.1021/bi2003795"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH PHOSPHORYLATED BRIP1 PEPTIDE</scope>
<scope>INTERACTION WITH BRIP1</scope>
<scope>MUTAGENESIS OF GLY-1656; THR-1700; ARG-1835 AND GLU-1836</scope>
<scope>CHARACTERIZATION OF VARIANTS BC GLN-1699 AND TRP-1699</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2013" name="Acta Crystallogr. F" volume="69" first="1401" last="1404">
<title>Preliminary crystallographic studies of BRCA1 BRCT-ABRAXAS complex.</title>
<authorList>
<person name="Badgujar D.C."/>
<person name="Sawant U."/>
<person name="Vikrant X."/>
<person name="Yadav L."/>
<person name="Hosur M.V."/>
<person name="Varma A.K."/>
</authorList>
<dbReference type="PubMed" id="24316840"/>
<dbReference type="DOI" id="10.1107/S1744309113030649"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.50 ANGSTROMS) OF 1649-1859 IN COMPLEX WITH ABRAXAS1</scope>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2016" name="Mol. Cell" volume="61" first="434" last="448">
<title>Structure of BRCA1-BRCT/Abraxas complex reveals phosphorylation-dependent BRCT dimerization at DNA damage sites.</title>
<authorList>
<person name="Wu Q."/>
<person name="Paul A."/>
<person name="Su D."/>
<person name="Mehmood S."/>
<person name="Foo T.K."/>
<person name="Ochi T."/>
<person name="Bunting E.L."/>
<person name="Xia B."/>
<person name="Robinson C.V."/>
<person name="Wang B."/>
<person name="Blundell T.L."/>
</authorList>
<dbReference type="PubMed" id="26778126"/>
<dbReference type="DOI" id="10.1016/j.molcel.2015.12.017"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH ABRAXAS1</scope>
<scope>INTERACTION WITH ABRAXAS1</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF PHE-1662; MET-1663; TYR-1666; ARG-1670 AND LYS-1671</scope>
</reference>
<reference key="76">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="8" last="18">
<title>Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene.</title>
<authorList>
<person name="Couch F.J."/>
<person name="Weber B.L."/>
</authorList>
<dbReference type="PubMed" id="8807330"/>
<dbReference type="DOI" id="10.1002/humu.1380080102"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="77">
<citation type="journal article" date="1994" name="Science" volume="266" first="120" last="122">
<title>BRCA1 mutations in primary breast and ovarian carcinomas.</title>
<authorList>
<person name="Futreal P.A."/>
<person name="Liu Q."/>
<person name="Shattuck-Eidens D."/>
<person name="Cochran C."/>
<person name="Harshman K."/>
<person name="Tavtigian S."/>
<person name="Bennett L.M."/>
<person name="Haugen-Strano A."/>
<person name="Swensen J."/>
<person name="Miki Y."/>
<person name="Eddington K."/>
<person name="McClure M."/>
<person name="Frye C."/>
<person name="Weaver-Felhaus J."/>
<person name="Ding W."/>
<person name="Gholami Z."/>
<person name="Soederkvist P."/>
<person name="Terry L."/>
<person name="Jhanwar S."/>
<person name="Berchuk A."/>
<person name="Iglehart J.D."/>
<person name="Marks J."/>
<person name="Ballinger D.G."/>
<person name="Barrett J.C."/>
<person name="Skolnick M.H."/>
<person name="Kamb A."/>
<person name="Wiseman R."/>
</authorList>
<dbReference type="PubMed" id="7939630"/>
<dbReference type="DOI" id="10.1126/science.7939630"/>
</citation>
<scope>VARIANT BC ARG-1775</scope>
<scope>VARIANTS LEU-1637 AND GLU-1708</scope>
</reference>
<reference key="78">
<citation type="journal article" date="1994" name="Nat. Genet." volume="8" first="387" last="391">
<title>Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.</title>
<authorList>
<person name="Castilla L.H."/>
<person name="Couch F.J."/>
<person name="Erdos M.R."/>
<person name="Hoskins K.F."/>
<person name="Calzone K."/>
<person name="Garber J.E."/>
<person name="Boyd J."/>
<person name="Lubin M.B."/>
<person name="Deshano M.L."/>
<person name="Brody L.C."/>
<person name="Collins F.S."/>
<person name="Weber B.L."/>
</authorList>
<dbReference type="PubMed" id="7894491"/>
<dbReference type="DOI" id="10.1038/ng1294-387"/>
</citation>
<scope>VARIANT BC GLY-64</scope>
<scope>VARIANTS ALA-772; ASN-1040 AND GLY-1443</scope>
</reference>
<reference key="79">
<citation type="journal article" date="1994" name="Nat. Genet." volume="8" first="399" last="404">
<title>Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.</title>
<authorList>
<person name="Friedman L.S."/>
<person name="Ostermeyer E.A."/>
<person name="Szabo C.I."/>
<person name="Dowd P."/>
<person name="Lynch E.D."/>
<person name="Rowell S.E."/>
<person name="King M.-C."/>
</authorList>
<dbReference type="PubMed" id="7894493"/>
<dbReference type="DOI" id="10.1038/ng1294-399"/>
</citation>
<scope>VARIANT BC GLY-61</scope>
<scope>VARIANTS ARG-356; GLY-1038; ASN-1040; ARG-1183 AND GLY-1613</scope>
</reference>
<reference key="80">
<citation type="journal article" date="1996" name="Am. J. Hum. Genet." volume="58" first="42" last="51">
<title>A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.</title>
<authorList>
<person name="Serova O."/>
<person name="Montagna M."/>
<person name="Torchard D."/>
<person name="Narod S.A."/>
<person name="Tonin P."/>
<person name="Sylla B."/>
<person name="Lynch H.T."/>
<person name="Feunteun J."/>
<person name="Lenoir G.M."/>
</authorList>
<dbReference type="PubMed" id="8554067"/>
</citation>
<scope>VARIANT BC GLY-61</scope>
</reference>
<reference key="81">
<citation type="journal article" date="1996" name="Genet. Epidemiol." volume="13" first="595" last="604">
<title>BRCA1 R841W: a strong candidate for a common mutation with moderate phenotype.</title>
<authorList>
<person name="Barker D.F."/>
<person name="Almeida E.F.A."/>
<person name="Casey G."/>
<person name="Fain P.R."/>
<person name="Liao S.-Y."/>
<person name="Masunaka I."/>
<person name="Noble B."/>
<person name="Kurosaki T."/>
<person name="Anton-Culver H."/>
</authorList>
<dbReference type="PubMed" id="8968716"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-2272(1996)13:6&lt;595::AID-GEPI5&gt;3.3.CO;2-0"/>
</citation>
<scope>VARIANT BROVCA1 TRP-841</scope>
</reference>
<reference key="82">
<citation type="journal article" date="1996" name="Hum. Mol. Genet." volume="5" first="835" last="842">
<title>Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations.</title>
<authorList>
<person name="Durocher F."/>
<person name="Shattuck-Eidens D."/>
<person name="McClure M."/>
<person name="Labrie F."/>
<person name="Skolnick M.H."/>
<person name="Goldgar D.E."/>
<person name="Simard J."/>
</authorList>
<dbReference type="PubMed" id="8776600"/>
<dbReference type="DOI" id="10.1093/hmg/5.6.835"/>
</citation>
<scope>VARIANTS BC AND BROVCA1</scope>
</reference>
<reference key="83">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="7" first="334" last="339">
<title>Mutations in the BRCA1 gene in Japanese breast cancer patients.</title>
<authorList>
<person name="Katagiri T."/>
<person name="Emi M."/>
<person name="Ito I."/>
<person name="Kobayashi K."/>
<person name="Yoshimoto M."/>
<person name="Iwase T."/>
<person name="Kasumi F."/>
<person name="Miki Y."/>
<person name="Skolnick M.H."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="8723683"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)7:4&lt;334::AID-HUMU7&gt;3.3.CO;2-K"/>
</citation>
<scope>VARIANTS BC MET-271 AND SER-1150</scope>
</reference>
<reference key="84">
<citation type="journal article" date="1998" name="Hum. Genet." volume="103" first="154" last="161">
<title>A high proportion of mutations in the BRCA1 gene in German breast/ovarian cancer families with clustering of mutations in the 3' third of the gene.</title>
<authorList>
<person name="Dong J."/>
<person name="Chang-Claude J."/>
<person name="Wu Y."/>
<person name="Schumacher V."/>
<person name="Debatin I."/>
<person name="Tonin P."/>
<person name="Royer-Pokora B."/>
</authorList>
<dbReference type="PubMed" id="9760198"/>
<dbReference type="DOI" id="10.1007/s004390050799"/>
</citation>
<scope>VARIANT BC GLY-61</scope>
<scope>VARIANTS ARG-239; TRP-841 AND ILE-1512</scope>
</reference>
<reference key="85">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="166" last="174">
<title>Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.</title>
<authorList>
<person name="Andersen T.I."/>
<person name="Eiken H.G."/>
<person name="Couch F."/>
<person name="Kaada G."/>
<person name="Skrede M."/>
<person name="Johnsen H."/>
<person name="Aloysius T.A."/>
<person name="Tveit K.M."/>
<person name="Tranebjaerg L."/>
<person name="Doerum A."/>
<person name="Moeller P."/>
<person name="Weber B.L."/>
<person name="Boerresen-Dale A.-L."/>
</authorList>
<dbReference type="PubMed" id="9482581"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1998)11:2&lt;166::AID-HUMU10&gt;3.0.CO;2-X"/>
</citation>
<scope>VARIANT BC GLY-64</scope>
<scope>VARIANTS ALA-772; GLU-820; ASN-1040; GLY-1443; ILE-1512; LEU-1637 AND ILE-1652</scope>
</reference>
<reference key="86">
<citation type="journal article" date="1998" name="J. Hum. Genet." volume="43" first="42" last="48">
<title>High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families.</title>
<authorList>
<person name="Katagiri T."/>
<person name="Kasumi F."/>
<person name="Yoshimoto M."/>
<person name="Nomizu T."/>
<person name="Asaishi K."/>
<person name="Abe R."/>
<person name="Tsuchiya A."/>
<person name="Sugano M."/>
<person name="Takai S."/>
<person name="Yoneda M."/>
<person name="Fukutomi T."/>
<person name="Nanba K."/>
<person name="Makita M."/>
<person name="Okazaki H."/>
<person name="Hirata K."/>
<person name="Okazaki M."/>
<person name="Furutsuma Y."/>
<person name="Morishita Y."/>
<person name="Iino Y."/>
<person name="Karino T."/>
<person name="Ayabe H."/>
<person name="Hara S."/>
<person name="Kajiwara T."/>
<person name="Houga S."/>
<person name="Shimizu T."/>
<person name="Toda M."/>
<person name="Yamazaki Y."/>
<person name="Uchida T."/>
<person name="Kunitomo K."/>
<person name="Sonoo H."/>
<person name="Kurebayashi J."/>
<person name="Shimotsuma K."/>
<person name="Nakamura Y."/>
<person name="Miki Y."/>
</authorList>
<dbReference type="PubMed" id="9609997"/>
<dbReference type="DOI" id="10.1007/s100380050035"/>
</citation>
<scope>VARIANTS BC SER-22; LEU-461; ASP-465; VAL-552; SER-892; ASP-960; ILE-1025 AND ALA-1047</scope>
</reference>
<reference key="87">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="65" first="1021" last="1029">
<title>The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.</title>
<authorList>
<person name="Gayther S.A."/>
<person name="Russell P."/>
<person name="Harrington P."/>
<person name="Antoniou A.C."/>
<person name="Easton D.F."/>
<person name="Ponder B.A.J."/>
</authorList>
<dbReference type="PubMed" id="10486320"/>
<dbReference type="DOI" id="10.1086/302583"/>
</citation>
<scope>VARIANT OVARIAN CANCER ARG-1749</scope>
</reference>
<reference key="88">
<citation type="journal article" date="1999" name="Hum. Genet." volume="104" first="201" last="204">
<title>Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan.</title>
<authorList>
<person name="Li S.S.-L."/>
<person name="Tseng H.-M."/>
<person name="Yang T.-P."/>
<person name="Liu C.-H."/>
<person name="Teng S.-J."/>
<person name="Huang H.-W."/>
<person name="Chen L.-M."/>
<person name="Kao H.-W."/>
<person name="Chen J.H."/>
<person name="Tseng J.-N."/>
<person name="Chen A."/>
<person name="Hou M.-F."/>
<person name="Huang T.-J."/>
<person name="Chang H.-T."/>
<person name="Mok K.-T."/>
<person name="Tsai J.-H."/>
</authorList>
<dbReference type="PubMed" id="10323242"/>
<dbReference type="DOI" id="10.1007/s004390050936"/>
</citation>
<scope>VARIANT BC SER-346</scope>
<scope>VARIANTS LEU-871; GLY-1038; ARG-1183 AND GLY-1613</scope>
</reference>
<reference key="89">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="889" last="897">
<title>Germline BRCA1 alterations in a population-based series of ovarian cancer cases.</title>
<authorList>
<person name="Janezic S.A."/>
<person name="Ziogas A."/>
<person name="Krumroy L.M."/>
<person name="Krasner M."/>
<person name="Plummer S.J."/>
<person name="Cohen P."/>
<person name="Gildea M."/>
<person name="Barker D."/>
<person name="Haile R."/>
<person name="Casey G."/>
<person name="Anton-Culver H."/>
</authorList>
<dbReference type="PubMed" id="10196379"/>
<dbReference type="DOI" id="10.1093/hmg/8.5.889"/>
</citation>
<scope>VARIANTS OVARIAN CANCER</scope>
<scope>VARIANTS</scope>
</reference>
<reference key="90">
<citation type="journal article" date="2002" name="Genet. Test." volume="6" first="119" last="121">
<title>Characterization of common BRCA1 and BRCA2 variants.</title>
<authorList>
<person name="Deffenbaugh A.M."/>
<person name="Frank T.S."/>
<person name="Hoffman M."/>
<person name="Cannon-Albright L."/>
<person name="Neuhausen S.L."/>
</authorList>
<dbReference type="PubMed" id="12215251"/>
<dbReference type="DOI" id="10.1089/10906570260199375"/>
</citation>
<scope>VARIANTS GLY-1347; ILE-1512 AND ILE-1652</scope>
</reference>
<reference key="91">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="474" last="474">
<title>BRCA1 and BRCA2 sequence variants in Chinese breast cancer families.</title>
<authorList>
<person name="Zhi X."/>
<person name="Szabo C."/>
<person name="Chopin S."/>
<person name="Suter N."/>
<person name="Wang Q.-S."/>
<person name="Ostrander E.A."/>
<person name="Sinilnikova O.M."/>
<person name="Lenoir G.M."/>
<person name="Goldgar D."/>
<person name="Shi Y.-R."/>
</authorList>
<dbReference type="PubMed" id="12442274"/>
<dbReference type="DOI" id="10.1002/humu.9083"/>
</citation>
<scope>VARIANTS ILE-656; LEU-871 AND GLY-1613</scope>
</reference>
<reference key="92">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="474" last="475">
<title>BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico.</title>
<authorList>
<person name="Ruiz-Flores P."/>
<person name="Sinilnikova O.M."/>
<person name="Badzioch M."/>
<person name="Calderon-Garciduenas A.L."/>
<person name="Chopin S."/>
<person name="Fabrice O."/>
<person name="Gonzalez-Guerrero J.F."/>
<person name="Szabo C."/>
<person name="Lenoir G."/>
<person name="Goldgar D.E."/>
<person name="Barrera-Saldana H.A."/>
</authorList>
<dbReference type="PubMed" id="12442275"/>
<dbReference type="DOI" id="10.1002/humu.9084"/>
</citation>
<scope>VARIANT BC TYR-749</scope>
</reference>
<reference key="93">
<citation type="journal article" date="2003" name="Hum. Mutat." volume="22" first="259" last="259">
<title>Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.</title>
<authorList>
<person name="Meyer P."/>
<person name="Voigtlaender T."/>
<person name="Bartram C.R."/>
<person name="Klaes R."/>
</authorList>
<dbReference type="PubMed" id="12938098"/>
<dbReference type="DOI" id="10.1002/humu.9174"/>
</citation>
<scope>VARIANTS BC GLY-61; LYS-71; GLN-866; TYR-888; ILE-1139; GLY-1210 AND PRO-1297</scope>
<scope>VARIANTS BROVCA1 TYR-835 AND PRO-1786</scope>
</reference>
<reference key="94">
<citation type="journal article" date="2004" name="Br. J. Cancer" volume="90" first="1244" last="1251">
<title>BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families.</title>
<authorList>
<person name="Claes K."/>
<person name="Poppe B."/>
<person name="Coene I."/>
<person name="De Paepe A."/>
<person name="Messiaen L."/>
</authorList>
<dbReference type="PubMed" id="15026808"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6601656"/>
</citation>
<scope>VARIANTS ASN-693; ASN-1040; ALA-1060 AND MET-1665</scope>
</reference>
<reference key="95">
<citation type="journal article" date="2004" name="Eur. J. Cancer" volume="40" first="422" last="428">
<title>One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.</title>
<authorList>
<person name="Malander S."/>
<person name="Ridderheim M."/>
<person name="Masbaeck A."/>
<person name="Loman N."/>
<person name="Kristoffersson U."/>
<person name="Olsson H."/>
<person name="Nilbert M."/>
<person name="Borg A."/>
</authorList>
<dbReference type="PubMed" id="14746861"/>
<dbReference type="DOI" id="10.1016/j.ejca.2003.09.016"/>
</citation>
<scope>VARIANTS OVARIAN CANCER GLY-61; THR-1411; ARG-1697 AND TRP-1699</scope>
</reference>
<reference key="96">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="23" first="205" last="205">
<title>Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.</title>
<authorList>
<person name="Valarmathi M.T."/>
<person name="Sawhney M."/>
<person name="Deo S.S.V."/>
<person name="Shukla N.K."/>
<person name="Das S.N."/>
</authorList>
<dbReference type="PubMed" id="14722926"/>
<dbReference type="DOI" id="10.1002/humu.9213"/>
</citation>
<scope>VARIANTS BC/BROVCA1 LYS-10; LYS-23; ILE-1187; HIS-1200 AND TYR-1217</scope>
<scope>VARIANTS BC ILE-1204 AND ASN-1207</scope>
<scope>VARIANTS BROVCA1 LEU-1226 AND GLY-1243</scope>
<scope>VARIANT ARG-1183</scope>
</reference>
<reference key="97">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="24" first="350" last="350">
<title>BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.</title>
<authorList>
<person name="Seo J.H."/>
<person name="Cho D.-Y."/>
<person name="Ahn S.-H."/>
<person name="Yoon K.-S."/>
<person name="Kang C.-S."/>
<person name="Cho H.M."/>
<person name="Lee H.S."/>
<person name="Choe J.J."/>
<person name="Choi C.W."/>
<person name="Kim B.S."/>
<person name="Shin S.W."/>
<person name="Kim Y.H."/>
<person name="Kim J.S."/>
<person name="Son G.-S."/>
<person name="Lee J.-B."/>
<person name="Koo B.H."/>
</authorList>
<dbReference type="PubMed" id="15365993"/>
<dbReference type="DOI" id="10.1002/humu.9275"/>
</citation>
<scope>VARIANTS HIS-856; LEU-871; GLY-1038; ARG-1183; THR-1628; GLN-1690 AND GLY-1713</scope>
</reference>
<reference key="98">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] PHE-30; PHE-758 AND CYS-778</scope>
</reference>
<reference key="99">
<citation type="journal article" date="2007" name="Am. J. Hum. Genet." volume="81" first="873" last="883">
<title>A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.</title>
<authorList>
<person name="Easton D.F."/>
<person name="Deffenbaugh A.M."/>
<person name="Pruss D."/>
<person name="Frye C."/>
<person name="Wenstrup R.J."/>
<person name="Allen-Brady K."/>
<person name="Tavtigian S.V."/>
<person name="Monteiro A.N.A."/>
<person name="Iversen E.S."/>
<person name="Couch F.J."/>
<person name="Goldgar D.E."/>
</authorList>
<dbReference type="PubMed" id="17924331"/>
<dbReference type="DOI" id="10.1086/521032"/>
</citation>
<scope>VARIANTS THR-18; MET-1495; GLY-1623; ILE-1685; ALA-1685; ARG-1689; TRP-1699; GLU-1706; GLU-1708; ARG-1715; ARG-1738; PRO-1764; SER-1766 AND VAL-1788</scope>
</reference>
<reference key="100">
<citation type="journal article" date="2010" name="Hum. Mutat." volume="31" first="E1484" last="E1505">
<title>Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity.</title>
<authorList>
<person name="Walker L.C."/>
<person name="Whiley P.J."/>
<person name="Couch F.J."/>
<person name="Farrugia D.J."/>
<person name="Healey S."/>
<person name="Eccles D.M."/>
<person name="Lin F."/>
<person name="Butler S.A."/>
<person name="Goff S.A."/>
<person name="Thompson B.A."/>
<person name="Lakhani S.R."/>
<person name="Da Silva L.M."/>
<person name="Tavtigian S.V."/>
<person name="Goldgar D.E."/>
<person name="Brown M.A."/>
<person name="Spurdle A.B."/>
</authorList>
<dbReference type="PubMed" id="20513136"/>
<dbReference type="DOI" id="10.1002/humu.21267"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS GLY-1623 AND ILE-1685</scope>
</reference>
<reference key="101">
<citation type="journal article" date="2013" name="Cancer Discov." volume="3" first="1142" last="1155">
<title>A high-throughput functional complementation assay for classification of BRCA1 missense variants.</title>
<authorList>
<person name="Bouwman P."/>
<person name="van der Gulden H."/>
<person name="van der Heijden I."/>
<person name="Drost R."/>
<person name="Klijn C.N."/>
<person name="Prasetyanti P."/>
<person name="Pieterse M."/>
<person name="Wientjens E."/>
<person name="Seibler J."/>
<person name="Hogervorst F.B."/>
<person name="Jonkers J."/>
</authorList>
<dbReference type="PubMed" id="23867111"/>
<dbReference type="DOI" id="10.1158/2159-8290.CD-13-0094"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS BC PHE-4; THR-18; GLN-45; GLY-61; GLY-64; TYR-67; LYS-132; HIS-142; PHE-147; PRO-165; TRP-170; TYR-186; ILE-191; MET-231; VAL-245; VAL-246; LEU-271; PHE-668; ASN-695; LEU-798; TYR-810; LYS-826; GLN-841; HIS-856; ASN-1101; ASN-1140; GLY-1140; LYS-1214; LYS-1236; SER-1267; VAL-1282; SER-1297 DEL; ARG-1301; LYS-1346; ILE-1378; VAL-1400; PRO-1407; THR-1411; GLY-1443; GLY-1448; CYS-1486; MET-1534; PRO-1589; THR-1628; PRO-1651; PHE-1651; PHE-1655; ARG-1686; GLN-1686; VAL-1688 DEL; ILE-1691; TRP-1699; GLN-1699; GLU-1706; ALA-1706; GLU-1708; CYS-1718; ALA-1720; LYS-1735; ALA-1736; GLY-1739; VAL-1739; GLN-1746; THR-1753; PRO-1764; SER-1767; VAL-1770; CYS-1782; THR-1789; ASP-1794; ASP-1804; ARG-1812; ARG-1837 AND LEU-1862</scope>
<scope>VARIANTS CYS-105; CYS-866; ALA-1060; LYS-1250 AND ILE-1652</scope>
</reference>
<reference key="102">
<citation type="journal article" date="2017" name="Breast" volume="33" first="109" last="116">
<title>Suggestion of BRCA1 c.5339T&gt;C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea.</title>
<authorList>
<person name="Ryu J.M."/>
<person name="Kang G."/>
<person name="Nam S.J."/>
<person name="Kim S.W."/>
<person name="Yu J."/>
<person name="Lee S.K."/>
<person name="Bae S.Y."/>
<person name="Park S."/>
<person name="Paik H.J."/>
<person name="Kim J.W."/>
<person name="Park S.S."/>
<person name="Lee J.E."/>
<person name="Kim S.W."/>
</authorList>
<dbReference type="PubMed" id="28364669"/>
<dbReference type="DOI" id="10.1016/j.breast.2017.03.006"/>
</citation>
<scope>VARIANT BC PRO-1780</scope>
<scope>VARIANT BROVCA1 PRO-1780</scope>
<scope>VARIANT OC PRO-1780</scope>
</reference>
<comment type="function">
<text evidence="23 24 32 41 42 47 48 56 58 60 64 69 71 73 74 75">E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719).</text>
</comment>
<comment type="catalytic activity">
<text evidence="23 41 42 58 64 74">S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="64">The E3 ubiquitin-protein ligase activity is inhibited by phosphorylation by AURKA. Activity is increased by phosphatase treatment.</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="24 25 27 28 29 30 31 32 33 36 37 42 44 47 48 50 51 53 55 56 57 58 60 61 62 66 68 69 70 71 72 73 74 78 79 81 82 83 84 97 99 101">Heterodimer with BARD1 (PubMed:11573085, PubMed:12890688, PubMed:14976165). Part of the BRCA1-associated genome surveillance complex (BASC), which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2 and the MRE11-RAD50-NBN protein (MRN) complex (PubMed:10783165). This association could be a dynamic process changing throughout the cell cycle and within subnuclear domains (PubMed:10783165). Component of the BRCA1-A complex, at least composed of BRCA1, BARD1, UIMC1/RAP80, ABRAXAS1, BRCC3/BRCC36, BABAM2 and BABAM1/NBA1 (PubMed:19261746, PubMed:19261748, PubMed:19261749, PubMed:20351172). Interacts (via the BRCT domains) with ABRAXAS1 (phosphorylated form); this is important for recruitment to sites of DNA damage (PubMed:17525340, PubMed:17643121, PubMed:17643122, PubMed:24316840, PubMed:26778126). Can form a heterotetramer with two molecules of ABRAXAS1 (phosphorylated form) (PubMed:26778126). Component of the BRCA1-RBBP8 complex (PubMed:16101277). Interacts (via the BRCT domains) with RBBP8 ('Ser-327' phosphorylated form); the interaction ubiquitinates RBBP8, regulates CHEK1 activation, and involves RBBP8 in BRCA1-dependent G2/M checkpoint control on DNA damage (PubMed:16818604, PubMed:9811458). Associates with RNA polymerase II holoenzyme (PubMed:9662397). Interacts with SMC1A, COBRA1, DCLRE1C, CLSPN (PubMed:11877377, PubMed:15096610, PubMed:15456891). Interacts with CHEK1, CHEK2, BAP1, BRCC3, AURKA, UBXN1 and PCLAF (PubMed:10724175, PubMed:11836499, PubMed:14636569, PubMed:14990569, PubMed:20351172, PubMed:21673012). Interacts (via BRCT domains) with BRIP1 (phosphorylated form) (PubMed:11301010, PubMed:15133502, PubMed:21473589). Interacts with FANCD2 (ubiquitinated form) (PubMed:11239454). Interacts with H2AFX (phosphorylated on 'Ser-140') (PubMed:12419185). Interacts (via the BRCT domains) with ACACA (phosphorylated form); the interaction prevents dephosphorylation of ACACA (PubMed:12360400, PubMed:16326698, PubMed:16698035, PubMed:18452305). Part of a BRCA complex containing BRCA1, BRCA2 and PALB2 (PubMed:19369211). Interacts directly with PALB2; the interaction is essential for its function in HRR (PubMed:19369211, PubMed:28319063). Interacts directly with BRCA2; the interaction occurs only in the presence of PALB2 which serves as the bridging protein (PubMed:19369211). Interacts (via the BRCT domains) with LMO4; the interaction represses the transcriptional activity of BRCA1 (PubMed:11751867). Interacts (via the BRCT domains) with CCAR2 (via N-terminus); the interaction represses the transcriptional activator activity of BRCA1 (PubMed:20160719). Interacts with EXD2 (PubMed:26807646). Interacts (via C-terminus) with DHX9; this interaction is direct and links BRCA1 to the RNA polymerase II holoenzyme (PubMed:9662397).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-1263451">
<id>Q6UWZ7</id>
<label>ABRAXAS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-717681">
<id>Q13085</id>
<label>ACACA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-1791447">
<id>Q92560</id>
<label>BAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-473181">
<id>Q99728</id>
<label>BARD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-77694">
<id>P10415</id>
<label>BCL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-349900">
<id>Q7Z569</id>
<label>BRAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-10826195">
<id>Q6PJG6</id>
<label>BRAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-3509650">
<id>Q9BX63</id>
<label>BRIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-375001">
<id>P24385</id>
<label>CCND1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-519526">
<id>P24864</id>
<label>CCNE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-974488">
<id>O14757</id>
<label>CHEK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-904311">
<id>Q61188</id>
<label>Ezh2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-701903">
<id>Q14192</id>
<label>FHL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-359622">
<id>P78347</id>
<label>GTF2I</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-494830">
<id>P16104</id>
<label>H2AFX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-2556203">
<id>O75330</id>
<label>HMMR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-352528">
<id>P10809</id>
<label>HSPD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-2867186">
<id>Q16666</id>
<label>IFI16</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-349938">
<id>P52292</id>
<label>KPNA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-347721">
<id>Q8WX92</id>
<label>NELFB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
<label>PALB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>23</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-357253">
<id>P62136</id>
<label>PPP1CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-352350">
<id>P62140</id>
<label>PPP1CB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-356283">
<id>P36873</id>
<label>PPP1CC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-745715">
<id>Q99708</id>
<label>RBBP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-473220">
<id>P61956</id>
<label>SUMO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-539628">
<id>P11388</id>
<label>TOP2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-399128">
<id>Q9Y4A5</id>
<label>TRRAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-725300">
<id>Q96RL1</id>
<label>UIMC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-9640371">
<id>Q96RL1-1</id>
<label>UIMC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-1263058">
<id>Q6NZY4</id>
<label>ZCCHC8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-396421">
<id>Q9GZX5</id>
<label>ZNF350</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="51 60 73 77 82 97">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Chromosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="73">Cytoplasm</location>
</subcellularLocation>
<text evidence="73 82">Localizes at sites of DNA damage at double-strand breaks (DSBs); recruitment to DNA damage sites is mediated by ABRAXAS1 and the BRCA1-A complex (PubMed:26778126). Translocated to the cytoplasm during UV-induced apoptosis (PubMed:20160719).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 5</molecule>
<subcellularLocation>
<location evidence="94">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>P38398-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P38398-2</id>
<name>2</name>
<sequence type="described" ref="VSP_047891"/>
<text>May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</isoform>
<isoform>
<id>P38398-3</id>
<name>3</name>
<name>Delta11b</name>
<sequence type="described" ref="VSP_035399 VSP_043797"/>
</isoform>
<isoform>
<id>P38398-4</id>
<name>4</name>
<name>DeltaBRCA1(17aa)</name>
<sequence type="described" ref="VSP_035396"/>
<text>Produced by alternative initiation at Met-18 of isoform 1.</text>
</isoform>
<isoform>
<id>P38398-5</id>
<name>5</name>
<name>Delta11</name>
<name>Delta772-3095</name>
<sequence type="described" ref="VSP_035398"/>
</isoform>
<isoform>
<id>P38398-6</id>
<name>6</name>
<sequence type="described" ref="VSP_035399 VSP_043797 VSP_043798"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P38398-7</id>
<name>7</name>
<sequence type="described" ref="VSP_055404"/>
<text evidence="107">No experimental confirmation available. Ref.8 (AAI15038) sequence is in conflict in position: 1461:N-&gt;D.</text>
</isoform>
<isoform>
<id>P38398-8</id>
<name>8</name>
<sequence type="described" ref="VSP_057569"/>
<text evidence="107">No experimental confirmation available. The N-terminus is confirmed by several cDNAs.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.</text>
</comment>
<comment type="domain">
<text evidence="72">The BRCT domains recognize and bind phosphorylated pSXXF motif on proteins. The interaction with the phosphorylated pSXXF motif of ABRAXAS1, recruits BRCA1 at DNA damage sites.</text>
</comment>
<comment type="domain">
<text evidence="72">The RING-type zinc finger domain interacts with BAP1.</text>
</comment>
<comment type="PTM">
<text evidence="24 26 34 48 64 75 77">Phosphorylation at Ser-308 by AURKA is required for normal cell cycle progression from G2 to mitosis. Phosphorylated in response to IR, UV, and various stimuli that cause checkpoint activation, probably by ATM or ATR. Phosphorylation at Ser-988 by CHEK2 regulates mitotic spindle assembly.</text>
</comment>
<comment type="PTM">
<text evidence="42 74">Autoubiquitinated, undergoes 'Lys-6'-linked polyubiquitination. 'Lys-6'-linked polyubiquitination does not promote degradation.</text>
</comment>
<comment type="polymorphism">
<text>There is evidence that the presence of the rare form of Gln-356-Arg and Leu-871-Pro polymorphisms may be associated with an increased risk for developing ovarian cancer.</text>
</comment>
<comment type="disease" evidence="21 26 28 38 40 43 45 51 65 78 80 85 86 87 88 89 90 91 92 96 98 100">
<disease id="DI-02602">
<name>Breast cancer</name>
<acronym>BC</acronym>
<description>A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.</description>
<dbReference type="MIM" id="114480"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3-fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.</text>
</comment>
<comment type="disease" evidence="43 45 85 93">
<disease id="DI-01559">
<name>Breast-ovarian cancer, familial, 1</name>
<acronym>BROVCA1</acronym>
<description>A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate.</description>
<dbReference type="MIM" id="604370"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.</text>
</comment>
<comment type="disease" evidence="20 22 46 85">
<disease id="DI-01655">
<name>Ovarian cancer</name>
<acronym>OC</acronym>
<description>The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease.</description>
<dbReference type="MIM" id="167000"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="67">
<disease id="DI-03281">
<name>Pancreatic cancer 4</name>
<acronym>PNCA4</acronym>
<description>A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue.</description>
<dbReference type="MIM" id="614320"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="sequence caution" evidence="107">
<conflict type="erroneous translation">
<sequence resource="EMBL-CDS" id="AAB61673" version="1"/>
</conflict>
<text>Wrong choice of CDS.</text>
</comment>
<comment type="sequence caution" evidence="107">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAI15038" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="sequence caution" evidence="107">
<conflict type="erroneous termination">
<sequence resource="EMBL-CDS" id="AAI15038" version="1"/>
</conflict>
<location>
<position position="526"/>
</location>
<text>Translated as Gln.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/BRCA1ID163ch17q21.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/brca1/"/>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=BRCA1"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/BRCA1"/>
<text>BRCA1 entry</text>
</comment>
<dbReference type="EC" id="2.3.2.27" evidence="23 41 42 58 64 74"/>
<dbReference type="EMBL" id="U14680">
<property type="protein sequence ID" value="AAA73985.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L78833">
<property type="protein sequence ID" value="AAC37594.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U64805">
<property type="protein sequence ID" value="AAC00049.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF005068">
<property type="protein sequence ID" value="AAB61673.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190450">
<property type="protein sequence ID" value="ABA29208.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190451">
<property type="protein sequence ID" value="ABA29211.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190452">
<property type="protein sequence ID" value="ABA29214.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190453">
<property type="protein sequence ID" value="ABA29217.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190454">
<property type="protein sequence ID" value="ABA29220.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190455">
<property type="protein sequence ID" value="ABA29223.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190456">
<property type="protein sequence ID" value="ABA29226.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY273801">
<property type="protein sequence ID" value="AAP12647.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC060780">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC135721">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC072418">
<property type="protein sequence ID" value="AAH72418.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC115037">
<property type="protein sequence ID" value="AAI15038.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11453.1">
<molecule id="P38398-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11454.2">
<molecule id="P38398-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11455.2">
<molecule id="P38398-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11456.2">
<molecule id="P38398-7"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11459.2">
<molecule id="P38398-8"/>
</dbReference>
<dbReference type="PIR" id="A58881">
<property type="entry name" value="A58881"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009225.1">
<molecule id="P38398-1"/>
<property type="nucleotide sequence ID" value="NM_007294.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009228.2">
<molecule id="P38398-8"/>
<property type="nucleotide sequence ID" value="NM_007297.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009229.2">
<molecule id="P38398-3"/>
<property type="nucleotide sequence ID" value="NM_007298.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009230.2">
<molecule id="P38398-6"/>
<property type="nucleotide sequence ID" value="NM_007299.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009231.2">
<molecule id="P38398-7"/>
<property type="nucleotide sequence ID" value="NM_007300.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.194143"/>
<dbReference type="PDB" id="1JM7">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-110"/>
</dbReference>
<dbReference type="PDB" id="1JNX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="X=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1N5O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="X=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1OQA">
<property type="method" value="NMR"/>
<property type="chains" value="A=1755-1863"/>
</dbReference>
<dbReference type="PDB" id="1T15">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1T29">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1T2U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1T2V">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B/C/D/E=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1Y98">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="2ING">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="X=1649-1859"/>
</dbReference>
<dbReference type="PDB" id="3COJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.21"/>
<property type="chains" value="A/B/C/D/E/F/G/X=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3K0H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3K0K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3K15">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3K16">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3PXA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3PXB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3PXC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="X=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3PXD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3PXE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A/B/C/D=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4IFI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4IGK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4JLU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A=1649-1859"/>
</dbReference>
<dbReference type="PDB" id="4OFB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4U4A">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.51"/>
<property type="chains" value="A/B/C=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4Y18">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B/C/D/E/F/G/H=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4Y2G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDBsum" id="1JM7"/>
<dbReference type="PDBsum" id="1JNX"/>
<dbReference type="PDBsum" id="1N5O"/>
<dbReference type="PDBsum" id="1OQA"/>
<dbReference type="PDBsum" id="1T15"/>
<dbReference type="PDBsum" id="1T29"/>
<dbReference type="PDBsum" id="1T2U"/>
<dbReference type="PDBsum" id="1T2V"/>
<dbReference type="PDBsum" id="1Y98"/>
<dbReference type="PDBsum" id="2ING"/>
<dbReference type="PDBsum" id="3COJ"/>
<dbReference type="PDBsum" id="3K0H"/>
<dbReference type="PDBsum" id="3K0K"/>
<dbReference type="PDBsum" id="3K15"/>
<dbReference type="PDBsum" id="3K16"/>
<dbReference type="PDBsum" id="3PXA"/>
<dbReference type="PDBsum" id="3PXB"/>
<dbReference type="PDBsum" id="3PXC"/>
<dbReference type="PDBsum" id="3PXD"/>
<dbReference type="PDBsum" id="3PXE"/>
<dbReference type="PDBsum" id="4IFI"/>
<dbReference type="PDBsum" id="4IGK"/>
<dbReference type="PDBsum" id="4JLU"/>
<dbReference type="PDBsum" id="4OFB"/>
<dbReference type="PDBsum" id="4U4A"/>
<dbReference type="PDBsum" id="4Y18"/>
<dbReference type="PDBsum" id="4Y2G"/>
<dbReference type="DisProt" id="DP00238"/>
<dbReference type="ProteinModelPortal" id="P38398"/>
<dbReference type="SMR" id="P38398"/>
<dbReference type="BioGrid" id="107140">
<property type="interactions" value="581"/>
</dbReference>
<dbReference type="CORUM" id="P38398"/>
<dbReference type="DIP" id="DIP-5971N"/>
<dbReference type="IntAct" id="P38398">
<property type="interactions" value="84"/>
</dbReference>
<dbReference type="MINT" id="MINT-90433"/>
<dbReference type="STRING" id="9606.ENSP00000418960"/>
<dbReference type="BindingDB" id="P38398"/>
<dbReference type="ChEMBL" id="CHEMBL5990"/>
<dbReference type="iPTMnet" id="P38398"/>
<dbReference type="PhosphoSitePlus" id="P38398"/>
<dbReference type="BioMuta" id="BRCA1"/>
<dbReference type="DMDM" id="728984"/>
<dbReference type="PaxDb" id="P38398"/>
<dbReference type="PeptideAtlas" id="P38398"/>
<dbReference type="PRIDE" id="P38398"/>
<dbReference type="DNASU" id="672"/>
<dbReference type="Ensembl" id="ENST00000352993">
<molecule id="P38398-5"/>
<property type="protein sequence ID" value="ENSP00000312236"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000357654">
<molecule id="P38398-1"/>
<property type="protein sequence ID" value="ENSP00000350283"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000461221">
<molecule id="P38398-2"/>
<property type="protein sequence ID" value="ENSP00000418548"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000461798">
<molecule id="P38398-2"/>
<property type="protein sequence ID" value="ENSP00000417988"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000468300">
<molecule id="P38398-6"/>
<property type="protein sequence ID" value="ENSP00000417148"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000471181">
<molecule id="P38398-7"/>
<property type="protein sequence ID" value="ENSP00000418960"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000491747">
<molecule id="P38398-3"/>
<property type="protein sequence ID" value="ENSP00000420705"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000493795">
<molecule id="P38398-8"/>
<property type="protein sequence ID" value="ENSP00000418775"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="GeneID" id="672"/>
<dbReference type="KEGG" id="hsa:672"/>
<dbReference type="UCSC" id="uc002icq.4">
<molecule id="P38398-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc010cyx.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="672"/>
<dbReference type="DisGeNET" id="672"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000012048.20"/>
<dbReference type="GeneCards" id="BRCA1"/>
<dbReference type="GeneReviews" id="BRCA1"/>
<dbReference type="HGNC" id="HGNC:1100">
<property type="gene designation" value="BRCA1"/>
</dbReference>
<dbReference type="HPA" id="CAB001946"/>
<dbReference type="HPA" id="HPA034966"/>
<dbReference type="MalaCards" id="BRCA1"/>
<dbReference type="MIM" id="113705">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="114480">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="167000">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604370">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="614320">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P38398"/>
<dbReference type="OpenTargets" id="ENSG00000012048"/>
<dbReference type="Orphanet" id="1333">
<property type="disease" value="Familial pancreatic carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="1331">
<property type="disease" value="Familial prostate cancer"/>
</dbReference>
<dbReference type="Orphanet" id="145">
<property type="disease" value="Hereditary breast and ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="227535">
<property type="disease" value="Hereditary breast cancer"/>
</dbReference>
<dbReference type="Orphanet" id="213524">
<property type="disease" value="Hereditary site-specific ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="168829">
<property type="disease" value="Primary peritoneal carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA25411"/>
<dbReference type="eggNOG" id="ENOG410ITQ4">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4112BIH">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00440000034289"/>
<dbReference type="HOGENOM" id="HOG000230969"/>
<dbReference type="HOVERGEN" id="HBG050730"/>
<dbReference type="InParanoid" id="P38398"/>
<dbReference type="KO" id="K10605"/>
<dbReference type="OMA" id="FQHLLFG"/>
<dbReference type="OrthoDB" id="EOG091G0670"/>
<dbReference type="PhylomeDB" id="P38398"/>
<dbReference type="BRENDA" id="6.3.2.19">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1221632">
<property type="pathway name" value="Meiotic synapsis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3108214">
<property type="pathway name" value="SUMOylation of DNA damage response and repair proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685938">
<property type="pathway name" value="HDR through Single Strand Annealing (SSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685942">
<property type="pathway name" value="HDR through Homologous Recombination (HRR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689901">
<property type="pathway name" value="Metalloprotease DUBs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693554">
<property type="pathway name" value="Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693568">
<property type="pathway name" value="Resolution of D-loop Structures through Holliday Junction Intermediates"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693571">
<property type="pathway name" value="Nonhomologous End-Joining (NHEJ)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693579">
<property type="pathway name" value="Homologous DNA Pairing and Strand Exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6796648">
<property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8953750">
<property type="pathway name" value="Transcriptional Regulation by E2F6"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912446">
<property type="pathway name" value="Meiotic recombination"/>
</dbReference>
<dbReference type="SignaLink" id="P38398"/>
<dbReference type="SIGNOR" id="P38398"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="ChiTaRS" id="BRCA1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P38398"/>
<dbReference type="GeneWiki" id="BRCA1"/>
<dbReference type="GenomeRNAi" id="672"/>
<dbReference type="PMAP-CutDB" id="P38398"/>
<dbReference type="PRO" id="PR:P38398"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000012048"/>
<dbReference type="CleanEx" id="HS_BRCA1"/>
<dbReference type="ExpressionAtlas" id="P38398">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P38398">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070531">
<property type="term" value="C:BRCA1-A complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031436">
<property type="term" value="C:BRCA1-BARD1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008274">
<property type="term" value="C:gamma-tubulin ring complex"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030529">
<property type="term" value="C:intracellular ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000800">
<property type="term" value="C:lateral element"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000151">
<property type="term" value="C:ubiquitin ligase complex"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050681">
<property type="term" value="F:androgen receptor binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003684">
<property type="term" value="F:damaged DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070063">
<property type="term" value="F:RNA polymerase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001105">
<property type="term" value="F:RNA polymerase II transcription coactivator activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044212">
<property type="term" value="F:transcription regulatory region DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015631">
<property type="term" value="F:tubulin binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0030521">
<property type="term" value="P:androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071681">
<property type="term" value="P:cellular response to indole-3-methanol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007098">
<property type="term" value="P:centrosome cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043009">
<property type="term" value="P:chordate embryonic development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007059">
<property type="term" value="P:chromosome segregation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006978">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000729">
<property type="term" value="P:DNA double-strand break processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000731">
<property type="term" value="P:DNA synthesis involved in DNA repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009048">
<property type="term" value="P:dosage compensation by inactivation of X chromosome"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0006303">
<property type="term" value="P:double-strand break repair via nonhomologous end joining"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006633">
<property type="term" value="P:fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008630">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0044818">
<property type="term" value="P:mitotic G2/M transition checkpoint"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046600">
<property type="term" value="P:negative regulation of centriole replication"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902042">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045717">
<property type="term" value="P:negative regulation of fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070317">
<property type="term" value="P:negative regulation of G0 to G1 transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035067">
<property type="term" value="P:negative regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051572">
<property type="term" value="P:negative regulation of histone H3-K4 methylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051573">
<property type="term" value="P:negative regulation of histone H3-K9 methylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033147">
<property type="term" value="P:negative regulation of intracellular estrogen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:2000378">
<property type="term" value="P:negative regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071158">
<property type="term" value="P:positive regulation of cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045739">
<property type="term" value="P:positive regulation of DNA repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035066">
<property type="term" value="P:positive regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051571">
<property type="term" value="P:positive regulation of histone H3-K4 methylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000617">
<property type="term" value="P:positive regulation of histone H3-K9 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051574">
<property type="term" value="P:positive regulation of histone H3-K9 methylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000620">
<property type="term" value="P:positive regulation of histone H4-K16 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070512">
<property type="term" value="P:positive regulation of histone H4-K20 methylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031398">
<property type="term" value="P:positive regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010575">
<property type="term" value="P:positive regulation of vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006301">
<property type="term" value="P:postreplication repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0051865">
<property type="term" value="P:protein autoubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0085020">
<property type="term" value="P:protein K6-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044030">
<property type="term" value="P:regulation of DNA methylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006349">
<property type="term" value="P:regulation of gene expression by genetic imprinting"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006359">
<property type="term" value="P:regulation of transcription from RNA polymerase III promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010212">
<property type="term" value="P:response to ionizing radiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072425">
<property type="term" value="P:signal transduction involved in G2 DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000732">
<property type="term" value="P:strand displacement"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd00027">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10190">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR011364">
<property type="entry name" value="BRCA1"/>
</dbReference>
<dbReference type="InterPro" id="IPR031099">
<property type="entry name" value="BRCA1-associated"/>
</dbReference>
<dbReference type="InterPro" id="IPR025994">
<property type="entry name" value="BRCA1_serine_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001357">
<property type="entry name" value="BRCT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036420">
<property type="entry name" value="BRCT_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR018957">
<property type="entry name" value="Znf_C3HC4_RING-type"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13763">
<property type="entry name" value="PTHR13763"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13763:SF0">
<property type="entry name" value="PTHR13763:SF0"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00533">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF12820">
<property type="entry name" value="BRCT_assoc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00097">
<property type="entry name" value="zf-C3HC4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001734">
<property type="entry name" value="BRCA1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00493">
<property type="entry name" value="BRSTCANCERI"/>
</dbReference>
<dbReference type="SMART" id="SM00292">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52113">
<property type="entry name" value="SSF52113"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50172">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0233">DNA recombination</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0275">Fatty acid biosynthesis</keyword>
<keyword id="KW-0276">Fatty acid metabolism</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0444">Lipid biosynthesis</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Breast cancer type 1 susceptibility protein" id="PRO_0000055830">
<location>
<begin position="1"/>
<end position="1863"/>
</location>
</feature>
<feature type="domain" description="BRCT 1" evidence="18">
<location>
<begin position="1642"/>
<end position="1736"/>
</location>
</feature>
<feature type="domain" description="BRCT 2" evidence="18">
<location>
<begin position="1756"/>
<end position="1855"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="19">
<location>
<begin position="24"/>
<end position="65"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PALB2" evidence="71">
<location>
<begin position="1397"/>
<end position="1424"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="651"/>
<end position="654"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="12">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11 13">
<location>
<position position="114"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AURKA" evidence="48">
<location>
<position position="308"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9">
<location>
<position position="395"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="423"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="434"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="551"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 13">
<location>
<position position="694"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="708"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="725"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="753"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="840"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CHEK2" evidence="24 75">
<location>
<position position="988"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="1009"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATR; in vitro" evidence="26">
<location>
<position position="1143"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="1189"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="1191"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="1211"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="1217"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 11">
<location>
<position position="1218"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATR; in vitro" evidence="26">
<location>
<position position="1280"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1328"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 10 11">
<location>
<position position="1336"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11">
<location>
<position position="1342"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM and ATR" evidence="26">
<location>
<position position="1387"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by ATR; in vitro" evidence="26">
<location>
<position position="1394"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM and ATR" evidence="26">
<location>
<position position="1423"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATR; in vitro" evidence="26">
<location>
<position position="1457"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM" evidence="77">
<location>
<position position="1524"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="1542"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="109"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="301"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14 15 16">
<location>
<position position="339"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="15 16">
<location>
<position position="443"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14 16">
<location>
<position position="459"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="519"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14 15 16">
<location>
<position position="583"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="654"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="734"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="739"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="918"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="987"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="1079"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8." id="VSP_057569">
<location>
<begin position="1"/>
<end position="47"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_035396" evidence="107">
<location>
<begin position="1"/>
<end position="17"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_047891" evidence="106">
<location>
<begin position="64"/>
<end position="1863"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_035398" evidence="107">
<location>
<begin position="224"/>
<end position="1365"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 6." id="VSP_035399" evidence="104 105">
<location>
<begin position="264"/>
<end position="1366"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 6." id="VSP_043797" evidence="104 105">
<location>
<position position="1453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_055404" evidence="104">
<original>A</original>
<variation>DSHIHGQRNNSMFSKRPREHIS</variation>
<location>
<position position="1453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_043798" evidence="104">
<original>DQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIPHSHY</original>
<variation>GCPPNCGCAARCLDRGQWLPCNWADV</variation>
<location>
<begin position="1778"/>
<end position="1863"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs786203152." id="VAR_070458" evidence="80">
<original>S</original>
<variation>F</variation>
<location>
<position position="4"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and BROVCA1." id="VAR_020679" evidence="45">
<original>E</original>
<variation>K</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80357017." id="VAR_007754">
<original>V</original>
<variation>A</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356929." id="VAR_063899" evidence="63 80">
<original>M</original>
<variation>T</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80357406." id="VAR_007755">
<original>I</original>
<variation>V</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs80357438." id="VAR_007756" evidence="98">
<original>L</original>
<variation>S</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and BROVCA1." id="VAR_020680" evidence="45">
<original>E</original>
<variation>K</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035947" evidence="59">
<original>L</original>
<variation>F</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs769650474." id="VAR_070459" evidence="80">
<original>K</original>
<variation>Q</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and ovarian cancer; no interaction with BAP1; dbSNP:rs28897672." id="VAR_007757" evidence="43 46 80 88 90 97 100">
<original>C</original>
<variation>G</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; no interaction with BAP1; dbSNP:rs80357064." id="VAR_007758" evidence="80 87 96 97">
<original>C</original>
<variation>G</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55851803." id="VAR_007759">
<original>C</original>
<variation>Y</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357102." id="VAR_070460" evidence="80">
<original>D</original>
<variation>Y</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356913." id="VAR_020681" evidence="43">
<original>R</original>
<variation>K</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897673." id="VAR_070461" evidence="80">
<original>Y</original>
<variation>C</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357413." id="VAR_070462" evidence="80">
<original>N</original>
<variation>K</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs55971303." id="VAR_070463" evidence="80">
<original>P</original>
<variation>H</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs748876625." id="VAR_070464" evidence="80">
<original>L</original>
<variation>F</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897674." id="VAR_052077">
<original>S</original>
<variation>R</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070465" evidence="80">
<original>L</original>
<variation>P</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357325." id="VAR_070466" evidence="80">
<original>R</original>
<variation>W</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs55688530." id="VAR_070467" evidence="80">
<original>S</original>
<variation>Y</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357090." id="VAR_070468" evidence="80">
<original>V</original>
<variation>I</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance." id="VAR_008759">
<original>E</original>
<variation>K</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357001." id="VAR_070469" evidence="80">
<original>T</original>
<variation>M</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80357396." id="VAR_007760" evidence="95 100">
<original>H</original>
<variation>R</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80356865." id="VAR_070470" evidence="80">
<original>D</original>
<variation>V</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897675." id="VAR_070471" evidence="80">
<original>L</original>
<variation>V</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357244." id="VAR_070472" evidence="80">
<original>V</original>
<variation>L</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs80357244." id="VAR_007761" evidence="91">
<original>V</original>
<variation>M</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8176153." id="VAR_019944" evidence="103">
<original>G</original>
<variation>S</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357015." id="VAR_008760" evidence="21">
<original>P</original>
<variation>S</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs1799950." id="VAR_007762" evidence="88 102 103">
<original>Q</original>
<variation>R</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_007763">
<location>
<position position="369"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56128296." id="VAR_007764">
<original>I</original>
<variation>M</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs56046357." id="VAR_007765" evidence="98">
<original>F</original>
<variation>L</variation>
<location>
<position position="461"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397508869." id="VAR_007766" evidence="98">
<original>Y</original>
<variation>D</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80357224." id="VAR_007767">
<original>R</original>
<variation>I</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397508893." id="VAR_007768" evidence="98">
<original>G</original>
<variation>V</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_020682" evidence="39">
<original>N</original>
<variation>I</variation>
<location>
<position position="656"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357250." id="VAR_070473" evidence="80">
<original>L</original>
<variation>F</variation>
<location>
<position position="668"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs4986850." id="VAR_007769" evidence="49 103">
<original>D</original>
<variation>N</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897681." id="VAR_070474" evidence="80">
<original>D</original>
<variation>N</variation>
<location>
<position position="695"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986845." id="VAR_020110">
<original>N</original>
<variation>D</variation>
<location>
<position position="723"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs80357114." id="VAR_020683" evidence="40">
<original>D</original>
<variation>Y</variation>
<location>
<position position="749"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035948" evidence="59">
<original>L</original>
<variation>F</variation>
<location>
<position position="758"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs80357467." id="VAR_007770" evidence="87 96">
<original>V</original>
<variation>A</variation>
<location>
<position position="772"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035949" evidence="59">
<original>G</original>
<variation>C</variation>
<location>
<position position="778"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs876660005." id="VAR_070475" evidence="80">
<original>P</original>
<variation>L</variation>
<location>
<position position="798"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897682." id="VAR_070476" evidence="80">
<original>N</original>
<variation>Y</variation>
<location>
<position position="810"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs56082113." id="VAR_007771" evidence="96">
<original>K</original>
<variation>E</variation>
<location>
<position position="820"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897683." id="VAR_007772" evidence="80">
<original>T</original>
<variation>K</variation>
<location>
<position position="826"/>
</location>
</feature>
<feature type="sequence variant" description="In BROVCA1; unknown pathological significance; dbSNP:rs751656678." id="VAR_020684" evidence="43">
<original>H</original>
<variation>Y</variation>
<location>
<position position="835"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357337." id="VAR_070477" evidence="80">
<original>R</original>
<variation>Q</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In BROVCA1; unknown pathological significance; dbSNP:rs1800709." id="VAR_007773" evidence="93 100">
<original>R</original>
<variation>W</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with sporadic breast cancer; unknown pathological significance; dbSNP:rs80356892." id="VAR_020685" evidence="52 80">
<original>Y</original>
<variation>H</variation>
<location>
<position position="856"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41286300." id="VAR_070478" evidence="80">
<original>R</original>
<variation>C</variation>
<location>
<position position="866"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020686" evidence="43">
<original>R</original>
<variation>Q</variation>
<location>
<position position="866"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs799917." id="VAR_007774" evidence="21 39 52 54 103">
<original>P</original>
<variation>L</variation>
<location>
<position position="871"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357480." id="VAR_020687" evidence="43">
<original>H</original>
<variation>Y</variation>
<location>
<position position="888"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397508994." id="VAR_007775" evidence="98">
<original>L</original>
<variation>S</variation>
<location>
<position position="892"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986847." id="VAR_021913">
<original>I</original>
<variation>L</variation>
<location>
<position position="925"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397509022." id="VAR_007776" evidence="98">
<original>G</original>
<variation>D</variation>
<location>
<position position="960"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986848." id="VAR_020111">
<original>F</original>
<variation>S</variation>
<location>
<position position="989"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs1800704." id="VAR_007777">
<original>M</original>
<variation>I</variation>
<location>
<position position="1008"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397509034." id="VAR_007778" evidence="98">
<original>T</original>
<variation>I</variation>
<location>
<position position="1025"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs16941." id="VAR_007779" evidence="21 52 54 88 103">
<original>E</original>
<variation>G</variation>
<location>
<position position="1038"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs4986852." id="VAR_007780" evidence="49 87 88 96 103">
<original>S</original>
<variation>N</variation>
<location>
<position position="1040"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397509037." id="VAR_007781" evidence="98">
<original>V</original>
<variation>A</variation>
<location>
<position position="1047"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80357184." id="VAR_020688" evidence="49 80">
<original>E</original>
<variation>A</variation>
<location>
<position position="1060"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs41293447." id="VAR_070479" evidence="80">
<original>S</original>
<variation>N</variation>
<location>
<position position="1101"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357228." id="VAR_020689" evidence="43">
<original>S</original>
<variation>I</variation>
<location>
<position position="1139"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs2227945." id="VAR_019945" evidence="80 103">
<original>S</original>
<variation>G</variation>
<location>
<position position="1140"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070480" evidence="80">
<original>S</original>
<variation>N</variation>
<location>
<position position="1140"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs80357272." id="VAR_007782" evidence="91">
<original>P</original>
<variation>S</variation>
<location>
<position position="1150"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs16942." id="VAR_007783" evidence="21 45 52 54 88 103">
<original>K</original>
<variation>R</variation>
<location>
<position position="1183"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and BROVCA1." id="VAR_020690" evidence="45">
<original>S</original>
<variation>I</variation>
<location>
<position position="1187"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and BROVCA1; dbSNP:rs56214134." id="VAR_020691" evidence="45">
<original>Q</original>
<variation>H</variation>
<location>
<position position="1200"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020692" evidence="45">
<original>R</original>
<variation>I</variation>
<location>
<position position="1204"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020693" evidence="45">
<original>K</original>
<variation>N</variation>
<location>
<position position="1207"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020694" evidence="43">
<original>E</original>
<variation>G</variation>
<location>
<position position="1210"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80356923." id="VAR_070481" evidence="80">
<original>E</original>
<variation>K</variation>
<location>
<position position="1214"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and BROVCA1." id="VAR_020695" evidence="45">
<original>S</original>
<variation>Y</variation>
<location>
<position position="1217"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80356876." id="VAR_007784">
<original>E</original>
<variation>D</variation>
<location>
<position position="1219"/>
</location>
</feature>
<feature type="sequence variant" description="In BROVCA1." id="VAR_020696" evidence="45">
<original>F</original>
<variation>L</variation>
<location>
<position position="1226"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897687." id="VAR_052078" evidence="80">
<original>N</original>
<variation>K</variation>
<location>
<position position="1236"/>
</location>
</feature>
<feature type="sequence variant" description="In BROVCA1." id="VAR_020697" evidence="45">
<original>R</original>
<variation>G</variation>
<location>
<position position="1243"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897686." id="VAR_052079" evidence="80">
<original>E</original>
<variation>K</variation>
<location>
<position position="1250"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs587782190." id="VAR_070482" evidence="80">
<original>L</original>
<variation>S</variation>
<location>
<position position="1267"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357217." id="VAR_070483" evidence="80">
<original>E</original>
<variation>V</variation>
<location>
<position position="1282"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020698" evidence="43">
<original>S</original>
<variation>P</variation>
<location>
<position position="1297"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070484" evidence="80">
<location>
<position position="1297"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs273900719." id="VAR_070485" evidence="80">
<original>S</original>
<variation>R</variation>
<location>
<position position="1301"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357407." id="VAR_070486" evidence="80">
<original>E</original>
<variation>K</variation>
<location>
<position position="1346"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897689." id="VAR_007785" evidence="35">
<original>R</original>
<variation>G</variation>
<location>
<position position="1347"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897690." id="VAR_070487" evidence="80">
<original>V</original>
<variation>I</variation>
<location>
<position position="1378"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357306." id="VAR_070488" evidence="80">
<original>M</original>
<variation>V</variation>
<location>
<position position="1400"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; dbSNP:rs1800707." id="VAR_008761">
<original>K</original>
<variation>N</variation>
<location>
<position position="1406"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357492." id="VAR_070489" evidence="80">
<original>L</original>
<variation>P</variation>
<location>
<position position="1407"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and ovarian cancer; unknown pathological significance; decreased interaction with PALB2; dbSNP:rs273900729." id="VAR_020699" evidence="46 71 80">
<original>M</original>
<variation>T</variation>
<location>
<position position="1411"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_007786">
<original>S</original>
<variation>P</variation>
<location>
<position position="1431"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs41293455." id="VAR_007787" evidence="80 87 96">
<original>R</original>
<variation>G</variation>
<location>
<position position="1443"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986849." id="VAR_020112">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1443"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357486." id="VAR_070490" evidence="80">
<original>S</original>
<variation>G</variation>
<location>
<position position="1448"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs397507232." id="VAR_070491" evidence="80">
<original>S</original>
<variation>C</variation>
<location>
<position position="1486"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357389." id="VAR_063900" evidence="63">
<original>R</original>
<variation>M</variation>
<location>
<position position="1495"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800744." id="VAR_007788" evidence="35 96 100">
<original>S</original>
<variation>I</variation>
<location>
<position position="1512"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs55815649." id="VAR_070492" evidence="80">
<original>V</original>
<variation>M</variation>
<location>
<position position="1534"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast cancer; unknown pathological significance; dbSNP:rs56158747." id="VAR_007789">
<original>T</original>
<variation>I</variation>
<location>
<position position="1561"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070493" evidence="80">
<original>R</original>
<variation>P</variation>
<location>
<position position="1589"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast cancer; unknown pathological significance; dbSNP:rs80356943." id="VAR_007790">
<original>K</original>
<variation>E</variation>
<location>
<position position="1606"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs1799966." id="VAR_007791" evidence="21 39 54 88 95 103">
<original>S</original>
<variation>G</variation>
<location>
<position position="1613"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8176219." id="VAR_019946" evidence="103">
<original>T</original>
<variation>A</variation>
<location>
<position position="1620"/>
</location>
</feature>
<feature type="sequence variant" description="Could be associated with cancer susceptibility; major splicing aberration identified with this mutant; dbSNP:rs80356862." id="VAR_063901" evidence="63 76">
<original>A</original>
<variation>G</variation>
<location>
<position position="1623"/>
</location>
</feature>
<feature type="sequence variant" description="In some patients with sporadic breast cancer; unknown pathological significance; dbSNP:rs4986854." id="VAR_007793" evidence="52 80">
<original>M</original>
<variation>T</variation>
<location>
<position position="1628"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast and ovarian cancer patients; unknown pathological significance; dbSNP:rs80357465." id="VAR_007792">
<original>M</original>
<variation>V</variation>
<location>
<position position="1628"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs80357048." id="VAR_007794" evidence="89 96">
<original>P</original>
<variation>L</variation>
<location>
<position position="1637"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance; dbSNP:rs1800726." id="VAR_008762">
<original>A</original>
<variation>P</variation>
<location>
<position position="1641"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356938." id="VAR_070494" evidence="80">
<original>S</original>
<variation>F</variation>
<location>
<position position="1651"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs879254042." id="VAR_070495" evidence="80">
<original>S</original>
<variation>P</variation>
<location>
<position position="1651"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs1799967." id="VAR_007795" evidence="35 54 80 96">
<original>M</original>
<variation>I</variation>
<location>
<position position="1652"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357390." id="VAR_070496" evidence="80">
<original>S</original>
<variation>F</variation>
<location>
<position position="1655"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897695." id="VAR_052080">
<original>F</original>
<variation>C</variation>
<location>
<position position="1662"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80357169." id="VAR_020700" evidence="49">
<original>V</original>
<variation>M</variation>
<location>
<position position="1665"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356890." id="VAR_063902" evidence="63">
<original>T</original>
<variation>A</variation>
<location>
<position position="1685"/>
</location>
</feature>
<feature type="sequence variant" description="Could be associated with cancer susceptibility; multifactorial likelihood analysis provides evidence for pathogenicity; dbSNP:rs80357043." id="VAR_063903" evidence="63 76">
<original>T</original>
<variation>I</variation>
<location>
<position position="1685"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs397509218." id="VAR_070497" evidence="80">
<original>H</original>
<variation>Q</variation>
<location>
<position position="1686"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs730882166." id="VAR_070498" evidence="80">
<original>H</original>
<variation>R</variation>
<location>
<position position="1686"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro." id="VAR_070499" evidence="80">
<location>
<position position="1688"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357061." id="VAR_063904" evidence="63">
<original>M</original>
<variation>R</variation>
<location>
<position position="1689"/>
</location>
</feature>
<feature type="sequence variant" description="In some patients with sporadic breast cancer; unknown pathological significance; dbSNP:rs397507239." id="VAR_020701" evidence="52">
<original>K</original>
<variation>Q</variation>
<location>
<position position="1690"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357034." id="VAR_070500" evidence="80">
<original>T</original>
<variation>I</variation>
<location>
<position position="1691"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance; dbSNP:rs80187739." id="VAR_008763">
<original>D</original>
<variation>N</variation>
<location>
<position position="1692"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; dbSNP:rs80356993." id="VAR_020702" evidence="46">
<original>C</original>
<variation>R</variation>
<location>
<position position="1697"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; strongly reduces affinity for a BRIP1 phosphopeptide; functionally impaired in vitro; dbSNP:rs41293459." id="VAR_070501" evidence="78 80">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1699"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and ovarian cancer; impairs protein stability; functionally impaired in vitro; dbSNP:rs55770810." id="VAR_075666" evidence="46 63 78 80">
<original>R</original>
<variation>W</variation>
<location>
<position position="1699"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356860." id="VAR_070502" evidence="80">
<original>G</original>
<variation>A</variation>
<location>
<position position="1706"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356860." id="VAR_063905" evidence="63 80">
<original>G</original>
<variation>E</variation>
<location>
<position position="1706"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; abolishes ACACA binding; dbSNP:rs28897696." id="VAR_007796" evidence="63 80 89">
<original>A</original>
<variation>E</variation>
<location>
<position position="1708"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_007797" evidence="52">
<original>V</original>
<variation>G</variation>
<location>
<position position="1713"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357094." id="VAR_063906" evidence="63">
<original>S</original>
<variation>R</variation>
<location>
<position position="1715"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357239." id="VAR_070503" evidence="80">
<original>W</original>
<variation>C</variation>
<location>
<position position="1718"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; no effect on in vitro phosphorylation by ATR; dbSNP:rs56195342." id="VAR_070504" evidence="26 80">
<original>T</original>
<variation>A</variation>
<location>
<position position="1720"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs397509238." id="VAR_070505" evidence="80">
<original>E</original>
<variation>K</variation>
<location>
<position position="1735"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs45553935." id="VAR_070506" evidence="80">
<original>V</original>
<variation>A</variation>
<location>
<position position="1736"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356937." id="VAR_063907" evidence="63">
<original>G</original>
<variation>R</variation>
<location>
<position position="1738"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357227." id="VAR_070507" evidence="80">
<original>D</original>
<variation>G</variation>
<location>
<position position="1739"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357227." id="VAR_070508" evidence="80">
<original>D</original>
<variation>V</variation>
<location>
<position position="1739"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs786202389." id="VAR_070509" evidence="80">
<original>H</original>
<variation>Q</variation>
<location>
<position position="1746"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance; abolishes ACACA binding and strongly reduces BRIP1 binding; dbSNP:rs80357462." id="VAR_007798" evidence="22 28 51">
<original>P</original>
<variation>R</variation>
<location>
<position position="1749"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs397509246." id="VAR_070510" evidence="80">
<original>R</original>
<variation>T</variation>
<location>
<position position="1753"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357281." id="VAR_063908" evidence="63 80">
<original>L</original>
<variation>P</variation>
<location>
<position position="1764"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357463." id="VAR_063909" evidence="63">
<original>I</original>
<variation>S</variation>
<location>
<position position="1766"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070511" evidence="80">
<original>C</original>
<variation>S</variation>
<location>
<position position="1767"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro." id="VAR_070512" evidence="80">
<original>G</original>
<variation>V</variation>
<location>
<position position="1770"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; strongly reduced transcription transactivation; abolishes interaction with BRIP1 and RBBP8; dbSNP:rs41293463." id="VAR_063212" evidence="65">
<original>M</original>
<variation>K</variation>
<location>
<position position="1775"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; alters protein stability and abolishes ACACA and BRIP1 binding; dbSNP:rs41293463." id="VAR_007799" evidence="28 38 51 86 89">
<original>M</original>
<variation>R</variation>
<location>
<position position="1775"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance; dbSNP:rs1800757." id="VAR_008764">
<original>P</original>
<variation>S</variation>
<location>
<position position="1776"/>
</location>
</feature>
<feature type="sequence variant" description="In BC, BROVCA1 and OC; unknown pathological significance; dbSNP:rs80357474." id="VAR_079607" evidence="85">
<original>L</original>
<variation>P</variation>
<location>
<position position="1780"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070513" evidence="80">
<original>W</original>
<variation>C</variation>
<location>
<position position="1782"/>
</location>
</feature>
<feature type="sequence variant" description="In BROVCA1; unknown pathological significance; dbSNP:rs398122697." id="VAR_020704" evidence="43">
<original>L</original>
<variation>P</variation>
<location>
<position position="1786"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357069." id="VAR_063910" evidence="63">
<original>G</original>
<variation>V</variation>
<location>
<position position="1788"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357078." id="VAR_070514" evidence="80">
<original>A</original>
<variation>T</variation>
<location>
<position position="1789"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs397509275." id="VAR_070515" evidence="80">
<original>E</original>
<variation>D</variation>
<location>
<position position="1794"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80356920." id="VAR_070516" evidence="80">
<original>V</original>
<variation>D</variation>
<location>
<position position="1804"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070517" evidence="80">
<original>P</original>
<variation>R</variation>
<location>
<position position="1812"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance; dbSNP:rs1800751." id="VAR_008765">
<original>P</original>
<variation>S</variation>
<location>
<position position="1812"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80356959." id="VAR_070518" evidence="80">
<original>W</original>
<variation>R</variation>
<location>
<position position="1837"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357183." id="VAR_070519" evidence="80">
<original>H</original>
<variation>L</variation>
<location>
<position position="1862"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts the interaction with E2 enzymes, thereby abolishing the E3 ubiquitin-protein ligase activity." evidence="58 74">
<original>I</original>
<variation>A</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="mutagenesis site" description="No ubiquitination of RBBP8. No restoration RBBP8-mediated focus formation or G2/M checkpoint control upon DNA damage." evidence="58 74">
<original>I</original>
<variation>E</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with BAP1." evidence="97">
<original>R</original>
<variation>G</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by AURKA and interferes with cell cycle progression from G2 to mitosis." evidence="48">
<original>S</original>
<variation>N</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1143"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1239"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1280"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1298"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1330"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of IR-induced S-phase checkpoint. Reduces in vitro phosphorylation by ATR." evidence="26 34">
<original>S</original>
<variation>A</variation>
<location>
<position position="1387"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by ATR." evidence="26">
<original>T</original>
<variation>A</variation>
<location>
<position position="1394"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibition of the infrared-induced G2 arrest. Reduces phosphorylation by ATR." evidence="26 34">
<original>S</original>
<variation>A</variation>
<location>
<position position="1423"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1457"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1466"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in infrared S-phase delay; when associated with A-1387. No effect on in vitro phosphorylation by ATR." evidence="26 34">
<original>S</original>
<variation>A</variation>
<location>
<position position="1524"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with BRIP1." evidence="51">
<original>S</original>
<variation>A</variation>
<location>
<position position="1655"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on affinity for a BRIP1 phosphopeptide." evidence="78">
<original>G</original>
<variation>D</variation>
<location>
<position position="1656"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not abolish ABRAXAS1 binding, but abolishes formation of a heterotetramer with ABRAXAS1." evidence="82">
<original>F</original>
<variation>S</variation>
<location>
<position position="1662"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not abolish ABRAXAS1 binding, but abolishes formation of a heterotetramer with ABRAXAS1." evidence="82">
<original>M</original>
<variation>K</variation>
<location>
<position position="1663"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not abolish ABRAXAS1 binding, but impairs formation of a heterotetramer with ABRAXAS1." evidence="82">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1666"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs formation of a heterotetramer with ABRAXAS1." evidence="82">
<original>R</original>
<variation>E</variation>
<location>
<position position="1670"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs formation of a heterotetramer with ABRAXAS1." evidence="82">
<original>K</original>
<variation>E</variation>
<location>
<position position="1671"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces affinity for a BRIP1 phosphopeptide." evidence="78">
<original>T</original>
<variation>A</variation>
<location>
<position position="1700"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with BRIP1." evidence="51">
<original>K</original>
<variation>M</variation>
<location>
<position position="1702"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with BRIP1." evidence="51">
<original>G</original>
<variation>E</variation>
<location>
<position position="1738"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1755"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mildly reduces affinity for a BRIP1 phosphopeptide." evidence="78">
<original>R</original>
<variation>P</variation>
<location>
<position position="1835"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduces affinity for a BRIP1 phosphopeptide." evidence="78">
<original>E</original>
<variation>K</variation>
<location>
<position position="1836"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAB61673." ref="4" evidence="107">
<original>I</original>
<variation>T</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAB61673." ref="4" evidence="107">
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC00049." ref="3" evidence="107">
<original>A</original>
<variation>V</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAI15038." ref="8" evidence="107">
<original>S</original>
<variation>P</variation>
<location>
<position position="713"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAB61673." ref="4" evidence="107">
<original>G</original>
<variation>R</variation>
<location>
<position position="1077"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC00049." ref="3" evidence="107">
<original>S</original>
<variation>P</variation>
<location>
<position position="1426"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAI15038." ref="8" evidence="107">
<original>E</original>
<variation>G</variation>
<location>
<position position="1527"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="3"/>
<end position="5"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="8"/>
<end position="21"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="25"/>
<end position="27"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="46"/>
<end position="53"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="54"/>
<end position="58"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="62"/>
<end position="64"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="70"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="78"/>
<end position="80"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="81"/>
<end position="96"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1651"/>
<end position="1656"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1659"/>
<end position="1671"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1675"/>
<end position="1679"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1686"/>
<end position="1689"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1695"/>
<end position="1697"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1701"/>
<end position="1708"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1712"/>
<end position="1715"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1717"/>
<end position="1725"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1731"/>
<end position="1734"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="1740"/>
<end position="1742"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1743"/>
<end position="1745"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1748"/>
<end position="1754"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1755"/>
<end position="1757"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="1760"/>
<end position="1763"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1765"/>
<end position="1768"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1770"/>
<end position="1772"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1773"/>
<end position="1775"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1777"/>
<end position="1786"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1790"/>
<end position="1794"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1795"/>
<end position="1797"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1801"/>
<end position="1803"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1806"/>
<end position="1810"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1812"/>
<end position="1814"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1817"/>
<end position="1819"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1820"/>
<end position="1822"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1824"/>
<end position="1827"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1828"/>
<end position="1830"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1832"/>
<end position="1834"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1835"/>
<end position="1844"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1851"/>
<end position="1853"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1JM7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1OQA"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1T29"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1T2V"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PXE"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4IGK"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P48754"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00033"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10196379"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10323242"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10486320"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10500182"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10724175"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10783165"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11114888"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11239454"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11301010"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11573085"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11739404"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11751867"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11836499"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11877377"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12183412"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12215251"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12360400"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12419185"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12427738"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442274"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442275"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12887909"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12890688"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12938098"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14636569"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14722926"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14746861"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14976165"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14990569"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15026808"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15096610"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15133502"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15365993"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15456891"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16101277"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16326698"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16698035"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16818604"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17525340"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17643121"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17643122"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17924331"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18056443"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18285836"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18452305"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18762988"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19261746"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19261748"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19261749"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19369211"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20159462"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20160719"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20351172"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20364141"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20513136"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21144835"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21473589"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21673012"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23867111"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24316840"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26778126"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26807646"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28319063"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28364669"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7545954"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7894491"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7894493"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7939630"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8554067"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8723683"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8776600"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8968716"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8972225"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9010228"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9482581"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9528852"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9609997"/>
</source>
</evidence>
<evidence key="99" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9662397"/>
</source>
</evidence>
<evidence key="100" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9760198"/>
</source>
</evidence>
<evidence key="101" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9811458"/>
</source>
</evidence>
<evidence key="102" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="103" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="104" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="105" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9010228"/>
</source>
</evidence>
<evidence key="106" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="107" type="ECO:0000305"/>
<sequence length="1863" mass="207721" checksum="89C6D83FF56312AF" modified="1995-02-01" version="2">
MDLSALRVEEVQNVINAMQKILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQ
CPLCKNDITKRSLQESTRFSQLVEELLKIICAFQLDTGLEYANSYNFAKKENNSPEHLKD
EVSIIQSMGYRNRAKRLLQSEPENPSLQETSLSVQLSNLGTVRTLRTKQRIQPQKTSVYI
ELGSDSSEDTVNKATYCSVGDQELLQITPQGTRDEISLDSAKKAACEFSETDVTNTEHHQ
PSNNDLNTTEKRAAERHPEKYQGSSVSNLHVEPCGTNTHASSLQHENSSLLLTKDRMNVE
KAEFCNKSKQPGLARSQHNRWAGSKETCNDRRTPSTEKKVDLNADPLCERKEWNKQKLPC
SENPRDTEDVPWITLNSSIQKVNEWFSRSDELLGSDDSHDGESESNAKVADVLDVLNEVD
EYSGSSEKIDLLASDPHEALICKSERVHSKSVESNIEDKIFGKTYRKKASLPNLSHVTEN
LIIGAFVTEPQIIQERPLTNKLKRKRRPTSGLHPEDFIKKADLAVQKTPEMINQGTNQTE
QNGQVMNITNSGHENKTKGDSIQNEKNPNPIESLEKESAFKTKAEPISSSISNMELELNI
HNSKAPKKNRLRRKSSTRHIHALELVVSRNLSPPNCTELQIDSCSSSEEIKKKKYNQMPV
RHSRNLQLMEGKEPATGAKKSNKPNEQTSKRHDSDTFPELKLTNAPGSFTKCSNTSELKE
FVNPSLPREEKEEKLETVKVSNNAEDPKDLMLSGERVLQTERSVESSSISLVPGTDYGTQ
ESISLLEVSTLGKAKTEPNKCVSQCAAFENPKGLIHGCSKDNRNDTEGFKYPLGHEVNHS
RETSIEMEESELDAQYLQNTFKVSKRQSFAPFSNPGNAEEECATFSAHSGSLKKQSPKVT
FECEQKEENQGKNESNIKPVQTVNITAGFPVVGQKDKPVDNAKCSIKGGSRFCLSSQFRG
NETGLITPNKHGLLQNPYRIPPLFPIKSFVKTKCKKNLLEENFEEHSMSPEREMGNENIP
STVSTISRNNIRENVFKEASSSNINEVGSSTNEVGSSINEIGSSDENIQAELGRNRGPKL
NAMLRLGVLQPEVYKQSLPGSNCKHPEIKKQEYEEVVQTVNTDFSPYLISDNLEQPMGSS
HASQVCSETPDDLLDDGEIKEDTSFAENDIKESSAVFSKSVQKGELSRSPSPFTHTHLAQ
GYRRGAKKLESSEENLSSEDEELPCFQHLLFGKVNNIPSQSTRHSTVATECLSKNTEENL
LSLKNSLNDCSNQVILAKASQEHHLSEETKCSASLFSSQCSELEDLTANTNTQDPFLIGS
SKQMRHQSESQGVGLSDKELVSDDEERGTGLEENNQEEQSMDSNLGEAASGCESETSVSE
DCSGLSSQSDILTTQQRDTMQHNLIKLQQEMAELEAVLEQHGSQPSNSYPSIISDSSALE
DLRNPEQSTSEKAVLTSQKSSEYPISQNPEGLSADKFEVSADSSTSKNKEPGVERSSPSK
CPSLDDRWYMHSCSGSLQNRNYPSQEELIKVVDVEEQQLEESGPHDLTETSYLPRQDLEG
TPYLESGISLFSDDPESDPSEDRAPESARVGNIPSSTSALKVPQLKVAESAQSPAAAHTT
DTAGYNAMEESVSREKPELTASTERVNKRMSMVVSGLTPEEFMLVYKFARKHHITLTNLI
TEETTHVVMKTDAEFVCERTLKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDV
VNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNMPTDQLEWMVQLCGASVVKELSSFTL
GTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIPH
SHY
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2003-11-14" modified="2017-12-20" version="137">
<accession>O35923</accession>
<name>BRCA2_RAT</name>
<protein>
<recommendedName>
<fullName>Breast cancer type 2 susceptibility protein homolog</fullName>
</recommendedName>
<alternativeName>
<fullName>Fanconi anemia group D1 protein homolog</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">Brca2</name>
<name type="synonym">Fancd1</name>
</gene>
<organism>
<name type="scientific">Rattus norvegicus</name>
<name type="common">Rat</name>
<dbReference type="NCBI Taxonomy" id="10116"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Rattus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Cancer Res." volume="57" first="3121" last="3125">
<title>Characterization of the rat and mouse homologues of the BRCA2 breast cancer susceptibility gene.</title>
<authorList>
<person name="McAllister K.A."/>
<person name="Haugen-Strano A."/>
<person name="Hagevik S."/>
<person name="Brownlee H.A."/>
<person name="Collins N.K."/>
<person name="Futreal P.A."/>
<person name="Bennett L.M."/>
<person name="Wiseman R.W."/>
</authorList>
<dbReference type="PubMed" id="9242436"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<strain>Sprague-Dawley</strain>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2002" name="Science" volume="297" first="1837" last="1848">
<title>BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.</title>
<authorList>
<person name="Yang H."/>
<person name="Jeffrey P.D."/>
<person name="Miller J."/>
<person name="Kinnucan E."/>
<person name="Sun Y."/>
<person name="Thoma N.H."/>
<person name="Zheng N."/>
<person name="Chen P.L."/>
<person name="Lee W.H."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="12228710"/>
<dbReference type="DOI" id="10.1126/science.297.5588.1837"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 2335-3151 IN COMPLEX WITH SEM1</scope>
<scope>INTERACTION WITH SEM1</scope>
</reference>
<comment type="function">
<text evidence="2 3">Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SEM1, and is required to prevent R-loop-associated DNA damage and thus transcription-associated genomic instability, independently of its known role in homologous recombination (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="3 4">Monomer and dimer. Interacts with RAD51; regulates RAD51 recruitment and function at sites of DNA repair. Interacts with SEM1, WDR16, USP11, DMC1, ROCK2 and NPM1. Interacts with both nonubiquitinated and monoubiquitinated FANCD2; this complex also includes XRCC3 and phosphorylated FANCG. Part of a BRCA complex containing BRCA1, BRCA2 and PALB2. Interacts directly with PALB2 which may serve as a scaffold for a HR complex containing PALB2, BRCA2, RAD51C, RAD51 and XRCC3. Interacts with BRCA1 only in the presence of PALB2 which serves as the bridging protein. Interacts with POLH; the interaction is direct. Interacts with the TREX-2 complex subunits PCID2 and SEM1 (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="2">Cytoplasm</location>
<location evidence="2">cytoskeleton</location>
<location evidence="2">microtubule organizing center</location>
<location evidence="2">centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Highest expression in testis. Also expressed in spleen, skeletal muscle, thymus, mammary gland, heart, ovary, prostate, liver, lung, kidney and brain.</text>
</comment>
<comment type="PTM">
<text evidence="2">Phosphorylation by CHEK1 and CHEK2 regulates interaction with RAD51. Phosphorylation at Ser-3222 by CDK1 and CDK2 is low in S phase when recombination is active, but increases as cells progress towards mitosis; this phosphorylation prevents homologous recombination-dependent repair during S phase and G2 by inhibiting RAD51 binding (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="2">Ubiquitinated in the absence of DNA damage; this does not lead to proteasomal degradation. In contrast, ubiquitination in response to DNA damage leads to proteasomal degradation (By similarity).</text>
</comment>
<dbReference type="EMBL" id="U89653">
<property type="protein sequence ID" value="AAB71378.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="PIR" id="T42207">
<property type="entry name" value="T42207"/>
</dbReference>
<dbReference type="UniGene" id="Rn.103225"/>
<dbReference type="PDB" id="1IYJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="B/D=2335-3151"/>
</dbReference>
<dbReference type="PDBsum" id="1IYJ"/>
<dbReference type="ProteinModelPortal" id="O35923"/>
<dbReference type="SMR" id="O35923"/>
<dbReference type="STRING" id="10116.ENSRNOP00000001475"/>
<dbReference type="PaxDb" id="O35923"/>
<dbReference type="PRIDE" id="O35923"/>
<dbReference type="UCSC" id="RGD:2219">
<property type="organism name" value="rat"/>
</dbReference>
<dbReference type="RGD" id="2219">
<property type="gene designation" value="Brca2"/>
</dbReference>
<dbReference type="eggNOG" id="KOG4751">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410Y06W">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000139693"/>
<dbReference type="HOVERGEN" id="HBG050731"/>
<dbReference type="InParanoid" id="O35923"/>
<dbReference type="PhylomeDB" id="O35923"/>
<dbReference type="EvolutionaryTrace" id="O35923"/>
<dbReference type="PRO" id="PR:O35923"/>
<dbReference type="Proteomes" id="UP000002494">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0033593">
<property type="term" value="C:BRCA2-MAGE-D1 complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0000800">
<property type="term" value="C:lateral element"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0000784">
<property type="term" value="C:nuclear chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0030141">
<property type="term" value="C:secretory granule"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0043015">
<property type="term" value="F:gamma-tubulin binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0010484">
<property type="term" value="F:H3 histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0010485">
<property type="term" value="F:H4 histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0003697">
<property type="term" value="F:single-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0007569">
<property type="term" value="P:cell aging"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0051298">
<property type="term" value="P:centrosome duplication"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0043009">
<property type="term" value="P:chordate embryonic development"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0051276">
<property type="term" value="P:chromosome organization"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006978">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006310">
<property type="term" value="P:DNA recombination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070200">
<property type="term" value="P:establishment of protein localization to telomere"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0008585">
<property type="term" value="P:female gonad development"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0030097">
<property type="term" value="P:hemopoiesis"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0043966">
<property type="term" value="P:histone H3 acetylation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0043967">
<property type="term" value="P:histone H4 acetylation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0031619">
<property type="term" value="P:homologous chromosome orientation involved in meiotic metaphase I plate congression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0001833">
<property type="term" value="P:inner cell mass cell proliferation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0008630">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0007141">
<property type="term" value="P:male meiosis I"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0030879">
<property type="term" value="P:mammary gland development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:1990426">
<property type="term" value="P:mitotic recombination-dependent replication fork processing"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0035264">
<property type="term" value="P:multicellular organism growth"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0033600">
<property type="term" value="P:negative regulation of mammary gland epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006289">
<property type="term" value="P:nucleotide-excision repair"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0001556">
<property type="term" value="P:oocyte maturation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0045931">
<property type="term" value="P:positive regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032465">
<property type="term" value="P:regulation of cytokinesis"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048478">
<property type="term" value="P:replication fork protection"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0010332">
<property type="term" value="P:response to gamma radiation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0007584">
<property type="term" value="P:response to nutrient"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0010225">
<property type="term" value="P:response to UV-C"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0010165">
<property type="term" value="P:response to X-ray"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0000722">
<property type="term" value="P:telomere maintenance via recombination"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="CDD" id="cd04493">
<property type="entry name" value="BRCA2DBD_OB1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd04495">
<property type="entry name" value="BRCA2DBD_OB3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015525">
<property type="entry name" value="BRCA2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015252">
<property type="entry name" value="BRCA2_hlx"/>
</dbReference>
<dbReference type="InterPro" id="IPR036315">
<property type="entry name" value="BRCA2_hlx_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR015187">
<property type="entry name" value="BRCA2_OB_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015188">
<property type="entry name" value="BRCA2_OB_3"/>
</dbReference>
<dbReference type="InterPro" id="IPR002093">
<property type="entry name" value="BRCA2_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR012340">
<property type="entry name" value="NA-bd_OB-fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR015205">
<property type="entry name" value="Tower_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11289">
<property type="entry name" value="PTHR11289"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09169">
<property type="entry name" value="BRCA-2_helical"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09103">
<property type="entry name" value="BRCA-2_OB1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09104">
<property type="entry name" value="BRCA-2_OB3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00634">
<property type="entry name" value="BRCA2"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="Pfam" id="PF09121">
<property type="entry name" value="Tower"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF002397">
<property type="entry name" value="BRCA2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01341">
<property type="entry name" value="Tower"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50249">
<property type="entry name" value="SSF50249"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81872">
<property type="entry name" value="SSF81872"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50138">
<property type="entry name" value="BRCA2_REPEAT"/>
<property type="match status" value="6"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0233">DNA recombination</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Breast cancer type 2 susceptibility protein homolog" id="PRO_0000064986">
<location>
<begin position="1"/>
<end position="3343"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 1">
<location>
<begin position="984"/>
<end position="1018"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 2">
<location>
<begin position="1197"/>
<end position="1231"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 3">
<location>
<begin position="1405"/>
<end position="1439"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 4">
<location>
<begin position="1503"/>
<end position="1537"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 5">
<location>
<begin position="1645"/>
<end position="1669"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 6">
<location>
<begin position="1828"/>
<end position="1845"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 7">
<location>
<begin position="1939"/>
<end position="1973"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 8">
<location>
<begin position="2019"/>
<end position="2053"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PALB2" evidence="2">
<location>
<begin position="1"/>
<end position="40"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NPM1" evidence="2">
<location>
<begin position="622"/>
<end position="982"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with FANCD2" evidence="2">
<location>
<begin position="2313"/>
<end position="2475"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SEM1" evidence="3">
<location>
<begin position="2411"/>
<end position="2762"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal; masked by interaction with SEM1" evidence="3">
<location>
<begin position="2612"/>
<end position="2628"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="70"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="475"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="736"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="2063"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1 and CDK2" evidence="3">
<location>
<position position="3222"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="3250"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2407"/>
<end position="2409"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2410"/>
<end position="2428"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2441"/>
<end position="2443"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2444"/>
<end position="2446"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2453"/>
<end position="2457"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2467"/>
<end position="2469"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2470"/>
<end position="2473"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2479"/>
<end position="2481"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2484"/>
<end position="2489"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2494"/>
<end position="2498"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2500"/>
<end position="2502"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2503"/>
<end position="2505"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2509"/>
<end position="2511"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2512"/>
<end position="2514"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2515"/>
<end position="2517"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2527"/>
<end position="2535"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2542"/>
<end position="2544"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2547"/>
<end position="2567"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2569"/>
<end position="2571"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2573"/>
<end position="2575"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2576"/>
<end position="2578"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2579"/>
<end position="2593"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2601"/>
<end position="2606"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2615"/>
<end position="2622"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2649"/>
<end position="2652"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2657"/>
<end position="2660"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2664"/>
<end position="2671"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2680"/>
<end position="2684"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2687"/>
<end position="2690"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2697"/>
<end position="2699"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2705"/>
<end position="2707"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2710"/>
<end position="2712"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2713"/>
<end position="2715"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2718"/>
<end position="2720"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2722"/>
<end position="2724"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2746"/>
<end position="2748"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2759"/>
<end position="2763"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2765"/>
<end position="2772"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2774"/>
<end position="2782"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2895"/>
<end position="2903"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2905"/>
<end position="2909"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2913"/>
<end position="2919"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2922"/>
<end position="2927"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2934"/>
<end position="2938"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2962"/>
<end position="2965"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2970"/>
<end position="2973"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2974"/>
<end position="2976"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2985"/>
<end position="2989"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2996"/>
<end position="2998"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2999"/>
<end position="3005"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3008"/>
<end position="3010"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3013"/>
<end position="3015"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3018"/>
<end position="3022"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3028"/>
<end position="3035"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3046"/>
<end position="3054"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="3064"/>
<end position="3076"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="3080"/>
<end position="3097"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="3101"/>
<end position="3110"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1IYJ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P51587"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12228710"/>
</source>
</evidence>
<sequence length="3343" mass="372216" checksum="653DB110D2302A8D" modified="1998-01-01" version="1">
MTVEYKRRPTFWEIFKARCSTADLGPISLNWFEELFSEAPPYNTEHPEESEYKPQGHEPQ
LFKTPQRNPSYHQFASTPIMFKEQSQTLPLDQSPFKELGNVVANSKRKHHSKKKARKDPV
VDVASLPLKACPSESPCTPRCTQVAPQRRKPVVSGSLFYTPKLEETPKHISESLGVEVDP
DMSWTSSLATPPTLSSTVLIARDEEAHRNAFPADSPASLKSYFSNHNESLKKNDRFIPSV
SDSENKSQQEAFSQGLEKMLGDSSSKINRFRDCLRKPIPNVLEDGETAVDTSGEDSFSLC
FPKRRTRNLQKTRMGKMKKKIFSETRTDGLSEEARGQADDKNSFALEIEPRDSEPLDPSV
TNQKPLYSQSGDISSEAGQCSDSIWSQPDPSGLNGTQTRKIPLLHISFHKQSILEDFIDM
KKEGTGSITFPHISSLPEPEKMFSEETLVDKEHEGQHLESLEDSISGKQMVSGTSQTACL
SPSIRKSIVKMREPLEETLDTVFSDSMTSSAFTEELDASAGGLEIHTACSQREDSLCPSS
VDTGSWPTTLTDTSATVKNAGLITTLKNKRRKFIYSVSDDASHQGKKLQTQRQSELTNLS
APFEASAFEVPFPFTNVDSGIPDSSIKRSNLPNDPEEPSLSLTNSFVTAASKEISYIHAL
ISQDLNDKEAILSEEKPQPYTALEADFLSCLPERSCENDQKSPKVSDRKEKVLVSACRPS
GRLAAAVQLSSISFDSQENPLGSHNVTSTLKLTPSPKTPLSKPVVVSRGKMCKMPEKLQC
KSCKDNIELSKNIPLGVNEMCVLSENSETPELLPPLEYITEVSSSVKSQFNQNTKIAVVQ
KDQKDSTFISEVTVHMNSEELFPEKENNFAFQVTNESNKPNIGSTVEFQEEDLSHAKGHS
LKNSPMTVDRDLDDEQAGQVLITEDSDSLAVVHDCTKKSRNTIEQHQKGTADKDFKSNSS
LYLKSDGNNDYLDKWSEFLDPLMNHKLGGSFRTASNKEIKLSEDNVKKSKMFFKDIEEQY
PTSLDCIDTVSTLQLANKKRLSEPHTFDLKSGTTVSTQCHSQSSVSHEDTHTAPQMLSSK
QDFHSSHNLTPSQKAEITELSTILEESGSQFEFTQFKNPSHIAQNNTSAVLGNQMAVVRT
ASEEWKDVDLHLPLNPSSVGQIDHNKKFECLVGVKQSSSHLLEDTCNQNTSCFLPIKEME
FGGFCSALGTKLSVSNEALRKAMKLFSDIENISEEPSTKVGPRGFSSCAHHDSVASVFKI
KKQNTDKSFDEKSSKCQVTVQNNKEMTTCILVDENPENYVKNIKQDNNYTGSQRNAYKLE
NSDVSKSSTSGTVYINKGDSDLPFAAEKGNKYPESCTQYVREENAQIKESVSDLTCLEVM
KAEETCHMKSSDKEQLPSDKMEQNMKEFNISFQTASGKNIRVSKESLNKSVNILDQETED
LTVTSDSLNSKILCGINKDKMHISCHKKSINIKKVFEEHFPIGTVSQLPALQQYPEYEIE
SIKEPTLLSFHTASGKKVKIMQESLDKVKNLFDETQYVRKTTNFGHQESKPLKDREDYKE
RLTLAYEKIEVTASKCEEMQNFVSKQTEMLPQQNDHMYRQTENLTSNGSSPKVHGNIENK
IEKNPRICCICQSSYFVTEDSALACYTGDSRKTCVGESSLSKGKKWLREQSDKLGTRNTI
EIQCVKEHTEDFAGNALYEHSLVIIRTEIDTSHVSENQASTLFSDPNVCHSYLSHSSFCH
HDDMHNDSGYFLKDKIDSDVQPDMKNTEGNAIFPKISATKEIKLHPQTVNEECVQKLETN
ASPYANKNIAIDSAMLDLRNCKVGSPVFITTHSQETVRMKEIFTDNCSKIVEQNRESKPD
TCQTSCHKALDNSEDFICPSSSGDVCINSPMAIFYPQSEQILQHNQSVSGLKKAATPPVS
LETWDTCKSIRGSPQEVHPSRTYGFFSTASGKAVQVSDASLEKARQVFSEIDGDAKQLAS
MVSLEGNEKSHHSVKRESSVVHNTHGVLSLRKTLPGNVSSFVFSGFSTAGGKLVTVSESA
LHKVKGMLEEFDLIRTEHTLQHSPTPEDVSKIPPQPCLESRTPEYSVSSKLQKTYNDKSR
SPSNYKESGSSGNTQSLEVSPQLSQMERKQETQSVLGTKVSQRKTNILEKKQNLPQNIKI
ESNKMETFSDVSMKTNVGEYYSKEPENYFETEAVEIAKAFMEDDELTDSEQTHAKCSLFA
CPQNEALLNSRTRKRGGMAGVAVGQPPIKRSLLNEFDRIIESKGKSLTPSKSTPDGTIKD
RRLFTHHMSLEPVTCGPFCSSKERQETQSPHVTSPAQGLQSKEHPSRHSAVGKSSSNPTV
SALRSERTRHSVSDKSTKVFVPPFKVKSRFHRDEHFDSKNVNLEGKNQKSADGVSEDGND
SDFPQFNKDLMSSLQNARDLQDIRIKNKERHHLCPQPGSLYLTKSSTLPRISLQAAVGDS
VPSACSPKQLYMYGVSKACISVNSKNAEYFQFAIEDHFGKEALCAGKGFRLADGGWLIPS
DDGKAGKEEFYRALCDTPGVDPKLISSVWVSNHYRWIVWKLAAMEFAFPKEFANRCLNPE
RVLLQLKYRYDVEIDNSSRSALKKILERDDTAAKTLVLCVSDIISLSTNVSETSGSKASS
EDSNKVDTIELTDGWYAVKAQLDPPLLALVKSGRLTVGQKIITQGAELVGSPDACAPLEA
PDSLRLKISANSTRPARWHSKLGFFHDPRPFPLPLSSLFSDGGNVGCVDVIVQRVYPLQW
VEKTVSGSYIFRNEREEEKEALRFAEAQQKKLEALFTKVHTELKEHEEDIAQRRVLSRAL
TRQQVHALQDGAELYAAVQDASDPEHLETCFSEEQLRALNNYRQMLSDKKQARIQSEFRK
ALEAAEKEEGLSRDVSTVWKLRVTSYKKREKSALLSIWRPSSDLPSLLTEGQRYRIYHLS
VSKSKNKFEWPSIQLTATKRTQYQQLPVSSETLLQLYQPRELLPFSKLSDPAFQPPCSEV
DVVGVVVSVVKPIGLAPLVYLSDECLHLLVVKFGIDLNEDIKPRVLIAASNLQWRPESTS
RVPTLFAGNFSVFSASPKEAHFQERVTNMKHAIENIDTFYKEAEKKLIQVLKGDSPKWST
PNKDPTREPYPASTCSASDLASGGQLPRSSPTDQQSYRSPLSCCTPTGKSTPLAHSAWMA
AKSCSGENEIEDPKTCRKKRALDLLSRLPLPPPLSPVCTFVSPAAQKAFQPPRSCGTKYP
TPLKKEGPSSPWSRAPFQKASGVSLLDCDSVADEELALLSTQALVPHSVGGSEQVFPSDS
TRTEGPSASTEARPANRSKRESLRDCRDDSDGKLAAETVPDYS
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2018-01-31" version="176">
<accession>P48754</accession>
<accession>A2A4Q4</accession>
<accession>Q60957</accession>
<accession>Q60983</accession>
<name>BRCA1_MOUSE</name>
<protein>
<recommendedName>
<fullName>Breast cancer type 1 susceptibility protein homolog</fullName>
<ecNumber evidence="4">2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="10">RING-type E3 ubiquitin transferase BRCA1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">Brca1</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="2265" last="2273">
<title>Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains.</title>
<authorList>
<person name="Abel K.J."/>
<person name="Xy J."/>
<person name="Yin G.Y."/>
<person name="Lyons R.H."/>
<person name="Meisler M.H."/>
<person name="Weber B.L."/>
</authorList>
<dbReference type="PubMed" id="8634697"/>
<dbReference type="DOI" id="10.1093/hmg/4.12.2265"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<strain>C57BL/6J</strain>
<tissue>Embryo</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="2275" last="2278">
<title>Murine Brca1: sequence and significance for human missense mutations.</title>
<authorList>
<person name="Sharan S.K."/>
<person name="Wims M."/>
<person name="Bradley A."/>
</authorList>
<dbReference type="PubMed" id="8634698"/>
<dbReference type="DOI" id="10.1093/hmg/4.12.2275"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<strain>C57BL/6J</strain>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="Genomics" volume="29" first="576" last="581">
<title>Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11.</title>
<authorList>
<person name="Bennett L.M."/>
<person name="Haugen-Strano A."/>
<person name="Cochran C."/>
<person name="Brownlee H.A."/>
<person name="Fiedorek F.T. Jr."/>
<person name="Wiseman R.W."/>
</authorList>
<dbReference type="PubMed" id="8575748"/>
<dbReference type="DOI" id="10.1006/geno.1995.9963"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<strain>129/SvJ</strain>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1995" name="Genes Dev." volume="9" first="2712" last="2722">
<title>Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice.</title>
<authorList>
<person name="Lane T.F."/>
<person name="Deng C."/>
<person name="Elson A."/>
<person name="Lyu M.S."/>
<person name="Kozak C.A."/>
<person name="Leder P."/>
</authorList>
<dbReference type="PubMed" id="7590247"/>
<dbReference type="DOI" id="10.1101/gad.9.21.2712"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<strain>129/SvJ</strain>
<tissue>Embryo</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2009" name="PLoS Biol." volume="7" first="E1000112" last="E1000112">
<title>Lineage-specific biology revealed by a finished genome assembly of the mouse.</title>
<authorList>
<person name="Church D.M."/>
<person name="Goodstadt L."/>
<person name="Hillier L.W."/>
<person name="Zody M.C."/>
<person name="Goldstein S."/>
<person name="She X."/>
<person name="Bult C.J."/>
<person name="Agarwala R."/>
<person name="Cherry J.L."/>
<person name="DiCuccio M."/>
<person name="Hlavina W."/>
<person name="Kapustin Y."/>
<person name="Meric P."/>
<person name="Maglott D."/>
<person name="Birtle Z."/>
<person name="Marques A.C."/>
<person name="Graves T."/>
<person name="Zhou S."/>
<person name="Teague B."/>
<person name="Potamousis K."/>
<person name="Churas C."/>
<person name="Place M."/>
<person name="Herschleb J."/>
<person name="Runnheim R."/>
<person name="Forrest D."/>
<person name="Amos-Landgraf J."/>
<person name="Schwartz D.C."/>
<person name="Cheng Z."/>
<person name="Lindblad-Toh K."/>
<person name="Eichler E.E."/>
<person name="Ponting C.P."/>
</authorList>
<dbReference type="PubMed" id="19468303"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000112"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>C57BL/6J</strain>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1995" name="Nat. Genet." volume="11" first="17" last="26">
<title>The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues.</title>
<authorList>
<person name="Marquis S.T."/>
<person name="Rajan J.V."/>
<person name="Wynshaw-Boris A."/>
<person name="Xu J."/>
<person name="Yin G.Y."/>
<person name="Abel K.J."/>
<person name="Weber B.L."/>
<person name="Chodosh L.A."/>
</authorList>
<dbReference type="PubMed" id="7550308"/>
<dbReference type="DOI" id="10.1038/ng0995-17"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 727-1111</scope>
<source>
<strain>C57BL/6J</strain>
<tissue>Embryo</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1996" name="Hum. Genet." volume="97" first="256" last="259">
<title>The murine homolog of the human breast and ovarian cancer susceptibility gene Brca1 maps to mouse chromosome 11D.</title>
<authorList>
<person name="Schroeck E."/>
<person name="Badger P."/>
<person name="Larson D."/>
<person name="Erdos M."/>
<person name="Wynshaw-Boris A."/>
<person name="Ried T."/>
<person name="Brody L."/>
</authorList>
<dbReference type="PubMed" id="8566965"/>
<dbReference type="DOI" id="10.1007/BF02265277"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 789-1250</scope>
<source>
<strain>129/SvJ</strain>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="6729" last="6739">
<title>BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains.</title>
<authorList>
<person name="Magnard C."/>
<person name="Bachelier R."/>
<person name="Vincent A."/>
<person name="Jaquinod M."/>
<person name="Kieffer S."/>
<person name="Lenoir G.M."/>
<person name="Venezia N.D."/>
</authorList>
<dbReference type="PubMed" id="12360400"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205915"/>
</citation>
<scope>INTERACTION WITH ACACA</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-831</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic fibroblast</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2010" name="Cell" volume="143" first="1174" last="1189">
<title>A tissue-specific atlas of mouse protein phosphorylation and expression.</title>
<authorList>
<person name="Huttlin E.L."/>
<person name="Jedrychowski M.P."/>
<person name="Elias J.E."/>
<person name="Goswami T."/>
<person name="Rad R."/>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Haas W."/>
<person name="Sowa M.E."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="21183079"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.12.001"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-706 AND SER-717</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Lung</tissue>
<tissue>Spleen</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2012" name="Genes Cells" volume="17" first="897" last="912">
<title>HORMAD2 is essential for synapsis surveillance during meiotic prophase via the recruitment of ATR activity.</title>
<authorList>
<person name="Kogo H."/>
<person name="Tsutsumi M."/>
<person name="Inagaki H."/>
<person name="Ohye T."/>
<person name="Kiyonari H."/>
<person name="Kurahashi H."/>
</authorList>
<dbReference type="PubMed" id="23039116"/>
<dbReference type="DOI" id="10.1111/gtc.12005"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2012" name="Genes Dev." volume="26" first="958" last="973">
<title>Meiotic DNA double-strand breaks and chromosome asynapsis in mice are monitored by distinct HORMAD2-independent and -dependent mechanisms.</title>
<authorList>
<person name="Wojtasz L."/>
<person name="Cloutier J.M."/>
<person name="Baumann M."/>
<person name="Daniel K."/>
<person name="Varga J."/>
<person name="Fu J."/>
<person name="Anastassiadis K."/>
<person name="Stewart A.F."/>
<person name="Remenyi A."/>
<person name="Turner J.M."/>
<person name="Toth A."/>
</authorList>
<dbReference type="PubMed" id="22549958"/>
<dbReference type="DOI" id="10.1101/gad.187559.112"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="4 7">E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (By similarity). Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation.</text>
</comment>
<comment type="catalytic activity">
<text evidence="4">S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="4 7">Heterodimer with BARD1. Part of the BRCA1-associated genome surveillance complex (BASC), which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2 and the MRE11-RAD50-NBN protein (MRN) complex. This association could be a dynamic process changing throughout the cell cycle and within subnuclear domains. Component of the BRCA1-A complex, at least composed of BRCA1, BARD1, UIMC1/RAP80, ABRAXAS1, BRCC3/BRCC36, BABAM2 and BABAM1/NBA1. Interacts (via the BRCT domains) with ABRAXAS1 (phosphorylated form); this is important for recruitment to sites of DNA damage. Can form a heterotetramer with two molecules of ABRAXAS1 (phosphorylated form). Component of the BRCA1-RBBP8 complex. Interacts (via the BRCT domains) with RBBP8 ('Ser-327' phosphorylated form); the interaction ubiquitinates RBBP8, regulates CHEK1 activation, and involves RBBP8 in BRCA1-dependent G2/M checkpoint control on DNA damage. Associates with RNA polymerase II holoenzyme. Interacts with SMC1A, COBRA1, DCLRE1C, CLSPN. CHEK1, CHEK2, BAP1, BRCC3, AURKA, UBXN1 and PCLAF. Interacts (via BRCT domains) with BRIP1 (phosphorylated form). Interacts with FANCD2 (ubiquitinated form). Interacts with H2AFX (phosphorylated on 'Ser-140'). Interacts (via the BRCT domains) with ACACA (phosphorylated form); the interaction prevents dephosphorylation of ACACA. Part of a BRCA complex containing BRCA1, BRCA2 and PALB2. Interacts directly with PALB2; the interaction is essential for its function in HRR. Interacts directly with BRCA2; the interaction occurs only in the presence of PALB2 which serves as the bridging protein. Interacts (via the BRCT domains) with LMO4; the interaction represses the transcriptional activity of BRCA1. Interacts (via the BRCT domains) with CCAR2 (via N-terminus); the interaction represses the transcriptional activator activity of BRCA1 (By similarity). Interacts with EXD2 (By similarity). Interacts (via C-terminus) with DHX9; this interaction is direct and links BRCA1 to the RNA polymerase II holoenzyme (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="8 9">Chromosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="4">Cytoplasm</location>
</subcellularLocation>
<text evidence="4">Localizes at sites of DNA damage at double-strand breaks (DSBs); recruitment to DNA damage sites is mediated by the BRCA1-A complex. Translocated to the cytoplasm during UV-induced apoptosis.</text>
</comment>
<comment type="tissue specificity">
<text>In the embryo, expressed in otic vesicles at day 9.5. At day 10.5, this expression decreases and high levels are found in the neuroectoderm. At days 11-12.5, high levels in differentiating keratinocytes and whisker pad primordia. At days 14-17, expression also observed in kidney epithelial cells. In the adult, highest levels found in spleen, thymus, lymph nodes, epithelial organs, and alveolar and ductal epithelial cells of the mammary gland. Very low levels in brain, kidney, and skin. No expression in heart, liver or lung.</text>
</comment>
<comment type="developmental stage">
<text>In the mammary gland, expression increases dramatically during pregnancy. Levels fall during lactation and increase again during post-lactational regression of the mammary gland.</text>
</comment>
<comment type="domain">
<text evidence="4">The BRCT domains recognize and bind phosphorylated pSXXF motif on proteins. The interaction with the phosphorylated pSXXF motif of ABRAXAS1, recruits BRCA1 at DNA damage sites.</text>
</comment>
<comment type="domain">
<text evidence="4">The RING-type zinc finger domain interacts with BAP1.</text>
</comment>
<comment type="PTM">
<text evidence="4">Phosphorylated in response to IR, UV, and various stimuli that cause checkpoint activation, probably by ATM or ATR. Phosphorylation at Ser-971 by CHEK2 regulates mitotic spindle assembly.</text>
</comment>
<comment type="PTM">
<text evidence="4">Autoubiquitinated, undergoes 'Lys-6'-linked polyubiquitination. 'Lys-6'-linked polyubiquitination does not promote degradation.</text>
</comment>
<dbReference type="EC" id="2.3.2.27" evidence="4"/>
<dbReference type="EMBL" id="U31625">
<property type="protein sequence ID" value="AAB17114.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U35641">
<property type="protein sequence ID" value="AAB17113.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U32446">
<property type="protein sequence ID" value="AAA96393.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U36475">
<property type="protein sequence ID" value="AAC52323.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL590996">
<property type="protein sequence ID" value="CAM21026.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U33835">
<property type="protein sequence ID" value="AAA99742.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS25474.1"/>
<dbReference type="PIR" id="I49350">
<property type="entry name" value="I49350"/>
</dbReference>
<dbReference type="RefSeq" id="NP_033894.3">
<property type="nucleotide sequence ID" value="NM_009764.3"/>
</dbReference>
<dbReference type="UniGene" id="Mm.244975"/>
<dbReference type="ProteinModelPortal" id="P48754"/>
<dbReference type="SMR" id="P48754"/>
<dbReference type="BioGrid" id="198383">
<property type="interactions" value="43"/>
</dbReference>
<dbReference type="DIP" id="DIP-41981N"/>
<dbReference type="IntAct" id="P48754">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000017290"/>
<dbReference type="iPTMnet" id="P48754"/>
<dbReference type="PhosphoSitePlus" id="P48754"/>
<dbReference type="EPD" id="P48754"/>
<dbReference type="MaxQB" id="P48754"/>
<dbReference type="PaxDb" id="P48754"/>
<dbReference type="PeptideAtlas" id="P48754"/>
<dbReference type="PRIDE" id="P48754"/>
<dbReference type="Ensembl" id="ENSMUST00000017290">
<property type="protein sequence ID" value="ENSMUSP00000017290"/>
<property type="gene ID" value="ENSMUSG00000017146"/>
</dbReference>
<dbReference type="GeneID" id="12189"/>
<dbReference type="KEGG" id="mmu:12189"/>
<dbReference type="UCSC" id="uc007lpd.2">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="672"/>
<dbReference type="MGI" id="MGI:104537">
<property type="gene designation" value="Brca1"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ITQ6">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4111WR7">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00440000034289"/>
<dbReference type="HOGENOM" id="HOG000230969"/>
<dbReference type="HOVERGEN" id="HBG050730"/>
<dbReference type="InParanoid" id="P48754"/>
<dbReference type="KO" id="K10605"/>
<dbReference type="OMA" id="FQHLLFG"/>
<dbReference type="OrthoDB" id="EOG091G0670"/>
<dbReference type="TreeFam" id="TF105060"/>
<dbReference type="Reactome" id="R-MMU-1221633">
<property type="pathway name" value="Meiotic Synapsis"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-3108214">
<property type="pathway name" value="SUMOylation of DNA damage response and repair proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5685938">
<property type="pathway name" value="HDR through Single Strand Annealing (SSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5685942">
<property type="pathway name" value="HDR through Homologous Recombination (HRR)"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5689901">
<property type="pathway name" value="Metalloprotease DUBs"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5693554">
<property type="pathway name" value="Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5693568">
<property type="pathway name" value="Resolution of D-loop Structures through Holliday Junction Intermediates"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5693571">
<property type="pathway name" value="Nonhomologous End-Joining (NHEJ)"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5693579">
<property type="pathway name" value="Homologous DNA Pairing and Strand Exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-MMU-912497">
<property type="pathway name" value="Meiotic Recombination"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="PRO" id="PR:P48754"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000017146"/>
<dbReference type="CleanEx" id="MM_BRCA1"/>
<dbReference type="ExpressionAtlas" id="P48754">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P48754">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0070531">
<property type="term" value="C:BRCA1-A complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031436">
<property type="term" value="C:BRCA1-BARD1 complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000793">
<property type="term" value="C:condensed chromosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000794">
<property type="term" value="C:condensed nuclear chromosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030529">
<property type="term" value="C:intracellular ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000800">
<property type="term" value="C:lateral element"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003684">
<property type="term" value="F:damaged DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070063">
<property type="term" value="F:RNA polymerase binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001105">
<property type="term" value="F:RNA polymerase II transcription coactivator activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044212">
<property type="term" value="F:transcription regulatory region DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071681">
<property type="term" value="P:cellular response to indole-3-methanol"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007098">
<property type="term" value="P:centrosome cycle"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0051298">
<property type="term" value="P:centrosome duplication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043009">
<property type="term" value="P:chordate embryonic development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007059">
<property type="term" value="P:chromosome segregation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009048">
<property type="term" value="P:dosage compensation by inactivation of X chromosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006633">
<property type="term" value="P:fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008630">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0044818">
<property type="term" value="P:mitotic G2/M transition checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1902042">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045717">
<property type="term" value="P:negative regulation of fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035067">
<property type="term" value="P:negative regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051572">
<property type="term" value="P:negative regulation of histone H3-K4 methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051573">
<property type="term" value="P:negative regulation of histone H3-K9 methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033147">
<property type="term" value="P:negative regulation of intracellular estrogen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:2000378">
<property type="term" value="P:negative regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071158">
<property type="term" value="P:positive regulation of cell cycle arrest"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045739">
<property type="term" value="P:positive regulation of DNA repair"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0035066">
<property type="term" value="P:positive regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051571">
<property type="term" value="P:positive regulation of histone H3-K4 methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000617">
<property type="term" value="P:positive regulation of histone H3-K9 acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051574">
<property type="term" value="P:positive regulation of histone H3-K9 methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000620">
<property type="term" value="P:positive regulation of histone H4-K16 acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070512">
<property type="term" value="P:positive regulation of histone H4-K20 methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031398">
<property type="term" value="P:positive regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010575">
<property type="term" value="P:positive regulation of vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006301">
<property type="term" value="P:postreplication repair"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0051865">
<property type="term" value="P:protein autoubiquitination"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0085020">
<property type="term" value="P:protein K6-linked ubiquitination"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0044030">
<property type="term" value="P:regulation of DNA methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006349">
<property type="term" value="P:regulation of gene expression by genetic imprinting"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010212">
<property type="term" value="P:response to ionizing radiation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0072425">
<property type="term" value="P:signal transduction involved in G2 DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd00027">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10190">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR011364">
<property type="entry name" value="BRCA1"/>
</dbReference>
<dbReference type="InterPro" id="IPR031099">
<property type="entry name" value="BRCA1-associated"/>
</dbReference>
<dbReference type="InterPro" id="IPR025994">
<property type="entry name" value="BRCA1_serine_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001357">
<property type="entry name" value="BRCT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036420">
<property type="entry name" value="BRCT_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR018957">
<property type="entry name" value="Znf_C3HC4_RING-type"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13763">
<property type="entry name" value="PTHR13763"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13763:SF0">
<property type="entry name" value="PTHR13763:SF0"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00533">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF12820">
<property type="entry name" value="BRCT_assoc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00097">
<property type="entry name" value="zf-C3HC4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001734">
<property type="entry name" value="BRCA1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00493">
<property type="entry name" value="BRSTCANCERI"/>
</dbReference>
<dbReference type="SMART" id="SM00292">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52113">
<property type="entry name" value="SSF52113"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50172">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0233">DNA recombination</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0275">Fatty acid biosynthesis</keyword>
<keyword id="KW-0276">Fatty acid metabolism</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0444">Lipid biosynthesis</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Breast cancer type 1 susceptibility protein homolog" id="PRO_0000055832">
<location>
<begin position="1"/>
<end position="1812"/>
</location>
</feature>
<feature type="domain" description="BRCT 1" evidence="5">
<location>
<begin position="1585"/>
<end position="1679"/>
</location>
</feature>
<feature type="domain" description="BRCT 2" evidence="5">
<location>
<begin position="1698"/>
<end position="1797"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="6">
<location>
<begin position="24"/>
<end position="65"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PALB2" evidence="3">
<location>
<begin position="1353"/>
<end position="1380"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="1562"/>
<end position="1567"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="4">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="114"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="305"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="392"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="686"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="706"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="717"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="831"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CHEK2" evidence="4">
<location>
<position position="971"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="992"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1152"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1154"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1174"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1180"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1241"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1297"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1303"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1343"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4">
<location>
<position position="1350"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1413"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1481"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1495"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4">
<location>
<position position="109"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4">
<location>
<position position="298"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4">
<location>
<position position="336"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4">
<location>
<position position="440"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4">
<location>
<position position="456"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4">
<location>
<position position="512"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4">
<location>
<position position="1048"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA96393." ref="3" evidence="10">
<original>F</original>
<variation>L</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>S</original>
<variation>T</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>A</original>
<variation>P</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA96393." ref="3" evidence="10">
<original>Q</original>
<variation>E</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA96393." ref="3" evidence="10">
<original>K</original>
<variation>Q</variation>
<location>
<position position="550"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>P</original>
<variation>A</variation>
<location>
<position position="652"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA96393 and 4; AAC52323." ref="3 4" evidence="10">
<original>S</original>
<variation>P</variation>
<location>
<position position="765"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA96393." ref="3" evidence="10">
<original>P</original>
<variation>L</variation>
<location>
<position position="917"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA96393 and 7; AAA99742." ref="3 7" evidence="10">
<original>C</original>
<variation>S</variation>
<location>
<position position="933"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB17114." ref="1" evidence="10">
<original>C</original>
<variation>R</variation>
<location>
<position position="1091"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>I</original>
<variation>K</variation>
<location>
<position position="1122"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA96393." ref="3" evidence="10">
<original>S</original>
<variation>R</variation>
<location>
<position position="1206"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA96393." ref="3" evidence="10">
<original>RM</original>
<variation>GI</variation>
<location>
<begin position="1212"/>
<end position="1213"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA96393." ref="3" evidence="10">
<original>S</original>
<variation>R</variation>
<location>
<position position="1255"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA96393." ref="3" evidence="10">
<original>H</original>
<variation>N</variation>
<location>
<position position="1261"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>A</original>
<variation>V</variation>
<location>
<position position="1264"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>A</original>
<variation>P</variation>
<location>
<position position="1269"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>K</original>
<variation>T</variation>
<location>
<position position="1283"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>N</original>
<variation>T</variation>
<location>
<position position="1337"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>T</original>
<variation>P</variation>
<location>
<position position="1349"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>QR</original>
<variation>EG</variation>
<location>
<begin position="1352"/>
<end position="1353"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>P</original>
<variation>S</variation>
<location>
<position position="1381"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>A</original>
<variation>G</variation>
<location>
<position position="1390"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>D</original>
<variation>V</variation>
<location>
<position position="1400"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>Q</original>
<variation>E</variation>
<location>
<position position="1503"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>A</original>
<variation>V</variation>
<location>
<position position="1549"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>K</original>
<variation>T</variation>
<location>
<position position="1680"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>E</original>
<variation>D</variation>
<location>
<position position="1712"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB17113." ref="2" evidence="10">
<original>E</original>
<variation>D</variation>
<location>
<position position="1721"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB17114." ref="1" evidence="10">
<original>D</original>
<variation>G</variation>
<location>
<position position="1791"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21183079"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P38398"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00033"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12360400"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22549958"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23039116"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000305"/>
<sequence length="1812" mass="198795" checksum="2B47FB55B149FD71" modified="2012-10-03" version="3">
MDLSAVQIQEVQNVLHAMQKILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQ
CPLCKNEITKRSLQGSTRFSQLAEELLRIMAAFELDTGMQLTNGFSFSKKRNNSCERLNE
EASIIQSVGYRNRVRRLPQVEPGNATLKDSLGVQLSNLGIVRSVKKNRQTQPRKKSVYIE
LDSDSSEETVTKPGDCSVRDQELLQTAPQEAGDEGKLHSAEEAACEFSEGIRNIEHHQCS
DDLNPTENHATERHPEKCQSISISNVCVEPCGTDAHASSLQPETSSLLLIEDRMNAEKAE
FCNKSKQPGIAVSQQSRWAASKGTCNDRQVPSTGEKVGPNADSLSDREKWTHPQSLCPEN
SGATTDVPWITLNSSVQKVNEWFSRTGEMLTSDSASARRHESNAEAAVVLEVSNEVDGGF
SSSRKTDLVTPDPHHTLMCKSGRDFSKPVEDNISDKIFGKSYQRKGSRPHLNHVTEIIGT
FITEPQITQEQPFTNKLKRKRSTSLQPEDFIKKADSAGVQRTPDNINQGTDLMEPNEQAV
STTSNCQENKIAGSNLQKEKSAHPTESLRKEPASTAGAKSISNSVSDLEVELNVHSSKAP
KKNRLRRKSSIRCALPLEPISRNPSPPTCAELQIDSCGSSEETKKNHSNQQPAGHLREPQ
LIEDTEPAADAKKNEPNEHIRKRRASDAFPEEKLMNKAGLLTSCSSPRKSQGPVNPSPQR
TGTEQLETRQMSDSAKELGDRVLGGEPSGKTTDRSEESTSVSLVSDTDYDTQNSVSVLDA
HTVRYARTGSAQCMTQFVASENPKELVHGSNNAGSGTEGLKPPLRHALNLSQEKVEMEDS
ELDTQYLQNTFQVSKRQSFALFSKPRSPQKDCAHSVPSKELSPKVTAKGKQKERQGQEEF
EISHVQAVAATVGLPVPCQEGKLAADTMCDRGCRLCPSSHYRSGENGLSATGKSGISQNS
HFKQSVSPIRSSIKTDNRKPLTEGRFERHTSSTEMAVGNENILQSTVHTVSLNNRGNACQ
EAGSGSIHEVCSTGDSFPGQLGRNRGPKVNTVPPLDSMQPGVCQQSVPVSDKYLEIKKQE
GEAVCADFSPCLFSDHLEQSMSGKVFQVCSETPDDLLDDVEIQGHTSFGEGDIMERSAVF
NGSILRRESSRSPSPVTHASKSQSLHRASRKLESSEESDSTEDEDLPCFQHLLSRISNTP
ELTRCSSAVTQRMPEKAEGTQAPWKGSSSDCNNEVIMIEASQEHQFSEDPRCSGSMFSSQ
HSAAQGSTANANSQDSNFIPPSKQRSHQCGNEEAFLSDKELISDNEEMATCLEEDNDQEE
DSIIPDSEASGYESETNLSEDCSQSDILTTQQRATMKYNLIKLQQEMAHLEAVLEQRGNQ
PSGHSPSLLADPCALEDLPDLEPNMSGAAILTSKNINENPVSQNLKSACDDKFQLQHLEG
PTSGDDESGMGRPSPFKSPLAGSRGSAHGCSRHLQKRNSPSQEELLQPAGSEASSEPHNS
TGQSCLPRRELEGTPYLGSGISLFSSRDPESESPKEPAHIGTTPASTSALKIPQGQVAFR
SAAAAGADKAVVGIVSKIKPELTSSEERADRDISMVVSGLTPKEVMTVQKFAEKYRLTLT
DAITEETTHVIIKTDAEFVCERTLKYFLGIAGGKWIVSYSWVVRSIQERRLLNVHEFEVK
GDVVTGRNHQGPRRSRESREKLFKGLQVYCCEPFTNMPKDELERMLQLCGASVVKELPSL
THDTGAHLVVIVQPSAWTEDSNCPDIGQLCKARLVMWDWVLDSLSSYRCRDLDAYLVQNI
TCDSSEPQDSND
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2017-12-20" version="201">
<accession>P51587</accession>
<accession>O00183</accession>
<accession>O15008</accession>
<accession>Q13879</accession>
<accession>Q5TBJ7</accession>
<name>BRCA2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Breast cancer type 2 susceptibility protein</fullName>
</recommendedName>
<alternativeName>
<fullName>Fanconi anemia group D1 protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">BRCA2</name>
<name type="synonym">FACD</name>
<name type="synonym">FANCD1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Nature" volume="378" first="789" last="792">
<title>Identification of the breast cancer susceptibility gene BRCA2.</title>
<authorList>
<person name="Wooster R."/>
<person name="Bignell G."/>
<person name="Lancaster J."/>
<person name="Swift S."/>
<person name="Seal S."/>
<person name="Mangion J."/>
<person name="Collins N."/>
<person name="Gregory S."/>
<person name="Gumbs C."/>
<person name="Micklem G."/>
<person name="Barfoot R."/>
<person name="Hamoudi R."/>
<person name="Patel S."/>
<person name="Rice C."/>
<person name="Biggs P."/>
<person name="Hashim Y."/>
<person name="Smith A."/>
<person name="Connor F."/>
<person name="Arason A."/>
<person name="Gudmundsson J."/>
<person name="Ficenec D."/>
<person name="Kelsell D."/>
<person name="Ford D."/>
<person name="Tonin P."/>
<person name="Bishop D.T."/>
<person name="Spurr N.K."/>
<person name="Ponder B.A.J."/>
<person name="Eeles R."/>
<person name="Peto J."/>
<person name="Devilee P."/>
<person name="Cornelisse C."/>
<person name="Lynch H."/>
<person name="Narod S."/>
<person name="Lenoir G."/>
<person name="Egilsson V."/>
<person name="Barkadottir R.B."/>
<person name="Easton D.F."/>
<person name="Bentley D.R."/>
<person name="Futreal P.A."/>
<person name="Ashworth A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="8524414"/>
<dbReference type="DOI" id="10.1038/378789a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Nat. Genet." volume="12" first="333" last="337">
<title>The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.</title>
<authorList>
<person name="Tavtigian S.V."/>
<person name="Simard J."/>
<person name="Rommens J."/>
<person name="Couch F."/>
<person name="Shattuck-Eidens D."/>
<person name="Neuhausen S."/>
<person name="Merajver S."/>
<person name="Thorlacius S."/>
<person name="Offit K."/>
<person name="Stoppa-Lyonnet D."/>
<person name="Belanger C."/>
<person name="Bell R."/>
<person name="Berry S."/>
<person name="Bogden R."/>
<person name="Chen Q."/>
<person name="Davis T."/>
<person name="Dumont M."/>
<person name="Frye C."/>
<person name="Hattier T."/>
<person name="Jammulapati S."/>
<person name="Janecki T."/>
<person name="Jiang P."/>
<person name="Kehrer R."/>
<person name="Leblanc J.-F."/>
<person name="Mitchell J.T."/>
<person name="McArthur-Morrison J."/>
<person name="Nguyen K."/>
<person name="Peng Y."/>
<person name="Samson C."/>
<person name="Schroeder M."/>
<person name="Snyder S.C."/>
<person name="Steele L."/>
<person name="Stringfellow M."/>
<person name="Stroup C."/>
<person name="Swedlund B."/>
<person name="Swensen J."/>
<person name="Teng D."/>
<person name="Thomas A."/>
<person name="Tran T."/>
<person name="Tran T."/>
<person name="Tranchant M."/>
<person name="Weaver-Feldhaus J."/>
<person name="Wong A.K.C."/>
<person name="Shizuya H."/>
<person name="Eyfjord J.E."/>
<person name="Cannon-Albright L."/>
<person name="Labrie F."/>
<person name="Skolnick M.H."/>
<person name="Weber B."/>
<person name="Kamb A."/>
<person name="Goldar D.E."/>
</authorList>
<dbReference type="PubMed" id="8589730"/>
<dbReference type="DOI" id="10.1038/ng0396-333"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS HIS-372 AND PHE-599</scope>
</reference>
<reference key="3">
<citation type="submission" date="2003-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS HIS-289; GLN-322; HIS-372; VAL-784; SER-929; PHE-976; ILE-987; ASP-991; ASN-1561; LYS-1880; MET-1915; PHE-2138; ARG-2162; ARG-2440; VAL-2466; THR-2490; PRO-2835; ALA-2856; PHE-2944; THR-2951; ILE-3244 AND VAL-3412</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="428" first="522" last="528">
<title>The DNA sequence and analysis of human chromosome 13.</title>
<authorList>
<person name="Dunham A."/>
<person name="Matthews L.H."/>
<person name="Burton J."/>
<person name="Ashurst J.L."/>
<person name="Howe K.L."/>
<person name="Ashcroft K.J."/>
<person name="Beare D.M."/>
<person name="Burford D.C."/>
<person name="Hunt S.E."/>
<person name="Griffiths-Jones S."/>
<person name="Jones M.C."/>
<person name="Keenan S.J."/>
<person name="Oliver K."/>
<person name="Scott C.E."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews D.T."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Bannerjee R."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burrill W."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M.E."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S.C."/>
<person name="Cobley V."/>
<person name="Collins J.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Deloukas P."/>
<person name="Dhami P."/>
<person name="Dunham I."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.G."/>
<person name="Faulkner L."/>
<person name="Frankish A.G."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gilbert J.G.R."/>
<person name="Gilson C.J."/>
<person name="Ghori J."/>
<person name="Grafham D.V."/>
<person name="Gribble S.M."/>
<person name="Griffiths C."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C.J."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Lloyd C."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="McLaren S.J."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K.M."/>
<person name="Rice C.M."/>
<person name="Searle S."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thomas D.W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wright M.W."/>
<person name="Young L."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Beck S."/>
<person name="Bentley D.R."/>
<person name="Rogers J."/>
<person name="Ross M.T."/>
</authorList>
<dbReference type="PubMed" id="15057823"/>
<dbReference type="DOI" id="10.1038/nature02379"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="Nat. Genet." volume="16" first="17" last="18">
<title>Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients.</title>
<authorList>
<person name="Ozcelik H."/>
<person name="Schmocker B."/>
<person name="Di Nicola N."/>
<person name="Shi X.H."/>
<person name="Langer B."/>
<person name="Moore M."/>
<person name="Taylor B.R."/>
<person name="Narod S.A."/>
<person name="Darlington G."/>
<person name="Andrulis I.L."/>
<person name="Gallinger S."/>
<person name="Redston M."/>
</authorList>
<dbReference type="PubMed" id="9140390"/>
<dbReference type="DOI" id="10.1038/ng0597-17"/>
</citation>
<scope>INVOLVEMENT IN PNCA2</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="4633" last="4642">
<title>Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals.</title>
<authorList>
<person name="Marston N.J."/>
<person name="Richards W.J."/>
<person name="Hughes D."/>
<person name="Bertwistle D."/>
<person name="Marshall C.J."/>
<person name="Ashworth A."/>
</authorList>
<dbReference type="PubMed" id="10373512"/>
<dbReference type="DOI" id="10.1128/MCB.19.7.4633"/>
</citation>
<scope>INTERACTION WITH SEM1</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="1241" last="1248">
<title>Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways.</title>
<authorList>
<person name="Hussain S."/>
<person name="Wilson J.B."/>
<person name="Medhurst A.L."/>
<person name="Hejna J."/>
<person name="Witt E."/>
<person name="Ananth S."/>
<person name="Davies A."/>
<person name="Masson J.-Y."/>
<person name="Moses R."/>
<person name="West S.C."/>
<person name="de Winter J.P."/>
<person name="Ashworth A."/>
<person name="Jones N.J."/>
<person name="Mathew C.G."/>
</authorList>
<dbReference type="PubMed" id="15115758"/>
<dbReference type="DOI" id="10.1093/hmg/ddh135"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FANCD2</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="5850" last="5862">
<title>Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin.</title>
<authorList>
<person name="Wang X.Z."/>
<person name="Andreassen P.R."/>
<person name="D'Andrea A.D."/>
</authorList>
<dbReference type="PubMed" id="15199141"/>
<dbReference type="DOI" id="10.1128/MCB.24.13.5850-5862.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH FANCD2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="7444" last="7455">
<title>BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage.</title>
<authorList>
<person name="Schoenfeld A.R."/>
<person name="Apgar S."/>
<person name="Dolios G."/>
<person name="Wang R."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="15314155"/>
<dbReference type="DOI" id="10.1128/MCB.24.17.7444-7455.2004"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION</scope>
<scope>INTERACTION WITH USP11</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="J. Med. Genet." volume="42" first="147" last="151">
<title>Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour.</title>
<authorList>
<consortium name="The famillial Wilms tumor collaboration"/>
<person name="Reid S."/>
<person name="Renwick A."/>
<person name="Seal S."/>
<person name="Baskcomb L."/>
<person name="Barfoot R."/>
<person name="Jayatilake H."/>
<person name="Pritchard-Jones K."/>
<person name="Stratton M.R."/>
<person name="Ridolfi-Luethy A."/>
<person name="Rahman N."/>
</authorList>
<dbReference type="PubMed" id="15689453"/>
<dbReference type="DOI" id="10.1136/jmg.2004.022673"/>
</citation>
<scope>INVOLVEMENT IN GLM3</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="14877" last="14883">
<title>FANCD2 functions independently of BRCA2 and RAD51 associated homologous recombination in response to DNA damage.</title>
<authorList>
<person name="Ohashi A."/>
<person name="Zdzienicka M.Z."/>
<person name="Chen J."/>
<person name="Couch F.J."/>
</authorList>
<dbReference type="PubMed" id="15671039"/>
<dbReference type="DOI" id="10.1074/jbc.M414669200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Nature" volume="434" first="598" last="604">
<title>CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair.</title>
<authorList>
<person name="Esashi F."/>
<person name="Christ N."/>
<person name="Gannon J."/>
<person name="Liu Y."/>
<person name="Hunt T."/>
<person name="Jasin M."/>
<person name="West S.C."/>
</authorList>
<dbReference type="PubMed" id="15800615"/>
<dbReference type="DOI" id="10.1038/nature03404"/>
</citation>
<scope>PHOSPHORYLATION AT SER-3291 BY CDK2</scope>
<scope>INTERACTION WITH RAD51</scope>
<scope>MUTAGENESIS OF SER-3291</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Neoplasia" volume="7" first="348" last="355">
<title>WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation.</title>
<authorList>
<person name="Silva F.P."/>
<person name="Hamamoto R."/>
<person name="Nakamura Y."/>
<person name="Furukawa Y."/>
</authorList>
<dbReference type="PubMed" id="15967112"/>
<dbReference type="DOI" id="10.1593/neo.04544"/>
</citation>
<scope>INTERACTION WITH WDR16</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Mol. Cell" volume="22" first="719" last="729">
<title>Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.</title>
<authorList>
<person name="Xia B."/>
<person name="Sheng Q."/>
<person name="Nakanishi K."/>
<person name="Ohashi A."/>
<person name="Wu J."/>
<person name="Christ N."/>
<person name="Liu X."/>
<person name="Jasin M."/>
<person name="Couch F.J."/>
<person name="Livingston D.M."/>
</authorList>
<dbReference type="PubMed" id="16793542"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.05.022"/>
</citation>
<scope>INTERACTION WITH PALB2</scope>
<scope>CHARACTERIZATION OF VARIANTS BC ARG-25; CYS-31 AND ARG-31</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="1186" last="1194">
<title>DSS1 is required for the stability of BRCA2.</title>
<authorList>
<person name="Li J."/>
<person name="Zou C."/>
<person name="Bai Y."/>
<person name="Wazer D.E."/>
<person name="Band V."/>
<person name="Gao Q."/>
</authorList>
<dbReference type="PubMed" id="16205630"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209153"/>
</citation>
<scope>INTERACTION WITH SEM1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-755</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="3641" last="3652">
<title>FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.</title>
<authorList>
<person name="Wilson J.B."/>
<person name="Yamamoto K."/>
<person name="Marriott A.S."/>
<person name="Hussain S."/>
<person name="Sung P."/>
<person name="Hoatlin M.E."/>
<person name="Mathew C.G."/>
<person name="Takata M."/>
<person name="Thompson L.H."/>
<person name="Kupfer G.M."/>
<person name="Jones N.J."/>
</authorList>
<dbReference type="PubMed" id="18212739"/>
<dbReference type="DOI" id="10.1038/sj.onc.1211034"/>
</citation>
<scope>INTERACTION WITH FANCD2; FANCG AND XRCC3</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="3977" last="3985">
<title>The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.</title>
<authorList>
<person name="Bahassi E.M."/>
<person name="Ovesen J.L."/>
<person name="Riesenberg A.L."/>
<person name="Bernstein W.Z."/>
<person name="Hasty P.E."/>
<person name="Stambrook P.J."/>
</authorList>
<dbReference type="PubMed" id="18317453"/>
<dbReference type="DOI" id="10.1038/onc.2008.17"/>
</citation>
<scope>FUNCTION IN RAD51-DEPENDENT DNA REPAIR</scope>
<scope>PHOSPHORYLATION AT THR-3387 BY CHEK1 AND CHEK2</scope>
<scope>MUTAGENESIS OF THR-3387</scope>
<scope>INTERACTION WITH RAD51</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="7155" last="7160">
<title>PALB2 is an integral component of the BRCA complex required for homologous recombination repair.</title>
<authorList>
<person name="Sy S.M."/>
<person name="Huen M.S."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19369211"/>
<dbReference type="DOI" id="10.1073/pnas.0811159106"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN A BRCA COMPLEX WITH BRCA1 AND PALB2</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="1260" last="1262">
<title>Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA.</title>
<authorList>
<person name="Liu J."/>
<person name="Doty T."/>
<person name="Gibson B."/>
<person name="Heyer W.D."/>
</authorList>
<dbReference type="PubMed" id="20729859"/>
<dbReference type="DOI" id="10.1038/nsmb.1904"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAD51</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="1263" last="1265">
<title>The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA.</title>
<authorList>
<person name="Thorslund T."/>
<person name="McIlwraith M.J."/>
<person name="Compton S.A."/>
<person name="Lekomtsev S."/>
<person name="Petronczki M."/>
<person name="Griffith J.D."/>
<person name="West S.C."/>
</authorList>
<dbReference type="PubMed" id="20729858"/>
<dbReference type="DOI" id="10.1038/nsmb.1905"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Nature" volume="467" first="678" last="683">
<title>Purified human BRCA2 stimulates RAD51-mediated recombination.</title>
<authorList>
<person name="Jensen R.B."/>
<person name="Carreira A."/>
<person name="Kowalczykowski S.C."/>
</authorList>
<dbReference type="PubMed" id="20729832"/>
<dbReference type="DOI" id="10.1038/nature09399"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAD51 AND DMC1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="68" last="77">
<title>BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2.</title>
<authorList>
<person name="Wang H.F."/>
<person name="Takenaka K."/>
<person name="Nakanishi A."/>
<person name="Miki Y."/>
</authorList>
<dbReference type="PubMed" id="21084279"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-0030"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ROCK2 AND NPM1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Exp. Cell Res." volume="317" first="1203" last="1213">
<title>Homologous recombination proteins are associated with centrosomes and are required for mitotic stability.</title>
<authorList>
<person name="Cappelli E."/>
<person name="Townsend S."/>
<person name="Griffin C."/>
<person name="Thacker J."/>
</authorList>
<dbReference type="PubMed" id="21276791"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2011.01.021"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-445; SER-492; SER-1970; THR-2035; SER-2095 AND SER-3319</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="Nat. Struct. Mol. Biol." volume="20" first="1191" last="1198">
<title>A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization.</title>
<authorList>
<person name="Jeyasekharan A.D."/>
<person name="Liu Y."/>
<person name="Hattori H."/>
<person name="Pisupati V."/>
<person name="Jonsdottir A.B."/>
<person name="Rajendra E."/>
<person name="Lee M."/>
<person name="Sundaramoorthy E."/>
<person name="Schlachter S."/>
<person name="Kaminski C.F."/>
<person name="Ofir-Rosenfeld Y."/>
<person name="Sato K."/>
<person name="Savill J."/>
<person name="Ayoub N."/>
<person name="Venkitaraman A.R."/>
</authorList>
<dbReference type="PubMed" id="24013206"/>
<dbReference type="DOI" id="10.1038/nsmb.2666"/>
</citation>
<scope>INTERACTION WITH SEM1</scope>
<scope>CHARACTERIZATION OF VARIANT BC HIS-2723</scope>
<scope>MUTAGENESIS OF TRP-2725</scope>
<scope>NUCLEAR EXPORT SIGNAL</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="Oncogene" volume="33" first="4803" last="4812">
<title>Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.</title>
<authorList>
<person name="Park J.Y."/>
<person name="Singh T.R."/>
<person name="Nassar N."/>
<person name="Zhang F."/>
<person name="Freund M."/>
<person name="Hanenberg H."/>
<person name="Meetei A.R."/>
<person name="Andreassen P.R."/>
</authorList>
<dbReference type="PubMed" id="24141787"/>
<dbReference type="DOI" id="10.1038/onc.2013.421"/>
</citation>
<scope>INTERACTION WITH PALB2</scope>
<scope>IDENTIFICATION IN A PALB2-CONTAINING HR COMPLEX</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2014" name="Cell Rep." volume="6" first="553" last="564">
<title>Breast cancer proteins PALB2 and BRCA2 stimulate polymerase eta in recombination-associated DNA synthesis at blocked replication forks.</title>
<authorList>
<person name="Buisson R."/>
<person name="Niraj J."/>
<person name="Pauty J."/>
<person name="Maity R."/>
<person name="Zhao W."/>
<person name="Coulombe Y."/>
<person name="Sung P."/>
<person name="Masson J.Y."/>
</authorList>
<dbReference type="PubMed" id="24485656"/>
<dbReference type="DOI" id="10.1016/j.celrep.2014.01.009"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH POLH</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="Nature" volume="511" first="362" last="365">
<title>BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2.</title>
<authorList>
<person name="Bhatia V."/>
<person name="Barroso S.I."/>
<person name="Garcia-Rubio M.L."/>
<person name="Tumini E."/>
<person name="Herrera-Moyano E."/>
<person name="Aguilera A."/>
</authorList>
<dbReference type="PubMed" id="24896180"/>
<dbReference type="DOI" id="10.1038/nature13374"/>
</citation>
<scope>FUNCTION IN R-LOOP PROCESSING</scope>
<scope>INTERACTION WITH SEM1 AND PCID2</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2017" name="Oncogene" volume="36" first="4161" last="4170">
<title>Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.</title>
<authorList>
<person name="Foo T.K."/>
<person name="Tischkowitz M."/>
<person name="Simhadri S."/>
<person name="Boshari T."/>
<person name="Zayed N."/>
<person name="Burke K.A."/>
<person name="Berman S.H."/>
<person name="Blecua P."/>
<person name="Riaz N."/>
<person name="Huo Y."/>
<person name="Ding Y.C."/>
<person name="Neuhausen S.L."/>
<person name="Weigelt B."/>
<person name="Reis-Filho J.S."/>
<person name="Foulkes W.D."/>
<person name="Xia B."/>
</authorList>
<dbReference type="PubMed" id="28319063"/>
<dbReference type="DOI" id="10.1038/onc.2017.46"/>
</citation>
<scope>INTERACTION WITH PALB2</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2002" name="Nature" volume="420" first="287" last="293">
<title>Insights into DNA recombination from the structure of a RAD51-BRCA2 complex.</title>
<authorList>
<person name="Pellegrini L."/>
<person name="Yu D.S."/>
<person name="Lo T."/>
<person name="Anand S."/>
<person name="Lee M."/>
<person name="Blundell T.L."/>
<person name="Venkitaraman A.R."/>
</authorList>
<dbReference type="PubMed" id="12442171"/>
<dbReference type="DOI" id="10.1038/nature01230"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1519-1551 IN COMPLEX WITH RAD51</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="EMBO Rep." volume="10" first="990" last="996">
<title>Structural basis for recruitment of BRCA2 by PALB2.</title>
<authorList>
<person name="Oliver A.W."/>
<person name="Swift S."/>
<person name="Lord C.J."/>
<person name="Ashworth A."/>
<person name="Pearl L.H."/>
</authorList>
<dbReference type="PubMed" id="19609323"/>
<dbReference type="DOI" id="10.1038/embor.2009.126"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 21-39 IN COMPLEX WITH PALB2</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1996" name="Cancer Res." volume="56" first="2738" last="2741">
<title>Mutations of the BRCA2 gene in ovarian carcinomas.</title>
<authorList>
<person name="Takahashi H."/>
<person name="Chiu H.-C."/>
<person name="Bandera C.A."/>
<person name="Behbakht K."/>
<person name="Liu P.C."/>
<person name="Couch F.J."/>
<person name="Weber B.L."/>
<person name="LiVolsi V.A."/>
<person name="Furusato M."/>
<person name="Rebane B.A."/>
<person name="Cardonick A."/>
<person name="Benjamin I."/>
<person name="Morgan M.A."/>
<person name="King S.A."/>
<person name="Mikuta J.J."/>
<person name="Rubin S.C."/>
<person name="Boyd J."/>
</authorList>
<dbReference type="PubMed" id="8665505"/>
</citation>
<scope>VARIANT OVARIAN CANCER HIS-2787</scope>
<scope>VARIANTS HIS-372; MET-1915 AND VAL-2466</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="123" last="125">
<title>BRCA2 germline mutations in male breast cancer cases and breast cancer families.</title>
<authorList>
<person name="Couch F.J."/>
<person name="Farid L.M."/>
<person name="Deshano M.L."/>
<person name="Tavtigian S.V."/>
<person name="Calzone K."/>
<person name="Campeau L."/>
<person name="Peng Y."/>
<person name="Bogden B."/>
<person name="Chen Q."/>
<person name="Neuhausen S."/>
<person name="Shattuck-Eidens D."/>
<person name="Godwin A.K."/>
<person name="Daly M."/>
<person name="Radford D.M."/>
<person name="Sedlacek S."/>
<person name="Rommens J."/>
<person name="Simard J."/>
<person name="Garber J."/>
<person name="Merajver S."/>
<person name="Weber B.L."/>
</authorList>
<dbReference type="PubMed" id="8673091"/>
<dbReference type="DOI" id="10.1038/ng0596-123"/>
</citation>
<scope>VARIANTS HIS-372; ASP-991; SER-1147; MET-1915 AND CYS-2034</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="238" last="240">
<title>BRCA2 mutations in primary breast and ovarian cancers.</title>
<authorList>
<person name="Lancaster J.M."/>
<person name="Wooster R."/>
<person name="Mangion J."/>
<person name="Phelan C.M."/>
<person name="Cochran C."/>
<person name="Gumbs C."/>
<person name="Seal S."/>
<person name="Barfoot R."/>
<person name="Collins N."/>
<person name="Bignell G."/>
<person name="Patel S."/>
<person name="Hamoudi R."/>
<person name="Larsson C."/>
<person name="Wiseman R.W."/>
<person name="Berchuck A."/>
<person name="Iglehart J.D."/>
<person name="Marks J.R."/>
<person name="Ashworth A."/>
<person name="Stratton M.R."/>
<person name="Futreal P.A."/>
</authorList>
<dbReference type="PubMed" id="8640235"/>
<dbReference type="DOI" id="10.1038/ng0696-238"/>
</citation>
<scope>VARIANT GLU-3095</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="241" last="244">
<title>Low incidence of BRCA2 mutations in breast carcinoma and other cancers.</title>
<authorList>
<person name="Teng D.H.-F."/>
<person name="Bogden R."/>
<person name="Mitchell J."/>
<person name="Baumgard M."/>
<person name="Bell R."/>
<person name="Berry S."/>
<person name="Davis T."/>
<person name="Ha P.C."/>
<person name="Kehrer R."/>
<person name="Jammulapati S."/>
<person name="Chen Q."/>
<person name="Offit K."/>
<person name="Skolnick M.H."/>
<person name="Tavtigian S.V."/>
<person name="Jhanwar S."/>
<person name="Swedlund B."/>
<person name="Wong A.K.C."/>
<person name="Kamb A."/>
</authorList>
<dbReference type="PubMed" id="8640236"/>
<dbReference type="DOI" id="10.1038/ng0696-241"/>
</citation>
<scope>VARIANTS</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="245" last="247">
<title>Mutation analysis in the BRCA2 gene in primary breast cancers.</title>
<authorList>
<person name="Miki Y."/>
<person name="Katagiri T."/>
<person name="Kasumi F."/>
<person name="Yoshimoto T."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="8640237"/>
<dbReference type="DOI" id="10.1038/ng0696-245"/>
</citation>
<scope>VARIANT BC ASN-2415</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1997" name="Am. J. Hum. Genet." volume="60" first="1050" last="1058">
<title>A low proportion of BRCA2 mutations in Finnish breast cancer families.</title>
<authorList>
<person name="Vehmanen P."/>
<person name="Friedman L.S."/>
<person name="Eerola H."/>
<person name="Sarantaus L."/>
<person name="Pyrhoenen S."/>
<person name="Ponder B.A.J."/>
<person name="Muhonen T."/>
<person name="Nevanlinna H."/>
</authorList>
<dbReference type="PubMed" id="9150152"/>
</citation>
<scope>VARIANT BC ASP-2089</scope>
<scope>VARIANT VAL-3412</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1998" name="Hum. Genet." volume="102" first="549" last="556">
<title>High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.</title>
<authorList>
<person name="Ganguly T."/>
<person name="Dhulipala R."/>
<person name="Godmilow L."/>
<person name="Ganguly A."/>
</authorList>
<dbReference type="PubMed" id="9654203"/>
<dbReference type="DOI" id="10.1007/s004390050738"/>
</citation>
<scope>VARIANT BC/PANCREAS CANCER TRP-554</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1998" name="J. Hum. Genet." volume="43" first="42" last="48">
<title>High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families.</title>
<authorList>
<person name="Katagiri T."/>
<person name="Kasumi F."/>
<person name="Yoshimoto M."/>
<person name="Nomizu T."/>
<person name="Asaishi K."/>
<person name="Abe R."/>
<person name="Tsuchiya A."/>
<person name="Sugano M."/>
<person name="Takai S."/>
<person name="Yoneda M."/>
<person name="Fukutomi T."/>
<person name="Nanba K."/>
<person name="Makita M."/>
<person name="Okazaki H."/>
<person name="Hirata K."/>
<person name="Okazaki M."/>
<person name="Furutsuma Y."/>
<person name="Morishita Y."/>
<person name="Iino Y."/>
<person name="Karino T."/>
<person name="Ayabe H."/>
<person name="Hara S."/>
<person name="Kajiwara T."/>
<person name="Houga S."/>
<person name="Shimizu T."/>
<person name="Toda M."/>
<person name="Yamazaki Y."/>
<person name="Uchida T."/>
<person name="Kunitomo K."/>
<person name="Sonoo H."/>
<person name="Kurebayashi J."/>
<person name="Shimotsuma K."/>
<person name="Nakamura Y."/>
<person name="Miki Y."/>
</authorList>
<dbReference type="PubMed" id="9609997"/>
<dbReference type="DOI" id="10.1007/s100380050035"/>
</citation>
<scope>VARIANTS BC LEU-32; ARG-53; LEU-81; ARG-201; ALA-211; SER-222 AND THR-3118</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="65" first="1021" last="1029">
<title>The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.</title>
<authorList>
<person name="Gayther S.A."/>
<person name="Russell P."/>
<person name="Harrington P."/>
<person name="Antoniou A.C."/>
<person name="Easton D.F."/>
<person name="Ponder B.A.J."/>
</authorList>
<dbReference type="PubMed" id="10486320"/>
<dbReference type="DOI" id="10.1086/302583"/>
</citation>
<scope>VARIANTS OVARIAN CANCER PRO-75; HIS-2502 AND HIS-3098</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1999" name="Hum. Genet." volume="104" first="201" last="204">
<title>Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan.</title>
<authorList>
<person name="Li S.S.-L."/>
<person name="Tseng H.-M."/>
<person name="Yang T.-P."/>
<person name="Liu C.-H."/>
<person name="Teng S.-J."/>
<person name="Huang H.-W."/>
<person name="Chen L.-M."/>
<person name="Kao H.-W."/>
<person name="Chen J.H."/>
<person name="Tseng J.-N."/>
<person name="Chen A."/>
<person name="Hou M.-F."/>
<person name="Huang T.-J."/>
<person name="Chang H.-T."/>
<person name="Mok K.-T."/>
<person name="Tsai J.-H."/>
</authorList>
<dbReference type="PubMed" id="10323242"/>
<dbReference type="DOI" id="10.1007/s004390050936"/>
</citation>
<scope>VARIANTS HIS-289; HIS-372; ASP-991 AND VAL-3412</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="413" last="423">
<title>Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.</title>
<authorList>
<person name="Wagner T.M.U."/>
<person name="Hirtenlehner K."/>
<person name="Shen P."/>
<person name="Moeslinger R."/>
<person name="Muhr D."/>
<person name="Fleischmann E."/>
<person name="Concin H."/>
<person name="Doeller W."/>
<person name="Haid A."/>
<person name="Lang A.H."/>
<person name="Mayer P."/>
<person name="Petru E."/>
<person name="Ropp E."/>
<person name="Langbauer G."/>
<person name="Kubista E."/>
<person name="Scheiner O."/>
<person name="Underhill P."/>
<person name="Mountain J."/>
<person name="Stierer M."/>
<person name="Zielinski C."/>
<person name="Oefner P."/>
</authorList>
<dbReference type="PubMed" id="9971877"/>
<dbReference type="DOI" id="10.1093/hmg/8.3.413"/>
</citation>
<scope>VARIANTS BC</scope>
<scope>VARIANTS</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1999" name="Int. J. Cancer" volume="82" first="325" last="328">
<title>Germline brca2 sequence variants in patients with ocular melanoma.</title>
<authorList>
<person name="Sinilnikova O.M."/>
<person name="Egan K.M."/>
<person name="Quinn J.L."/>
<person name="Boutrand L."/>
<person name="Lenoir G.M."/>
<person name="Stoppa-Lyonnet D."/>
<person name="Desjardins L."/>
<person name="Levy C."/>
<person name="Goldgar D."/>
<person name="Gragoudas E.S."/>
</authorList>
<dbReference type="PubMed" id="10399947"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-0215(19990730)82:3&lt;325::AID-IJC3&gt;3.0.CO;2-G"/>
</citation>
<scope>VARIANT BC ARG-326</scope>
<scope>VARIANT ILE-2728</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2000" name="Nat. Genet." volume="26" first="362" last="364">
<title>A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.</title>
<authorList>
<person name="Healey C.S."/>
<person name="Dunning A.M."/>
<person name="Teare M.D."/>
<person name="Chase D."/>
<person name="Parker L."/>
<person name="Burn J."/>
<person name="Chang-Claude J."/>
<person name="Mannermaa A."/>
<person name="Kataja V."/>
<person name="Huntsman D.G."/>
<person name="Pharoah P.D.P."/>
<person name="Luben R.N."/>
<person name="Easton D.F."/>
<person name="Ponder B.A.J."/>
</authorList>
<dbReference type="PubMed" id="11062481"/>
<dbReference type="DOI" id="10.1038/81691"/>
</citation>
<scope>VARIANT HIS-372</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2000" name="J. Med. Genet." volume="37" first="E17" last="E17">
<title>BRCA2 germline mutations among early onset breast cancer patients unselected for family history of the disease.</title>
<authorList>
<person name="Plaschke J."/>
<person name="Commer T."/>
<person name="Jacobi C."/>
<person name="Schackert H.K."/>
<person name="Chang-Claude J."/>
</authorList>
<dbReference type="PubMed" id="10978364"/>
<dbReference type="DOI" id="10.1136/jmg.37.9.e17"/>
</citation>
<scope>VARIANTS BC MET-729; ILE-2515 AND ILE-2728</scope>
<scope>VARIANTS HIS-289; HIS-372; ASP-991; MET-1915 AND VAL-3412</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2001" name="Hum. Mutat." volume="17" first="73" last="73">
<title>BRCA2 germline mutations in male breast cancer patients in the Polish population.</title>
<authorList>
<person name="Kwiatkowska E."/>
<person name="Teresiak M."/>
<person name="Lamperska K.M."/>
<person name="Karczewska A."/>
<person name="Breborowicz D."/>
<person name="Stawicka M."/>
<person name="Godlewski D."/>
<person name="Krzyzosiak W.J."/>
<person name="Mackiewicz A."/>
</authorList>
<dbReference type="PubMed" id="11139248"/>
<dbReference type="DOI" id="10.1002/1098-1004(2001)17:1&lt;73::AID-HUMU12&gt;3.3.CO;2-F"/>
</citation>
<scope>VARIANTS BC ASN-1179; ILE-3124 AND GLU-3196</scope>
<scope>VARIANT TYR-1420</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2001" name="Hum. Mutat." volume="17" first="220" last="232">
<title>An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations-fluorescent mutation detection (F-MD).</title>
<authorList>
<person name="Edwards S.M."/>
<person name="Kote-Jarai Z."/>
<person name="Hamoudi R."/>
<person name="Eeles R.A."/>
</authorList>
<dbReference type="PubMed" id="11241844"/>
<dbReference type="DOI" id="10.1002/humu.7"/>
</citation>
<scope>VARIANTS BC THR-505; TYR-1730; HIS-2135 AND CYS-2222</scope>
<scope>VARIANT LYS-1880</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="71" first="625" last="631">
<title>BRCA2 T2722R is a deleterious allele that causes exon skipping.</title>
<authorList>
<person name="Fackenthal J.D."/>
<person name="Cartegni L."/>
<person name="Krainer A.R."/>
<person name="Olopade O.I."/>
</authorList>
<dbReference type="PubMed" id="12145750"/>
<dbReference type="DOI" id="10.1086/342192"/>
</citation>
<scope>VARIANT BC ARG-2722</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="73" first="1477" last="1477">
<authorList>
<person name="Fackenthal J.D."/>
<person name="Cartegni L."/>
<person name="Krainer A.R."/>
<person name="Olopade O.I."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2002" name="Br. J. Cancer" volume="87" first="888" last="891">
<title>BRCA2 gene mutations in families with aggregations of breast and stomach cancers.</title>
<authorList>
<person name="Jakubowska A."/>
<person name="Nej K."/>
<person name="Huzarski T."/>
<person name="Scott R.J."/>
<person name="Lubinski J."/>
</authorList>
<dbReference type="PubMed" id="12373604"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6600562"/>
</citation>
<scope>VARIANTS BC CYS-2072; CYS-2094 AND ASN-2128</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2002" name="Cancer Res." volume="62" first="3789" last="3793">
<title>Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.</title>
<authorList>
<person name="Murphy K.M."/>
<person name="Brune K.A."/>
<person name="Griffin C."/>
<person name="Sollenberger J.E."/>
<person name="Petersen G.M."/>
<person name="Bansal R."/>
<person name="Hruban R.H."/>
<person name="Kern S.E."/>
</authorList>
<dbReference type="PubMed" id="12097290"/>
</citation>
<scope>VARIANT THR-192</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2002" name="Clin. Cancer Res." volume="8" first="1121" last="1126">
<title>Infrequent mutation in the BRCA2 gene in esophageal squamous cell carcinoma.</title>
<authorList>
<person name="Hu N."/>
<person name="Li G."/>
<person name="Li W.-J."/>
<person name="Wang C."/>
<person name="Goldstein A.M."/>
<person name="Tang Z.-Z."/>
<person name="Roth M.J."/>
<person name="Dawsey S.M."/>
<person name="Huang J."/>
<person name="Wang Q.-H."/>
<person name="Ding T."/>
<person name="Giffen C."/>
<person name="Taylor P.R."/>
<person name="Emmert-Buck M.R."/>
</authorList>
<dbReference type="PubMed" id="11948123"/>
</citation>
<scope>VARIANTS HIS-118; SER-315; ILE-1988; CYS-2842 AND SER-3300</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2002" name="Genet. Test." volume="6" first="119" last="121">
<title>Characterization of common BRCA1 and BRCA2 variants.</title>
<authorList>
<person name="Deffenbaugh A.M."/>
<person name="Frank T.S."/>
<person name="Hoffman M."/>
<person name="Cannon-Albright L."/>
<person name="Neuhausen S.L."/>
</authorList>
<dbReference type="PubMed" id="12215251"/>
<dbReference type="DOI" id="10.1089/10906570260199375"/>
</citation>
<scope>VARIANTS ALA-598; TYR-1420; CYS-2034; ILE-2728 AND THR-2951</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="473" last="474">
<title>BRCA1 and BRCA2 in Indian breast cancer patients.</title>
<authorList>
<person name="Saxena S."/>
<person name="Szabo C.I."/>
<person name="Chopin S."/>
<person name="Barjhoux L."/>
<person name="Sinilnikova O."/>
<person name="Lenoir G."/>
<person name="Goldgar D.E."/>
<person name="Bhatanager D."/>
</authorList>
<dbReference type="PubMed" id="12442273"/>
<dbReference type="DOI" id="10.1002/humu.9082"/>
</citation>
<scope>VARIANTS ASP-1593 AND SER-2706</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="474" last="474">
<title>BRCA1 and BRCA2 sequence variants in Chinese breast cancer families.</title>
<authorList>
<person name="Zhi X."/>
<person name="Szabo C."/>
<person name="Chopin S."/>
<person name="Suter N."/>
<person name="Wang Q.-S."/>
<person name="Ostrander E.A."/>
<person name="Sinilnikova O.M."/>
<person name="Lenoir G.M."/>
<person name="Goldgar D."/>
<person name="Shi Y.-R."/>
</authorList>
<dbReference type="PubMed" id="12442274"/>
<dbReference type="DOI" id="10.1002/humu.9083"/>
</citation>
<scope>VARIANT BC ASN-2729</scope>
<scope>VARIANT VAL-3412</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="474" last="475">
<title>BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico.</title>
<authorList>
<person name="Ruiz-Flores P."/>
<person name="Sinilnikova O.M."/>
<person name="Badzioch M."/>
<person name="Calderon-Garciduenas A.L."/>
<person name="Chopin S."/>
<person name="Fabrice O."/>
<person name="Gonzalez-Guerrero J.F."/>
<person name="Szabo C."/>
<person name="Lenoir G."/>
<person name="Goldgar D.E."/>
<person name="Barrera-Saldana H.A."/>
</authorList>
<dbReference type="PubMed" id="12442275"/>
<dbReference type="DOI" id="10.1002/humu.9084"/>
</citation>
<scope>VARIANTS BC CYS-42; ARG-613; LEU-2118; LEU-2293 AND ARG-2793</scope>
<scope>VARIANT ILE-3374</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2002" name="Int. J. Cancer" volume="98" first="943" last="945">
<title>Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer.</title>
<authorList>
<person name="Kwiatkowska E."/>
<person name="Teresiak M."/>
<person name="Breborowicz D."/>
<person name="Mackiewicz A."/>
</authorList>
<dbReference type="PubMed" id="11948477"/>
<dbReference type="DOI" id="10.1002/ijc.10289"/>
</citation>
<scope>VARIANTS BC TYR-1580 AND MET-1915</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2002" name="Science" volume="297" first="606" last="609">
<title>Biallelic inactivation of BRCA2 in Fanconi anemia.</title>
<authorList>
<person name="Howlett N.G."/>
<person name="Taniguchi T."/>
<person name="Olson S."/>
<person name="Cox B."/>
<person name="Waisfisz Q."/>
<person name="de Die-Smulders C."/>
<person name="Persky N."/>
<person name="Grompe M."/>
<person name="Joenje H."/>
<person name="Pals G."/>
<person name="Ikeda H."/>
<person name="Fox E.A."/>
<person name="D'Andrea A.D."/>
</authorList>
<dbReference type="PubMed" id="12065746"/>
<dbReference type="DOI" id="10.1126/science.1073834"/>
</citation>
<scope>INVOLVEMENT IN FANCD1</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2003" name="Hum. Mutat." volume="21" first="171" last="171">
<title>BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.</title>
<authorList>
<person name="Hadjisavvas A."/>
<person name="Charalambous E."/>
<person name="Adamou A."/>
<person name="Christodoulou C.G."/>
<person name="Kyriacou K."/>
</authorList>
<dbReference type="PubMed" id="12552570"/>
<dbReference type="DOI" id="10.1002/humu.9110"/>
</citation>
<scope>VARIANTS HIS-289; HIS-372; GLY-462; ASP-991; SER-1279; TYR-1420; ASP-1771 AND VAL-2466</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2003" name="Hum. Mutat." volume="22" first="259" last="259">
<title>Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.</title>
<authorList>
<person name="Meyer P."/>
<person name="Voigtlaender T."/>
<person name="Bartram C.R."/>
<person name="Klaes R."/>
</authorList>
<dbReference type="PubMed" id="12938098"/>
<dbReference type="DOI" id="10.1002/humu.9174"/>
</citation>
<scope>VARIANTS BC ILE-431; LYS-1036; ARG-1106 AND VAL-1524</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2003" name="J. Hum. Genet." volume="48" first="130" last="137">
<title>Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1and BRCA2genes in familial breast cancer.</title>
<authorList>
<person name="Sakayori M."/>
<person name="Kawahara M."/>
<person name="Shiraishi K."/>
<person name="Nomizu T."/>
<person name="Shimada A."/>
<person name="Kudo T."/>
<person name="Abe R."/>
<person name="Ohuchi N."/>
<person name="Takenoshita S."/>
<person name="Kanamaru R."/>
<person name="Ishioka C."/>
</authorList>
<dbReference type="PubMed" id="12624724"/>
<dbReference type="DOI" id="10.1007/s100380300020"/>
</citation>
<scope>VARIANTS PRO-582; PHE-1522 AND VAL-2044</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2003" name="J. Natl. Cancer Inst." volume="95" first="214" last="221">
<title>BRCA2 germline mutations in familial pancreatic carcinoma.</title>
<authorList>
<person name="Hahn S.A."/>
<person name="Greenhalf B."/>
<person name="Ellis I."/>
<person name="Sina-Frey M."/>
<person name="Rieder H."/>
<person name="Korte B."/>
<person name="Gerdes B."/>
<person name="Kress R."/>
<person name="Ziegler A."/>
<person name="Raeburn J.A."/>
<person name="Campra D."/>
<person name="Gruetzmann R."/>
<person name="Rehder H."/>
<person name="Rothmund M."/>
<person name="Schmiegel W."/>
<person name="Neoptolemos J.P."/>
<person name="Bartsch D.K."/>
</authorList>
<dbReference type="PubMed" id="12569143"/>
<dbReference type="DOI" id="10.1093/jnci/95.3.214"/>
</citation>
<scope>VARIANTS CYS-2034 AND GLU-3076</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2004" name="Blood" volume="103" first="2554" last="2559">
<title>Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood.</title>
<authorList>
<person name="Hirsch B."/>
<person name="Shimamura A."/>
<person name="Moreau L."/>
<person name="Baldinger S."/>
<person name="Hag-alshiekh M."/>
<person name="Bostrom B."/>
<person name="Sencer S."/>
<person name="D'Andrea A.D."/>
</authorList>
<dbReference type="PubMed" id="14670928"/>
<dbReference type="DOI" id="10.1182/blood-2003-06-1970"/>
</citation>
<scope>VARIANT FANCD1 PRO-2510</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2004" name="Br. J. Cancer" volume="90" first="1244" last="1251">
<title>BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families.</title>
<authorList>
<person name="Claes K."/>
<person name="Poppe B."/>
<person name="Coene I."/>
<person name="De Paepe A."/>
<person name="Messiaen L."/>
</authorList>
<dbReference type="PubMed" id="15026808"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6601656"/>
</citation>
<scope>VARIANTS BC SER-60; ARG-405; HIS-448; GLY-462; GLY-2275; ARG-2353; LYS-2488; HIS-2723; ASN-2950; ILE-3013 AND HIS-3098</scope>
<scope>VARIANTS ASP-991; ALA-2856 AND VAL-3412</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2004" name="Cancer Genet. Cytogenet." volume="151" first="152" last="156">
<title>Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation.</title>
<authorList>
<person name="Hadjisavvas A."/>
<person name="Charalambous E."/>
<person name="Adamou A."/>
<person name="Neuhausen S.L."/>
<person name="Christodoulou C.G."/>
<person name="Kyriacou K."/>
</authorList>
<dbReference type="PubMed" id="15172753"/>
<dbReference type="DOI" id="10.1016/j.cancergencyto.2003.09.020"/>
</citation>
<scope>VARIANTS BC ILE-64; GLY-462; ASN-1690; ASP-1771; MET-1887; MET-1915 AND GLU-2456</scope>
<scope>VARIANTS HIS-289; HIS-372; ASP-991; SER-1279; TYR-1420; CYS-2108 AND VAL-2466</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2004" name="Eur. J. Cancer" volume="40" first="422" last="428">
<title>One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.</title>
<authorList>
<person name="Malander S."/>
<person name="Ridderheim M."/>
<person name="Masbaeck A."/>
<person name="Loman N."/>
<person name="Kristoffersson U."/>
<person name="Olsson H."/>
<person name="Nilbert M."/>
<person name="Borg A."/>
</authorList>
<dbReference type="PubMed" id="14746861"/>
<dbReference type="DOI" id="10.1016/j.ejca.2003.09.016"/>
</citation>
<scope>VARIANT OVARIAN CANCER CYS-42</scope>
<scope>VARIANTS SER-3063 AND VAL-3412</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="23" first="205" last="205">
<title>Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.</title>
<authorList>
<person name="Valarmathi M.T."/>
<person name="Sawhney M."/>
<person name="Deo S.S.V."/>
<person name="Shukla N.K."/>
<person name="Das S.N."/>
</authorList>
<dbReference type="PubMed" id="14722926"/>
<dbReference type="DOI" id="10.1002/humu.9213"/>
</citation>
<scope>VARIANTS BC ILE-1679; ALA-1804; LYS-1901 AND LEU-2096</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="24" first="272" last="272">
<title>RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1.</title>
<authorList>
<person name="Sharp A."/>
<person name="Pichert G."/>
<person name="Lucassen A."/>
<person name="Eccles D."/>
</authorList>
<dbReference type="PubMed" id="15300854"/>
<dbReference type="DOI" id="10.1002/humu.9267"/>
</citation>
<scope>VARIANT ALA-225</scope>
<scope>CHARACTERIZATION OF VARIANT ALA-225</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="24" first="350" last="350">
<title>BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.</title>
<authorList>
<person name="Seo J.H."/>
<person name="Cho D.-Y."/>
<person name="Ahn S.-H."/>
<person name="Yoon K.-S."/>
<person name="Kang C.-S."/>
<person name="Cho H.M."/>
<person name="Lee H.S."/>
<person name="Choe J.J."/>
<person name="Choi C.W."/>
<person name="Kim B.S."/>
<person name="Shin S.W."/>
<person name="Kim Y.H."/>
<person name="Kim J.S."/>
<person name="Son G.-S."/>
<person name="Lee J.-B."/>
<person name="Koo B.H."/>
</authorList>
<dbReference type="PubMed" id="15365993"/>
<dbReference type="DOI" id="10.1002/humu.9275"/>
</citation>
<scope>VARIANTS BC THR-1445; VAL-1929 AND ALA-2031</scope>
<scope>VARIANTS HIS-289; HIS-372; VAL-784; ASP-991 AND VAL-3412</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2005" name="J. Med. Genet." volume="42" first="E5" last="E5">
<title>Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer cases.</title>
<authorList>
<person name="Kim S.-W."/>
<person name="Lee C.S."/>
<person name="Fey J.V."/>
<person name="Borgen P.I."/>
<person name="Boyd J."/>
</authorList>
<dbReference type="PubMed" id="15635067"/>
<dbReference type="DOI" id="10.1136/jmg.2004.025056"/>
</citation>
<scope>VARIANTS LEU-1172; TYR-1420; PHE-2944; ASN-2950 AND ILE-3013</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2007" name="Am. J. Hum. Genet." volume="81" first="873" last="883">
<title>A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.</title>
<authorList>
<person name="Easton D.F."/>
<person name="Deffenbaugh A.M."/>
<person name="Pruss D."/>
<person name="Frye C."/>
<person name="Wenstrup R.J."/>
<person name="Allen-Brady K."/>
<person name="Tavtigian S.V."/>
<person name="Monteiro A.N.A."/>
<person name="Iversen E.S."/>
<person name="Couch F.J."/>
<person name="Goldgar D.E."/>
</authorList>
<dbReference type="PubMed" id="17924331"/>
<dbReference type="DOI" id="10.1086/521032"/>
</citation>
<scope>VARIANTS HIS-2336; CYS-2502; CYS-2626; PHE-2627; PRO-2653; LYS-2659; VAL-2663; ARG-2722; GLY-2723; ASP-2748 AND GLU-3095</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2007" name="J. Med. Genet." volume="44" first="1" last="9">
<title>Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.</title>
<authorList>
<person name="Alter B.P."/>
<person name="Rosenberg P.S."/>
<person name="Brody L.C."/>
</authorList>
<dbReference type="PubMed" id="16825431"/>
<dbReference type="DOI" id="10.1136/jmg.2006.043257"/>
</citation>
<scope>VARIANTS FANCD1 HIS-2336 AND CYS-2626</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2010" name="Hum. Mutat." volume="31" first="E1484" last="E1505">
<title>Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity.</title>
<authorList>
<person name="Walker L.C."/>
<person name="Whiley P.J."/>
<person name="Couch F.J."/>
<person name="Farrugia D.J."/>
<person name="Healey S."/>
<person name="Eccles D.M."/>
<person name="Lin F."/>
<person name="Butler S.A."/>
<person name="Goff S.A."/>
<person name="Thompson B.A."/>
<person name="Lakhani S.R."/>
<person name="Da Silva L.M."/>
<person name="Tavtigian S.V."/>
<person name="Goldgar D.E."/>
<person name="Brown M.A."/>
<person name="Spurdle A.B."/>
</authorList>
<dbReference type="PubMed" id="20513136"/>
<dbReference type="DOI" id="10.1002/humu.21267"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS VAL-2663; GLY-2723 AND TRP-3052</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2011" name="Blood" volume="118" first="2430" last="2442">
<title>A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay.</title>
<authorList>
<person name="Biswas K."/>
<person name="Das R."/>
<person name="Alter B.P."/>
<person name="Kuznetsov S.G."/>
<person name="Stauffer S."/>
<person name="North S.L."/>
<person name="Burkett S."/>
<person name="Brody L.C."/>
<person name="Meyer S."/>
<person name="Byrd R.A."/>
<person name="Sharan S.K."/>
</authorList>
<dbReference type="PubMed" id="21719596"/>
<dbReference type="DOI" id="10.1182/blood-2010-12-324541"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS FANCD1 HIS-2336; PRO-2510 AND CYS-2626</scope>
<scope>CHARACTERIZATION OF VARIANTS THR-2490 AND ASN-2729</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SEM1</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2016" name="J. Med. Genet." volume="53" first="138" last="144">
<title>Homozygous missense mutation in the LMAN2L gene segregates with intellectual disability in a large consanguineous Pakistani family.</title>
<authorList>
<person name="Rafiullah R."/>
<person name="Aslamkhan M."/>
<person name="Paramasivam N."/>
<person name="Thiel C."/>
<person name="Mustafa G."/>
<person name="Wiemann S."/>
<person name="Schlesner M."/>
<person name="Wade R.C."/>
<person name="Rappold G.A."/>
<person name="Berkel S."/>
</authorList>
<dbReference type="PubMed" id="26566883"/>
<dbReference type="DOI" id="10.1136/jmedgenet-2015-103179"/>
</citation>
<scope>VARIANTS LEU-606 AND TYR-1420</scope>
</reference>
<comment type="function">
<text evidence="33 35 40 49 53 54 55 56 58 61 62">Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SEM1, and is required to prevent R-loop-associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180).</text>
</comment>
<comment type="subunit">
<text evidence="6 20 33 35 37 42 43 44 45 48 49 50 51 53 54 55 56 58 59 60 61 62 64">Monomer and dimer (PubMed:20729858). Interacts with RAD51; regulates RAD51 recruitment and function at sites of DNA repair (PubMed:12442171, PubMed:15800615, PubMed:18317453, PubMed:20729832, PubMed:20729859). Interacts with WDR16, USP11, DMC1, ROCK2 and NPM1 (PubMed:15314155, PubMed:15967112, PubMed:20729832, PubMed:21084279). Interacts with SEM1; the interaction masks a nuclear export signal in BRCA2 (PubMed:10373512, PubMed:16205630, PubMed:21719596, PubMed:24013206). Interacts with both nonubiquitinated and monoubiquitinated FANCD2; this complex also includes XRCC3 and phosphorylated FANCG (PubMed:15115758, PubMed:15199141, PubMed:18212739). Part of a BRCA complex containing BRCA1, BRCA2 and PALB2 (PubMed:19369211). Interacts directly with PALB2 which may serve as a scaffold for a HR complex containing PALB2, BRCA2, RAD51C, RAD51 and XRCC3 (PubMed:19369211, PubMed:24141787, PubMed:28319063, PubMed:16793542, PubMed:19609323). Interacts with BRCA1 only in the presence of PALB2 which serves as the bridging protein (PubMed:19369211). Interacts with POLH; the interaction is direct (PubMed:24485656). Interacts with the TREX-2 complex subunits PCID2 and SEM1 (PubMed:24896180, PubMed:21719596).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-79792"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-930865">
<id>Q14565</id>
<label>DMC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-359343">
<id>Q9BXW9</id>
<label>FANCD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-596878">
<id>Q9BXW9-2</id>
<label>FANCD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-713401">
<id>Q9P0W2</id>
<label>HMG20B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
<label>PALB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-1175604">
<id>Q9NTI5</id>
<label>PDS5B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>26</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-2827270">
<id>Q9Y253</id>
<label>POLH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-297202">
<id>Q06609</id>
<label>RAD51</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>45</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-15557721">
<id>Q06609-1</id>
<label>RAD51</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-79819">
<id>P60896</id>
<label>SEM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="59 77">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="57">Cytoplasm</location>
<location evidence="57">cytoskeleton</location>
<location evidence="57">microtubule organizing center</location>
<location evidence="57">centrosome</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.</text>
</comment>
<comment type="PTM">
<text evidence="35 42 49">Phosphorylated by ATM upon irradiation-induced DNA damage. Phosphorylation by CHEK1 and CHEK2 regulates interaction with RAD51. Phosphorylation at Ser-3291 by CDK1 and CDK2 is low in S phase when recombination is active, but increases as cells progress towards mitosis; this phosphorylation prevents homologous recombination-dependent repair during S phase and G2 by inhibiting RAD51 binding.</text>
</comment>
<comment type="PTM">
<text evidence="37">Ubiquitinated in the absence of DNA damage; this does not lead to proteasomal degradation. In contrast, ubiquitination in response to DNA damage leads to proteasomal degradation.</text>
</comment>
<comment type="disease" evidence="7 9 11 12 14 17 19 22 23 27 29 31 34 38 45 59 67 71 72 73 74">
<disease id="DI-02602">
<name>Breast cancer</name>
<acronym>BC</acronym>
<description>A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.</description>
<dbReference type="MIM" id="114480"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="70">
<disease id="DI-02847">
<name>Pancreatic cancer 2</name>
<acronym>PNCA2</acronym>
<description>A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue.</description>
<dbReference type="MIM" id="613347"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-02603">
<name>Breast-ovarian cancer, familial, 2</name>
<acronym>BROVCA2</acronym>
<description>A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate.</description>
<dbReference type="MIM" id="612555"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="15 28 46 58">
<disease id="DI-01601">
<name>Fanconi anemia complementation group D1</name>
<acronym>FANCD1</acronym>
<description>A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.</description>
<dbReference type="MIM" id="605724"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="41">
<disease id="DI-02629">
<name>Glioma 3</name>
<acronym>GLM3</acronym>
<description>Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.</description>
<dbReference type="MIM" id="613029"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Fanconi Anemia Mutation Database">
<link uri="http://www2.rockefeller.edu/fanconi/genes/jumpd1"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/brca2/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/BRCA2"/>
<text>BRCA2 entry</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/BRCA2ID164ch13q13.html"/>
</comment>
<dbReference type="EMBL" id="X95152">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95153">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95154">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95155">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95156">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95157">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95158">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95159">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95160">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95161">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95162">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95163">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95164">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95165">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95166">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95167">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95168">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95169">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95170">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95171">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95172">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95173">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95174">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95175">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95176">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95177">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U43746">
<property type="protein sequence ID" value="AAB07223.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY436640">
<property type="protein sequence ID" value="AAQ97181.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL137247">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL445212">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z74739">
<property type="protein sequence ID" value="CAA98995.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z73359">
<property type="protein sequence ID" value="CAA97728.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9344.1"/>
<dbReference type="PIR" id="G02334">
<property type="entry name" value="G02334"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000050.2">
<property type="nucleotide sequence ID" value="NM_000059.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.34012"/>
<dbReference type="PDB" id="1N0W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="B=1517-1551"/>
</dbReference>
<dbReference type="PDB" id="3EU7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="X=21-39"/>
</dbReference>
<dbReference type="PDBsum" id="1N0W"/>
<dbReference type="PDBsum" id="3EU7"/>
<dbReference type="ProteinModelPortal" id="P51587"/>
<dbReference type="SMR" id="P51587"/>
<dbReference type="BioGrid" id="107142">
<property type="interactions" value="98"/>
</dbReference>
<dbReference type="CORUM" id="P51587"/>
<dbReference type="DIP" id="DIP-24214N"/>
<dbReference type="ELM" id="P51587"/>
<dbReference type="IntAct" id="P51587">
<property type="interactions" value="32"/>
</dbReference>
<dbReference type="MINT" id="MINT-1540184"/>
<dbReference type="STRING" id="9606.ENSP00000369497"/>
<dbReference type="iPTMnet" id="P51587"/>
<dbReference type="PhosphoSitePlus" id="P51587"/>
<dbReference type="BioMuta" id="BRCA2"/>
<dbReference type="DMDM" id="14424438"/>
<dbReference type="EPD" id="P51587"/>
<dbReference type="PaxDb" id="P51587"/>
<dbReference type="PeptideAtlas" id="P51587"/>
<dbReference type="PRIDE" id="P51587"/>
<dbReference type="DNASU" id="675"/>
<dbReference type="Ensembl" id="ENST00000380152">
<property type="protein sequence ID" value="ENSP00000369497"/>
<property type="gene ID" value="ENSG00000139618"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000544455">
<property type="protein sequence ID" value="ENSP00000439902"/>
<property type="gene ID" value="ENSG00000139618"/>
</dbReference>
<dbReference type="GeneID" id="675"/>
<dbReference type="KEGG" id="hsa:675"/>
<dbReference type="UCSC" id="uc001uub.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="675"/>
<dbReference type="DisGeNET" id="675"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000139618.14"/>
<dbReference type="GeneCards" id="BRCA2"/>
<dbReference type="GeneReviews" id="BRCA2"/>
<dbReference type="HGNC" id="HGNC:1101">
<property type="gene designation" value="BRCA2"/>
</dbReference>
<dbReference type="HPA" id="HPA026815"/>
<dbReference type="MalaCards" id="BRCA2"/>
<dbReference type="MIM" id="114480">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600185">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="605724">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="612555">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613029">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613347">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P51587"/>
<dbReference type="Orphanet" id="1333">
<property type="disease" value="Familial pancreatic carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="1331">
<property type="disease" value="Familial prostate cancer"/>
</dbReference>
<dbReference type="Orphanet" id="84">
<property type="disease" value="Fanconi anemia"/>
</dbReference>
<dbReference type="Orphanet" id="145">
<property type="disease" value="Hereditary breast and ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="227535">
<property type="disease" value="Hereditary breast cancer"/>
</dbReference>
<dbReference type="Orphanet" id="213524">
<property type="disease" value="Hereditary site-specific ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="319462">
<property type="disease" value="Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations"/>
</dbReference>
<dbReference type="PharmGKB" id="PA25412"/>
<dbReference type="eggNOG" id="KOG4751">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410Y06W">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000139693"/>
<dbReference type="HOVERGEN" id="HBG050731"/>
<dbReference type="InParanoid" id="P51587"/>
<dbReference type="KO" id="K08775"/>
<dbReference type="OrthoDB" id="EOG091G0C79"/>
<dbReference type="TreeFam" id="TF105041"/>
<dbReference type="Reactome" id="R-HSA-5685942">
<property type="pathway name" value="HDR through Homologous Recombination (HRR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693554">
<property type="pathway name" value="Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693568">
<property type="pathway name" value="Resolution of D-loop Structures through Holliday Junction Intermediates"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693579">
<property type="pathway name" value="Homologous DNA Pairing and Strand Exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912446">
<property type="pathway name" value="Meiotic recombination"/>
</dbReference>
<dbReference type="SignaLink" id="P51587"/>
<dbReference type="SIGNOR" id="P51587"/>
<dbReference type="EvolutionaryTrace" id="P51587"/>
<dbReference type="GeneWiki" id="BRCA2"/>
<dbReference type="GenomeRNAi" id="675"/>
<dbReference type="PRO" id="PR:P51587"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 13"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000139618"/>
<dbReference type="CleanEx" id="HS_BRCA2"/>
<dbReference type="ExpressionAtlas" id="P51587">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P51587">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0033593">
<property type="term" value="C:BRCA2-MAGE-D1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000800">
<property type="term" value="C:lateral element"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000784">
<property type="term" value="C:nuclear chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030141">
<property type="term" value="C:secretory granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043015">
<property type="term" value="F:gamma-tubulin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010484">
<property type="term" value="F:H3 histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010485">
<property type="term" value="F:H4 histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003697">
<property type="term" value="F:single-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007569">
<property type="term" value="P:cell aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051298">
<property type="term" value="P:centrosome duplication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000910">
<property type="term" value="P:cytokinesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006978">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000731">
<property type="term" value="P:DNA synthesis involved in DNA repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070200">
<property type="term" value="P:establishment of protein localization to telomere"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008585">
<property type="term" value="P:female gonad development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030097">
<property type="term" value="P:hemopoiesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043966">
<property type="term" value="P:histone H3 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043967">
<property type="term" value="P:histone H4 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001833">
<property type="term" value="P:inner cell mass cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007141">
<property type="term" value="P:male meiosis I"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990426">
<property type="term" value="P:mitotic recombination-dependent replication fork processing"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033600">
<property type="term" value="P:negative regulation of mammary gland epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006289">
<property type="term" value="P:nucleotide-excision repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001556">
<property type="term" value="P:oocyte maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045931">
<property type="term" value="P:positive regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032465">
<property type="term" value="P:regulation of cytokinesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048478">
<property type="term" value="P:replication fork protection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010332">
<property type="term" value="P:response to gamma radiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010225">
<property type="term" value="P:response to UV-C"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010165">
<property type="term" value="P:response to X-ray"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000732">
<property type="term" value="P:strand displacement"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000722">
<property type="term" value="P:telomere maintenance via recombination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd04493">
<property type="entry name" value="BRCA2DBD_OB1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd04495">
<property type="entry name" value="BRCA2DBD_OB3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015525">
<property type="entry name" value="BRCA2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015252">
<property type="entry name" value="BRCA2_hlx"/>
</dbReference>
<dbReference type="InterPro" id="IPR036315">
<property type="entry name" value="BRCA2_hlx_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR015187">
<property type="entry name" value="BRCA2_OB_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015188">
<property type="entry name" value="BRCA2_OB_3"/>
</dbReference>
<dbReference type="InterPro" id="IPR002093">
<property type="entry name" value="BRCA2_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR012340">
<property type="entry name" value="NA-bd_OB-fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR015205">
<property type="entry name" value="Tower_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11289">
<property type="entry name" value="PTHR11289"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF09169">
<property type="entry name" value="BRCA-2_helical"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09103">
<property type="entry name" value="BRCA-2_OB1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09104">
<property type="entry name" value="BRCA-2_OB3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00634">
<property type="entry name" value="BRCA2"/>
<property type="match status" value="8"/>
</dbReference>
<dbReference type="Pfam" id="PF09121">
<property type="entry name" value="Tower"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF002397">
<property type="entry name" value="BRCA2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01341">
<property type="entry name" value="Tower"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50249">
<property type="entry name" value="SSF50249"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81872">
<property type="entry name" value="SSF81872"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50138">
<property type="entry name" value="BRCA2_REPEAT"/>
<property type="match status" value="8"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0233">DNA recombination</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0923">Fanconi anemia</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Breast cancer type 2 susceptibility protein" id="PRO_0000064984">
<location>
<begin position="1"/>
<end position="3418"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 1">
<location>
<begin position="1002"/>
<end position="1036"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 2">
<location>
<begin position="1212"/>
<end position="1246"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 3">
<location>
<begin position="1421"/>
<end position="1455"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 4">
<location>
<begin position="1517"/>
<end position="1551"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 5">
<location>
<begin position="1664"/>
<end position="1698"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 6">
<location>
<begin position="1837"/>
<end position="1871"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 7">
<location>
<begin position="1971"/>
<end position="2005"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 8">
<location>
<begin position="2051"/>
<end position="2085"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PALB2">
<location>
<begin position="1"/>
<end position="40"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NPM1" evidence="56">
<location>
<begin position="639"/>
<end position="1000"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with POLH" evidence="61">
<location>
<begin position="1338"/>
<end position="1781"/>
</location>
</feature>
<feature type="region of interest" description="Required for stimulation of POLH DNA polymerization activity">
<location>
<begin position="1410"/>
<end position="1595"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with FANCD2">
<location>
<begin position="2350"/>
<end position="2545"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SEM1" evidence="6 44">
<location>
<begin position="2481"/>
<end position="2832"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal; masked by interaction with SEM1" evidence="59">
<location>
<begin position="2682"/>
<end position="2698"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="70"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="445"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="492"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="755"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1970"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4">
<location>
<position position="2035"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="2095"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1 and CDK2" evidence="42">
<location>
<position position="3291"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="3319"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CHEK1 and CHEK2" evidence="49">
<location>
<position position="3387"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; abolishes interaction with PALB2." id="VAR_028167" evidence="45">
<original>G</original>
<variation>R</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; abolishes interaction with PALB2." id="VAR_028168" evidence="45">
<original>W</original>
<variation>C</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; abolishes interaction with PALB2." id="VAR_028169" evidence="45">
<original>W</original>
<variation>R</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005085" evidence="72">
<original>F</original>
<variation>L</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and ovarian cancer; unknown pathological significance; dbSNP:rs4987046." id="VAR_020705" evidence="23 30">
<original>Y</original>
<variation>C</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005086" evidence="72">
<original>K</original>
<variation>R</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020706" evidence="31">
<original>N</original>
<variation>S</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032712" evidence="34">
<original>T</original>
<variation>I</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer and renal cancer; unknown pathological significance; dbSNP:rs28897701." id="VAR_005087" evidence="8">
<original>A</original>
<variation>P</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005088" evidence="72">
<original>F</original>
<variation>L</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008766">
<original>N</original>
<variation>H</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with esophageal carcinoma." id="VAR_032713" evidence="13">
<original>R</original>
<variation>H</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with pancreatic cancer." id="VAR_032714" evidence="16">
<original>M</original>
<variation>T</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005089" evidence="72">
<original>P</original>
<variation>R</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005090" evidence="72">
<original>V</original>
<variation>A</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005091" evidence="72">
<original>P</original>
<variation>S</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with BC; normal RNA expression and splicing." id="VAR_032715" evidence="36">
<original>T</original>
<variation>A</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; was originally thought to be linked to ovarian cancer; dbSNP:rs766173." id="VAR_005092" evidence="5 9 24 34 38 75">
<original>N</original>
<variation>H</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with esophageal carcinoma; dbSNP:rs79483201." id="VAR_032716" evidence="13">
<original>C</original>
<variation>S</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571640." id="VAR_018908" evidence="75">
<original>K</original>
<variation>Q</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs28897706." id="VAR_032717" evidence="7">
<original>S</original>
<variation>R</variation>
<location>
<position position="326"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_008767">
<original>K</original>
<variation>E</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="sequence variant" description="In lung cancer." id="VAR_005093">
<original>V</original>
<variation>L</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; may be associated with an increased risk of breast cancer; dbSNP:rs144848." id="VAR_005094" evidence="5 9 10 24 32 34 38 68 69 75">
<original>N</original>
<variation>H</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020707" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="405"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020708" evidence="27">
<original>T</original>
<variation>I</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020709" evidence="31">
<original>R</original>
<variation>H</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs56403624." id="VAR_020710" evidence="24 31 34">
<original>E</original>
<variation>G</variation>
<location>
<position position="462"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs28897708." id="VAR_032718" evidence="12">
<original>I</original>
<variation>T</variation>
<location>
<position position="505"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897709." id="VAR_056751">
<original>K</original>
<variation>R</variation>
<location>
<position position="513"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and pancreas cancer." id="VAR_005095" evidence="73">
<original>C</original>
<variation>W</variation>
<location>
<position position="554"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80358457." id="VAR_008768" evidence="26">
<original>T</original>
<variation>P</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897710." id="VAR_020711" evidence="18">
<original>T</original>
<variation>A</variation>
<location>
<position position="598"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1046984." id="VAR_035436" evidence="65">
<original>S</original>
<variation>F</variation>
<location>
<position position="599"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_076440" evidence="63">
<original>P</original>
<variation>L</variation>
<location>
<position position="606"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020712" evidence="23">
<original>L</original>
<variation>R</variation>
<location>
<position position="613"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer." id="VAR_005096">
<original>T</original>
<variation>I</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80358487." id="VAR_008769">
<original>D</original>
<variation>Y</variation>
<location>
<position position="707"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005097">
<original>D</original>
<variation>A</variation>
<location>
<position position="728"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032719" evidence="9">
<original>I</original>
<variation>M</variation>
<location>
<position position="729"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571653." id="VAR_008770" evidence="38 75">
<original>M</original>
<variation>V</variation>
<location>
<position position="784"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008771">
<original>N</original>
<variation>I</variation>
<location>
<position position="886"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2227943." id="VAR_018909" evidence="75">
<original>L</original>
<variation>S</variation>
<location>
<position position="929"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs28897716." id="VAR_008772">
<original>D</original>
<variation>N</variation>
<location>
<position position="935"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571656." id="VAR_018910" evidence="75">
<original>S</original>
<variation>F</variation>
<location>
<position position="976"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897717." id="VAR_056752">
<original>I</original>
<variation>L</variation>
<location>
<position position="982"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2227944." id="VAR_018911" evidence="75">
<original>N</original>
<variation>I</variation>
<location>
<position position="987"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs1799944." id="VAR_005098" evidence="5 9 24 31 34 38 69 75">
<original>N</original>
<variation>D</variation>
<location>
<position position="991"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020713" evidence="27">
<original>E</original>
<variation>K</variation>
<location>
<position position="1036"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020714" evidence="27">
<original>S</original>
<variation>R</variation>
<location>
<position position="1106"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1799951." id="VAR_005099" evidence="69">
<original>N</original>
<variation>S</variation>
<location>
<position position="1147"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_032720" evidence="39">
<original>S</original>
<variation>L</variation>
<location>
<position position="1172"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020715" evidence="11">
<original>S</original>
<variation>N</variation>
<location>
<position position="1179"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_020716" evidence="24 34">
<original>N</original>
<variation>S</variation>
<location>
<position position="1279"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008773">
<location>
<position position="1286"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41293485." id="VAR_008774">
<original>C</original>
<variation>Y</variation>
<location>
<position position="1290"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005100">
<location>
<position position="1302"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs70953664." id="VAR_008775">
<original>T</original>
<variation>M</variation>
<location>
<position position="1414"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897727." id="VAR_008776" evidence="11 18 24 34 39 63">
<original>D</original>
<variation>Y</variation>
<location>
<position position="1420"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020717" evidence="38">
<original>K</original>
<variation>T</variation>
<location>
<position position="1445"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008777">
<original>D</original>
<variation>N</variation>
<location>
<position position="1513"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with BC." id="VAR_032721" evidence="26">
<original>L</original>
<variation>F</variation>
<location>
<position position="1522"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020718" evidence="27">
<original>F</original>
<variation>V</variation>
<location>
<position position="1524"/>
</location>
</feature>
<feature type="sequence variant" description="In bladder cancer; dbSNP:rs28897728." id="VAR_005101">
<original>G</original>
<variation>R</variation>
<location>
<position position="1529"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897729." id="VAR_056753">
<original>V</original>
<variation>M</variation>
<location>
<position position="1542"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2219594." id="VAR_018912" evidence="75">
<original>H</original>
<variation>N</variation>
<location>
<position position="1561"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; somatic mutation." id="VAR_020719" evidence="14">
<original>C</original>
<variation>Y</variation>
<location>
<position position="1580"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008778" evidence="21">
<original>E</original>
<variation>D</variation>
<location>
<position position="1593"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897731." id="VAR_056754">
<original>V</original>
<variation>A</variation>
<location>
<position position="1643"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020720" evidence="29">
<original>T</original>
<variation>I</variation>
<location>
<position position="1679"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032722" evidence="34">
<original>K</original>
<variation>N</variation>
<location>
<position position="1690"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032723" evidence="12">
<original>N</original>
<variation>Y</variation>
<location>
<position position="1730"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80358755." id="VAR_008779" evidence="24 34">
<original>G</original>
<variation>D</variation>
<location>
<position position="1771"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020721" evidence="29">
<original>V</original>
<variation>A</variation>
<location>
<position position="1804"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80358765." id="VAR_008780">
<original>N</original>
<variation>S</variation>
<location>
<position position="1805"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; was originally thought to be linked to breast cancer; dbSNP:rs11571657." id="VAR_005102" evidence="12 75">
<original>N</original>
<variation>K</variation>
<location>
<position position="1880"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032724" evidence="34">
<original>T</original>
<variation>M</variation>
<location>
<position position="1887"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020722" evidence="29">
<original>E</original>
<variation>K</variation>
<location>
<position position="1901"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4987048." id="VAR_008781">
<original>D</original>
<variation>N</variation>
<location>
<position position="1902"/>
</location>
</feature>
<feature type="sequence variant" description="May be a rare polymorphism; somatic mutation; dbSNP:rs4987117." id="VAR_005103" evidence="9 14 34 68 69 75">
<original>T</original>
<variation>M</variation>
<location>
<position position="1915"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs79538375." id="VAR_020723" evidence="38">
<original>I</original>
<variation>V</variation>
<location>
<position position="1929"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897737." id="VAR_056755">
<original>S</original>
<variation>R</variation>
<location>
<position position="1979"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with esophageal carcinoma; somatic mutation." id="VAR_032725" evidence="13">
<original>V</original>
<variation>I</variation>
<location>
<position position="1988"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020724" evidence="38">
<original>T</original>
<variation>A</variation>
<location>
<position position="2031"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1799954." id="VAR_005104" evidence="18 25 69">
<original>R</original>
<variation>C</variation>
<location>
<position position="2034"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with BC; dbSNP:rs56191579." id="VAR_032726" evidence="26">
<original>G</original>
<variation>V</variation>
<location>
<position position="2044"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020725" evidence="19">
<original>S</original>
<variation>C</variation>
<location>
<position position="2072"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34309943." id="VAR_008782">
<original>H</original>
<variation>N</variation>
<location>
<position position="2074"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_008783" evidence="71">
<original>E</original>
<variation>D</variation>
<location>
<position position="2089"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020726" evidence="19">
<original>Y</original>
<variation>C</variation>
<location>
<position position="2094"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020727" evidence="29">
<original>P</original>
<variation>L</variation>
<location>
<position position="2096"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55794205." id="VAR_032727" evidence="34">
<original>R</original>
<variation>C</variation>
<location>
<position position="2108"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55953736." id="VAR_061563">
<original>H</original>
<variation>R</variation>
<location>
<position position="2116"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020728" evidence="23">
<original>V</original>
<variation>L</variation>
<location>
<position position="2118"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020729" evidence="19">
<original>K</original>
<variation>N</variation>
<location>
<position position="2128"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032728" evidence="12">
<original>N</original>
<variation>H</variation>
<location>
<position position="2135"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571659." id="VAR_008784" evidence="75">
<original>V</original>
<variation>F</variation>
<location>
<position position="2138"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571660." id="VAR_018913" evidence="75">
<original>K</original>
<variation>R</variation>
<location>
<position position="2162"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032729" evidence="12">
<original>Y</original>
<variation>C</variation>
<location>
<position position="2222"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897742." id="VAR_056756">
<original>D</original>
<variation>E</variation>
<location>
<position position="2238"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005105">
<original>G</original>
<variation>V</variation>
<location>
<position position="2274"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020730" evidence="31">
<original>E</original>
<variation>G</variation>
<location>
<position position="2275"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020731" evidence="23">
<original>F</original>
<variation>L</variation>
<location>
<position position="2293"/>
</location>
</feature>
<feature type="sequence variant" description="In FANCD1; affects protein splicing and expression; decreases homologous recombination-mediated DNA repair; dbSNP:rs28897743." id="VAR_032730" evidence="46 47 58">
<original>R</original>
<variation>H</variation>
<location>
<position position="2336"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897743." id="VAR_056757">
<original>R</original>
<variation>Q</variation>
<location>
<position position="2336"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020732" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="2353"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005106" evidence="67">
<original>H</original>
<variation>N</variation>
<location>
<position position="2415"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005107">
<original>Q</original>
<variation>H</variation>
<location>
<position position="2421"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986860." id="VAR_018914" evidence="75">
<original>H</original>
<variation>R</variation>
<location>
<position position="2440"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986859." id="VAR_056758">
<original>N</original>
<variation>D</variation>
<location>
<position position="2447"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032731" evidence="34">
<original>Q</original>
<variation>E</variation>
<location>
<position position="2456"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; was originally thought to be linked to ovarian cancer." id="VAR_008785" evidence="24 32 34 68 75">
<original>A</original>
<variation>V</variation>
<location>
<position position="2466"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80358965." id="VAR_008786">
<original>L</original>
<variation>V</variation>
<location>
<position position="2480"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020733" evidence="31">
<original>R</original>
<variation>K</variation>
<location>
<position position="2488"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; no effect on homologous recombination-mediated DNA repair; no effect on interaction with SEM1; dbSNP:rs11571707." id="VAR_008787" evidence="58 75">
<original>I</original>
<variation>T</variation>
<location>
<position position="2490"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_063911" evidence="47">
<original>R</original>
<variation>C</variation>
<location>
<position position="2502"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance." id="VAR_008788" evidence="8">
<original>R</original>
<variation>H</variation>
<location>
<position position="2502"/>
</location>
</feature>
<feature type="sequence variant" description="In FANCD1; hypersensitive to DNA damage; disrupts interaction with SEM1." id="VAR_032732" evidence="28 58">
<original>L</original>
<variation>P</variation>
<location>
<position position="2510"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs28897744." id="VAR_008789" evidence="9">
<original>T</original>
<variation>I</variation>
<location>
<position position="2515"/>
</location>
</feature>
<feature type="sequence variant" description="In FANCD1; hypersensitive to DNA damage; no effect on interaction with SEM1." id="VAR_032733" evidence="46 47 58">
<original>W</original>
<variation>C</variation>
<location>
<position position="2626"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_063912" evidence="47">
<original>I</original>
<variation>F</variation>
<location>
<position position="2627"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_063913" evidence="47">
<original>L</original>
<variation>P</variation>
<location>
<position position="2653"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_063914" evidence="47">
<original>R</original>
<variation>K</variation>
<location>
<position position="2659"/>
</location>
</feature>
<feature type="sequence variant" description="Could be associated with cancer susceptibility; major splicing aberration identified with this mutant; multifactorial likelihood analysis provides evidence for pathogenicity." id="VAR_063915" evidence="47 52">
<original>E</original>
<variation>V</variation>
<location>
<position position="2663"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897746." id="VAR_056759">
<original>L</original>
<variation>P</variation>
<location>
<position position="2686"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_020734" evidence="21">
<original>N</original>
<variation>S</variation>
<location>
<position position="2706"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_018661" evidence="17 47">
<original>T</original>
<variation>R</variation>
<location>
<position position="2722"/>
</location>
</feature>
<feature type="sequence variant" description="Could be associated with cancer susceptibility; has abrogated function consistent with pathogenicity; major splicing aberration identified with this mutant." id="VAR_063916" evidence="47 52">
<original>D</original>
<variation>G</variation>
<location>
<position position="2723"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; disrupts interaction with SEM1 promoting interaction with XPO1 and BRCA2 cytoplasmic localization; in heterozygous state promotes RAD51 cytoplasmic localization." id="VAR_020735" evidence="31 59">
<original>D</original>
<variation>H</variation>
<location>
<position position="2723"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs28897749." id="VAR_020736" evidence="7 9 18">
<original>V</original>
<variation>I</variation>
<location>
<position position="2728"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; no effect on homologous recombination-mediated DNA repair; no effect on interaction with SEM1; dbSNP:rs80359065." id="VAR_020737" evidence="22 58">
<original>K</original>
<variation>N</variation>
<location>
<position position="2729"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_063917" evidence="47">
<original>G</original>
<variation>D</variation>
<location>
<position position="2748"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; somatic mutation." id="VAR_008790" evidence="68">
<original>R</original>
<variation>H</variation>
<location>
<position position="2787"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897751." id="VAR_056760">
<original>L</original>
<variation>P</variation>
<location>
<position position="2792"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020738" evidence="23">
<original>G</original>
<variation>R</variation>
<location>
<position position="2793"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571746." id="VAR_018915" evidence="75">
<original>S</original>
<variation>P</variation>
<location>
<position position="2835"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with esophageal carcinoma; somatic mutation." id="VAR_032734" evidence="13">
<original>R</original>
<variation>C</variation>
<location>
<position position="2842"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571747." id="VAR_018916" evidence="31 75">
<original>E</original>
<variation>A</variation>
<location>
<position position="2856"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4987047." id="VAR_008791" evidence="39 75">
<original>I</original>
<variation>F</variation>
<location>
<position position="2944"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs28897754." id="VAR_020739" evidence="31 39">
<original>K</original>
<variation>N</variation>
<location>
<position position="2950"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571769." id="VAR_008792" evidence="18 75">
<original>A</original>
<variation>T</variation>
<location>
<position position="2951"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs59004709." id="VAR_008793">
<original>V</original>
<variation>M</variation>
<location>
<position position="2969"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs28897755." id="VAR_020740" evidence="31 39">
<original>T</original>
<variation>I</variation>
<location>
<position position="3013"/>
</location>
</feature>
<feature type="sequence variant" description="Could be associated with cancer susceptibility; has abrogated function consistent with pathogenicity; multifactorial likelihood analysis provides evidence for pathogenicity." id="VAR_063918" evidence="52">
<original>R</original>
<variation>W</variation>
<location>
<position position="3052"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with ovarian cancer; unknown pathological significance." id="VAR_020741" evidence="30">
<original>P</original>
<variation>S</variation>
<location>
<position position="3063"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_020742" evidence="25">
<original>G</original>
<variation>E</variation>
<location>
<position position="3076"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_005108" evidence="47 66">
<original>D</original>
<variation>E</variation>
<location>
<position position="3095"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and ovarian cancer; unknown pathological significance; dbSNP:rs41293521." id="VAR_008794" evidence="8 31">
<original>Y</original>
<variation>H</variation>
<location>
<position position="3098"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897758." id="VAR_056761">
<original>L</original>
<variation>R</variation>
<location>
<position position="3101"/>
</location>
</feature>
<feature type="sequence variant" description="In melanoma." id="VAR_005109">
<original>I</original>
<variation>M</variation>
<location>
<position position="3103"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005110" evidence="72">
<original>M</original>
<variation>T</variation>
<location>
<position position="3118"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020743" evidence="11">
<original>N</original>
<variation>I</variation>
<location>
<position position="3124"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs80359228." id="VAR_020744" evidence="11">
<original>K</original>
<variation>E</variation>
<location>
<position position="3196"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571831." id="VAR_018917" evidence="75">
<original>V</original>
<variation>I</variation>
<location>
<position position="3244"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008795">
<original>K</original>
<variation>R</variation>
<location>
<position position="3257"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008796">
<original>R</original>
<variation>S</variation>
<location>
<position position="3276"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with esophageal carcinoma." id="VAR_032735" evidence="13">
<original>P</original>
<variation>S</variation>
<location>
<position position="3300"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005111">
<original>T</original>
<variation>R</variation>
<location>
<position position="3357"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56309455." id="VAR_020745" evidence="23">
<original>T</original>
<variation>I</variation>
<location>
<position position="3374"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; was originally thought to be associated with breast cancer; dbSNP:rs1801426." id="VAR_005112" evidence="5 9 22 30 31 38 71 75">
<original>I</original>
<variation>V</variation>
<location>
<position position="3412"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with SEM1." evidence="59">
<original>W</original>
<variation>A</variation>
<location>
<position position="2725"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired interaction with RAD51." evidence="42">
<original>S</original>
<variation>E</variation>
<location>
<position position="3291"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by CHEK1 and CHEK2 (in vitro)." evidence="49">
<original>T</original>
<variation>A</variation>
<location>
<position position="3387"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA64484." ref="1" evidence="76">
<original>S</original>
<variation>N</variation>
<location>
<position position="758"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA64484." ref="1" evidence="76">
<original>GY</original>
<variation>RI</variation>
<location>
<begin position="1761"/>
<end position="1762"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA64484." ref="1" evidence="76">
<original>K</original>
<variation>N</variation>
<location>
<position position="1767"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA98995." ref="4" evidence="76">
<original>S</original>
<variation>P</variation>
<location>
<position position="2536"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA97728." ref="4" evidence="76">
<original>L</original>
<variation>LVS</variation>
<location>
<position position="3216"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="31"/>
<end position="35"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1520"/>
<end position="1522"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1536"/>
<end position="1541"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1542"/>
<end position="1546"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1N0W"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EU7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10323242"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10373512"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10399947"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10486320"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10978364"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11062481"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11139248"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11241844"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11948123"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11948477"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12065746"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12097290"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12145750"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12215251"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12373604"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442171"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442273"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442274"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442275"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12552570"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12569143"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12624724"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12938098"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14670928"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14722926"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14746861"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15026808"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15057823"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15115758"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15172753"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15199141"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15300854"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15314155"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15365993"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15635067"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15671039"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15689453"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15800615"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15967112"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16205630"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16793542"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16825431"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17924331"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18212739"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18317453"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19369211"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19609323"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20513136"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20729832"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20729858"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20729859"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21084279"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21276791"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21719596"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24013206"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24141787"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24485656"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24896180"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26566883"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28319063"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8589730"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8640235"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8640237"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8665505"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8673091"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9140390"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9150152"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9609997"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9654203"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9971877"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="76" type="ECO:0000305"/>
<evidence key="77" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21276791"/>
</source>
</evidence>
<sequence length="3418" mass="384202" checksum="6A0B3B7B332153EB" modified="2015-11-11" version="3">
MPIGSKERPTFFEIFKTRCNKADLGPISLNWFEELSSEAPPYNSEPAEESEHKNNNYEPN
LFKTPQRKPSYNQLASTPIIFKEQGLTLPLYQSPVKELDKFKLDLGRNVPNSRHKSLRTV
KTKMDQADDVSCPLLNSCLSESPVVLQCTHVTPQRDKSVVCGSLFHTPKFVKGRQTPKHI
SESLGAEVDPDMSWSSSLATPPTLSSTVLIVRNEEASETVFPHDTTANVKSYFSNHDESL
KKNDRFIASVTDSENTNQREAASHGFGKTSGNSFKVNSCKDHIGKSMPNVLEDEVYETVV
DTSEEDSFSLCFSKCRTKNLQKVRTSKTRKKIFHEANADECEKSKNQVKEKYSFVSEVEP
NDTDPLDSNVANQKPFESGSDKISKEVVPSLACEWSQLTLSGLNGAQMEKIPLLHISSCD
QNISEKDLLDTENKRKKDFLTSENSLPRISSLPKSEKPLNEETVVNKRDEEQHLESHTDC
ILAVKQAISGTSPVASSFQGIKKSIFRIRESPKETFNASFSGHMTDPNFKKETEASESGL
EIHTVCSQKEDSLCPNLIDNGSWPATTTQNSVALKNAGLISTLKKKTNKFIYAIHDETSY
KGKKIPKDQKSELINCSAQFEANAFEAPLTFANADSGLLHSSVKRSCSQNDSEEPTLSLT
SSFGTILRKCSRNETCSNNTVISQDLDYKEAKCNKEKLQLFITPEADSLSCLQEGQCEND
PKSKKVSDIKEEVLAAACHPVQHSKVEYSDTDFQSQKSLLYDHENASTLILTPTSKDVLS
NLVMISRGKESYKMSDKLKGNNYESDVELTKNIPMEKNQDVCALNENYKNVELLPPEKYM
RVASPSRKVQFNQNTNLRVIQKNQEETTSISKITVNPDSEELFSDNENNFVFQVANERNN
LALGNTKELHETDLTCVNEPIFKNSTMVLYGDTGDKQATQVSIKKDLVYVLAEENKNSVK
QHIKMTLGQDLKSDISLNIDKIPEKNNDYMNKWAGLLGPISNHSFGGSFRTASNKEIKLS
EHNIKKSKMFFKDIEEQYPTSLACVEIVNTLALDNQKKLSKPQSINTVSAHLQSSVVVSD
CKNSHITPQMLFSKQDFNSNHNLTPSQKAEITELSTILEESGSQFEFTQFRKPSYILQKS
TFEVPENQMTILKTTSEECRDADLHVIMNAPSIGQVDSSKQFEGTVEIKRKFAGLLKNDC
NKSASGYLTDENEVGFRGFYSAHGTKLNVSTEALQKAVKLFSDIENISEETSAEVHPISL
SSSKCHDSVVSMFKIENHNDKTVSEKNNKCQLILQNNIEMTTGTFVEEITENYKRNTENE
DNKYTAASRNSHNLEFDGSDSSKNDTVCIHKDETDLLFTDQHNICLKLSGQFMKEGNTQI
KEDLSDLTFLEVAKAQEACHGNTSNKEQLTATKTEQNIKDFETSDTFFQTASGKNISVAK
ESFNKIVNFFDQKPEELHNFSLNSELHSDIRKNKMDILSYEETDIVKHKILKESVPVGTG
NQLVTFQGQPERDEKIKEPTLLGFHTASGKKVKIAKESLDKVKNLFDEKEQGTSEITSFS
HQWAKTLKYREACKDLELACETIEITAAPKCKEMQNSLNNDKNLVSIETVVPPKLLSDNL
CRQTENLKTSKSIFLKVKVHENVEKETAKSPATCYTNQSPYSVIENSALAFYTSCSRKTS
VSQTSLLEAKKWLREGIFDGQPERINTADYVGNYLYENNSNSTIAENDKNHLSEKQDTYL
SNSSMSNSYSYHSDEVYNDSGYLSKNKLDSGIEPVLKNVEDQKNTSFSKVISNVKDANAY
PQTVNEDICVEELVTSSSPCKNKNAAIKLSISNSNNFEVGPPAFRIASGKIVCVSHETIK
KVKDIFTDSFSKVIKENNENKSKICQTKIMAGCYEALDDSEDILHNSLDNDECSTHSHKV
FADIQSEEILQHNQNMSGLEKVSKISPCDVSLETSDICKCSIGKLHKSVSSANTCGIFST
ASGKSVQVSDASLQNARQVFSEIEDSTKQVFSKVLFKSNEHSDQLTREENTAIRTPEHLI
SQKGFSYNVVNSSAFSGFSTASGKQVSILESSLHKVKGVLEEFDLIRTEHSLHYSPTSRQ
NVSKILPRVDKRNPEHCVNSEMEKTCSKEFKLSNNLNVEGGSSENNHSIKVSPYLSQFQQ
DKQQLVLGTKVSLVENIHVLGKEQASPKNVKMEIGKTETFSDVPVKTNIEVCSTYSKDSE
NYFETEAVEIAKAFMEDDELTDSKLPSHATHSLFTCPENEEMVLSNSRIGKRRGEPLILV
GEPSIKRNLLNEFDRIIENQEKSLKASKSTPDGTIKDRRLFMHHVSLEPITCVPFRTTKE
RQEIQNPNFTAPGQEFLSKSHLYEHLTLEKSSSNLAVSGHPFYQVSATRNEKMRHLITTG
RPTKVFVPPFKTKSHFHRVEQCVRNINLEENRQKQNIDGHGSDDSKNKINDNEIHQFNKN
NSNQAAAVTFTKCEEEPLDLITSLQNARDIQDMRIKKKQRQRVFPQPGSLYLAKTSTLPR
ISLKAAVGGQVPSACSHKQLYTYGVSKHCIKINSKNAESFQFHTEDYFGKESLWTGKGIQ
LADGGWLIPSNDGKAGKEEFYRALCDTPGVDPKLISRIWVYNHYRWIIWKLAAMECAFPK
EFANRCLSPERVLLQLKYRYDTEIDRSRRSAIKKIMERDDTAAKTLVLCVSDIISLSANI
SETSSNKTSSADTQKVAIIELTDGWYAVKAQLDPPLLAVLKNGRLTVGQKIILHGAELVG
SPDACTPLEAPESLMLKISANSTRPARWYTKLGFFPDPRPFPLPLSSLFSDGGNVGCVDV
IIQRAYPIQWMEKTSSGLYIFRNEREEEKEAAKYVEAQQKRLEALFTKIQEEFEEHEENT
TKPYLPSRALTRQQVRALQDGAELYEAVKNAADPAYLEGYFSEEQLRALNNHRQMLNDKK
QAQIQLEIRKAMESAEQKEQGLSRDVTTVWKLRIVSYSKKEKDSVILSIWRPSSDLYSLL
TEGKRYRIYHLATSKSKSKSERANIQLAATKKTQYQQLPVSDEILFQIYQPREPLHFSKF
LDPDFQPSCSEVDLIGFVVSVVKKTGLAPFVYLSDECYNLLAIKFWIDLNEDIIKPHMLI
AASNLQWRPESKSGLLTLFAGDFSVFSASPKEGHFQETFNKMKNTVENIDILCNEAENKL
MHILHANDPKWSTPTKDCTSGPYTAQIIPGTGNKLLMSSPNCEIYYQSPLSLCMAKRKSV
STPVSAQMTSKSCKGEKEIDDQKNCKKRRALDFLSRLPLPPPVSPICTFVSPAAQKAFQP
PRSCGTKYETPIKKKELNSPQMTPFKKFNEISLLESNSIADEELALINTQALLSGSTGEK
QFISVSESTRTAPTSSEDYLRLKRRCTTSLIKEQESSQASTEECEKNKQDTITTKKYI
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2006-01-24" modified="2017-10-25" version="153">
<accession>Q8N163</accession>
<accession>A6NL03</accession>
<accession>B2RB79</accession>
<accession>D3DSR6</accession>
<accession>Q6P0Q9</accession>
<accession>Q8N3G7</accession>
<accession>Q8N8M1</accession>
<accession>Q8TF34</accession>
<accession>Q9H9Q9</accession>
<accession>Q9HD12</accession>
<accession>Q9NT55</accession>
<name>CCAR2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cell cycle and apoptosis regulator protein 2</fullName>
</recommendedName>
<alternativeName>
<fullName>Cell division cycle and apoptosis regulator protein 2</fullName>
</alternativeName>
<alternativeName>
<fullName>DBIRD complex subunit KIAA1967</fullName>
</alternativeName>
<alternativeName>
<fullName>Deleted in breast cancer gene 1 protein</fullName>
<shortName>DBC-1</shortName>
<shortName>DBC.1</shortName>
</alternativeName>
<alternativeName>
<fullName>NET35</fullName>
</alternativeName>
<alternativeName>
<fullName>p30 DBC</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CCAR2</name>
<name type="synonym">DBC1</name>
<name type="synonym">KIAA1967</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Amygdala</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lymph</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="DNA Res." volume="8" first="319" last="327">
<title>Prediction of the coding sequences of unidentified human genes. XXII. The complete sequences of 50 new cDNA clones which code for large proteins.</title>
<authorList>
<person name="Nagase T."/>
<person name="Kikuno R."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="11853319"/>
<dbReference type="DOI" id="10.1093/dnares/8.6.319"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 133-923 (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="13647" last="13652">
<title>DBC2, a candidate for a tumor suppressor gene involved in breast cancer.</title>
<authorList>
<person name="Hamaguchi M."/>
<person name="Meth J.L."/>
<person name="von Klitzing C."/>
<person name="Wei W."/>
<person name="Esposito D."/>
<person name="Rodgers L."/>
<person name="Walsh T."/>
<person name="Welcsh P."/>
<person name="King M.C."/>
<person name="Wigler M.H."/>
</authorList>
<dbReference type="PubMed" id="12370419"/>
<dbReference type="DOI" id="10.1073/pnas.212516099"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 439-845</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-675; SER-678 AND SER-681</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="Nature" volume="451" first="583" last="586">
<title>DBC1 is a negative regulator of SIRT1.</title>
<authorList>
<person name="Kim J.-E."/>
<person name="Chen J."/>
<person name="Lou Z."/>
</authorList>
<dbReference type="PubMed" id="18235501"/>
<dbReference type="DOI" id="10.1038/nature06500"/>
</citation>
<scope>FUNCTION AS SIRT1 INHIBITOR</scope>
<scope>INTERACTION WITH SIRT1</scope>
<scope>MUTAGENESIS OF 243-LEU--LEU-264</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Nature" volume="451" first="587" last="590">
<title>Negative regulation of the deacetylase SIRT1 by DBC1.</title>
<authorList>
<person name="Zhao W."/>
<person name="Kruse J.-P."/>
<person name="Tang Y."/>
<person name="Jung S.Y."/>
<person name="Qin J."/>
<person name="Gu W."/>
</authorList>
<dbReference type="PubMed" id="18235502"/>
<dbReference type="DOI" id="10.1038/nature06515"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
<scope>INTERACTION WITH SIRT1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124; SER-675; SER-678 AND SER-681</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="7542" last="7552">
<title>Identification and characterization of a novel nuclear protein complex involved in nuclear hormone receptor-mediated gene regulation.</title>
<authorList>
<person name="Garapaty S."/>
<person name="Xu C.F."/>
<person name="Trojer P."/>
<person name="Mahajan M.A."/>
<person name="Neubert T.A."/>
<person name="Samuels H.H."/>
</authorList>
<dbReference type="PubMed" id="19131338"/>
<dbReference type="DOI" id="10.1074/jbc.M805872200"/>
</citation>
<scope>FUNCTION IN TRANSCRIPTIONAL REGULATION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH HCFC1; MKI67; EMSY; MATR3; HSPA8; TUBB2A; ZNF335; ASCL2; RBBP5 AND WDR5</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="10361" last="10366">
<title>Inhibition of SUV39H1 methyltransferase activity by DBC1.</title>
<authorList>
<person name="Li Z."/>
<person name="Chen L."/>
<person name="Kabra N."/>
<person name="Wang C."/>
<person name="Fang J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19218236"/>
<dbReference type="DOI" id="10.1074/jbc.M900956200"/>
</citation>
<scope>FUNCTION AS SUV39H1 INHIBITOR</scope>
<scope>INTERACTION WITH SUV39H1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-35; SER-675; SER-678 AND SER-681</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-215</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="392" first="357" last="362">
<title>Repression of estrogen receptor beta function by putative tumor suppressor DBC1.</title>
<authorList>
<person name="Koyama S."/>
<person name="Wada-Hiraike O."/>
<person name="Nakagawa S."/>
<person name="Tanikawa M."/>
<person name="Hiraike H."/>
<person name="Miyamoto Y."/>
<person name="Sone K."/>
<person name="Oda K."/>
<person name="Fukuhara H."/>
<person name="Nakagawa K."/>
<person name="Kato S."/>
<person name="Yano T."/>
<person name="Taketani Y."/>
</authorList>
<dbReference type="PubMed" id="20074560"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.01.025"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ESR1 AND ESR2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Br. J. Cancer" volume="102" first="1061" last="1067">
<title>Identification of DBC1 as a transcriptional repressor for BRCA1.</title>
<authorList>
<person name="Hiraike H."/>
<person name="Wada-Hiraike O."/>
<person name="Nakagawa S."/>
<person name="Koyama S."/>
<person name="Miyamoto Y."/>
<person name="Sone K."/>
<person name="Tanikawa M."/>
<person name="Tsuruga T."/>
<person name="Nagasaka K."/>
<person name="Matsumoto Y."/>
<person name="Oda K."/>
<person name="Shoji K."/>
<person name="Fukuhara H."/>
<person name="Saji S."/>
<person name="Nakagawa K."/>
<person name="Kato S."/>
<person name="Yano T."/>
<person name="Taketani Y."/>
</authorList>
<dbReference type="PubMed" id="20160719"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6605577"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BRCA1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="40830" last="40837">
<title>HDAC3 is negatively regulated by the nuclear protein DBC1.</title>
<authorList>
<person name="Chini C.C."/>
<person name="Escande C."/>
<person name="Nin V."/>
<person name="Chini E.N."/>
</authorList>
<dbReference type="PubMed" id="21030595"/>
<dbReference type="DOI" id="10.1074/jbc.M110.153270"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HDAC1; HDAC3; SIRT1 AND MEF2D</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-35; SER-124; SER-675; SER-678 AND SER-681</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-678</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="J. Mol. Cell Biol." volume="4" first="294" last="303">
<title>DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.</title>
<authorList>
<person name="Zannini L."/>
<person name="Buscemi G."/>
<person name="Kim J.E."/>
<person name="Fontanella E."/>
<person name="Delia D."/>
</authorList>
<dbReference type="PubMed" id="22735644"/>
<dbReference type="DOI" id="10.1093/jmcb/mjs035"/>
</citation>
<scope>PHOSPHORYLATION AT THR-454</scope>
<scope>MUTAGENESIS OF THR-454</scope>
<scope>INTERACTION WITH SIRT1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Nature" volume="484" first="386" last="389">
<title>DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation.</title>
<authorList>
<person name="Close P."/>
<person name="East P."/>
<person name="Dirac-Svejstrup A.B."/>
<person name="Hartmann H."/>
<person name="Heron M."/>
<person name="Maslen S."/>
<person name="Chariot A."/>
<person name="Soding J."/>
<person name="Skehel M."/>
<person name="Svejstrup J.Q."/>
</authorList>
<dbReference type="PubMed" id="22446626"/>
<dbReference type="DOI" id="10.1038/nature10925"/>
</citation>
<scope>IDENTIFICATION IN THE DBIRD COMPLEX</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ZNF326</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="Biochem. J." volume="451" first="453" last="461">
<title>DBC1 (Deleted in Breast Cancer 1) modulates the stability and function of the nuclear receptor Rev-erbalpha.</title>
<authorList>
<person name="Chini C.C."/>
<person name="Escande C."/>
<person name="Nin V."/>
<person name="Chini E.N."/>
</authorList>
<dbReference type="PubMed" id="23398316"/>
<dbReference type="DOI" id="10.1042/BJ20121085"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NR1D1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="Biosci. Rep." volume="33">
<title>Deleted in breast cancer-1 (DBC-1) in the interface between metabolism, aging and cancer.</title>
<authorList>
<person name="Chini E.N."/>
<person name="Chini C.C."/>
<person name="Nin V."/>
<person name="Escande C."/>
</authorList>
<dbReference type="PubMed" id="23841676"/>
<dbReference type="DOI" id="10.1042/BSR20130062"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2013" name="Cancer Lett." volume="333" first="180" last="186">
<title>Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage.</title>
<authorList>
<person name="Kim W."/>
<person name="Kim J.E."/>
</authorList>
<dbReference type="PubMed" id="23352644"/>
<dbReference type="DOI" id="10.1016/j.canlet.2013.01.026"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH SIRT1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124; THR-454; SER-569; SER-675; SER-678; SER-681; SER-687; SER-808 AND THR-897</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="J. Proteomics. Bioinform.">
<title>A functional proteomics perspective of dbc1 as a regulator of transcription.</title>
<authorList>
<person name="Joshi P."/>
<person name="Quach O.L."/>
<person name="Giguere S.S."/>
<person name="Cristea I.M."/>
</authorList>
<dbReference type="PubMed" id="24273392"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="4960" last="4970">
<title>hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1.</title>
<authorList>
<person name="Zheng H."/>
<person name="Yang L."/>
<person name="Peng L."/>
<person name="Izumi V."/>
<person name="Koomen J."/>
<person name="Seto E."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="24126058"/>
<dbReference type="DOI" id="10.1128/MCB.00874-13"/>
</citation>
<scope>ACETYLATION AT LYS-112 AND LYS-215</scope>
<scope>INTERACTION WITH SIRT1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="5518" last="5527">
<title>Deleted in breast cancer 1 (DBC1) protein regulates hepatic gluconeogenesis.</title>
<authorList>
<person name="Nin V."/>
<person name="Chini C.C."/>
<person name="Escande C."/>
<person name="Capellini V."/>
<person name="Chini E.N."/>
</authorList>
<dbReference type="PubMed" id="24415752"/>
<dbReference type="DOI" id="10.1074/jbc.M113.512913"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-484; SER-569; SER-627 AND SER-687</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.O113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT LYS-123 AND ARG-180</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="5483" last="5483">
<title>Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.</title>
<authorList>
<person name="Park J.H."/>
<person name="Lee S.W."/>
<person name="Yang S.W."/>
<person name="Yoo H.M."/>
<person name="Park J.M."/>
<person name="Seong M.W."/>
<person name="Ka S.H."/>
<person name="Oh K.H."/>
<person name="Jeon Y.J."/>
<person name="Chung C.H."/>
</authorList>
<dbReference type="PubMed" id="25406032"/>
<dbReference type="DOI" id="10.1038/ncomms6483"/>
</citation>
<scope>SUMOYLATION AT LYS-591</scope>
<scope>DESUMOYLATION</scope>
<scope>PHOSPHORYLATION AT THR-454</scope>
<scope>MUTAGENESIS OF THR-454; LYS-591; LYS-667 AND LYS-839</scope>
<scope>INTERACTION WITH SIRT1; PSIA3 AND SENP1</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-591</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="13150" last="13160">
<title>Chk2 and REGgamma-dependent DBC1 regulation in DNA damage induced apoptosis.</title>
<authorList>
<person name="Magni M."/>
<person name="Ruscica V."/>
<person name="Buscemi G."/>
<person name="Kim J.E."/>
<person name="Nachimuthu B.T."/>
<person name="Fontanella E."/>
<person name="Delia D."/>
<person name="Zannini L."/>
</authorList>
<dbReference type="PubMed" id="25361978"/>
<dbReference type="DOI" id="10.1093/nar/gku1065"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CHEK2 AND PSEM3</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1324" last="1334">
<title>DBC1 functions as a tumor suppressor by regulating p53 stability.</title>
<authorList>
<person name="Qin B."/>
<person name="Minter-Dykhouse K."/>
<person name="Yu J."/>
<person name="Zhang J."/>
<person name="Liu T."/>
<person name="Zhang H."/>
<person name="Lee S."/>
<person name="Kim J."/>
<person name="Wang L."/>
<person name="Lou Z."/>
</authorList>
<dbReference type="PubMed" id="25732823"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.01.066"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TP53</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2015" name="Int. J. Cancer" volume="136" first="55" last="64">
<title>MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.</title>
<authorList>
<person name="Pangon L."/>
<person name="Mladenova D."/>
<person name="Watkins L."/>
<person name="Van Kralingen C."/>
<person name="Currey N."/>
<person name="Al-Sohaily S."/>
<person name="Lecine P."/>
<person name="Borg J.P."/>
<person name="Kohonen-Corish M.R."/>
</authorList>
<dbReference type="PubMed" id="24824780"/>
<dbReference type="DOI" id="10.1002/ijc.28967"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH MCC</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2015" name="Int. J. Cancer" volume="136" first="797" last="809">
<title>CK2alpha phosphorylates DBC1 and is involved in the progression of gastric carcinoma and predicts poor survival of gastric carcinoma patients.</title>
<authorList>
<person name="Bae J.S."/>
<person name="Park S.H."/>
<person name="Kim K.M."/>
<person name="Kwon K.S."/>
<person name="Kim C.Y."/>
<person name="Lee H.K."/>
<person name="Park B.H."/>
<person name="Park H.S."/>
<person name="Lee H."/>
<person name="Moon W.S."/>
<person name="Chung M.J."/>
<person name="Sylvester K.G."/>
<person name="Jang K.Y."/>
</authorList>
<dbReference type="PubMed" id="24962073"/>
<dbReference type="DOI" id="10.1002/ijc.29043"/>
</citation>
<scope>PHOSPHORYLATION AT THR-454</scope>
<scope>MUTAGENESIS OF THR-454</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH CSNK2A1</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2015" name="J. Steroid Biochem. Mol. Biol." volume="149" first="80" last="88">
<title>CCAR2 negatively regulates nuclear receptor LXRalpha by competing with SIRT1 deacetylase.</title>
<authorList>
<person name="Sakurabashi A."/>
<person name="Wada-Hiraike O."/>
<person name="Hirano M."/>
<person name="Fu H."/>
<person name="Isono W."/>
<person name="Fukuda T."/>
<person name="Morita Y."/>
<person name="Tanikawa M."/>
<person name="Miyamoto Y."/>
<person name="Oda K."/>
<person name="Kawana K."/>
<person name="Osuga Y."/>
<person name="Fujii T."/>
</authorList>
<dbReference type="PubMed" id="25661920"/>
<dbReference type="DOI" id="10.1016/j.jsbmb.2015.02.001"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH NR1H2 AND NR1H3</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-591</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<comment type="function">
<text evidence="14 15 16 17 18 19 20 21 23 24 26 27 29 31 32">Core component of the DBIRD complex, a multiprotein complex that acts at the interface between core mRNP particles and RNA polymerase II (RNAPII) and integrates transcript elongation with the regulation of alternative splicing: the DBIRD complex affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions. Inhibits SIRT1 deacetylase activity leading to increasing levels of p53/TP53 acetylation and p53-mediated apoptosis. Inhibits SUV39H1 methyltransferase activity. As part of a histone H3-specific methyltransferase complex may mediate ligand-dependent transcriptional activation by nuclear hormone receptors. Plays a critical role in maintaining genomic stability and cellular integrity following UV-induced genotoxic stress. Regulates the circadian expression of the core clock components NR1D1 and ARNTL/BMAL1. Enhances the transcriptional repressor activity of NR1D1 through stabilization of NR1D1 protein levels by preventing its ubiquitination and subsequent degradation (PubMed:18235501, PubMed:18235502, PubMed:19131338, PubMed:19218236, PubMed:22446626, PubMed:23352644, PubMed:23398316). Represses the ligand-dependent transcriptional activation function of ESR2 (PubMed:20074560). Acts as a regulator of PCK1 expression and gluconeogenesis by a mechanism that involves, at least in part, both NR1D1 and SIRT1 (PubMed:24415752). Negatively regulates the deacetylase activity of HDAC3 and can alter its subcellular localization (PubMed:21030595). Positively regulates the beta-catenin pathway (canonical Wnt signaling pathway) and is required for MCC-mediated repression of the beta-catenin pathway (PubMed:24824780). Represses ligand-dependent transcriptional activation function of NR1H2 and NR1H3 and inhibits the interaction of SIRT1 with NR1H3 (PubMed:25661920). Plays an important role in tumor suppression through p53/TP53 regulation; stabilizes p53/TP53 by affecting its interaction with ubiquitin ligase MDM2 (PubMed:25732823). Represses the transcriptional activator activity of BRCA1 (PubMed:20160719). Inhibits SIRT1 in a CHEK2 and PSEM3-dependent manner and inhibits the activity of CHEK2 in vitro (PubMed:25361978).</text>
</comment>
<comment type="subunit">
<text evidence="14 15 16 17 18 19 20 21 22 23 24 25 27 28 29 30 31 32">Component of the DBIRD complex. Interacts with ZNF326/ZIRD; the interaction is direct. Interacts (via N-terminus) with SIRT1, which inhibits the deacetylation of substrates. Interacts (via N-terminus) with SUV39H1; this interaction abolishes the interaction with SIRT1. Part of a complex composed at least of ASCL2, EMSY, HCFC1, HSPA8, CCAR2, MATR3, MKI67, RBBP5, TUBB2A, WDR5 and ZNF335; this complex may have a histone H3-specific methyltransferase activity. Interacts with NR1D1. Interacts (via N-terminus) with ESR1 and ESR2. Interacts (via N-terminus) with HDAC3 (via C-terminus). Interacts with HDAC1 and MED2F. Interacts with MCC. Interacts (via N-terminus) with NR1H2 and NR1H3 in a ligand-independent manner. Interacts with CSNK2A1. Interacts (via N-terminus) with p53/TP53. Interacts (via N-terminus) with BRCA1 (via the BRCT domains). Interacts (via N-terminus) with CHEK2 (via protein kinase domain). Interacts with PSEM3. Interacts (via N-terminus) with PSIA3 and SENP1. The sumoylated form shows a preferential interaction with SIRT1 as compared to its unmodified form.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355410"/>
<interactant intactId="EBI-447544">
<id>P01106</id>
<label>MYC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355410"/>
<interactant intactId="EBI-6248094">
<id>Q9Q2G4</id>
<label>ORF</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355410"/>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="18 19 23 27 28 31">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 27">Cytoplasm</location>
</subcellularLocation>
<text evidence="19 27">Recruited to chromatin, post-UV irradiation. Sequestered to the cytoplasm in the presence of MCC. Translocated to the cytoplasm during UV-induced apoptosis.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q8N163-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q8N163-2</id>
<name>2</name>
<sequence type="described" ref="VSP_017092"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="13 28">Expressed in gastric carcinoma tissue and the expression gradually increases with the progression of the carcinoma (at protein level). Expressed ubiquitously in normal tissues. Expressed in 84 to 100% of neoplastic breast, lung, and colon tissues.</text>
</comment>
<comment type="PTM">
<text evidence="22 30">ATM/ATR-mediated phosphorylation at Thr-454 upon DNA damage promotes binding to SIRT1. Phosphorylation at Thr-454 promotes its sumoylation by switching the binding partner of CCAR2 from SENP1 to PIAS3.</text>
</comment>
<comment type="PTM">
<text evidence="25">Acetylation at Lys-112 and Lys-215 by KAT8 prevents inhibitory binding to SIRT1 and increases its deacetylase activity.</text>
</comment>
<comment type="PTM">
<text evidence="30">Genotoxic stress induces its sumoylation and sumoylation promotes the SIRT1-CCAR2 interaction which in turn inhibits SIRT1-mediated deacetylation of p53/TP53. Sumoylation leads to transcriptional activation of p53/TP53 by sequestering SIRT1 from p53/TP53. Desumoylated by SENP1.</text>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAG02472" version="1"/>
</conflict>
<location>
<position position="610"/>
</location>
<location>
<position position="622"/>
</location>
<location>
<position position="794"/>
</location>
<location>
<position position="810"/>
</location>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB85553" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/KIAA1967ID46056ch8p21.html"/>
</comment>
<dbReference type="EMBL" id="AK096547">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314535">
<property type="protein sequence ID" value="BAG37126.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL834162">
<property type="protein sequence ID" value="CAD38866.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL834351">
<property type="protein sequence ID" value="CAD39016.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL834352">
<property type="protein sequence ID" value="CAD39017.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX640952">
<property type="protein sequence ID" value="CAE45976.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL137523">
<property type="protein sequence ID" value="CAB70788.3"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC037459">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471080">
<property type="protein sequence ID" value="EAW63658.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471080">
<property type="protein sequence ID" value="EAW63661.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC018269">
<property type="protein sequence ID" value="AAH18269.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC065495">
<property type="protein sequence ID" value="AAH65495.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB075847">
<property type="protein sequence ID" value="BAB85553.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF293335">
<property type="protein sequence ID" value="AAG02472.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS34863.1">
<molecule id="Q8N163-1"/>
</dbReference>
<dbReference type="PIR" id="T46368">
<property type="entry name" value="T46368"/>
</dbReference>
<dbReference type="RefSeq" id="NP_066997.3">
<molecule id="Q8N163-1"/>
<property type="nucleotide sequence ID" value="NM_021174.5"/>
</dbReference>
<dbReference type="UniGene" id="Hs.744848"/>
<dbReference type="ProteinModelPortal" id="Q8N163"/>
<dbReference type="SMR" id="Q8N163"/>
<dbReference type="BioGrid" id="121775">
<property type="interactions" value="106"/>
</dbReference>
<dbReference type="CORUM" id="Q8N163"/>
<dbReference type="DIP" id="DIP-38122N"/>
<dbReference type="IntAct" id="Q8N163">
<property type="interactions" value="60"/>
</dbReference>
<dbReference type="MINT" id="MINT-5003338"/>
<dbReference type="STRING" id="9606.ENSP00000310670"/>
<dbReference type="iPTMnet" id="Q8N163"/>
<dbReference type="PhosphoSitePlus" id="Q8N163"/>
<dbReference type="SwissPalm" id="Q8N163"/>
<dbReference type="BioMuta" id="KIAA1967"/>
<dbReference type="DMDM" id="85701135"/>
<dbReference type="EPD" id="Q8N163"/>
<dbReference type="MaxQB" id="Q8N163"/>
<dbReference type="PaxDb" id="Q8N163"/>
<dbReference type="PeptideAtlas" id="Q8N163"/>
<dbReference type="PRIDE" id="Q8N163"/>
<dbReference type="DNASU" id="57805"/>
<dbReference type="Ensembl" id="ENST00000308511">
<molecule id="Q8N163-1"/>
<property type="protein sequence ID" value="ENSP00000310670"/>
<property type="gene ID" value="ENSG00000158941"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000389279">
<molecule id="Q8N163-1"/>
<property type="protein sequence ID" value="ENSP00000373930"/>
<property type="gene ID" value="ENSG00000158941"/>
</dbReference>
<dbReference type="GeneID" id="57805"/>
<dbReference type="KEGG" id="hsa:57805"/>
<dbReference type="UCSC" id="uc003xch.4">
<molecule id="Q8N163-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="57805"/>
<dbReference type="DisGeNET" id="57805"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000158941.16"/>
<dbReference type="GeneCards" id="CCAR2"/>
<dbReference type="HGNC" id="HGNC:23360">
<property type="gene designation" value="CCAR2"/>
</dbReference>
<dbReference type="HPA" id="CAB072827"/>
<dbReference type="HPA" id="CAB072828"/>
<dbReference type="HPA" id="HPA019907"/>
<dbReference type="HPA" id="HPA019943"/>
<dbReference type="MIM" id="607359">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8N163"/>
<dbReference type="OpenTargets" id="ENSG00000158941"/>
<dbReference type="PharmGKB" id="PA134993792"/>
<dbReference type="eggNOG" id="KOG4246">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4111FW4">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063672"/>
<dbReference type="HOVERGEN" id="HBG081843"/>
<dbReference type="InParanoid" id="Q8N163"/>
<dbReference type="OMA" id="ASNQSEM"/>
<dbReference type="OrthoDB" id="EOG091G03QV"/>
<dbReference type="PhylomeDB" id="Q8N163"/>
<dbReference type="TreeFam" id="TF316387"/>
<dbReference type="Reactome" id="R-HSA-3371453">
<property type="pathway name" value="Regulation of HSF1-mediated heat shock response"/>
</dbReference>
<dbReference type="ChiTaRS" id="CCAR2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="KIAA1967"/>
<dbReference type="GenomeRNAi" id="57805"/>
<dbReference type="PRO" id="PR:Q8N163"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000158941"/>
<dbReference type="CleanEx" id="HS_DBC1"/>
<dbReference type="ExpressionAtlas" id="Q8N163">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8N163">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044609">
<property type="term" value="C:DBIRD complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005759">
<property type="term" value="C:mitochondrial matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004857">
<property type="term" value="F:enzyme inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000993">
<property type="term" value="F:RNA polymerase II core binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043653">
<property type="term" value="P:mitochondrial fragmentation involved in apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006397">
<property type="term" value="P:mRNA processing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043086">
<property type="term" value="P:negative regulation of catalytic activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030308">
<property type="term" value="P:negative regulation of cell growth"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902230">
<property type="term" value="P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032435">
<property type="term" value="P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090263">
<property type="term" value="P:positive regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000003">
<property type="term" value="P:positive regulation of DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900034">
<property type="term" value="P:regulation of cellular response to heat"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042752">
<property type="term" value="P:regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032784">
<property type="term" value="P:regulation of DNA-templated transcription, elongation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090311">
<property type="term" value="P:regulation of protein deacetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031647">
<property type="term" value="P:regulation of protein stability"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009411">
<property type="term" value="P:response to UV"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048511">
<property type="term" value="P:rhythmic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008380">
<property type="term" value="P:RNA splicing"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016055">
<property type="term" value="P:Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR025224">
<property type="entry name" value="CCAR1/CCAR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR028811">
<property type="entry name" value="CCAR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR025954">
<property type="entry name" value="DBC1/CARP1_inactive_NUDIX_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011992">
<property type="entry name" value="EF-hand-dom_pair"/>
</dbReference>
<dbReference type="InterPro" id="IPR025223">
<property type="entry name" value="S1-like_RNA-bd_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR14304">
<property type="entry name" value="PTHR14304"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR14304:SF12">
<property type="entry name" value="PTHR14304:SF12"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14443">
<property type="entry name" value="DBC1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14444">
<property type="entry name" value="S1-like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01122">
<property type="entry name" value="DBC1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47473">
<property type="entry name" value="SSF47473"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0481">Metalloenzyme inhibitor</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0507">mRNA processing</keyword>
<keyword id="KW-0508">mRNA splicing</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0879">Wnt signaling pathway</keyword>
<feature type="chain" description="Cell cycle and apoptosis regulator protein 2" id="PRO_0000050813">
<location>
<begin position="1"/>
<end position="923"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with MCC" evidence="27">
<location>
<begin position="610"/>
<end position="670"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NR1D1" evidence="24">
<location>
<begin position="704"/>
<end position="923"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="12">
<location>
<begin position="829"/>
<end position="909"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4 5">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by KAT8" evidence="25">
<location>
<position position="112"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine" evidence="8">
<location>
<position position="123"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 7">
<location>
<position position="124"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="8">
<location>
<position position="180"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by KAT8" evidence="3 25">
<location>
<position position="215"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by ATM, ATR and CK2" evidence="7 22 28">
<location>
<position position="454"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="484"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 9">
<location>
<position position="569"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="627"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2 4 5 7">
<location>
<position position="675"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2 4 5 6 7">
<location>
<position position="678"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2 4 5 7">
<location>
<position position="681"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 9">
<location>
<position position="687"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="808"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="897"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3); alternate" evidence="30">
<location>
<position position="591"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="10 11">
<location>
<position position="591"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_017092" evidence="33">
<original>ADSWVEKEEPAPSN</original>
<variation>VRWGWTRRQHSSFP</variation>
<location>
<begin position="910"/>
<end position="923"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to SIRT1." evidence="14">
<location>
<begin position="243"/>
<end position="264"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significantly reduces association with SIRT1. Decreases sumoylation and the interaction of the sumoylated form with SIRT1. Inhibits CCAR2-PSIA3 interaction. Increases CCAR2-SENP1 interaction. Down-regulation of the signals related with the epithelial-mesenchymal transition of gastric cancer cells." evidence="22 28 30">
<original>T</original>
<variation>A</variation>
<location>
<position position="454"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significantly increases association with SIRT1 and induces p53 acetylation and apoptosis. Increases sumoylation and the interaction of the sumoylated form with SIRT1. Promotes CCAR2-PSIA3 interaction. Decreases CCAR2-SENP1 interaction." evidence="22 30">
<original>T</original>
<variation>D</variation>
<location>
<position position="454"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of sumoylation." evidence="30">
<original>K</original>
<variation>R</variation>
<location>
<position position="591"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on sumoylation." evidence="30">
<original>K</original>
<variation>R</variation>
<location>
<position position="667"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on sumoylation." evidence="30">
<original>K</original>
<variation>R</variation>
<location>
<position position="839"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD38866/CAD39017." ref="2" evidence="34">
<original>R</original>
<variation>S</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAH65495." ref="5" evidence="34">
<original>T</original>
<variation>S</variation>
<location>
<position position="850"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD38866/CAD39017." ref="2" evidence="34">
<original>E</original>
<variation>G</variation>
<location>
<position position="908"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12370419"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18235501"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18235502"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19131338"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19218236"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20074560"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20160719"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21030595"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22446626"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22735644"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23352644"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23398316"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24126058"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24415752"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24824780"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24962073"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25361978"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25406032"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25661920"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25732823"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11853319"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<sequence length="923" mass="102902" checksum="1733934377E35D21" modified="2006-01-24" version="2">
MSQFKRQRINPLPGGRNFSGTASTSLLGPPPGLLTPPVATELSQNARHLQGGEKQRVFTG
IVTSLHDYFGVVDEEVFFQLSVVKGRLPQLGEKVLVKAAYNPGQAVPWNAVKVQTLSNQP
LLKSPAPPLLHVAALGQKQGILGAQPQLIFQPHRIPPLFPQKPLSLFQTSHTLHLSHLNR
FPARGPHGRLDQGRSDDYDSKKRKQRAGGEPWGAKKPRHDLPPYRVHLTPYTVDSPICDF
LELQRRYRSLLVPSDFLSVHLSWLSAFPLSQPFSLHHPSRIQVSSEKEAAPDAGAEPITA
DSDPAYSSKVLLLSSPGLEELYRCCMLFVDDMAEPRETPEHPLKQIKFLLGRKEEEAVLV
GGEWSPSLDGLDPQADPQVLVRTAIRCAQAQTGIDLSGCTKWWRFAEFQYLQPGPPRRLQ
TVVVYLPDVWTIMPTLEEWEALCQQKAAEAAPPTQEAQGETEPTEQAPDALEQAADTSRR
NAETPEATTQQETDTDLPEAPPPPLEPAVIARPGCVNLSLHGIVEDRRPKERISFEVMVL
AELFLEMLQRDFGYRVYKMLLSLPEKVVSPPEPEKEEAAKEEATKEEEAIKEEVVKEPKD
EAQNEGPATESEAPLKEDGLLPKPLSSGGEEEEKPRGEASEDLCEMALDPELLLLRDDGE
EEFAGAKLEDSEVRSVASNQSEMEFSSLQDMPKELDPSAVLPLDCLLAFVFFDANWCGYL
HRRDLERILLTLGIRLSAEQAKQLVSRVVTQNICQYRSLQYSRQEGLDGGLPEEVLFGNL
DLLPPPGKSTKPGAAPTEHKALVSHNGSLINVGSLLQRAEQQDSGRLYLENKIHTLELKL
EESHNRFSATEVTNKTLAAEMQELRVRLAEAEETARTAERQKSQLQRLLQELRRRLTPLQ
LEIQRVVEKADSWVEKEEPAPSN
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2008-04-08" modified="2017-11-22" version="133">
<accession>Q9NS87</accession>
<accession>Q17RV9</accession>
<accession>Q69YL6</accession>
<accession>Q96JX7</accession>
<accession>Q9H280</accession>
<name>KIF15_HUMAN</name>
<protein>
<recommendedName>
<fullName>Kinesin-like protein KIF15</fullName>
</recommendedName>
<alternativeName>
<fullName>Kinesin-like protein 2</fullName>
<shortName>hKLP2</shortName>
</alternativeName>
<alternativeName>
<fullName>Kinesin-like protein 7</fullName>
</alternativeName>
<alternativeName>
<fullName>Serologically defined breast cancer antigen NY-BR-62</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">KIF15</name>
<name type="synonym">KLP2</name>
<name type="synonym">KNSL7</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="28888" last="28892">
<title>The forkhead-associated domain of Ki-67 antigen interacts with the novel kinesin-like protein Hklp2.</title>
<authorList>
<person name="Sueishi M."/>
<person name="Takagi M."/>
<person name="Yoneda Y."/>
</authorList>
<dbReference type="PubMed" id="10878014"/>
<dbReference type="DOI" id="10.1074/jbc.M003879200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH MKI67</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 339-1388 (ISOFORMS 1/2)</scope>
<scope>VARIANT SER-996</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Cancer Immun." volume="1" first="4" last="4">
<title>Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.</title>
<authorList>
<person name="Scanlan M.J."/>
<person name="Gout I."/>
<person name="Gordon C.M."/>
<person name="Williamson B."/>
<person name="Stockert E."/>
<person name="Gure A.O."/>
<person name="Jaeger D."/>
<person name="Chen Y.-T."/>
<person name="Mackay A."/>
<person name="O'Hare M.J."/>
<person name="Old L.J."/>
</authorList>
<dbReference type="PubMed" id="12747765"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 786-1388 (ISOFORM 4)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT SER-996</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="Mol. Cancer Res." volume="1" first="271" last="279">
<title>repp86: a human protein associated in the progression of mitosis.</title>
<authorList>
<person name="Heidebrecht H.-J."/>
<person name="Adam-Klages S."/>
<person name="Szczepanowski M."/>
<person name="Pollmann M."/>
<person name="Buck F."/>
<person name="Endl E."/>
<person name="Kruse M.-L."/>
<person name="Rudolph P."/>
<person name="Parwaresch R."/>
</authorList>
<dbReference type="PubMed" id="12612055"/>
</citation>
<scope>INTERACTION WITH TPX2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1009</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1169</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-399 AND SER-1141</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<comment type="function">
<text evidence="6">Plus-end directed kinesin-like motor enzyme involved in mitotic spindle assembly.</text>
</comment>
<comment type="subunit">
<text evidence="9 10">Interacts with MKI67 and TPX2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712159"/>
<interactant intactId="EBI-876367">
<id>P46013</id>
<label>MKI67</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>cytoskeleton</location>
<location>spindle</location>
</subcellularLocation>
<text evidence="6">Detected during the interphase in the cytoplasm as finely punctuate pattern and irregularly shaped dots. Detected during mitosis on the mitotic spindle. Colocalizes with TPX2 in mitosis. Localizes at the central spindle at anaphase (By similarity). Localizes at the sites of invaginating cell membranes, a position that corresponds to the location of the contractile actomyosin ring of dividing cells (By similarity). Colocalizes with actin in interphase (By similarity). Colocalizes in dendrites and in growth cone of axons with microtubules (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9NS87-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9NS87-2</id>
<name>2</name>
<sequence type="described" ref="VSP_032753"/>
</isoform>
<isoform>
<id>Q9NS87-3</id>
<name>3</name>
<sequence type="described" ref="VSP_032752"/>
</isoform>
<isoform>
<id>Q9NS87-4</id>
<name>4</name>
<sequence type="described" ref="VSP_032754 VSP_032755"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="11">Expressed in testis, colon, thymus and in breast cancer.</text>
</comment>
<comment type="similarity">
<text evidence="8">Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. KLP2 subfamily.</text>
</comment>
<comment type="sequence caution" evidence="16">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAG48261" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="AB035898">
<property type="protein sequence ID" value="BAB03309.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK027816">
<property type="protein sequence ID" value="BAB55389.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC117174">
<property type="protein sequence ID" value="AAI17175.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL832908">
<property type="protein sequence ID" value="CAH10635.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF308294">
<property type="protein sequence ID" value="AAG48261.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33744.1">
<molecule id="Q9NS87-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_064627.1">
<molecule id="Q9NS87-1"/>
<property type="nucleotide sequence ID" value="NM_020242.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.658939"/>
<dbReference type="PDB" id="4BN2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C=19-375"/>
</dbReference>
<dbReference type="PDBsum" id="4BN2"/>
<dbReference type="ProteinModelPortal" id="Q9NS87"/>
<dbReference type="SMR" id="Q9NS87"/>
<dbReference type="BioGrid" id="121307">
<property type="interactions" value="28"/>
</dbReference>
<dbReference type="DIP" id="DIP-28133N"/>
<dbReference type="IntAct" id="Q9NS87">
<property type="interactions" value="18"/>
</dbReference>
<dbReference type="MINT" id="MINT-138026"/>
<dbReference type="STRING" id="9606.ENSP00000324020"/>
<dbReference type="ChEMBL" id="CHEMBL3632454"/>
<dbReference type="iPTMnet" id="Q9NS87"/>
<dbReference type="PhosphoSitePlus" id="Q9NS87"/>
<dbReference type="BioMuta" id="KIF15"/>
<dbReference type="DMDM" id="74752937"/>
<dbReference type="EPD" id="Q9NS87"/>
<dbReference type="MaxQB" id="Q9NS87"/>
<dbReference type="PaxDb" id="Q9NS87"/>
<dbReference type="PeptideAtlas" id="Q9NS87"/>
<dbReference type="PRIDE" id="Q9NS87"/>
<dbReference type="Ensembl" id="ENST00000326047">
<molecule id="Q9NS87-1"/>
<property type="protein sequence ID" value="ENSP00000324020"/>
<property type="gene ID" value="ENSG00000163808"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000627272">
<molecule id="Q9NS87-1"/>
<property type="protein sequence ID" value="ENSP00000486004"/>
<property type="gene ID" value="ENSG00000280610"/>
</dbReference>
<dbReference type="GeneID" id="56992"/>
<dbReference type="KEGG" id="hsa:56992"/>
<dbReference type="UCSC" id="uc003cnx.5">
<molecule id="Q9NS87-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="56992"/>
<dbReference type="DisGeNET" id="56992"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000163808.16"/>
<dbReference type="GeneCards" id="KIF15"/>
<dbReference type="HGNC" id="HGNC:17273">
<property type="gene designation" value="KIF15"/>
</dbReference>
<dbReference type="HPA" id="HPA035516"/>
<dbReference type="HPA" id="HPA035517"/>
<dbReference type="MIM" id="617569">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9NS87"/>
<dbReference type="OpenTargets" id="ENSG00000163808"/>
<dbReference type="PharmGKB" id="PA30183"/>
<dbReference type="eggNOG" id="KOG4280">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5059">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00890000139323"/>
<dbReference type="HOGENOM" id="HOG000113225"/>
<dbReference type="HOVERGEN" id="HBG062662"/>
<dbReference type="InParanoid" id="Q9NS87"/>
<dbReference type="KO" id="K10400"/>
<dbReference type="OMA" id="ERDMLCE"/>
<dbReference type="OrthoDB" id="EOG091G00LM"/>
<dbReference type="PhylomeDB" id="Q9NS87"/>
<dbReference type="TreeFam" id="TF320478"/>
<dbReference type="Reactome" id="R-HSA-2132295">
<property type="pathway name" value="MHC class II antigen presentation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811434">
<property type="pathway name" value="COPI-dependent Golgi-to-ER retrograde traffic"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983189">
<property type="pathway name" value="Kinesins"/>
</dbReference>
<dbReference type="GeneWiki" id="KIF15"/>
<dbReference type="GenomeRNAi" id="56992"/>
<dbReference type="PRO" id="PR:Q9NS87"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000163808"/>
<dbReference type="CleanEx" id="HS_KIF15"/>
<dbReference type="ExpressionAtlas" id="Q9NS87">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9NS87">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005874">
<property type="term" value="C:microtubule"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005873">
<property type="term" value="C:plus-end kinesin complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005819">
<property type="term" value="C:spindle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016887">
<property type="term" value="F:ATPase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0008017">
<property type="term" value="F:microtubule binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0003777">
<property type="term" value="F:microtubule motor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003774">
<property type="term" value="F:motor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019886">
<property type="term" value="P:antigen processing and presentation of exogenous peptide antigen via MHC class II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007018">
<property type="term" value="P:microtubule-based movement"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000278">
<property type="term" value="P:mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006890">
<property type="term" value="P:retrograde vesicle-mediated transport, Golgi to ER"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.850.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR031794">
<property type="entry name" value="HMMR_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR027640">
<property type="entry name" value="Kinesin-like_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR001752">
<property type="entry name" value="Kinesin_motor_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036961">
<property type="entry name" value="Kinesin_motor_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24115">
<property type="entry name" value="PTHR24115"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="Pfam" id="PF15908">
<property type="entry name" value="HMMR_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00225">
<property type="entry name" value="Kinesin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00380">
<property type="entry name" value="KINESINHEAVY"/>
</dbReference>
<dbReference type="SMART" id="SM00129">
<property type="entry name" value="KISc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50067">
<property type="entry name" value="KINESIN_MOTOR_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0493">Microtubule</keyword>
<keyword id="KW-0505">Motor protein</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="chain" description="Kinesin-like protein KIF15" id="PRO_0000328684">
<location>
<begin position="1"/>
<end position="1388"/>
</location>
</feature>
<feature type="domain" description="Kinesin motor" evidence="8">
<location>
<begin position="26"/>
<end position="363"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="8">
<location>
<begin position="109"/>
<end position="116"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="7">
<location>
<begin position="368"/>
<end position="1388"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5">
<location>
<position position="399"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="568"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="3">
<location>
<position position="1009"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="1141"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1169"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_032752" evidence="14">
<location>
<begin position="1"/>
<end position="952"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_032753" evidence="15">
<location>
<begin position="1"/>
<end position="97"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_032754" evidence="13">
<original>ELTKKEALIQELQHKLNQKKEEVEQKKN</original>
<variation>RTDQERSPDSGTSAQAKPKERGSRTEEE</variation>
<location>
<begin position="1092"/>
<end position="1119"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_032755" evidence="13">
<location>
<begin position="1200"/>
<end position="1388"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34862960." id="VAR_042464">
<original>A</original>
<variation>V</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11710339." id="VAR_042465" evidence="11 12">
<original>T</original>
<variation>S</variation>
<location>
<position position="996"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3804583." id="VAR_042466">
<original>L</original>
<variation>M</variation>
<location>
<position position="1206"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17076986." id="VAR_042467">
<original>E</original>
<variation>D</variation>
<location>
<position position="1272"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAG48261." ref="5" evidence="16">
<original>E</original>
<variation>K</variation>
<location>
<position position="1057"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="28"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="50"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="58"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="64"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="68"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="73"/>
<end position="76"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="82"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="103"/>
<end position="108"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="115"/>
<end position="119"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="135"/>
<end position="150"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="158"/>
<end position="172"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="174"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="186"/>
<end position="189"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="195"/>
<end position="198"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="208"/>
<end position="226"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="228"/>
<end position="231"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="236"/>
<end position="250"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="253"/>
<end position="265"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="290"/>
<end position="306"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="307"/>
<end position="309"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="315"/>
<end position="317"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="319"/>
<end position="323"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="325"/>
<end position="327"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="330"/>
<end position="340"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="344"/>
<end position="346"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="347"/>
<end position="360"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4BN2"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00283"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10878014"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12612055"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12747765"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12747765"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000305"/>
<sequence length="1388" mass="160160" checksum="E127EB4B991CA83A" modified="2000-10-01" version="1">
MAPGCKTELRSVTNGQSNQPSNEGDAIKVFVRIRPPAERSGSADGEQNLCLSVLSSTSLR
LHSNPEPKTFTFDHVADVDTTQESVFATVAKSIVESCMSGYNGTIFAYGQTGSGKTFTMM
GPSESDNFSHNLRGVIPRSFEYLFSLIDREKEKAGAGKSFLCKCSFIEIYNEQIYDLLDS
ASAGLYLREHIKKGVFVVGAVEQVVTSAAEAYQVLSGGWRNRRVASTSMNRESSRSHAVF
TITIESMEKSNEIVNIRTSLLNLVDLAGSERQKDTHAEGMRLKEAGNINRSLSCLGQVIT
ALVDVGNGKQRHVCYRDSKLTFLLRDSLGGNAKTAIIANVHPGSRCFGETLSTLNFAQRA
KLIKNKAVVNEDTQGNVSQLQAEVKRLKEQLAELASGQTPPESFLTRDKKKTNYMEYFQE
AMLFFKKSEQEKKSLIEKVTQLEDLTLKKEKFIQSNKMIVKFREDQIIRLEKLHKESRGG
FLPEEQDRLLSELRNEIQTLREQIEHHPRVAKYAMENHSLREENRRLRLLEPVKRAQEMD
AQTIAKLEKAFSEISGMEKSDKNQQGFSPKAQKEPCLFANTEKLKAQLLQIQTELNNSKQ
EYEEFKELTRKRQLELESELQSLQKANLNLENLLEATKACKRQEVSQLNKIHAETLKIIT
TPTKAYQLHSRPVPKLSPEMGSFGSLYTQNSSILDNDILNEPVPPEMNEQAFEAISEELR
TVQEQMSALQAKLDEEEHKNLKLQQHVDKLEHHSTQMQELFSSERIDWTKQQEELLSQLN
VLEKQLQETQTKNDFLKSEVHDLRVVLHSADKELSSVKLEYSSFKTNQEKEFNKLSERHM
HVQLQLDNLRLENEKLLESKACLQDSYDNLQEIMKFEIDQLSRNLQNFKKENETLKSDLN
NLMELLEAEKERNNKLSLQFEEDKENSSKEILKVLEAVRQEKQKETAKCEQQMAKVQKLE
ESLLATEKVISSLEKSRDSDKKVVADLMNQIQELRTSVCEKTETIDTLKQELKDINCKYN
SALVDREESRVLIKKQEVDILDLKETLRLRILSEDIERDMLCEDLAHATEQLNMLTEASK
KHSGLLQSAQEELTKKEALIQELQHKLNQKKEEVEQKKNEYNFKMRQLEHVMDSAAEDPQ
SPKTPPHFQTHLAKLLETQEQEIEDGRASKTSLEHLVTKLNEDREVKNAEILRMKEQLRE
MENLRLESQQLIEKNWLLQGQLDDIKRQKENSDQNHPDNQQLKNEQEESIKERLAKSKIV
EEMLKMKADLEEVQSALYNKEMECLRMTDEVERTQTLESKAFQEKEQLRSKLEEMYEERE
RTSQEMEMLRKQVECLAEENGKLVGHQNLHQKIQYVVRLKKENVRLAEETEKLRAENVFL
KEKKRSES
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1986-11-01" modified="2017-10-25" version="174">
<accession>P04155</accession>
<name>TFF1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Trefoil factor 1</fullName>
</recommendedName>
<alternativeName>
<fullName>Breast cancer estrogen-inducible protein</fullName>
</alternativeName>
<alternativeName>
<fullName>PNR-2</fullName>
</alternativeName>
<alternativeName>
<fullName>Polypeptide P1.A</fullName>
<shortName>hP1.A</shortName>
</alternativeName>
<alternativeName>
<fullName>Protein pS2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">TFF1</name>
<name type="synonym">BCEI</name>
<name type="synonym">PS2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1984" name="Nucleic Acids Res." volume="12" first="2861" last="2878">
<title>Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7.</title>
<authorList>
<person name="Jakowlew S.B."/>
<person name="Breathnach R."/>
<person name="Jeltsch J.-M."/>
<person name="Masiakowski P."/>
<person name="Chambon P."/>
</authorList>
<dbReference type="PubMed" id="6324130"/>
<dbReference type="DOI" id="10.1093/nar/12.6.2861"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1985" name="DNA" volume="4" first="11" last="21">
<title>Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells.</title>
<authorList>
<person name="Prud'Homme J.-F."/>
<person name="Fridlansky F."/>
<person name="le Cunff M."/>
<person name="Atger M."/>
<person name="Mercier-Bodart C."/>
<person name="Pichon M.-F."/>
<person name="Milgrom E."/>
</authorList>
<dbReference type="PubMed" id="3838275"/>
<dbReference type="DOI" id="10.1089/dna.1985.4.11"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Mammary cancer</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1987" name="Nucleic Acids Res." volume="15" first="1401" last="1414">
<title>Structure of the human oestrogen-responsive gene pS2.</title>
<authorList>
<person name="Jeltsch J.-M."/>
<person name="Roberts M."/>
<person name="Schatz C."/>
<person name="Garnier J.-M."/>
<person name="Brown A.M.C."/>
<person name="Chambon P."/>
</authorList>
<dbReference type="PubMed" id="3822834"/>
<dbReference type="DOI" id="10.1093/nar/15.4.1401"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1990" name="FEBS Lett." volume="261" first="283" last="286">
<title>Expression of the pS2 gene in human gastric cancer cells derived from poorly differentiated adenocarcinoma.</title>
<authorList>
<person name="Takahashi H."/>
<person name="Kida N."/>
<person name="Fujii R."/>
<person name="Tanaka K."/>
<person name="Ohta M."/>
<person name="Mori K."/>
<person name="Hayashi K."/>
</authorList>
<dbReference type="PubMed" id="2311759"/>
<dbReference type="DOI" id="10.1016/0014-5793(90)80572-Z"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Gastric carcinoma</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1990" name="J. Biochem." volume="107" first="73" last="76">
<title>Complete primary structure of the human estrogen-responsive gene (pS2) product.</title>
<authorList>
<person name="Mori K."/>
<person name="Fujii R."/>
<person name="Kida N."/>
<person name="Takahashi H."/>
<person name="Ohkubo S."/>
<person name="Fujino M."/>
<person name="Ohta M."/>
<person name="Hayashi K."/>
</authorList>
<dbReference type="PubMed" id="2185238"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Genomics" volume="68" first="22" last="29">
<title>Refined localization of autosomal recessive nonsyndromic deafness DFNB10 locus using 34 novel microsatellite markers, genomic structure, and exclusion of six known genes in the region.</title>
<authorList>
<person name="Berry A."/>
<person name="Scott H.S."/>
<person name="Kudoh J."/>
<person name="Talior I."/>
<person name="Korostishevsky M."/>
<person name="Wattenhofer M."/>
<person name="Guipponi M."/>
<person name="Barras C."/>
<person name="Rossier C."/>
<person name="Shibuya K."/>
<person name="Wang J."/>
<person name="Kawasaki K."/>
<person name="Asakawa S."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
<person name="Antonarakis S.E."/>
<person name="Bonne-Tamir B."/>
</authorList>
<dbReference type="PubMed" id="10950923"/>
<dbReference type="DOI" id="10.1006/geno.2000.6253"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="Nature" volume="405" first="311" last="319">
<title>The DNA sequence of human chromosome 21.</title>
<authorList>
<person name="Hattori M."/>
<person name="Fujiyama A."/>
<person name="Taylor T.D."/>
<person name="Watanabe H."/>
<person name="Yada T."/>
<person name="Park H.-S."/>
<person name="Toyoda A."/>
<person name="Ishii K."/>
<person name="Totoki Y."/>
<person name="Choi D.-K."/>
<person name="Groner Y."/>
<person name="Soeda E."/>
<person name="Ohki M."/>
<person name="Takagi T."/>
<person name="Sakaki Y."/>
<person name="Taudien S."/>
<person name="Blechschmidt K."/>
<person name="Polley A."/>
<person name="Menzel U."/>
<person name="Delabar J."/>
<person name="Kumpf K."/>
<person name="Lehmann R."/>
<person name="Patterson D."/>
<person name="Reichwald K."/>
<person name="Rump A."/>
<person name="Schillhabel M."/>
<person name="Schudy A."/>
<person name="Zimmermann W."/>
<person name="Rosenthal A."/>
<person name="Kudoh J."/>
<person name="Shibuya K."/>
<person name="Kawasaki K."/>
<person name="Asakawa S."/>
<person name="Shintani A."/>
<person name="Sasaki T."/>
<person name="Nagamine K."/>
<person name="Mitsuyama S."/>
<person name="Antonarakis S.E."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
<person name="Nordsiek G."/>
<person name="Hornischer K."/>
<person name="Brandt P."/>
<person name="Scharfe M."/>
<person name="Schoen O."/>
<person name="Desario A."/>
<person name="Reichelt J."/>
<person name="Kauer G."/>
<person name="Bloecker H."/>
<person name="Ramser J."/>
<person name="Beck A."/>
<person name="Klages S."/>
<person name="Hennig S."/>
<person name="Riesselmann L."/>
<person name="Dagand E."/>
<person name="Wehrmeyer S."/>
<person name="Borzym K."/>
<person name="Gardiner K."/>
<person name="Nizetic D."/>
<person name="Francis F."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Yaspo M.-L."/>
</authorList>
<dbReference type="PubMed" id="10830953"/>
<dbReference type="DOI" id="10.1038/35012518"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Colon</tissue>
<tissue>Kidney</tissue>
<tissue>Stomach</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1988" name="C. R. Acad. Sci. III, Sci. Vie" volume="307" first="825" last="831">
<title>Primary structure of human protein pS2.</title>
<authorList>
<person name="Rio M.-C."/>
<person name="Lepage P."/>
<person name="Diemunsch P."/>
<person name="Roitsch C."/>
<person name="Chambon P."/>
</authorList>
<dbReference type="PubMed" id="3146413"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-84</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Biochemistry" volume="44" first="7967" last="7975">
<title>Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a Brichos domain-containing protein with homology to SP-C.</title>
<authorList>
<person name="Westley B.R."/>
<person name="Griffin S.M."/>
<person name="May F.E.B."/>
</authorList>
<dbReference type="PubMed" id="15924415"/>
<dbReference type="DOI" id="10.1021/bi047287n"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-84</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH GKN2</scope>
<source>
<tissue>Stomach</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Clin. Invest." volume="115" first="3613" last="3622">
<title>Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.</title>
<authorList>
<person name="Chutipongtanate S."/>
<person name="Nakagawa Y."/>
<person name="Sritippayawan S."/>
<person name="Pittayamateekul J."/>
<person name="Parichatikanond P."/>
<person name="Westley B.R."/>
<person name="May F.E."/>
<person name="Malasit P."/>
<person name="Thongboonkerd V."/>
</authorList>
<dbReference type="PubMed" id="16308573"/>
<dbReference type="DOI" id="10.1172/JCI25342"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-63</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1988" name="Biochem. Biophys. Res. Commun." volume="155" first="366" last="372">
<title>Identification of a polypeptide secreted by human breast cancer cells (MCF-7) as the human estrogen-responsive gene (pS2) product.</title>
<authorList>
<person name="Mori K."/>
<person name="Fujii R."/>
<person name="Kida N."/>
<person name="Ohta M."/>
<person name="Hayashi K."/>
</authorList>
<dbReference type="PubMed" id="3261981"/>
<dbReference type="DOI" id="10.1016/S0006-291X(88)81094-5"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-60</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-39</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1988" name="Science" volume="241" first="705" last="708">
<title>Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa.</title>
<authorList>
<person name="Rio M.C."/>
<person name="Bellocq J.-P."/>
<person name="Daniel J.Y."/>
<person name="Tomasetto C."/>
<person name="Lathe R."/>
<person name="Chenard M.P."/>
<person name="Batzenschlager A."/>
<person name="Chambon P."/>
</authorList>
<dbReference type="PubMed" id="3041593"/>
<dbReference type="DOI" id="10.1126/science.3041593"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="World J. Gastroenterol." volume="12" first="3119" last="3122">
<title>Expression of trefoil factors 1 and 2 in precancerous condition and gastric cancer.</title>
<authorList>
<person name="Shi S.-Q."/>
<person name="Cai J.-T."/>
<person name="Yang J.-M."/>
</authorList>
<dbReference type="PubMed" id="16718800"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="World J. Gastroenterol." volume="12" first="7361" last="7364">
<title>Molecular forms of trefoil factor 1 in normal gastric mucosa and its expression in normal and abnormal gastric tissues.</title>
<authorList>
<person name="Ren J.L."/>
<person name="Luo J.-Y."/>
<person name="Lu Y.-P."/>
<person name="Wang L."/>
<person name="Shi H.-X."/>
</authorList>
<dbReference type="PubMed" id="17143957"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="J. Histochem. Cytochem." volume="55" first="505" last="513">
<title>Tissue localization of human trefoil factors 1, 2, and 3.</title>
<authorList>
<person name="Madsen J."/>
<person name="Nielsen O."/>
<person name="Tornoe I."/>
<person name="Thim L."/>
<person name="Holmskov U."/>
</authorList>
<dbReference type="PubMed" id="17242463"/>
<dbReference type="DOI" id="10.1369/jhc.6A7100.2007"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1995" name="Eur. J. Biochem." volume="233" first="847" last="855">
<title>NMR-based structural studies of the pNR-2/pS2 single domain trefoil peptide. Similarities to porcine spasmolytic peptide and evidence for a monomeric structure.</title>
<authorList>
<person name="Polshakov V.I."/>
<person name="Frenkiel T.A."/>
<person name="Westley B.R."/>
<person name="Chadwick M.P."/>
<person name="May F.E.B."/>
<person name="Carr M.D."/>
<person name="Feeney J."/>
</authorList>
<dbReference type="PubMed" id="8521850"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1995.847_3.x"/>
</citation>
<scope>STRUCTURE BY NMR</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1997" name="J. Mol. Biol." volume="267" first="418" last="432">
<title>High-resolution solution structure of human pNR-2/pS2: a single trefoil motif protein.</title>
<authorList>
<person name="Polshakov V.I."/>
<person name="Williams M.A."/>
<person name="Gargaro A.R."/>
<person name="Frenkiel T.A."/>
<person name="Westley B.R."/>
<person name="Chadwick M.P."/>
<person name="May F.E.B."/>
<person name="Feeney J."/>
</authorList>
<dbReference type="PubMed" id="9096235"/>
<dbReference type="DOI" id="10.1006/jmbi.1997.0896"/>
</citation>
<scope>STRUCTURE BY NMR</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Gastroenterology" volume="119" first="691" last="698">
<title>Somatic mutations of the trefoil factor family 1 gene in gastric cancer.</title>
<authorList>
<person name="Park W.-S."/>
<person name="Oh R.-R."/>
<person name="Park J.-Y."/>
<person name="Lee J.-H."/>
<person name="Shin M.-S."/>
<person name="Kim H.-S."/>
<person name="Lee H.-K."/>
<person name="Kim Y.-S."/>
<person name="Kim S.-Y."/>
<person name="Lee S.-H."/>
<person name="Yoo N.-J."/>
<person name="Lee J.-Y."/>
</authorList>
<dbReference type="PubMed" id="10982763"/>
<dbReference type="DOI" id="10.1053/gast.2000.16483"/>
</citation>
<scope>VARIANTS ILE-32; LYS-32; ASP-34; LYS-37; ILE-46 AND VAL-55</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Gastroenterology" volume="130" first="1696" last="1706">
<title>Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways.</title>
<authorList>
<person name="Yio X."/>
<person name="Diamond M."/>
<person name="Zhang J.-Y."/>
<person name="Weinstein H."/>
<person name="Wang L.-H."/>
<person name="Werther L."/>
<person name="Itzkowitz S."/>
</authorList>
<dbReference type="PubMed" id="16697734"/>
<dbReference type="DOI" id="10.1053/j.gastro.2006.01.040"/>
</citation>
<scope>VARIANTS ASP-34 AND LYS-37</scope>
<scope>MUTAGENESIS OF CYS-82</scope>
</reference>
<comment type="function">
<text evidence="6">Stabilizer of the mucous gel overlying the gastrointestinal mucosa that provides a physical barrier against various noxious agents. May inhibit the growth of calcium oxalate crystals in urine.</text>
</comment>
<comment type="subunit">
<text>Heterodimer with GKN2; disulfide linked.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743871"/>
<interactant intactId="EBI-2809309">
<id>O00481</id>
<label>BTN3A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743871"/>
<interactant intactId="EBI-4314379">
<id>Q6UX41</id>
<label>BTNL8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743871"/>
<interactant intactId="EBI-4314468">
<id>Q6UXZ3</id>
<label>CD300LD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743871"/>
<interactant intactId="EBI-4314687">
<id>Q96PJ5</id>
<label>FCRL4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743871"/>
<interactant intactId="EBI-4314991">
<id>Q9NYZ4</id>
<label>SIGLEC8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743871"/>
<interactant intactId="EBI-741480">
<id>Q9UMX0</id>
<label>UBQLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743871"/>
<interactant intactId="EBI-10177272">
<id>P15622-3</id>
<label>ZNF250</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="5 11">Secreted</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="5 6 8 9 10 11 14">Found in stomach, with highest levels in the upper gastric mucosal cells (at protein level). Detected in goblet cells of the small and large intestine and rectum, small submucosal glands in the esophagus, mucous acini of the sublingual gland, submucosal glands of the trachea, and epithelial cells lining the exocrine pancreatic ducts but not in the remainder of the pancreas (at protein level). Scattered expression is detected in the epithelial cells of the gallbladder and submucosal glands of the vagina, and weak expression is observed in the bronchial goblet cells of the pseudostratified epithelia in the respiratory system (at protein level). Detected in urine (at protein level). Strongly expressed in breast cancer but at low levels in normal mammary tissue. It is regulated by estrogen in MCF-7 cells. Strong expression found in normal gastric mucosa and in the regenerative tissues surrounding ulcerous lesions of gastrointestinal tract, but lower expression found in gastric cancer (at protein level).</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/TFF1ID201.html"/>
</comment>
<dbReference type="EMBL" id="X00474">
<property type="protein sequence ID" value="CAA25155.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M12075">
<property type="protein sequence ID" value="AAA52402.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X05030">
<property type="protein sequence ID" value="CAA28695.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X05321">
<property type="protein sequence ID" value="CAA28695.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X05322">
<property type="protein sequence ID" value="CAA28695.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X52003">
<property type="protein sequence ID" value="CAA36254.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB038162">
<property type="protein sequence ID" value="BAB13729.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001746">
<property type="protein sequence ID" value="BAA95532.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032811">
<property type="protein sequence ID" value="AAH32811.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13685.1"/>
<dbReference type="PIR" id="A26667">
<property type="entry name" value="A26667"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003216.1">
<property type="nucleotide sequence ID" value="NM_003225.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.162807"/>
<dbReference type="PDB" id="1HI7">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=25-84"/>
</dbReference>
<dbReference type="PDB" id="1PS2">
<property type="method" value="NMR"/>
<property type="chains" value="A=25-84"/>
</dbReference>
<dbReference type="PDBsum" id="1HI7"/>
<dbReference type="PDBsum" id="1PS2"/>
<dbReference type="ProteinModelPortal" id="P04155"/>
<dbReference type="SMR" id="P04155"/>
<dbReference type="BioGrid" id="112889">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="IntAct" id="P04155">
<property type="interactions" value="18"/>
</dbReference>
<dbReference type="MINT" id="MINT-1461530"/>
<dbReference type="STRING" id="9606.ENSP00000291527"/>
<dbReference type="BioMuta" id="TFF1"/>
<dbReference type="DMDM" id="131127"/>
<dbReference type="MaxQB" id="P04155"/>
<dbReference type="PaxDb" id="P04155"/>
<dbReference type="PeptideAtlas" id="P04155"/>
<dbReference type="PRIDE" id="P04155"/>
<dbReference type="DNASU" id="7031"/>
<dbReference type="Ensembl" id="ENST00000291527">
<property type="protein sequence ID" value="ENSP00000291527"/>
<property type="gene ID" value="ENSG00000160182"/>
</dbReference>
<dbReference type="GeneID" id="7031"/>
<dbReference type="KEGG" id="hsa:7031"/>
<dbReference type="UCSC" id="uc002zax.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7031"/>
<dbReference type="DisGeNET" id="7031"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000160182.2"/>
<dbReference type="GeneCards" id="TFF1"/>
<dbReference type="HGNC" id="HGNC:11755">
<property type="gene designation" value="TFF1"/>
</dbReference>
<dbReference type="HPA" id="CAB002170"/>
<dbReference type="HPA" id="HPA003425"/>
<dbReference type="MIM" id="113710">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04155"/>
<dbReference type="OpenTargets" id="ENSG00000160182"/>
<dbReference type="PharmGKB" id="PA36470"/>
<dbReference type="eggNOG" id="ENOG410J868">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410Z7FU">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00840000129881"/>
<dbReference type="HOGENOM" id="HOG000121778"/>
<dbReference type="HOVERGEN" id="HBG004364"/>
<dbReference type="InParanoid" id="P04155"/>
<dbReference type="OMA" id="PEEECEF"/>
<dbReference type="OrthoDB" id="EOG091G0XBT"/>
<dbReference type="PhylomeDB" id="P04155"/>
<dbReference type="TreeFam" id="TF336092"/>
<dbReference type="SIGNOR" id="P04155"/>
<dbReference type="ChiTaRS" id="TFF1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P04155"/>
<dbReference type="GeneWiki" id="Trefoil_factor_1"/>
<dbReference type="GenomeRNAi" id="7031"/>
<dbReference type="PRO" id="PR:P04155"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 21"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000160182"/>
<dbReference type="CleanEx" id="HS_TFF1"/>
<dbReference type="Genevisible" id="P04155">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008083">
<property type="term" value="F:growth factor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005975">
<property type="term" value="P:carbohydrate metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007586">
<property type="term" value="P:digestion"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030277">
<property type="term" value="P:maintenance of gastrointestinal epithelium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035902">
<property type="term" value="P:response to immobilization stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010039">
<property type="term" value="P:response to iron ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043434">
<property type="term" value="P:response to peptide hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="CDD" id="cd00111">
<property type="entry name" value="Trefoil"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR017994">
<property type="entry name" value="P_trefoil_chordata"/>
</dbReference>
<dbReference type="InterPro" id="IPR017957">
<property type="entry name" value="P_trefoil_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000519">
<property type="entry name" value="P_trefoil_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR028824">
<property type="entry name" value="TFF1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13826:SF18">
<property type="entry name" value="PTHR13826:SF18"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00088">
<property type="entry name" value="Trefoil"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00680">
<property type="entry name" value="PTREFOIL"/>
</dbReference>
<dbReference type="SMART" id="SM00018">
<property type="entry name" value="PD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00025">
<property type="entry name" value="P_TREFOIL_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51448">
<property type="entry name" value="P_TREFOIL_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0339">Growth factor</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<feature type="signal peptide" evidence="4 5 6 12 13">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Trefoil factor 1" id="PRO_0000023456">
<location>
<begin position="25"/>
<end position="84"/>
</location>
</feature>
<feature type="domain" description="P-type" evidence="2">
<location>
<begin position="29"/>
<end position="72"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu-rich (acidic)">
<location>
<begin position="79"/>
<end position="83"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="31"/>
<end position="57"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="41"/>
<end position="56"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="51"/>
<end position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34795821." id="VAR_053563">
<original>T</original>
<variation>I</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric carcinoma sample; somatic mutation." id="VAR_015281" evidence="3">
<original>T</original>
<variation>I</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric carcinoma sample; somatic mutation." id="VAR_015282" evidence="3">
<original>T</original>
<variation>K</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric carcinoma sample; somatic mutation; abolishes inhibition of gastric cancer cell growth; abolishes inhibition of apoptosis in gasterointestinal epithelial cells; increases invasive activity in epithelial cells." id="VAR_015283" evidence="3 7">
<original>A</original>
<variation>D</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric carcinoma sample; somatic mutation; abolishes inhibition of gastric cancer cell growth; abolishes inhibition of apoptosis in gasterointestinal epithelial cells; increases invasive activity in epithelial cells." id="VAR_015284" evidence="3 7">
<original>E</original>
<variation>K</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric adenoma sample; somatic mutation." id="VAR_015285" evidence="3">
<original>V</original>
<variation>I</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric carcinoma sample; somatic mutation." id="VAR_015286" evidence="3">
<original>G</original>
<variation>V</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes inhibition of gastric cancer cell growth." evidence="7">
<original>C</original>
<variation>S</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="28"/>
<end position="30"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="40"/>
<end position="42"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="48"/>
<end position="52"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="53"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="61"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="67"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="72"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="79"/>
<end position="82"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1HI7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00779"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10982763"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15924415"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16308573"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16697734"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16718800"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17143957"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17242463"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3041593"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3146413"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3261981"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3838275"/>
</source>
</evidence>
<sequence length="84" mass="9150" checksum="65198523BAD6EBC7" modified="1986-11-01" version="1" precursor="true">
MATMENKVICALVLVSMLALGTLAEAQTETCTVAPRERQNCGFPGVTPSQCANKGCCFDD
TVRGVPWCFYPNTIDVPPEEECEF
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2005-05-10" modified="2017-10-25" version="111">
<accession>Q8TD06</accession>
<accession>A4D120</accession>
<name>AGR3_HUMAN</name>
<protein>
<recommendedName>
<fullName>Anterior gradient protein 3</fullName>
<shortName>AG-3</shortName>
<shortName>AG3</shortName>
<shortName>hAG-3</shortName>
</recommendedName>
<alternativeName>
<fullName evidence="12">Anterior gradient 3 homolog</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="12">Breast cancer membrane protein 11</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="12">Protein disulfide isomerase family A, member 18</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">AGR3</name>
<name type="synonym">BCMP11</name>
<name type="synonym">PDIA18</name>
<name type="ORF">UNQ642/PRO1272</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="6482" last="6489">
<title>Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer.</title>
<authorList>
<person name="Adam P.J."/>
<person name="Boyd R."/>
<person name="Tyson K.L."/>
<person name="Fletcher G.C."/>
<person name="Stamps A."/>
<person name="Hudson L."/>
<person name="Poyser H.R."/>
<person name="Redpath N."/>
<person name="Griffiths M."/>
<person name="Steers G."/>
<person name="Harris A.L."/>
<person name="Patel S."/>
<person name="Berry J."/>
<person name="Loader J.A."/>
<person name="Townsend R.R."/>
<person name="Daviet L."/>
<person name="Legrain P."/>
<person name="Parekh R."/>
<person name="Terrett J.A."/>
</authorList>
<dbReference type="PubMed" id="12477722"/>
<dbReference type="DOI" id="10.1074/jbc.M210184200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2003" name="Genome Res." volume="13" first="2265" last="2270">
<title>The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.</title>
<authorList>
<person name="Clark H.F."/>
<person name="Gurney A.L."/>
<person name="Abaya E."/>
<person name="Baker K."/>
<person name="Baldwin D.T."/>
<person name="Brush J."/>
<person name="Chen J."/>
<person name="Chow B."/>
<person name="Chui C."/>
<person name="Crowley C."/>
<person name="Currell B."/>
<person name="Deuel B."/>
<person name="Dowd P."/>
<person name="Eaton D."/>
<person name="Foster J.S."/>
<person name="Grimaldi C."/>
<person name="Gu Q."/>
<person name="Hass P.E."/>
<person name="Heldens S."/>
<person name="Huang A."/>
<person name="Kim H.S."/>
<person name="Klimowski L."/>
<person name="Jin Y."/>
<person name="Johnson S."/>
<person name="Lee J."/>
<person name="Lewis L."/>
<person name="Liao D."/>
<person name="Mark M.R."/>
<person name="Robbie E."/>
<person name="Sanchez C."/>
<person name="Schoenfeld J."/>
<person name="Seshagiri S."/>
<person name="Simmons L."/>
<person name="Singh J."/>
<person name="Smith V."/>
<person name="Stinson J."/>
<person name="Vagts A."/>
<person name="Vandlen R.L."/>
<person name="Watanabe C."/>
<person name="Wieand D."/>
<person name="Woods K."/>
<person name="Xie M.-H."/>
<person name="Yansura D.G."/>
<person name="Yi S."/>
<person name="Yu G."/>
<person name="Yuan J."/>
<person name="Zhang M."/>
<person name="Zhang Z."/>
<person name="Goddard A.D."/>
<person name="Wood W.I."/>
<person name="Godowski P.J."/>
<person name="Gray A.M."/>
</authorList>
<dbReference type="PubMed" id="12975309"/>
<dbReference type="DOI" id="10.1101/gr.1293003"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2003" name="Science" volume="300" first="767" last="772">
<title>Human chromosome 7: DNA sequence and biology.</title>
<authorList>
<person name="Scherer S.W."/>
<person name="Cheung J."/>
<person name="MacDonald J.R."/>
<person name="Osborne L.R."/>
<person name="Nakabayashi K."/>
<person name="Herbrick J.-A."/>
<person name="Carson A.R."/>
<person name="Parker-Katiraee L."/>
<person name="Skaug J."/>
<person name="Khaja R."/>
<person name="Zhang J."/>
<person name="Hudek A.K."/>
<person name="Li M."/>
<person name="Haddad M."/>
<person name="Duggan G.E."/>
<person name="Fernandez B.A."/>
<person name="Kanematsu E."/>
<person name="Gentles S."/>
<person name="Christopoulos C.C."/>
<person name="Choufani S."/>
<person name="Kwasnicka D."/>
<person name="Zheng X.H."/>
<person name="Lai Z."/>
<person name="Nusskern D.R."/>
<person name="Zhang Q."/>
<person name="Gu Z."/>
<person name="Lu F."/>
<person name="Zeesman S."/>
<person name="Nowaczyk M.J."/>
<person name="Teshima I."/>
<person name="Chitayat D."/>
<person name="Shuman C."/>
<person name="Weksberg R."/>
<person name="Zackai E.H."/>
<person name="Grebe T.A."/>
<person name="Cox S.R."/>
<person name="Kirkpatrick S.J."/>
<person name="Rahman N."/>
<person name="Friedman J.M."/>
<person name="Heng H.H.Q."/>
<person name="Pelicci P.G."/>
<person name="Lo-Coco F."/>
<person name="Belloni E."/>
<person name="Shaffer L.G."/>
<person name="Pober B."/>
<person name="Morton C.C."/>
<person name="Gusella J.F."/>
<person name="Bruns G.A.P."/>
<person name="Korf B.R."/>
<person name="Quade B.J."/>
<person name="Ligon A.H."/>
<person name="Ferguson H."/>
<person name="Higgins A.W."/>
<person name="Leach N.T."/>
<person name="Herrick S.R."/>
<person name="Lemyre E."/>
<person name="Farra C.G."/>
<person name="Kim H.-G."/>
<person name="Summers A.M."/>
<person name="Gripp K.W."/>
<person name="Roberts W."/>
<person name="Szatmari P."/>
<person name="Winsor E.J.T."/>
<person name="Grzeschik K.-H."/>
<person name="Teebi A."/>
<person name="Minassian B.A."/>
<person name="Kere J."/>
<person name="Armengol L."/>
<person name="Pujana M.A."/>
<person name="Estivill X."/>
<person name="Wilson M.D."/>
<person name="Koop B.F."/>
<person name="Tosi S."/>
<person name="Moore G.E."/>
<person name="Boright A.P."/>
<person name="Zlotorynski E."/>
<person name="Kerem B."/>
<person name="Kroisel P.M."/>
<person name="Petek E."/>
<person name="Oscier D.G."/>
<person name="Mould S.J."/>
<person name="Doehner H."/>
<person name="Doehner K."/>
<person name="Rommens J.M."/>
<person name="Vincent J.B."/>
<person name="Venter J.C."/>
<person name="Li P.W."/>
<person name="Mural R.J."/>
<person name="Adams M.D."/>
<person name="Tsui L.-C."/>
</authorList>
<dbReference type="PubMed" id="12690205"/>
<dbReference type="DOI" id="10.1126/science.1083423"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 22-36</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Br. J. Cancer" volume="88" first="579" last="585">
<title>hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan.</title>
<authorList>
<person name="Fletcher G.C."/>
<person name="Patel S."/>
<person name="Tyson K."/>
<person name="Adam P.J."/>
<person name="Schenker M."/>
<person name="Loader J.A."/>
<person name="Daviet L."/>
<person name="Legrain P."/>
<person name="Parekh R."/>
<person name="Harris A.L."/>
<person name="Terrett J.A."/>
</authorList>
<dbReference type="PubMed" id="12592373"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6600740"/>
</citation>
<scope>INTERACTION WITH LYPD3 AND DAG1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="J. Cell Biol." volume="179" first="1193" last="1204">
<title>A molecular specificity code for the three mammalian KDEL receptors.</title>
<authorList>
<person name="Raykhel I."/>
<person name="Alanen H."/>
<person name="Salo K."/>
<person name="Jurvansuu J."/>
<person name="Nguyen V.D."/>
<person name="Latva-Ranta M."/>
<person name="Ruddock L."/>
</authorList>
<dbReference type="PubMed" id="18086916"/>
<dbReference type="DOI" id="10.1083/jcb.200705180"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 163-GLN--LEU-166</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2012" name="J. Immunol. Methods" volume="378" first="20" last="32">
<title>Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.</title>
<authorList>
<person name="Gray T.A."/>
<person name="MacLaine N.J."/>
<person name="Michie C.O."/>
<person name="Bouchalova P."/>
<person name="Murray E."/>
<person name="Howie J."/>
<person name="Hrstka R."/>
<person name="Maslon M.M."/>
<person name="Nenutil R."/>
<person name="Vojtesek B."/>
<person name="Langdon S."/>
<person name="Hayward L."/>
<person name="Gourley C."/>
<person name="Hupp T.R."/>
</authorList>
<dbReference type="PubMed" id="22361111"/>
<dbReference type="DOI" id="10.1016/j.jim.2012.01.013"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2013" name="FEBS J." volume="280" first="1249" last="1266">
<title>Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.</title>
<authorList>
<person name="Bu H."/>
<person name="Schweiger M.R."/>
<person name="Manke T."/>
<person name="Wunderlich A."/>
<person name="Timmermann B."/>
<person name="Kerick M."/>
<person name="Pasqualini L."/>
<person name="Shehu E."/>
<person name="Fuchsberger C."/>
<person name="Cato A.C."/>
<person name="Klocker H."/>
</authorList>
<dbReference type="PubMed" id="23294566"/>
<dbReference type="DOI" id="10.1111/febs.12118"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2015" name="Am. J. Respir. Cell Mol. Biol." volume="53" first="536" last="543">
<title>The ER resident protein AGR3 is required for regulation of ciliary beat frequency in the airway.</title>
<authorList>
<person name="Bonser L.R."/>
<person name="Schroeder B.W."/>
<person name="Ostrin L.A."/>
<person name="Baumlin N."/>
<person name="Olson J.L."/>
<person name="Salathe M."/>
<person name="Erle D.J."/>
</authorList>
<dbReference type="PubMed" id="25751668"/>
<dbReference type="DOI" id="10.1165/rcmb.2014-0318OC"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2015" name="Onco Targets Ther." volume="8" first="1523" last="1532">
<title>Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.</title>
<authorList>
<person name="Obacz J."/>
<person name="Brychtova V."/>
<person name="Podhorec J."/>
<person name="Fabian P."/>
<person name="Dobes P."/>
<person name="Vojtesek B."/>
<person name="Hrstka R."/>
</authorList>
<dbReference type="PubMed" id="26170690"/>
<dbReference type="DOI" id="10.2147/OTT.S82235"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13" evidence="1">
<citation type="submission" date="2010-11" db="PDB data bank">
<title>Crystal structure of the human anterior gradient protein 3.</title>
<authorList>
<person name="Nguyen V.D."/>
<person name="Ruddock L.W."/>
<person name="Salin M."/>
<person name="Wierenga R.K."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.83 ANGSTROMS) OF 24-166</scope>
</reference>
<comment type="function">
<text evidence="2">Required for calcium-mediated regulation of ciliary beat frequency and mucociliary clearance in the airway. Might be involved in the regulation of intracellular calcium in tracheal epithelial cells.</text>
</comment>
<comment type="subunit">
<text evidence="3">Interacts with LYPD3 and DAG1 (alphaDAG1).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3925742"/>
<interactant intactId="EBI-359299">
<id>O75477</id>
<label>ERLIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3925742"/>
<interactant intactId="EBI-347978">
<id>P37198</id>
<label>NUP62</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3925742"/>
<interactant intactId="EBI-347996">
<id>O43765</id>
<label>SGTA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3925742"/>
<interactant intactId="EBI-741480">
<id>Q9UMX0</id>
<label>UBQLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3925742"/>
<interactant intactId="EBI-10173939">
<id>Q9UMX0-2</id>
<label>UBQLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3925742"/>
<interactant intactId="EBI-947187">
<id>Q9UHD9</id>
<label>UBQLN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="5 8">Endoplasmic reticulum</location>
</subcellularLocation>
<text evidence="11">Found in the cytoplasm, which could include the endoplasmic reticulum.</text>
</comment>
<comment type="tissue specificity">
<text evidence="8 9">Expressed in the lung, in the ciliated cells of the airway epithelium (PubMed:25751668). Expression increased with differentiation of airway epithelial cells (PubMed:25751668). Not detected in the mucous cells (PubMed:25751668). Expressed in ciliated cells in the oviduct (PubMed:26170690). Also detected in stomach, colon, prostate and liver (PubMed:25751668). Expressed in breast, ovary, prostate and liver cancer (PubMed:26170690). Expression is associated with the level of differentiation of breast cancer (at protein level) (PubMed:26170690).</text>
</comment>
<comment type="induction">
<text evidence="6 7 8">Not induced as part of the cellular response to endoplasmic reticulum stress (PubMed:25751668). Up-regulated by androgens and by estrogens in prostate cancer cells (PubMed:23294566) Up-regulated by a hormone (estrogen-receptor alpha) independent mechanism in ovarian cancer (PubMed:22361111).</text>
</comment>
<comment type="similarity">
<text evidence="10">Belongs to the AGR family.</text>
</comment>
<dbReference type="EMBL" id="AY069977">
<property type="protein sequence ID" value="AAL55402.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY359065">
<property type="protein sequence ID" value="AAQ89424.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH236948">
<property type="protein sequence ID" value="EAL24282.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471073">
<property type="protein sequence ID" value="EAW93685.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC058284">
<property type="protein sequence ID" value="AAH58284.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5365.1"/>
<dbReference type="RefSeq" id="NP_789783.1">
<property type="nucleotide sequence ID" value="NM_176813.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005249684.1">
<property type="nucleotide sequence ID" value="XM_005249627.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.100686"/>
<dbReference type="PDB" id="3PH9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="A/B=24-166"/>
</dbReference>
<dbReference type="PDBsum" id="3PH9"/>
<dbReference type="ProteinModelPortal" id="Q8TD06"/>
<dbReference type="SMR" id="Q8TD06"/>
<dbReference type="BioGrid" id="127586">
<property type="interactions" value="17"/>
</dbReference>
<dbReference type="IntAct" id="Q8TD06">
<property type="interactions" value="17"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000308606"/>
<dbReference type="iPTMnet" id="Q8TD06"/>
<dbReference type="PhosphoSitePlus" id="Q8TD06"/>
<dbReference type="BioMuta" id="AGR3"/>
<dbReference type="DMDM" id="66774045"/>
<dbReference type="MaxQB" id="Q8TD06"/>
<dbReference type="PaxDb" id="Q8TD06"/>
<dbReference type="PeptideAtlas" id="Q8TD06"/>
<dbReference type="PRIDE" id="Q8TD06"/>
<dbReference type="DNASU" id="155465"/>
<dbReference type="Ensembl" id="ENST00000310398">
<property type="protein sequence ID" value="ENSP00000308606"/>
<property type="gene ID" value="ENSG00000173467"/>
</dbReference>
<dbReference type="GeneID" id="155465"/>
<dbReference type="KEGG" id="hsa:155465"/>
<dbReference type="UCSC" id="uc003sts.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="155465"/>
<dbReference type="DisGeNET" id="155465"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000173467.8"/>
<dbReference type="GeneCards" id="AGR3"/>
<dbReference type="HGNC" id="HGNC:24167">
<property type="gene designation" value="AGR3"/>
</dbReference>
<dbReference type="HPA" id="HPA053942"/>
<dbReference type="MIM" id="609482">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8TD06"/>
<dbReference type="OpenTargets" id="ENSG00000173467"/>
<dbReference type="PharmGKB" id="PA162375917"/>
<dbReference type="eggNOG" id="ENOG410IWAH">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4111K70">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063273"/>
<dbReference type="HOGENOM" id="HOG000231100"/>
<dbReference type="HOVERGEN" id="HBG006516"/>
<dbReference type="InParanoid" id="Q8TD06"/>
<dbReference type="KO" id="K20357"/>
<dbReference type="OMA" id="AQNNFIM"/>
<dbReference type="OrthoDB" id="EOG091G0RHV"/>
<dbReference type="PhylomeDB" id="Q8TD06"/>
<dbReference type="TreeFam" id="TF321449"/>
<dbReference type="GeneWiki" id="AGR3"/>
<dbReference type="GenomeRNAi" id="155465"/>
<dbReference type="PRO" id="PR:Q8TD06"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000173467"/>
<dbReference type="CleanEx" id="HS_AGR3"/>
<dbReference type="ExpressionAtlas" id="Q8TD06">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8TD06">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0002162">
<property type="term" value="F:dystroglycan binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060548">
<property type="term" value="P:negative regulation of cell death"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="InterPro" id="IPR036249">
<property type="entry name" value="Thioredoxin-like_sf"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52833">
<property type="entry name" value="SSF52833"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="21"/>
</location>
</feature>
<feature type="chain" description="Anterior gradient protein 3" id="PRO_0000001040">
<location>
<begin position="22"/>
<end position="166"/>
</location>
</feature>
<feature type="short sequence motif" description="Prevents secretion from ER" evidence="5">
<location>
<begin position="163"/>
<end position="166"/>
</location>
</feature>
<feature type="mutagenesis site" description="Leads to Golgi localization;." evidence="5">
<location>
<begin position="163"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="33"/>
<end position="35"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="48"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="62"/>
<end position="66"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="72"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="85"/>
<end position="93"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="96"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="107"/>
<end position="109"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="116"/>
<end position="122"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="145"/>
<end position="147"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="148"/>
<end position="159"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PH9"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8R3W7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12592373"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18086916"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22361111"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23294566"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25751668"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26170690"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000305"/>
<evidence key="11" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="26170690"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:24167"/>
</source>
</evidence>
<sequence length="166" mass="19171" checksum="B1A4804B47705D65" modified="2002-06-01" version="1" precursor="true">
MMLHSALGLCLLLVTVSSNLAIAIKKEKRPPQTLSRGWGDDITWVQTYEEGLFYAQKSKK
PLMVIHHLEDCQYSQALKKVFAQNEEIQEMAQNKFIMLNLMHETTDKNLSPDGQYVPRIM
FVDPSLTVRADIAGRYSNRLYTYEPRDLPLLIENMKKALRLIQSEL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>